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Abstract
Interest in the human microbiome has risen quickly in recent years as the microbes
that live in and on our body have been implicated in a growing number of human health
and disease states. This interest has been supported by advances in DNA sequencing
technology that have allowed us to obtain vast amounts of sequence data, and yet we
have diﬃculty assigning function to many of the gene sequences obtained. As research
on the role of these microorganisms continues, there will be an increased need for high-
throughput methods that can provide knowledge of microbial gene function. Functional
metagenomics is one such method, and it relies on ﬁrst cloning environmental DNA
to generate metagenomic libraries that are maintained in Escherichia coli and second,
screening the cloned DNA for particular functions of interest. This powerful function-
ﬁrst method allows for the isolation of genes whose role may not have been predicted
using DNA sequence homology. This thesis describes the analysis of techniques used in
functional metagenomics research, as well as the development of new strategies to aid
in functional screening of metagenomic libraries, particularly those constructed from
gut-derived DNA. The work is divided into four data chapters that each explore a
distinct aspect of the functional metagenomics approach.
The ﬁrst data chapter describes the evaluation of a pooled strategy for sequenc-
ing cosmid clones that were previously isolated in functional screens of metagenomic
libraries. Ninety-two large-insert clones were pooled for Illumina-sequencing and the
assembled sequence data were evaluated against reference sequence data that were ob-
tained from individual barcoded Illumina sequencing of the same clones. The results
indicated that a pooled strategy works well provided that suﬃcient sequencing depth
is obtained and that pooled clones do not share sequence similarity to the extent that
would be problematic for assembly of short reads that derive from those clones.
The second data chapter is an exploration of possible causes for the known cloning
bias of metagenomic libraries, by comparing environmental DNA before cloning to the
DNA cloned in the ﬁnal metagenomic library in E. coli. For a human gut metagenomic
library, DNA was sampled and Illumina-sequenced at three diﬀerent steps during the
construction of the library. Analyses of the sequence data showed that there was indeed
major bias in the ﬁnal library, but that the bias was not due to fragmentation of the
DNA during the cloning process as has been previously suggested; rather, the data
were consistent with alternative hypotheses that suggest bias occurs after the DNA is
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introduced into E. coli, and analyses provide support for the hypothesis that spurious
transcription of foreign DNA in E. coli may be contributing to the bias of libraries.
Bias was also examined for a soil metagenomic library using 16S rRNA gene sequencing
and though broad phylum-level biases were not as severe as observed for the human
gut library, analyses revealed a bias in the relative abundance of individual OTUs.
The third data chapter describes eﬀorts to develop Bacteroides thetaiotaomicron
(B. theta) VPI-5482 as a surrogate host for screening metagenomic libraries constructed
from human gut-derived DNA. In this strategy, metagenomic libraries that have been
constructed in E. coli can be transferred to B. theta using triparental conjugation. A
member of the Bacteroidetes was chosen to speciﬁcally address the likely barrier to
gene expression in E. coli of DNA that originates from this phylum. To allow the
library to be replicated in B. theta, a B. theta-compatible library cloning vector was
constructed, and this vector was used to generate genomic and metagenomic clone
libraries. A metagenomic library was successfully screened in B. theta, leading to
functional complementation of a B. theta mutant strain unable to grow on chondroitin
sulfate as sole carbon source. However, further examination of the complemented clones
indicated that the library clone DNA had integrated into the B. theta mutant genome.
To address this problem, an alternative method for screening was devised, and although
this method demonstrates that screening in B. theta remains feasible, more work is
required to optimize the conjugation eﬃciency and the level of throughput.
The fourth and last data chapter is an exploration of the use of transcriptional ter-
minator elements in library cloning vectors, inspired by the results of previous chapters.
Two unidirectional transcriptional terminators were added to a copy number-inducible
fosmid vector, ﬂanking the cloning site, with the intention of reducing insert-born
transcription into the vector backbone. The terminators were tested using a reporter
gene to conﬁrm their functionality in this context, and derivative vectors were gener-
ated for future testing of whether or in what contexts terminators may help alleviate
cloning bias in metagenomic libraries. The work described in this thesis contributes
to method advancement for functional metagenomics through the analysis of a cost-
eﬀective strategy for sequencing library clones, the examination of potential causes of
sequence bias in metagenomic libraries, the development of a surrogate host for more
productive functional screening, and the consideration of vector elements that may
improve metagenomic library stability in E. coli .
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1.2 Abstract
Interest in the human microbiome has risen quickly in recent years as technological
advancements have allowed us to explore the microbial world in unprecedented depth,
and the gut environment in particular has attracted much attention. The interaction
between the human host and their microorganisms begins at birth, varies between in-
dividuals, and ﬂuctuates throughout life with environmental inﬂuences such as diet.
These microbes contribute to our health, but have also been implicated in various dis-
ease states through an altered composition of microbiota although causal links for many
have yet to be shown. Moving from more correlative studies to those providing explana-
tory mechanisms will likely require a broader knowledge of microbial gene function, as
many genes identiﬁed from shotgun metagenomic sequencing datasets lack a sequence
homology-based functional annotation, interfering with our ability to understand the
role of the microorganisms present as a whole. To address this lack in knowledge will
require high-throughput methods to mine genes using a function-ﬁrst approach, al-
lowing function to be determined for those genes whose function could not have been
predicted using sequence homology. Functional metagenomics is one such method, in
which DNA is isolated from environmental samples, cloned en masse, and screened for
particular enzymatic activities. This thesis describes the analysis and development of
methods to advance functional metagenomics, particularly for study of the human gut
microbiome.
3
CHAPTER 1. INTRODUCTION
1.3 Interest in the human microbiome
Over the past couple of decades, there has been mounting interest in the human micro-
biome, that is, the community of microorganisms living on and in the human body and
the host environment with which they interact [171]. The microorganisms themselves
are distinctly referred to as the microbiota [199]. The productivity in this research area
has been largely due to technological advances in DNA sequencing, allowing researchers
to deep-sequence DNA samples isolated from various parts of the body. This requires
isolating the metagenomic DNA of these environments – a term originally coined by Jo
Handelsman during studies of soil microorganisms that refers to the collective genomic
DNA from an environmental sample [118].
Metagenomic methods are crucial in studies of the human microbiome, as many
of these organisms may not be easily cultured using standard laboratory techniques.
Some estimates of the fraction of uncultured bacteria in oliogtrophic environments have
been as high as 99% [242,319]; in the nutrient-rich system of the gastrointestinal tract,
however, previous studies have cited 50% uncultivated taxa in the stomach (2006)
[22], 80% in the distal intestine (2006) [102], and 70% in the oral cavity (2010) [60].
Although these taxa are occasionally referred to as “unculturable” [242], recent reports
have challenged this idea with the isolation hundreds of species from the human gut,
including novel ones, using carefully designed and comprehensive culturing techniques
[109,163,319].
In 2007, with growing interest in the scientiﬁc community and funding from the
NIH, the Human Microbiome Project (HMP) was inititated – a ﬁve-year, ✩150 million
collaborative endeavour to characterize various human microbial communities, target-
ing the skin, oral cavity, nasal cavity, vagina, and gastrointestinal tract [233]. Today,
the list of body sites has expanded to include other body parts, such as the urogenital
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tract, with the goal of providing 3,000 reference genomes, either sequenced or collected
from public databases. The majority of these genomes will be sequenced only to a
high-quality draft stage, which is the second of six possible stages of completion, as
provisionally deﬁned by the HMP Consortium. To be considered high-quality, the
draft sequence must, among other requirements, have >90% of the genome included in
contigs ≥500 bp, with >90% of bases at >5Ö read coverage, and >90% of Bacterial
“core genes” present. At the moment, the HMP has ∼1,700 bacterial reference genomes
either ﬁnished or in progress.
1.4 The human gut microbiome
A fact often given to illustrate the importance of the human microbiome is that micro-
bial cells outnumber human cells by at least a factor of 10, and their genes outnumber
human genes by at least a factor of 100 [102, 253], although a more recent study has
countered this widely cited claim with estimates that the bacterial cell to human cell
ratio is in fact closer to one-to-one [260]. Regardless of the precise number, it is indis-
putable that microorganisms occupy our body sites where they play an important role;
of all human microbiomes, the gut seems to have attracted the most research interest,
likely because the vast majority of the microbes we harbour reside in the gastroin-
testinal tract, particularly in the distal gut where they aid in host metabolism [102]
and inﬂuence host immunity [176, 246]. To determine which organisms form the mi-
crobiota, and in what proportion, the culture-independent approach of 16S rRNA gene
sequencing is often used – sequencing either the full 16S rRNA gene length or one of
the hypervariable regions. Typically, though somewhat arbitrarily, cut-oﬀs of 95% and
97-98% identity are used to deﬁne Genus and Species (or Operational Taxonomic Unit,
OTU), respectively [12].
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1.4.1 Initial colonization
The gastrointestinal tract of a newborn is sterile and, in a vaginal birth, the mother’s
microbes serve as the initial inoculum for the newborn, along with other external con-
tacts that may take place during birth. Initial colonizing bacteria are facultative,
lowering the redox potential of the environment, allowing strict anaerobes to ﬂour-
ish [150]. Later in life, other microorganisms are introduced; for example, with the
ingestion of food, bacterial survival through the acidic environment of the stomach is
aided by the rise in pH immediately following a meal [170]. Interestingly, studies have
suggested that birthing via caesarean section may have negative consequences. For ex-
ample, compared to infants delivered vaginally, initial colonization of the gut of infants
delivered by C-section was delayed, with persisting diﬀerences in microbiota composi-
tion. In addition, infant immune function may be aﬀected due to lack of exposure to
microorganisms [145].
With weaning and the introduction of solid food, the next major community
succession brings an increase in Bacteroidetes and Firmicutes, the dominant phyla of
the adult gut [145]. One study tracked the developing gut microbiota of an infant,
delivered vaginally, for the ﬁrst 2.5 years of life and found, as one might expect, that
changes in composition were associated with life events [156]. For instance, the early
microbiota provided lactate utilization functions, and later additions provided functions
for plant polysaccharide metabolism.
1.4.2 Diversity, variability, and individuality
Though the human gut harbours higher bacterial density than any environment, its
diversity is low when compared to that of soil [12], with fewer bacterial phyla repre-
sented [325]. Generally, the dominant phyla in the human gut are by far the Bac-
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teroidetes and Firmicutes, followed by a much smaller representation of the Proteobac-
teria, and then others [288]. Despite being from only a handful of phyla, it is estimated
that more than one thousand species are present in the human gut [164], although
there can be substantial diﬀerences between individuals [310]. As one might expect,
the diversity of the gut mcrobiota is greatly aﬀected by environmental factors; diet in
particular is very important in inﬂuencing gut microbial diversity [55]; such changes
may reﬂect the diﬀerent metabolic specializations of microbial species [288], and there
is evidence that certain taxa can be lost over time with a long-term diet that is low
in ﬁbre [284]. There have been eﬀorts to try to classify the microbiota of individuals
into groups, called “enterotypes” [8,338], although more recent work has acknowledged
that discrete groups may not exist and that variation in the microbiota appears to be
continuous [155].
Interestingly, one study attempted to use the microbiota from various body sites
of individuals as an identifying “code”, and found that the majority of microbiota
codes collected from the same individuals 30-300 days later uniquely identiﬁed their
host in a group of 120 people [93], suggesting remarkable potential stability of the
microbiota within an individual. Such ﬁndings naturally lead to the question of whether
host genotype can inﬂuence the composition of the microbiota. Although twin studies
have had conﬂicting results and suggest that any eﬀect of host genotype inﬂuence on
the microbiota is likely small, more systematic studies in mice suggest that there are
signiﬁcant associations between variations in certain host loci and variation in microbial
taxa, with most loci being involved in immunity and some in metabolism [288]. Future
genome-wide association studies are required, treating the gut microbiota composition
as a phenotype, to elucidate the relationship between variation in host genotype and
variation in the gut microbiota.
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Beyond environmental and host inﬂuences, there is still a substantial amount
of variability in gut microbial composition that appears to be random [288], which
may confound association studies. Rather than trying to assess variation by looking
at taxonomic compositions, it may be more informative to focus on the functional
composition. In one study, it was found that in lean individuals, despite a large variation
in microbial community, there existed a core gut microbiota at the functional level,
and deviations from this core were associated with obesity [309]. This emphasizes
the importance of a function-based viewpoint with respect to studies of the human
microbiome.
1.4.3 Mutualism between host and microbiota
The microorganisms comprising the microbiota have in the past often been described
as “commensals”, but such a label is misleading as more evidence suggests that host-
microbiota interactions tend to be mutualistic in nature [12]. The microbiota in the
gut possess a large arsenal of enzymes for breaking down complex polysaccharides
in the human diet and they contribute about 10% of the calories that are absorbed
[72]. Interestingly, diﬀerences in the gut microbiota between individuals can lead to
diﬀerences in the capacity to obtain energy from ingested food [311], and in addition
to contributing calories, the microbiota have also been shown to be involved in the
promotion of fat storage host adipocytes [11]. Although such consequences may be
undesirable in this age, they may have been very advantageous to our ancestors in
earlier times when food was much more scarce.
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While we do not necessarily need the additional calories provided by our resi-
dent microbes, colonocytes primarily use bacterially produced butyrate as an energy
source, and in its absence, these cells suﬀer from an energy deﬁcit that leads them to
degrade their own cellular components for survival [67]. This illustrates the impor-
tant mutualistic relationship that hosts have evolved over time with the microbiota,
leading to dependence on microbial metabolites. In some cases, the host may even
require metabolites; for example, germ-free mice raised without gut microbes require
supplementation of vitamin K and some forms of vitamin B [130]. The gut microbiota
produce metabolites that otherwise would not be circulating in the body and they also
change the concentrations of some that are produced [332]. Interestingly, a number of
metabolites that are predicted to be produced by the microbiota are currently used as
drugs, suggesting that many of these metabolites may be bioactive [134]. While the
vast number of small molecules produced by the microbes in the gut at high micromolar
concentrations remain to be identiﬁed, some are likely to be relevant for pharmaceutical
applications once their roles in human physiology are elucidated [66].
In addition to producing drug-like compounds, resident microbes may also af-
fect orally ingested drugs, a fact that can lead to unexpected consequences in health
care. In one study that examined urine metabolites of the widely used painkiller ac-
etaminophen, it was found that there were diﬀerences between individuals in the ratio
of two metabolites, acetaminophen glucuronide and acetaminophen sulfate, and the dif-
ference was attributed to bacterially produced compounds that compete for sulfonation
in the gut [46]. Another study in which the eﬃcacy of a statin used in the treatment
of high cholesterol was examined, researchers found that diﬀerences in eﬃcacy between
individuals correlated with gut-derived metabolites [140]. Interestingly, a case in which
the mechanism of drug metabolism was actually demonstrated was that for Eggerthella
lenta inactivating the drug digoxin, which is used in the treatment of cardiac disease:
9
CHAPTER 1. INTRODUCTION
a strain of E. lenta was known to inactivate the drug in vitro, and RNA-seq analysis
revealed that exposure to digoxin led to upregulation of an operon containing two genes
predicted to be cytochromes capable of using digoxin as an electron acceptor, and that
the presence of this operon was higher in the guts of individuals that showed a high
level of inactivation of the drug [116]. These examples illustrate the important and
likely under-appreciated inﬂuence of the gut microbiota on host drug metabolism.
1.4.4 Disease and the gut microbiota
Given that the host and the microbiota share such a close interaction, it would seem
to follow that in some situations, they may be able to cause harm, and indeed, mi-
crobes with whom the host participates in mutualism can sometimes take on the role of
pathogen [103]. In straightforward examples, opportunitistic pathogens may traverse
through broken barriers in the host such as wounds in the skin or perforations in the
lining of the gut [328]. Mutualistic organisms may also incidentally aid the virulence
of pathogens by generating metabolites such as sugars [53], or perhaps by harbouring
a reservoir of antibiotic resistance genes that can potentially spread to more serious
pathogens, although evidence suggests there may be barriers to the general transfer of
these genes among members of the microbiota [283].
Interestingly, there is a growing list of disease states that appear to be associated
with a change in the composition of the gut microbiota. For example, in both Type I
diabetic and obese individuals, the ratio of Firmicutes to Bacteroidetes has been shown
to be altered. With obesity, there appears to be an increase in the relative abundance
of Firmicutes [104]; the reverse is true for diabetes, in which there is both an increase
in Bacteroidetes and a decrease in Firmicutes as children become autoimmune [311].
Though these descriptions of the changing gut microbiota are very broad, it has been
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suggested that they may prove to be useful as diagnostic markers, for example, to
identify infants at high risk for onset of Type I diabetes.
A number of other GI-related disease states have also been shown to be associated
with changes in the microbiota, such as colorectal cancer [198,281], Type II diabetes [90,
322], and inﬂammatory bowel disease [92], including Crohn’s Disease [78, 196]. Other
non-gastrointestinal diseases have also implicated the microbiota, such as cardiovascular
disease [129], allergies [96], multiple sclerosis [19], and neurodevelopmental disorders
such as autism spectrum disorder [131]. There have also even been suggestions that
the microbiota may be involved in behavioural or mood disorders [91]. The many
health conditions in which the microbiota also vary are perhaps not surprising as the
microbes in the gut have been recognized for their importance in host immunity [246].
The interaction between an individual and their gut microbiota is a complex one, in
which both partners may inﬂuence the other. Though fascinating, the exact relationship
between certain disease states and their altered microbiota remains to be elucidated [83].
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1.5 Challenges in metagenomics and microbiome
research
The gut microbiome has recently become a hot topic in the popular media even as the
scientiﬁc community struggles to understand the speciﬁcs of how the microbiota con-
tribute to human health and disease. Challenges in the metagenomics and microbiome
ﬁelds tend to fall into two broad areas.
1.5.1 Correlation versus causation
The use of antibiotics leading to reduced diversity in the gut microbiota has been
blamed by some for many diﬀerent conditions [23] and while there is likely some truth
to the idea that widespread antibiotic use has had broad unexpected consequences,
more work is required to tease apart the many factors that contribute to complex
diseases. Furthermore, although certain disease states appear to be associated with
a change in the composition of microbiota based on 16S rRNA gene sequencing, the
exact mechanisms will need to be determined before causality can be ascribed. Even
gene function-based analyses of sequence data [189,234], although extremely useful for
generation of hypotheses, are in themselves merely correlative as there are many factors
that can inﬂuence the expression of genes in a given system, including physical linkage
to other genes as well as environmental and cell-to-cell interactions [2]. Knowledge
pertaining to these levels of regulation will need to be integrated for the generation of
meaningful and biologically relevant models of the microbiota.
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Thus, a current challenge in metagenomics and microbiome research is moving
beyond survey-type, correlation studies, and incorporating methods that allow causal-
ity to be determined [2], including biochemistry, genetics, and, generally, controlled
hypothesis-driven experiments [256], for example using enrichment cultures or cultures
of a subset of the microbiota. Recent eﬀorts to array cultured isolates from the human
gut microbiota combined with culture of these microbes in gnotobiotic mice [109] al-
low for tractable, combinatorial approaches to systematic identiﬁcation of organisms or
groups of organisms that result in speciﬁc phenotypes in the host [82]. These types of
methods will likely be critical in determining whether, in which direction, and to what
extent these relationships are causal.
1.5.2 Informatics and sequence data annotation
The HumanMicrobiome Project, along with other large-scale sequencing-heavy projects,
illustrate the power of today’s high-throughput, low-cost sequencing technology in aid-
ing our study of these previously underappreciated microbial communities, as well as
making such studies feasible for smaller laboratories. However, a 2011 review discussed
the limitations of the current shotgun sequencing approach [293], arguing that genomes
could only be assembled for the most dominant members of a complex community, cit-
ing previous work in the Sargasso Sea [315], and that the probability of capturing rare
organisms, such as methylotrophs, is low [223].
The generation of large amounts of sequence data across many diﬀerent labs
leads to many practical issues not discussed here but which include requiring an op-
timized/standardized work pipeline, large quantities of computer memory as well as
databases, high-quality analytical tools, and trained bioinformaticians [292]. Beyond
these issues lies an additional hurdle which must happen after obtaining genomes or
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metagenomes from a sequencing project: the functional annotation of genes. The
research community has recognized the need for easily accessible and user-friendly
computational tools to aid in the analysis of metagenomic sequence data, and many
stand-alone or web-based tools and databases, such as MG-RAST [211, 334], have be-
come available. To carry out automated functional assignments, these software use
homology-based annotation, comparing metagenomic sequences to existing protein and
nucleotide databases.
One obvious pitfall in a sequence homology-based strategy is genes that are similar
in function but dissimilar in sequence to known genes cannot be annotated. Further-
more, the case may very likely be that we currently simply have not amassed enough
sequences of known function to be able to accurately and thoroughly annotate new sets
of sequences. For example, in a 2007 dataset of 480 Mb of gut metagenomic sequence
data and a predicted 660,000 genes from 13 individuals [161], more than one-half of pre-
dicted genes could not be assigned to a Cluster of Orthologous Groups (COG) [300,301]
and therefore could not be given a functional assignment. Indeed, a 2015 US-initiated
call for a Uniﬁed Microbiome Initative has emphasized the need for characterizing genes
with currently unknown function [2]. Although there are computational approaches to
improve functional annotation of genes, such as inference of gene function from operon
rearrangements [217], it is becoming increasingly necessary to complement sequence-
based approaches with high-throughput approaches that provide proof-of-function for
genes, to obtain the information necessary to carry out functional annotation. To iden-
tify novel genes whose functions may not be predicted from their sequence alone, a
functional metagenomic approach can be used.
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1.6 Functional metagenomics
In general, use of the term “functional metagenomics” implies a very speciﬁc function-
based “wet-lab” methodology, herein described. Although the term is occasionally
co-opted to mean something diﬀerent – for example, to mean sequence-based metage-
nomics with a focus on gene function [62, 244] or even completely redeﬁned to mean
the study of functional members of the microbiota that inﬂuence human health [183]
– such uses are rare in the scientiﬁc literature. In this section, a brief introduction to
the overall methodology and its advantages is provided, setting the context for subse-
quent chapters of this thesis, in which various aspects of the functional metagenomic
approach are described in greater detail.
1.6.1 General methodology
Functional metagenomics is an experimental approach that involves isolating DNA
from microbial communities to study the functions of proteins encoded by that DNA,
typically through cloning DNA fragments, expressing genes in a surrogate host, and
screening for enzymatic activities of interest. Using such a function-based approach
can be powerful for the discovery of novel enzymes whose functions could not have
been predicted based on DNA sequence alone. New information from function-based
analyses can then be used to annotate genomes and metagenomes derived solely from
sequence-based analyses. In this way, functional metagenomics complements sequence-
based metagenomics, analogous to how molecular genetics of model organisms has
provided knowledge of gene function that has been widely applicable in genomics.
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Figure 1.1: Summary of metagenomic library construction. Steps involved in the construc-
tion of a metagenomic library, from original environmental sample to the ﬁnal library in the E. coli
host. Adapted from [166].
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Functional metagenomics begins with the construction of a metagenomic library,
the steps of which are summarized in Figure 1.1. Cosmid- or fosmid-based libraries
are preferred due to their large and consistent insert size and high cloning eﬃciency.
DNA is extracted from the environmental sample of interest, such as soil or feces.
After DNA is extracted from the sample, it is then size-selected through pulsed-ﬁeld
gel electrophoresis to enrich for high-molecular weight fragments. The fragments are
subsequently end-repaired and ligated to a linearized and blunt-ended cos-based vector.
The ligation mixture is then packaged into λ phage heads through recognition of the cos
site, and the phage are used to transduce E. coli to generate the metagenomic library
(Figure 1.1). The library contains relatively large insert DNA, typically 25 to 40 kb
for cos-based vectors. There are two major advantages to using a cos-based vector and
phage transduction to construct clone libraries: the high eﬃciency of transduction as
well as the reduced likelihood of insert concatemers.
Once the metagenomic library has been constructed in E. coli , functional screen-
ing can be carried out. In the most straightforward approach, screening of the library
can be done in the same E. coli host in which library construction took place. For ex-
ample, to isolate clones conferring antibiotic resistance genes, the host cells can simply
be plated on selective media containing antibiotics (Figure 1.2). This example, while
simple, has been useful for exploring the antibiotic resistance gene reservoir harboured
by our gut microbiota. Interestingly, in one study, it was found that resistance genes
isolated through a culture-independent approach were substantially more novel com-
pared to those that had been isolated through an aerobic culture-dependent approach,
with on average, ∼61% versus ∼90% identity at the nucleotide level to the best hit in
Genbank, respectively [283]. As this example illustrates, functional screening in E. coli
can be productive, although there may be limitations.
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E. coli carrying clone with 
antibiotic resistance gene
E. coli carrying clone without 
antibiotic resistance gene
Media containing antibiotic
Figure 1.2: Example of a functional screen in E. coli . The library in E. coli
is plated onto media with antibiotics to select for library clones that confer resistance.
Screening in hosts other than the E. coli library host, however, may provide ad-
ditional hits from functional screens due to possible diﬀerences in elements required
for gene expression between the original organism and E. coli . Though it is arguably
diﬃcult to quantify, one estimate of how much of the metagenome is accessible by
screening in E. coli is 40%, based on analysis of 32 genomes from diﬀerent bacteria
and archea, counting ORFs with ribosome-binding sites and promoters that would be
recognized in E. coli [97]. The fraction of “inaccessible” genes depends of course on the
particular environmental DNA sample. Regardless, to address this problem, metage-
nomic libraries can be transferred from the E. coli library host to other surrogate hosts
that may be more suitable for screening; this may be done eﬃciently using conjugation
or, if the recipient species is amenable, transformation or electroporation. The issue of
possible barriers to transcription and translation in E. coli is a particularly important
methodological limitation in functional metagenomics and will be discussed in greater
detail below and in subsequent chapters.
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1.6.2 The power of a function-based approach
In this section, several examples from the scientiﬁc literature have been speciﬁcally
chosen to highlight the strengths of a functional metagenomics approach.
Avoiding sequence-based biases
Functional metagenomics oﬀers an avenue to ﬁnding novel proteins by functional en-
richment or selection of metagenomic material. For example, one study identiﬁed three
clones from activated sludge and soil samples that each carried novel genes of a luxI-
luxR-type quorum sensing system [119]: when these gene sequences were compared to
the NCBI protein database, the novel luxI and luxR genes had only ∼30-50% similarity
to known lux proteins. It may be diﬃcult to predict the function of genes with such
low sequence similarity, illustrating the utility of a function-based approach.
In another study, the authors screened soil libraries containing a total of 3.6×109
bp for antibiotic resistance genes, and identiﬁed clones conferring resistance to ampi-
cillin, gentamicin, chloramphenicol, and trimethoprim [307]. Of particular interest was
the discovery of a novel trimethoprim resistance gene. Trimethoprim inhibits the en-
zyme dihydrofolate reductase (DHFR), and resistance to it is most commonly conferred
by a mutant DHFR. However, the authors found that their trimethoprim resistance gene
was very diﬀerent from known dhfr genes; from biochemical analyses, it was found to
be distinctly diﬀerent in its mechanism and properties, and was therefore deemed to
represent a novel group of DHFRs. Furthermore, its closest matches were to reductases
involved in lipid metabolism, not dhfr genes, illustrating that function cannot always
be surmised from sequence alone. Currently, we simply may not have enough data to
functionally annotate new sequences accurately.
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Enrichment of desired sequences
Not only can functional selections ﬁnd novel proteins, they can also greatly reduce the
sheer quantity of genetic material to be sequenced. In one study, a high-throughput
functional metagenomic approach was used to ﬁnd enzymes in the human gut involved
in dietary ﬁber catabolism, reducing the amount of metagenomic DNA to be sequenced
from 5.4×109 bp to 8.4×105 bp, a reduction of almost four orders of magnitude, simply
by selecting for the growth of library clones on diﬀerent polysaccharides [299]. Using
this approach, the authors identiﬁed 73 carbohydrate-active enzymes, corresponding
to a ﬁve-fold enrichment in the target-gene identiﬁcation over random sequencing. If
enrichment can be performed prior to sequencing, a great deal of time and resources
can be saved, not to mention the value of having experimental data regarding function.
High-throughput functional screening strategies
In addition to straightforward functional screens, it is possible to design more complex
screens that can still be high-throughput. An example of such a screen was one car-
ried out to identify metagenomic clones that could modulate NF-κB activity in human
intestinal epithelial cells [164]. NF-κB is a transcription factor involved in immunity
and inﬂammation in the gut. Using a reporter system in human cells, they screened
over 2,600 clones and identiﬁed 171 clones that either up- or down-regulated NF-κB in
human cells. They went on to analyze one stimulatory clone, using transposon muta-
genesis to identify two genes necessary for the stimulatory eﬀects. These genes were
predicted to encode a permease and putative lipoprotein, which allowed the authors to
surmise a putative mechanism for the clone’s modulatory activity. Again, there is an
important feedback loop to be appreciated here: functional annotations help function-
based studies, which in turn help future functional annotations, and so on.
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1.6.3 Important considerations
These several examples illustrate the wide applicability of functional screens. There are
important considerations, however, in undertaking a functional metagenomic approach.
First, consideration must be given to choosing an appropriate environment for the de-
sired target genes; for instance, a rumen sample from a grass-fed cow may be ideal for
generating a metagenomic library that is enriched with genes encoding enzymes for cel-
lulose degradation [108]. Second, an appropriate vector must be selected for the library
backbone, and the choice depends on various factors, such as whether a small-insert
or large-insert library is desired, and in the former case, whether expression vectors
would be advantageous to help drive gene expression in E. coli [141]. Third, surrogate
host(s) other than E. coli may be considered, for either an attempt to increase the hit
rate [302,312] or for the complementation of speciﬁc phenotypes [320]. Alternative ex-
pression hosts that have been used include Agrobacterium tumefaciens, Caulobacter vib-
rioides, Rhizobium leguminosarum, Ralstonia metallidurans, Pseudomonas fluorescens,
Pseudomonas putida, Xanthomonas campestris, Burkholderia graminis, Sinorhizobium
meliloti, and Bacillus subtilis [1, 50, 186,254,302,308,312].
Finally, other logistics in the screening strategy have to be considered, such as
whether to pool clones for screening or to instead keep clones arrayed and carry out indi-
vidual clone screening; in the latter case, the achievable throughput must be very care-
fully considered because, depending on the particular screen, clone-by-clone screening
may not be a feasible strategy, although the design of automated microﬂuidic screening
strategies is an exciting area of development [47, 313]. There are of course limitations
and biases in this method [71], as there are with all methods. Nevertheless, functional
metagenomics is a powerful experimental strategy that can help improve our under-
standing of the mechanisms that underlie biological phenomena as well as aid in the
functional annotation of the exponentially increasing number of metagenomes.
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1.7 Thesis outline
This thesis centres on methods to aid in the determination of gene function. The
objective of this work was to advance the methods used in functional metagenomics
research, through both the analysis of existing techniques as well as the development
of new strategies and systems for functional screening. The results of this work are
presented in four data chapters, each of which concerns a speciﬁc method or system:
❼ Chapter 3 evaluates the feasibility of using a pooled method for sequencing large-
insert metagenomic clones. A set of 92 clones, isolated from various functional
screens, was sequenced using Illumina in two ways: ﬁrst, experimentally as a
pool, and second, individually using barcodes. The latter was done to generate
reference data for evaluation of the former pooled strategy. The results from
pooled sequencing were analyzed for their accuracy and completeness to determine
whether such a strategy was worthwhile.
❼ Chapter 4 explores the sequence bias of a human gut metagenomic library, par-
ticularly the point at which bias is introduced during the cloning process. The
metagenomic DNA was sampled and sequenced at three points during library
construction, and the sequence data were analyzed for bias and potential causes.
❼ Chapter 5 describes the development of B. theta as a host for screening of
metagenomic libraries constructed from gut-derived DNA. A species from the
Bacteroidetes phylum was chosen to help combat the likely barrier to transcrip-
tion that may limit hit rates when screening gut metagenomic libraries in E. coli ,
as well as to open the door to new possibilities of phenotypes that can be com-
plemented. This chapter describes the modiﬁcation of vectors for use in B. theta;
the generation of B. theta-compatible clone libraries, including genomic as well
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as metagenomic libraries; and, importantly, the successful proof-of-principle func-
tional complementation of a B. theta polysaccharide degradation mutant using a
human gut metagenomic library.
❼ Chapter 6 concerns the transcriptional terminators that were designed into the
B. theta-compatible vector that was constructed for Chapter 5. This chapter pro-
vides the rationale for including the terminators; describes the design, synthesis,
and cloning of the fragment carrying the terminators; and presents the results of
testing the functionality of the terminators.
Though each data chapter above concerns a distinct topic, all are explorations of
various aspects of the function-based approach. Together, the work described in this
thesis furthers knowledge of the methods and techniques currently used in functional
metagenomics as well as those that may potentially be used in the future of this ﬁeld.
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2.2 Strains, plasmids, and oligonucleotides
2.2.1 Bacterial strains
All E. coli and Bacteroides strains used in this study are summarized in Table 2.1.
Genotypes and descriptions as well as literature references where applicable are pro-
vided for each strain. All strains can be found in the Charles Lab main frozen culture
collection. B. theta strains were archived as 25% glycerol stocks and E. coli strains
were archived as either 25% glycerol or 7% DMSO stocks.
2.2.2 Plasmids
All plasmids used in this study are summarized in Table 2.2. Descriptions and literature
references where applicable are provided for each plasmid. All plasmids can be found
in the Charles Lab E. coli frozen culture collection.
2.2.3 Oligonucleotide sequences
All oligonucleotides used in this study are summarized in Table 2.3. Descriptions and
DNA sequences are provided for each. Oligos were synthesized by either Integrated
DNA Technologies, Inc. or Bio Basic Inc. Lyophilized DNA was dissolved to a concen-
tration of 100 ➭M and stored at -20❽.
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Table 2.1: Bacterial strains used in this study.
Strain Genotype or description Ref./Source
E. coli DH5α F- supE44 ∆lacU169 hsdR17 recA1 endA1 gyrA96
(NxR) thi-1 relA1 (Φ80lacZ ∆M15)
[21]
E. coli EPI300 F- mcrA ∆(mrr-hsdRMS-mcrBC) Φ80dlacZ
∆M15 ∆lacX74 recA1 endA1 araD139 ∆(ara,
leu)7697 galU galK λ- rpsL (SmR) nupG trfA dhfr
Epicentre
E. coli HB101 F- mcrB mrr hsdS20 (rB- mB-) recA13 leuB6
ara-14 proA2 lacY1 galK2 xyl-5 mtl-1 rpsL20
(SmR) glnV44 λ-
[25]
E. coli S17-1 F- recA thi pro hsdR rspL (SmR)
RP4-2-Tc::Mu-aphA::Tn7 (KmS)
[88, 271]
E. coli S17-1 λ-pir λ lysogen of S17-1, providing pir protein required
for plasmids with R6K origin of replication
[271]
B. fragilis NCTC 9343 Bacteroides fragilis type strain; same as ATCC
25285
[126]
B. theta VPI-5482 Bacteroides thetaiotaomicron type strain; same as
ATCC 29148
[339]
B. theta BtUW24 VPI-5482 carrying deletion of tdk (BT 2275) [159]
B. theta BtUW25 BtUW24 carrying deletion of anSME (BT 0238);
anSME is also known as chuR
[17]
B. theta BtUW1 VPI-5482 thrC ::pKNOCK-bla-tetQ ; threonine
single recombinant auxotroph in BT 2401
This study
B. theta BtUW2 VPI-5482 trpD ::pKNOCK-bla-tetQ ; tryptophan
single recombinant auxotroph in BT 0530
This study
B. theta BtUW3 BtUW25 carrying presumably integrated clone
from BT3 genomic library designated chuR1
This study
B. theta BtUW4 BtUW25 carrying presumably integrated clone
from BT3 genomic library designated chuR2
This study
Continued on next page
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Table 2.1 – Continued from previous page
Strain Genotype/description Ref./Source
B. theta BtUW5 BtUW25 carrying presumably integrated clone
from BT3 genomic library designated chuR3
This study
B. theta BtUW6 BtUW25 carrying presumably integrated clone
from BT3 genomic library designated chuR4
This study
B. theta BtUW7 BtUW25 carrying presumably integrated clone
from BT3 genomic library designated chuR5
This study
B. theta BtUW8 BtUW25 carrying presumably integrated clone
from BT3 genomic library designated chuR6
This study
B. theta BtUW9 BtUW25 carrying presumably integrated clone
from BT3 genomic library designated chuR7
This study
B. theta BtUW10 BtUW25 carrying presumably integrated clone
from BT3 genomic library designated chuR8
This study
B. theta BtUW11 BtUW25 carrying presumably integrated clone
from BT3 genomic library designated chuR9
This study
B. theta BtUW12 BtUW25 carrying presumably integrated clone
from BT3 genomic library designated chuR10
This study
B. theta BtUW13 BtUW25 carrying presumably integrated clone
from BT3 genomic library designated chuR11
This study
B. theta BtUW14 BtUW25 carrying presumably integrated clone
from CLGM3 metagenomic library designated
chuR1
This study
B. theta BtUW15 BtUW25 carrying presumably integrated clone
from CLGM3 metagenomic library designated
chuR2
This study
B. theta BtUW16 BtUW25 carrying presumably integrated clone
from CLGM3 metagenomic library designated
chuR3
This study
Continued on next page
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Table 2.1 – Continued from previous page
Strain Genotype/description Ref./Source
B. theta BtUW17 BtUW25 carrying presumably integrated clone
from CLGM3 metagenomic library designated
chuR4
This study
B. theta BtUW18 BtUW25 carrying presumably integrated clone
from CLGM3 metagenomic library designated
chuR5
This study
B. theta BtUW19 BtUW25 carrying presumably integrated clone
from CLGM3 metagenomic library designated
chuR6
This study
B. theta BtUW20 BtUW25 carrying presumably integrated clone
from CLGM3 metagenomic library designated
chuR8
This study
B. theta BtUW21 BtUW25 carrying presumably integrated clone
from CLGM3 metagenomic library designated
chuR9
This study
B. theta BtUW22 BtUW25 carrying presumably integrated clone
5B2 from arrayed CLGM3 metagenomic library;
EPI300 clone from Plate 5 Row B, Well 2
This study
B. theta BtUW23 BtUW25 carrying presumably integrated clone
5B9 from arrayed CLGM3 metagenomic library;
EPI300 clone from Plate 5 Row B, Well 9
This study
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Table 2.2: Plasmids used in this study.
Plasmid Description Ref.
R751 Mobilizer plasmid used for triparental matings; TpR [137,212]
pRK2013 Mobilizer plasmid used for triparental matings; ColEI origin and
KmR (NmR)
[124]
pRK600 Derivative of pRK2013; KmR::Tn9; CmR [89]
pHC79 Cosmid vector derived from pBR322 [127]
pJC8 Cosmid vector with RK2 origin of replication; Genbank accession
KC149513
[43]
pAFD1 E. coli -Bacteroides shuttle vector with pUC origin of replication;
received from Nadja Shoemaker
[249]
pKNOCK-
bla-tetQ
B. theta suicide vector with E. coli R6K ori ; ApR in E. coli ; TcR
in B. theta
[200]
pJET1.2 Vector for blunt end PCR product cloning kit (Thermo Fisher
K1231); Genbank accession EF694056
[194]
pCC1FOS Copy-number inducible fosmid vector; Genbank accession
EU140751
Epicentre
pKL1 pAFD1 with cos sequence cloned in the BamHI site using BglII
fragment from pHC79; see Figure 5.8
This study
pKL2 pKL1 with polylinker between the EcoR1 and KpnI sites
(EcoR1-NotI-Eco72I-NdeI-KpnI linker); see Figure 5.8
This study
pKL3 pKL2 with gentamicin resistance stuﬀer cloned as Eco72I
fragment from pJC8; see Figure 5.8
This study
pKL4 pCC1FOS with gentamicin resistance stuﬀer cloned as Eco72I
fragment from pJC8; see Figure 5.12
This study
pKL5 pKL4 with RK2 oriT from pJC8 cloned in the HindIII site; see
Figure 5.12
This study
pKL6 pKL5 with ermF -repA fragment from pKL8 cloned in the EcoRI
site; see Figure 5.12
This study
Continued on next page
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Table 2.2 – Continued from previous page
Plasmid Description Ref.
pKL7 pKL6 with removal of the Eco72I stuﬀer carrying the gentamicin
resistance gene; see Figure 5.12
This study
pKL8 pJET1.2 with ermF -repA PCR product amplﬁed from pAFD1 This study
pKL9 pJET1.2 with synthesized transcriptional terminator (TT)
fragment; sequence veriﬁed
This study
pKL10A pKL7 with TT fragment blunt-end cloned in the Eco72I site of
pKL7; note that this clone has deletion of a single base A from
ilvGEDA terminator sequence; see Figure 6.5
This study
pKL10B pKL7 with TT fragment blunt-end cloned in the Eco72I site of
pKL7, in reverse orientation to pKL10A; note that this clone has
deletion of a single base A from ilvGEDA terminator sequence
This study
pKL11 pKL10 with the Eco72I stuﬀer removed; note that this plasmid
was constructed prior to determining that pKL10A had a deletion
of a single base A from the ilvGEDA terminator sequence
This study
pKL13 pKL7 with TT fragment blunt-end cloned in the Eco72I site of
pKL7; see Figure 5.12
This study
pKL14 pKL13 with removal of the Eco72I stuﬀer carrying Ptac and
gentamicin resistance gene; see Figure 6.9
This study
pKL15 pKL13 with GFPuv cloned in as PacI-SgsI fragment; see
Figure 6.7
This study
pKL16 pKL15 with removal of the PacI-NheI fragment containing the
transcriptional terminator (ilvGEDA TT) by double digestion,
blunting, and ligating; see Figure 6.7
This study
pKL17 pKL13 with ﬂipped Eco72I stuﬀer, so that Ptac driving
transcription in the opposite orientation to pKL13; see Figure 6.7
This study
pKL18 pKL17 with GFPuv cloned in as CpoI-SfaAI fragment; see
Figure 6.7
This study
Continued on next page
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Table 2.2 – Continued from previous page
Plasmid Description Ref.
pKL19 pKL18 with removal of the NsiI-CpoI fragment containing the
transcriptional terminator (rnpB T1 TT) by double digestion,
blunting, and ligating; see Figure 6.7
This study
pKL20 pKL14 with gentamicin resistance stuﬀer cloned as Eco72I
fragment from pJC8; see Figure 6.9
This study
pKL21 pKNOCK-bla-tetQ with ∼600 bp thrC fragment (BT 2401)
cloned as SalI-KpnI fragment; see Figure 5.15A
This study
pKL22 pKNOCK-bla-tetQ with ∼350 bp trpD fragment (BT 0530)
cloned as SalI-KpnI fragment; see Figure 5.15A
This study
BT2 random clone from BT1 genomic library; see Table 3.7 This study
BF4 random clone from BF1 genomic library; see Table 3.7 This study
PO3 random clone from CLGM1 metagenomic library; see Table 3.7 This study
CLGM3
5B2
chuR complementing clone from CLGM3 metagenomic library This study
CLGM3
5B9
chuR complementing clone from CLGM3 metagenomic library This study
32
CHAPTER 2. GENERAL MATERIALS AND METHODS
Table 2.3: Oligonucleotides used in this study.
Oligo Description Sequence (5’ to 3’)
KL10 Oligo 1 to generate EcoRI-NotI-Eco72I-NdeI-KpnI
polylinker
AATTCGCGGCCGCCACGTGCA
TATGGGTAC
KL11 Oligo 2 to generate EcoRI-NotI-Eco72I-NdeI-KpnI
polylinker
CCATATGCACGTGGCGGCCGC
G
KL12 F primer to amplify ∼800 bp containing RK2 oriT
from pJC8, with HindIII adaptor
CCT AAGCTT TCGGTCTTGC
CTTGCTCGTCGG
KL13 R primer to amplify ∼800 bp containing RK2 oriT
from pJC8, with HindIII adaptor
CCT AAGCTT GCGCTTTTCC
GCTGCATAACCC
KL14 F to amplify ∼4 kb containing ermF -IS4351-ori-repA
from pAFD1, with EcoR1 adaptor
CCT GAATTC ACTTTTGTGC
AATGTTGAAGATTAGTAATTC
TATTC
KL15 R to amplify ∼4 kb containing ermF -IS4351-ori-repA
from pAFD1, with EcoR1 adaptor
CCT GAATTC ATAACAGCCG
GTGACAGCCGGC
KL16 Primer walking round #2 of ermF -IS4351-ori-repA
fragment (#1 used KL14)
GTTCAACCAAAGCTGTGTCGT
TTTCAATAGC
KL33 Primer walking round #3 of ermF -IS4351-ori-repA
fragment
CAGGTATGCCAAACGTGGTTC
TAAAAATGC
KL42 Primer walking ermF -IS4351-ori-repA fragment;
check second A of round #2 results
GGAACTGCAAAATTCCTAAAA
TCACAACC
KL43 Primer walking round #4 of ermF -IS4351-ori-repA
fragment
CAAGCCCGTCAGGGCGCGTCA
GCGGGTGTTGG
KL44 Check orientation of 778 bp oriT in B. theta
compatible pCC1FOS derivatives
GGATCCTCTAGAGTCGACCTG
CAGGCATGC
KL45 Primer walking round #5 of ermF -IS4351-ori-repA
fragment
AACAGACAAAGCCGTTTATAA
AGGACTTGC
KL46 Primer walking round #6 of ermF -IS4351-ori-repA
fragment
GTCAGCAACAAAGGTAGTACT
TTATTATCG
Continued on next page
33
CHAPTER 2. GENERAL MATERIALS AND METHODS
Table 2.3 – Continued from previous page
Oligo Description Sequence (5’ to 3’)
KL47 F primer for GFPuv ORF +50 base upstream, with
PacI adapter
CCT TTAATTAA TGCATGCC
TGCAGGTCGACTCTAGAGGAT
CCCC
KL48 R primer for GFPuv ORF +100 base downstream,
with SgsI adapter
CCT GGCGCGCC CGCGCGAG
ACGAAAGGGCCCGTACGGCCG
KL49 F primer for GFPuv ORF +50 base upstream, with
CpoI adapter
CCT CGGACCG TGCATGCCT
GCAGGTCGACTCTAGAGGATC
CCC
KL50 R primer for GFPuv ORF +100 base downstream,
with SfaAI adapter
CTCCT GCGATCGC CGCGCG
AGACGAAAGGGCCCGTACGGC
CG
KL51 Sequence TT fragment primer 1 GGCAAATTGGCGATGGAGCCG
ACTTTTAGC
KL52 Sequence TT fragment primer 2 TATTTGCAGTACCAGCGTACG
GCCCACAG
KL53 Sequence TT fragment primer 3 ATCCTGCCACGTCGCCCGTTA
CACCGGACC
KL54 Sequence TT fragment primer 4 TCAGAAGGAAGGTCCAGTCGG
TCATGCCTTTGC
KL55 Sequence TT fragment primer 5 (for pKL10A) AATCTTCAACATTGCACAAAA
GTGAATTCG
KL56 Sequence TT fragment primer 6 (for pKL10A) GATAACAATTTCACACCCTAA
GGCACGTGG
KL57 Sequence TT fragment primer 7 (for pKL10B) ATTGCACTCCACCGCTGATGA
CATCAGTCG
KL58 Sequence TT fragment primer 8 (for pKL10B) AAATCCTGTATATCGTGCGAA
AAAGGATGG
KL59 Sequence TT fragment primer 9 (for pKL9B) CATTCGTATTGCACGACATTG
CACTCCACC
Continued on next page
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Table 2.3 – Continued from previous page
Oligo Description Sequence (5’ to 3’)
KL60 Sequence TT fragment primer 10 (for pKL9B) CCTACAACGGTTCCTGATGAG
GTGGTTAGC
KL61 F primer for B. theta chuR ORF (BT 0238) ATGAAAGCAACAACTTATGCA
CCTTTTGCCAAACC
KL62 R primer for B. theta chuR ORF (BT 0238) TTAATATTCTATTTTTAAACT
TCCGTCTTTTAGTGCTTTC
KL63 F primer for primer for B. theta chuR ORF
(BT 0238) 300 bp upstream
TCTCCATCCCTCAAAGTCTTC
AGATATAACATTTTTCC
KL65 R primer for primer for B. theta chuR ORF
(BT 0238) 300 bp upstream
TAACCGCAGTGATGGTTAGTC
AGGATCAAGC
KL66 Sequence chuR ORF from CLGM chuR5, toward
ORF start (nt 265 relative to B. theta sequence)
GGGCGTATTTCTTTTGCAGCT
CCATCG
KL67 Sequence chuR ORF from CLGM chuR5, toward
ORF start (nt 222 relative to B. theta sequence)
AAGCGGACGCATCAGCGTTTC
TCCACC
KL68 Sequence chuR ORF from CLGM chuR5, toward
ORF end (nt 1006 relative to B. theta sequence)
TCGGAACAATGAAATACCAAT
CACTCC
KL69 Sequence chuR ORF from CLGM chuR5, toward
ORF end (nt 1058 relative to B. theta sequence)
TCTATTTGCCTGCAACGGAGA
ATGTCC
thrCIDMF
(SalI)
F primer for amplifying B. theta ∼600-bp thrC
fragment (BT 2401) with SalI adapter, designed by
Eric Martens
GCGGTCGACGAGATTGCTTAT
CGGGTAGCC
thrCIDMR
(KpnI)
R primer for amplifying B. theta ∼600-bp trpD
fragment (BT 2401) KpnI adapter, designed by Eric
Martens
GCGGGTACCACACAAATCACG
GCATTATCGG
trpDIDMF
(SalI)
R primer for amplifying B. theta ∼350-bp trpD
fragment (BT 0530) KpnI adapter, designed by Eric
Martens
GCGGTCGACGGAAATGCGGGT
TCCGGTTG
Continued on next page
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Table 2.3 – Continued from previous page
Oligo Description Sequence (5’ to 3’)
trpDIDMR
(KpnI)
R primer for amplifying B. theta ∼350-bp trpD
fragment (BT 0530) KpnI adapter, designed by Eric
Martens
GCGGGTACCGAATGTACGTAC
CGCCAATCC
JC102 F sequencing primer for pJC8 [43] TAACAATTTCACACAGGAAAC
AGCTATGAC
JC103 R sequencing primer for pJC8 [43] GCGATTAAGTTGGGTAACGCC
AGGGTTTTC
KL-JC102 F sequencing primer for B. theta compatible fosmid;
see Figure 6.4
TAACAATTTCACACAGGAAAC
AGCTATGACG
KL-JC103 R sequencing primer for B. theta compatible fosmid;
see Figure 6.4
GCGATTAAGTTGGGTAACGCC
AGGGTTTTCG
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2.3 Bacterial culture
2.3.1 Growth media
All recipes for media and solutions are provided in Appendix A. The following sections
describe methods used for E. coli molecular biology work; for B. theta methods, see
Section 5.6 of Chapter 5. E. coli was routinely grown at 37❽ using LB, with shaking at
200 rpm. For cultures to be used for alkaline lysis-based minipreps, E. coli was grown
in either LB or TB media.
2.3.2 Antibiotics
Antiobiotics used in the culture of E. coli are summarized in Table 5.6. Concentrations
for antibiotics are denoted using the abbreviation (see Table 2.4) followed by the con-
centration as a subscript; for example ampicillin at 100 ➭g/ml would be Ap100. Note
that antibiotic concentrations were halved when used in liquid media.
Table 2.4: Antibiotic concentrations used for E. coli .
Antibiotic Abbrev. Solvent Final conc. agar
ampicillin Ap water 100 ➭g/ml
chloramphenicol Cm ethanol 10 ➭g/ml
gentamicin Gm water 25 ➭g/ml
kanamycin Km water 25 ➭g/ml
nalidixic acid NA water; add NaOH drops to dissolve 10 ➭g/ml
tetracycline Tc ethanol 10 ➭g/ml
trimethoprim Tp DMSO 400 ➭g/ml
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2.4 DNA introduction and extraction methods
2.4.1 Calcium chloride-based competent cell preparation
Competent cell preparation was based on the protocol from Sambrook and Russell [251].
The desired strain was streaked from frozen stock onto LB agar with antibiotic selection,
if possible (e.g., EPI300 was streaked onto LB Sm200). A single colony was used to
inoculate a liquid overnight culture, using the same antibiotic selection. The overnight
culture was used to inoculate liquid LB media, without antibiotics, at a volume ratio of
1:200. The culture was grown to OD600 ∼0.9 [298], as measured on a Spectronic Spec
20D spectrophotometer (warmed up for at least 15 minutes). The culture ﬂask was
chilled on ice for ∼30 minutes to halt cell growth. All subsequent work was performed
on ice to keep the cells cold at all times.
Cells were collected by centrifugation in polyethylene centrifuge bottles at 6,000Ög
at 4❽ for 10 minutes, using a rotor/adapter that was chilled at 4❽ for several hours.
The supernatant was decanted and the cells were gently resuspended in 0.1M CaCl2
(chilled overnight at 4❽), at a ratio of approximately 1 volume per 2-3 volumes of
overnight culture equivalent. The cells were again collected by centrifugation at 6,000Ög
at 4❽ for 10 minutes and the supernatant was decanted. The cells were then gently
resuspended in the same volume of chilled 0.1M CaCl2 and incubated for several hours
on ice or overnight on ice at 4❽. Cells were again pelleted at 6,000Ög at 4❽ for 10
minutes, using a rotor/adapter that had been chilled at 4❽. The supernatant was de-
canted, the bottle was pop-spun, and all remaining supernatant was carefully removed.
Cells were gently resuspended using 0.1M CaCl2 15% glycerol (v/v; chilled overnight
at 4❽) in a volume equal to 1.5% of the original culture volume. Cells were frozen at
-80❽ in 0.2 or 1ml aliquots.
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2.4.2 Calcium chloride-based transformation
Calcium chloride-based transformation was based on the protocol from Sambrook and
Russell [251]. Cells were thawed from -80❽ on ice, with periodic gentle ﬂicking of the
tube. DNA was mixed with cells in a microfuge tube, not exceeding a volume ratio
of 1:10. The mixture was incubated on ice for 30 minutes, then heat-shocked at 42❽
for 90 seconds, followed by immediate transfer to ice for 1-2 minutes. 1ml of LB was
added, and cells were allowed to recover at 37❽ for 1 hour without shaking. Cells
were pelleted by centrifugation at 8,000-13,000Ög for 1 minute. The supernatant was
decanted, leaving ∼100 ➭l to resuspend the cells for spreading onto selective agar plates.
2.4.3 Plasmid DNA miniprep
Home-made kit for routine plasmid preps
This protocol and the recipes for the solutions used in this protocol were obtained
from the OpenWetWare version of the commercial Qiagen QIAprep Spin Miniprep Kit.
Please see Section A.7 for the solution recipes.
Overnight cultures of E. coli were prepared using 3-5ml LB or 2-3ml TB with
the appropriate antibiotics and supplementation. 2-5ml of culture was pelleted in a
2-ml microfuge tube, and resuspended in 250 ➭l of Solution P1. 250 ➭l of the alkaline
Solution P2 was added, and the tube was inverted ∼10 times to lyse the cells. 250 ➭l of
Solution N3 was added and the tube was inverted ∼10 times to neutralize the mixture.
Cell debris was pelleted by centrifugation at 21,000Ög for 5-7 minutes. The super-
natant containing the plasmid DNA was transferred to a silica spin column (BioBasic
SD5005), the column was pop spun for ∼5 seconds at 13,000Ög, and the ﬂow-through
was discarded. If the strain carrying the plasmid was not an endA1 mutant, then
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500 ➭l of PB wash solution was pop spun through the column to remove contaminat-
ing nucleases, and the ﬂow-through was discarded. The column was then washed at
least 2 times with 500-750 ➭l of PE wash solution by pop spinning and discarding the
ﬂow-through. As much ethanol wash as possible was removed by gentle tapping of the
tube containing the ﬂow-through onto a paper towel, and the column was spun for 2
minutes at 13,000Ög. The spin column was transferred to a new microfuge tube, and
50 ➭l of T10E0.1 (pH 8.5) was added to the column. DNA was eluted by centrifuga-
tion at 10,000Ög for 30 seconds. Miniprepped plasmid DNA was quantiﬁed using the
Nanodrop ND-1000 Spectrophotometer.
Commercial kits for DNA sequencing
For samples intended for DNA sequencing, plasmid DNA was prepared using commer-
cial miniprep kits according to the manufacturer’s recommendations. Kits used were
the EZ-10 Spin Column Plasmid DNA Mini-preps Kit (BioBasic BS614), the GeneJET
Plasmid Miniprep Kit (Thermo-Fisher K0502), or the QIAprep spin miniprep kit (Qi-
agen 27106). Miniprepped plasmid DNA was quantiﬁed using the Nanodrop ND-1000
Spectrophotometer.
2.4.4 Plasmid DNA maxiprep
Large-scale preparations of plasmid DNA were based on the protocol from Charles,
1990 [35]; see Appendix A.9 for the solution recipes. All centrifugation steps were
carried out at room temperature.
The desired strain were streaked from frozen stock onto LB agar with the appro-
priate antibiotics. A single colony was used to inoculate 5ml liquid overnight culture,
using the same antibiotic selection. The 5-ml overnight was then used to seed an
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overnight 1 L culture, using the same antibiotic selection. The following day, the cells
were pelleted by centrifuging at 7,000Ög for 10 minutes, such that there were two cell
pellets with the equivalent of 500ml of culture each. Each pellet was resuspended in
10ml TEG and pooled for 20ml.
The cells were then lysed by the addition of 40ml ALS followed by inversion
∼10 times. The mixture was neutralized with 30 ml HSS followed by inversion ∼10
times, and cooled at -70❽ for 20-30 minutes. The debris was pelleted by centrifuging
at 10,000Ög for 10-15 minutes, and the solution was decanted through cheesecloth into
a fresh 250-ml centrifuge bottle. 90ml of isopropanol was added to the solution to
precipitate the DNA, followed by by centrifuging at 10,000Ög for 10 minutes. The
supernatant was discarded and the bottle was inverted on a paper towel to dry the
pellet. The pellet was resuspended in 8ml TE and the mixture was transferred to
40-ml centrifuge tube. 4ml of 7.5M NH4Ac was added and mixed, and proteins were
allowed to precipitate on ice for 15-30 minutes. Protein was pelleted by centrifuging at
10,000 Ö g for 10-15 minutes and the supernatant was transferred to a new tube. 12ml
isopropanol was added to the solution to precipitate the DNA, followed by centrifuging
at 10,000Ög for 10-15 minutes. The supernatant was discarded and the bottle was
inverted on a paper towel to dry the pellet.
The pellet was resuspended in 800 ➭l TE and transferred to two microcentrifuge
tubes, with 400 ➭l per tube. To each tube, 4 ➭l of 5M NaCl and 5 ➭l of 10mg/ml
RNase A was added, followed by incubation at 37❽ for 30 minutes. 2.5 ➭l of 20% SDS
and and 5 ➭l of 19.2mg/ml Proteinase K was added, followed by incubation at 37❽ for
30 minutes. The mixture was then extracted with an equal volume of phenol-chloroform
(1:1) and then extracted with an equal volume of only chloroform. To precipitate the
DNA, 25 ➭l of 5M NaCl and 500 ➭l isopropanol were added. The precipitated DNA
was carefully removed with a pipette and dipped into 70% ethanol to wash and placed
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into a new tube, with the precipitate from both tubes being combined. The DNA
was allowed to dry, and then resuspended in 1ml TE, and dissolved overnight at 4❽.
To quantify, the DNA was diluted 1-in-10 and 1-in-100; 25 ➭l of these dilutions was
quantiﬁed using the Nanodrop ND-1000 Spectrophotometer as well as run on a gel
to conﬁrm the concentrations. Typically, plasmid maxipreps can be obtained with
concentrations ∼1 ➭g/➭l.
2.4.5 HMW DNA extraction from fecal samples
Prior to DNA extraction, fecal samples were pre-processed based on the method de-
scribed by Lee and Hallam [175], by placing 5 g of sample in a mortar with 1ml of
denaturing solution (4M guanidine isothiocyanate, 10mM Tris-HCl [pH 8.0], 1mM
EDTA, 0.5% beta-mercaptoethanol). The sample was frozen using liquid nitrogen,
ground with a pestle to a homogeneous powder, then transferred to a conical tube for
storage at -80➦C.
DNA was extracted from soil or feces according to the method described by Zhou
et al. [347]. Brieﬂy, 5 g of soil or fecal sample were incubated in 13.5ml of extrac-
tion buﬀer (100mM Tris [pH 8.0], 100mM EDTA, 100mM sodium phosphate [pH 8.0],
1.5M NaCl, 1% CTAB), with the addition of proteinase K (to 75 ➭g/ml), shaking at
37➦C for 30 minutes. After adding SDS (to 2% w/v in 15ml), the sample was incu-
bated at 65➦C for 2 h with gentle inversions every 15 minutes. After centrifugation at
6,000Ög for 10 minutes at room temperature, the supernatant was collected, extracted
with chloroform:isoamyl alcohol (24:1), and DNA was precipitated with 0.6 volumes
of isopropanol at room temperature for 1 h. DNA was collected by centrifugation at
6,000Ö g for 20 minutes at room temperature, followed by a 70% ethanol wash. The
DNA pellet was suspended overnight at 4➦C in 0.5-3ml of TE buﬀer (10mM Tris-HCl
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[pH 8.0] and 0.1mM EDTA [pH 8.0]). The DNA was quantiﬁed by gel electrophoresis,
using bacteriophage λ DNA as a standard (see Section 2.5.8).
2.4.6 HMW DNA extraction from pure cultures
DNA was isolated from liquid bacterial cultures based on a method described by Charles
and Nester [36]. Brieﬂy, cells were cultured in 50ml of liquid media, and the cell pellets
were recovered after centrifugation at 7000Ög for 5 minutes at room temperature. Cells
were washed with 8ml of wash buﬀer (10mM Tris [pH 8.0], 25mM EDTA [pH 8.0],
150mM NaCl), and resuspended in 4ml of buﬀer (10mM Tris [pH 8.0], 25mM EDTA).
The following were added, to a ﬁnal volume of 5ml: NaCl (to 0.5M), proteinase K
(to 0.5mg/ml), and lysozyme (to 2.5mg/ml). After incubation at 37➦C for 30 minutes
with shaking, 250 ➭l of 20% SDS were added, the mixture was incubated at 65➦C for
60 minutes, then centrifuged at 6,000Ög for 10 minutes at room temperature. The
supernatant was collected, and protein was precipitated with 0.5 volumes of 7.5M
ammonium acetate on ice for 20 minutes. The mixture was centrifuged at 10,000Ög for
15 minutes, the supernatant was collected and centrifuged at 8,500Ög for 10 minutes
to further clear the supernatant. The supernatant was decanted and the mixtured was
extracted with chloroform in a 1:1 volume. The supernatant was collected and DNA
was precipitated with 1 volume of isopropanol at room temperature for 30 minutes.
DNA was spooled out, dipped in a 70% ethanol wash, and placed in a microfuge tube.
The tube was centrifuged at 15,000Ög for 1 minute, the supernatant was removed, and
the pellet was allowed to dry. Finally, the pellet was allowed to dissolve in 2ml of TE
overnight at 4➦C. The DNA was quantiﬁed by gel electrophoresis, using bacteriophage
λ DNA as a standard (see Section 2.5.8).
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2.5 DNA manipulation methods
2.5.1 Gel electrophoresis
Routine gel electrophoresis was carried out using TAE buﬀer; see Appendix A.6 for
the 50Ö TAE stock recipe. The stock was diluted to 1Ö in 20-L working volumes and
stored at room temperature for use. A concentration of 0.8% or 0.85% agarose was
used to visualize bands greater than 10-20 kb, including genomic DNA preparations;
1.0% agarose was used for fragments ranging between 500 and 10,000 bp; and on the
rare occasion, 2% agarose was used to visualize small bands, typically less than a
few hundred basepairs. Gels were typically run using 5V/cm. Commercial molecular
ladders were used for size estimation: 25-50 ng of either the λ-HindIII Ladder or the
1-kb DNA Ladder (Thermo-Fisher FERSM0101 and FERSM0311, respectively). For
visualization on the UV transilluminator, Gel Red stain was used; contrary to the
manufacturer’s recommendations, the stain was diluted 50,000Ö rather than 10,000Ö.
2.5.2 Ethanol precipitation
Ethanol precipitation was used to concentrate DNA or to change the buﬀer in which
the DNA was dissolved. Ions were added in the form of either 1/10 volume of 3M
sodium acetate (pH 5.2), 1/50 volume of 5M sodium chloride, or 1/2 volume of 7.5M
ammonium acetate. The solution was mixed, and alcohol was added in the form of
either 3 volumes of ethanol or 1 volume of isopropanol. DNA was chilled either on
ice or at -20❽ for 10-60 minutes, and centrifuged at 21,000Ög for 10-30 minutes. The
superntant was removed, the tube was pop spun, and the remaining supernatant was
carefully removed. 100 ➭l of 70% ethanol was washed over the pellet and immediately
removed. The pellet was allowed to dry with the tube inverted on a Kim Wipe for a
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few minutes until the edges of the pellet began to become translucent. The DNA was
dissolved in a small volume of TE buﬀer, typically 10-20 ➭l.
2.5.3 Gel extraction
This protocol is based on the Qiagen QIAquick Gel Extraction Kit, using a home-made
binding buﬀer recipe [149]. Please see Appendix A.8 for the solution recipes.
The sample of DNA was run on an 1Ö TAE agarose gel, using the appropriate
agarose concentration and 1mM guanosine [111]. The desired fragment was excised,
placed in a microfuge tube and weighed on an analytical balance. Binding buﬀer was
added to the fragment, using 3 or 4 ➭l per mg of gel; for example, 300-400 ➭l for a 100-
mg gel fragment. The gel was dissolved by incubating at 65❽ with frequent inverting
and vortexing. After dissolution, the mixture was transferred to a silica spin column
(BioBasic SD5005), the column was pop spun for ∼5 seconds at 13,000Ög, and the
ﬂow-through was discarded. The column was then washed at least 2 times with 500 to
750 ➭l of PE wash solution by pop spinning and discarding the ﬂow-through. As much
ethanol wash as possible was removed by gentle tapping of the tube containing the ﬂow-
through onto a paper towel, and the column was spun for 2 minutes at 13,000Ög. The
spin column was transferred to a new microfuge tube, and 30-50 ➭l of T10E0.1 (pH 8.5)
was added to the column. DNA was eluted by centrifugation at 10,000Ög for 30 seconds.
Extracted DNA was quantiﬁed using the Nanodrop ND-1000 Spectrophotometer.
2.5.4 Restriction enzyme digestion
Routine restriction enzyme digestion was carried out using the FastDigest line of en-
zymes from Thermo-Fisher Scientiﬁc, using the FastDigest universal Green Buﬀer with
loading dye included. Digestion conditions were generally modiﬁed from the manufac-
45
CHAPTER 2. GENERAL MATERIALS AND METHODS
turer’s recommendations, herein described. Restriction digestion was either carried out
on a larger scale to prepare DNA for cloning (Table 2.5) or on a smaller scale to conﬁrm
the results of cloning (Table 2.6). Enzyme volumes were not allowed to exceed 10%
of the total reaction volume. Digests were either used directly for cloning after heat
inactivation, or were puriﬁed by silica column using the protocol for gel extraction (see
Section 2.5.3) with a 3-4:1 volume ratio of binding buﬀer to digest.
Table 2.5: General digestion recipe for cloning purposes.
DNA ∼1-3 ➭g
FastDigest enzyme (1U/➭ l) 1-3 ➭l
10Ö FastDigest Green Buﬀer 3-6 ➭l
sterile dH2O top up
Total 30-60 ➭l
Table 2.6: General digestion recipe for diagnostic purposes.
DNA ∼50-100 ng
FastDigest enzyme (1U/➭ l) 0.5 ➭l
10Ö FastDigest Green Buﬀer 1 ➭l
sterile dH2O top up
Total 10 ➭l
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2.5.5 Ligation
Routine ligations were carried out in 10-15 ➭l volumes, using T4 DNA Ligase (Thermo-
Fisher L0014) or Fast-Link DNA Ligase (Epicentre LK0750H) according to the manu-
facturer’s recommendations. Sticky-end ligations were incubated for 1-3 hours at room
temperature whereas blunt-end ligations were incubated overnight either at 16❽ or
room temperature.
2.5.6 Estimation of digestion and dephosphorylation efficiency
The following outlines how to estimate the digestion and dephosphorylation eﬃciency
for a large-scale preparation of vector for library construction. It is recommended
that this be performed after puriﬁcation of the backbone from the stuﬀer (by either
gel extraction or electroelution) to test the integrity of the DNA for ligation, that is,
ensuring that the ends of the DNA are ligatable.
First, the large-scale digestion and dephosphorylation was set up as in Table 2.7,
using non-FastDigest Eco72I and FastAP (Themo-Fisher R0361 and F0651, respec-
tively). The reaction was incubated for 3.5 hours at 37❽, heat-inactivated for 30
minutes at 80❽, and stored at -20❽.
Table 2.7: Recipe for large-scale digest and desphosphorylation.
vector DNA 100 ➭g
10Ö Tango Buﬀer 100 ➭l
Eco72I 30 ➭l
FastAP 30 ➭l
sterile dH2O top up
Total 1000 ➭l
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After digestion and dephosphorylation, the mixture was assessed for cutting and
dephosphorylation eﬃciency; reactions were set up as summarized in Table 2.8 using
T4 polynucleotide kinase (Thermo-Fisher EF0651) and typically reactions were set up
in duplicate. Reactions were incubated for 45 minutes at room temperature (not 37❽
speciﬁcally), followed by addition of 0.25 ➭l Fast-Link ligase (Epicentre LK0750H), and
overnight incubation at 16❽. The mixtures were then used to transform home-made
EPI300 competent cells.
Table 2.8: Recipes for assessment of digestion and dephosphorylation eﬃciency
−PNK + ligase +PNK − ligase +PNK + ligase
DNA, dig. and dephos. 1 1 1
10Ö FL biﬀer 1 1 1
ATP, 10 mM 0.5 0.5 0.5
T4 PNK 0 0.5 0.5
H2O 7.5 7 7
Total 10 ➭l 10 ➭l 10 ➭l
No. transformants x y z
After transformation, colonies were counted (Table 2.8) and the eﬃciency of diges-
tion and dephosphorylation were estimated using the two equations below. Typically,
digestion eﬃciency was 97% and desphosphorylation eﬃciency was 99%.
% of vector DNA that is cut =
(
1−
y
z
)
× 100
% of cut vector that is desphosphorylated =
(
1−
x− y
z
)
× 100
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2.5.7 Sanger DNA sequencing
For routine Sanger sequencing, samples were typically submitted to The Centre for
Applied Genomics (Toronto) or BioBasic Inc. (Markham).
2.5.8 Gel quantification of genomic and metagenomic DNA
Both genomic and metagenomic DNA were quantiﬁed by agarose gel electrophoresis
against a dilution series of commercial λ DNA (Thermo-Fisher FERSD0011; 300 ng/➭ l).
For high-molecular-weight DNA species that may form a somewhat heterogeneous mix-
ture, the Nanodrop ND-1000 Spectrophotometer may not be as inaccurate as quantiﬁ-
cation on an agarose gel.
A series of λ DNA dilutions was prepared to use as standards: 0, 5, 10, 25, 50, 75,
and 100 ng. The standards were run on a 0.8% or 0.85% agarose gel pre-strained with
Gel Red (Section 2.5.8), along with varying volumes of the sample(s) to be quantiﬁed,
e.g., 0.1 and 0.9 ➭l (Figure 2.1A). Using the free software ImageJ [257], pixel intensity
was quantiﬁed for the standards and samples (Figure 2.1B). A line of best ﬁt was
generated for the data points from the λ DNA standard, which was then used to
estimate the concentration of DNA for the experimental sample(s) (Figure 2.1C).
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Figure 2.1: Gel quantification of high-molecular-weight DNA samples using λ DNA
dilution standards. (A) Samples of unknown concentration are run on a gel against the λ standard.
(B) ImageJ used to quantify pixel intensity in the selected lanes. (C) Pixel intensity for the λ standard
is plotted and a line of best ﬁt is generated.
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2.5.9 Pulsed field gel electrophoresis
Pulsed-ﬁeld gel electrophoresis was used to visualize/separate high-molecular-weight
DNA fragments. The following section describes the protocol and parameters for elec-
trophoresis as well as the preparation of λ DNA-based ladders.
Pulsed-field gel electrophoresis using Bio-Rad CHEF MAPPER
Gels were prepared using pulsed-ﬁeld certiﬁed agarose (Bio-Rad 1620137) at 1% agarose
in 100ml 1Ö TAE buﬀer. The gel rig was ﬁlled with 1Ö TAE, the parameters on the
Bio-Rad CHEF Mapper were set (Table 2.9), and the buﬀer was circulated to cool to
14❽. The cooling was stopped, the circulation was paused, the gel was was placed in
the rig, and samples were loaded; DNA extracts were either run for diagnostics (500 ng)
or for size-selection by excision (30 ➭g). The circulation was resumed followed by the
cooling, and the run was allowed to proceed overnight (Table 2.9).
The next day, the gel was post-stained. For diagnostic gels, post-staining was
done in 200ml of 1Ö TAE buﬀer supplemented with 20-25 ➭l of Gel Red stain diluted
1-in-5 in dH2O, shaking gently at room temperature for 1-2 hours; the gel was then
rinsed in buﬀer, destained in 200 ml of buﬀer for 15-60 minutes, and visualized on a
UV transilluminator. For excision gels, only the edges of the gel were stained and the
fragment was excised without exposure to either Gel Red stain or UV/blue light (see
Figure 2.2).
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Table 2.9: Settings for pulsed-ﬁeld gel electrophoresis on Bio-Rad CHEF Mapper.
Parameter Diagnostic gel Excision gel
input DNA range 10-100 kb 10-100 kb
calibration factor 1.0 1.0
buﬀer 0.5Ö TBE✯ 0.5Ö TBE✯
temperature 14❽ 14❽
agarose 1% 1%
voltage 6V/cm 5V/cm
pulse 1-10 s 0.5-8.5 s
ramping factor linear linear
runtime 16 h 14 h
Preparation of λ DNA molecular markers for pulsed-field electrophoresis
Commercial λ DNA (Thermo-Fisher FERSD0011; 300 ng/➭ l) was used to prepare
home-made molecular weight markers for use in pulsed-ﬁeld gel electrophoresis. The
size of the λ genome is 48.5 kb. λ DNA was self-ligated using T4 DNA ligase (Thermo-
Fisher FEREL0014) to generate concatemers appropriate for assessing the size range
of crude DNA extracts: ∼50 kb, ∼100 kb, ∼150 kb, etc. The recipe for the self-ligation
reaction is provided in Table 2.10. To generate a marker at ∼25 kb, λ DNA was digested
with XbaI, which halves the 48.5-kb genome. The recipe for the digestion reaction is
provided in Table 2.11.
✯setting used although buﬀer was 1Ö TAE
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The ligation and digestion mixtures were used to make a combined working ladder.
λ-ligated and λ-XbaI were diluted to 5 ng/➭l and 2.5 ng/➭l, respectively, with loading
dye added. For electrophoresis, 75-100 ng of the combined ladder was used; Figure 2.2
depicts the use of this combined ladder as a guide to excise a gel fragment, particularly
in comparison with a commercial ladder whose largest marker is 40 kb (Invitrogen
10511-012).
Table 2.10: Ligation recipe for self-ligated λ DNA.
λ DNA (300 ng/➭l) 33.3 ➭l
T4 DNA ligase 3 ➭l
10Ö T4 DNA Ligase Buﬀer 10 ➭l
sterile dH2O 53.7 ➭l
Total 100 ➭l (100 ng/➭l)
Table 2.11: Digestion recipe for XbaI-digested λ DNA.
λ DNA (300 ng/➭ l) 33.3 ➭l
FastDigest XbaI 10 ➭l
10Ö FastDigest Green Buﬀer 10 ➭l
sterile dH2O 46.7 ➭l
Total 100 ➭l (100 ng/➭l)
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Figure 2.2: Pulsed-field gel electrophoresis using home-made λ DNA mark-
ers. CM: commercial marker, 1 kb Extension Ladder (Invitrogen 10511-012); HM:
home-made λ marker, containing XbaI-digested λ and ligated λ DNA.
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2.5.10 Electroelution
Preparation of dialysis tubing
Dialysis tubing (Sigma D-9652) was cut in forearm-length segments and immersed in
2% sodium bicarbonate, 1mM EDTA. The tubing was boiled for 10 minutes, taking
care to keep the tubing submerged. The tubing was then removed and thoroughly
rinsed with distilled water straight from the tap, using three rinses outside and three
inside. The tubing was immersed in 1 mM EDTA, boiled for another 10 minutes,
and then transferred to 1mM EDTA, 20% ethanol. All air trapped air bubbles were
removed and the tubing was stored at 4❽ . Typically, ∼10 segments of tubing were
prepared at a time; the tubing will keep for years in the storage solution.
Electroelution
The DNA to be electroeluted was run on either a typical agarose gel (for example,
100 ➭g of digested vector DNA) or a pulsed-ﬁeld agarose gel (for example, 30 ➭g of
crude extract DNA from feces), and the desired fragment was excised from the gel. The
fragment was placed inside a segment of dialysis tubing that was previously thoroughly
rinsed with distilled water and equilibrated to room temperature in 1Ö TAE. One end
of the tubing was clamped, the same buﬀer was used to ﬁll the tubing, and the other
end was clamped (Figure 2.3A). The tubing was submerged in 1Ö TAE in the gel rig,
and the DNA was eluted using ∼3 V/cm for 3 hours (Figure 2.3B). The buﬀer inside
the tubing was then decanted into a sterile conical tube; the bag was rinsed twice
with 2-3ml of 1Ö TAE, and that buﬀer also retained, for a total volume of less than
50ml. The mixture of DNA was subsequently concentrated using a 30 kDa Amicon
centrifugal ﬁlter (Millipore UFC903024), followed by a standard ethanol precipitation
(see Section 2.5.2).
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A B
Figure 2.3: Setup of apparatus for electroelution. (A) Gel fragments containing
desired the DNA are excised and placed in dialysis tubing with buﬀer. (B) The fragment
is subjected to an electric ﬁeld and the DNA migrates into the buﬀer contained in the
dialysis tubing.
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2.6 Summary of constructed libraries
Several genomic and metagenomic libraries were constructed in this study; protocols
for library construction are provided in the speciﬁc materials and methods section of
each chapter. Table 2.12 summarizes the details for each library: the library name, the
source of the DNA, the vector used, the E. coli library host used for transduction, the
approximate number of unique clones, and the estimated average insert size.
Table 2.12: Genomic and metagenomic libraries constructed in this study.
Library
name
DNA source Vector Host No.
clones
Estimated avg.
insert size
BT1 B. theta genomic DNA pJC8 HB101 8,000 27 ➧8 kb (n=17)
BF1 B. frag genomic DNA pJC8 HB101 18,000 30 ➧7 kb (n=18)
CLGM1 pooled human feces pJC8 HB101 42,000 28 ➧9 kb (n=36)
BT2 B. theta genomic DNA pKL3 HB101 15,000 nd
CLGM2 pooled human feces pKL3 HB101 65,000 nd
BT3 B. theta genomic DNA pKL13❸ EPI300 36,000 nd
CLGM3 pooled human feces pKL13❸ EPI300 115,000 26 ➧10 kb (n=19)
❸Eco72I stuﬀer fragment not puriﬁed from backbone prior to ligation; see Section 5.6.9
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3.2 Abstract
High-throughput sequencing methods have been instrumental in the growing ﬁeld of
metagenomics, with technological improvements enabling greater throughput at de-
creased costs. Nonetheless, the economy of high-throughput sequencing cannot be
fully leveraged in the sub-discipline of functional metagenomics. In this area of re-
search, environmental DNA is typically cloned to generate large-insert libraries from
which individual clones are isolated, based on speciﬁc activities of interest. Sequence
data are required for complete characterization of such clones, but the sequencing of
a large set of clones requires individual barcode-based sample preparation; this can
become costly, as the cost of clone barcoding scales linearly with the number of clones
processed, and thus sequencing a large number of metagenomic clones often remains
cost-prohibitive.
This chapter investigates a hybrid Sanger/Illumina pooled sequencing strategy that
omits barcoding altogether, and evaluates the strategy by comparing the pooled se-
quencing results to reference sequence data obtained from traditional barcode-based
sequencing of the same set of clones. Using identity and coverage metrics, the results
show that pooled sequencing can generate high-quality sequence data, without pro-
ducing problematic chimeras. Though caveats of a pooled strategy exist and further
optimization of the method is required to improve recovery of complete clone sequences
and to avoid circumstances that generate unrecoverable clone sequences, our results
demonstrate that pooled sequencing represents an eﬀective and low-cost alternative for
sequencing large sets of metagenomic clones.
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3.3 Introduction
With the advent of high-throughput sequencing, metagenomics has emerged as a pow-
erful way to explore DNA recovered from terrestrial, aquatic, and host-associated mi-
crobial communities. Sequence-based metagenomics involves bulk sequencing of en-
vironmental DNA and has generated a wealth of genome information from myriad
environmental samples. With this wealth of sequence data serving as a foundational
resource, the stage is set for function-based metagenomics, or functional metagenomics,
which is arguably essential for the recovery and annotation of hypothetical proteins with
as-yet-unknown functions [117,242].
3.3.1 Sanger-based sequencing of metagenomic clones
Functional metagenomics allows exploration of the densely populated microbial habi-
tats that are rich resources for the discovery of novel enzymes. Applying this approach,
the genetic material of the microbial community is extracted from an environmental
sample, and the DNA is cloned into appropriate vectors to generate metagenomic li-
braries that are maintained using E. coli as a surrogate host. These libraries may
then be subjected to function-based activity screens, either in E. coli or various other
surrogate hosts, after which positive clones are isolated for analysis.
A critical step in functional metagenomic studies is obtaining DNA sequence for
the isolated clones in order to identify the gene(s) responsible for the function(s) of
interest, particularly if the goal is to identify novel enzymes. Prior to the existence
of high-throughput sequencing, it was, and still is, common to use other methods to
identify the gene or operon carried on the insert DNA. One strategy is to Sanger-
sequence the clone to obtain a sequence fragment, by primer-walking along the insert
[86, 136, 270, 307] or ﬁrst subcloning smaller fragments of the insert that carry the
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activity of interest [20,85,105,135,186,190,230,236,237,259]. A variant of this strategy
is to use transposon mutagenesis, which may be followed by screening for loss of activity
[3, 52, 73, 119, 164, 169, 254, 282, 318, 329]. Regardless of the speciﬁc strategy, multiple
steps are usually required to obtain sequence data for large-insert clones.
3.3.2 High-throughput sequencing of clones using barcodes
Although current high-throughput sequencing methods are an appropriate scale for
sequencing of microbial genomes, the throughput is typically far greater than required
for coverage of single clones. This has led to the practice of “multiplexing”, which
involves combining multiple clones for sequencing, using DNA barcodes (or indexes) to
track sequence reads from individual clones within the larger set (Figure 3.1, Barcoded
Sequencing). Examples of this strategy include the sequencing of large-insert clones
identiﬁed from screens for enzymes involved in dietary ﬁbre catabolism [299], prebiotic
breakdown [34], and cellulosic biomass conversion [108]. Barcoded sequencing enables
sequence data recovery from many clones simultaneously, yet the cost of barcoding
every clone can be several-fold higher than the cost of the sequencing itself. This
sample preparation cost can be a bottleneck for the smaller molecular microbiology lab,
where isolating clones is relatively easy, but sequence analysis of the clones becomes
cost-prohibitive.
3.3.3 Aims of this work
Our lab investigated the possibility of circumventing the barcoding step by testing a
clone pooling and sequencing approach (Figure 3.1, Pooled Sequencing). As part of this
sequencing strategy, end sequences for every clone are generated by Sanger-sequencing;
these sequences are called “end-tags” to describe their role in the downstream sequence
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retrieval process in which we match clones to next-generation sequence data assemblies.
In a pooled method, clones are sequenced together and users rely on the post-sequencing
assembly process to generate contigs that represent individual clones. After assembly,
contigs exist in a pool; to retrieve a speciﬁc clone’s contig, the clone’s end-tags are used
to query the pool.
A set of 92 large-insert clones was chosen for this analysis; cosmid clones were iso-
lated previously by diﬀerent members of the lab from various functional screens. End-
tags were obtained from Sanger sequencing each clone and, concurrently, the clones were
pooled for sequencing and assembly. Though the reduced cost of pooled sequencing is
very attractive, the data obtained could be of poorer quality; while some compromise
is of course made in a strategy that seeks economy, our lab was uncertain about the
extent of the trade-oﬀ. Therefore, to evaluate the results of the pooled sequencing
strategy, we had the same set of 92 large-insert clones sequenced using barcodes, gen-
erating sequences to which the pooled sequencing results could be compared. The aim
was not to do a comparison of the two methods to show that the pooled method is su-
perior; rather, the aim was to examine the results of the pooled sequencing approach,
using high-quality reference sequences from traditional barcoded sequencing. Although
a similar pooled clone sequencing method has recently been described by others for
metagenome-derived medium-insert plasmids [69] and large-insert fosmids [321], this
is the ﬁrst report of using a pooled strategy for sequencing large-insert metagenomic
clones while also critically evaluating the performance of this pooled strategy by com-
paring the results to barcoded reference sequences of the same clones.
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Figure 3.1: Overview of the two methods used in this study for sequencing of large-insert
cosmid clones, barcoded sequencing and pooled sequencing. Traditional barcoded sequencing
(left) uses DNA barcodes to keep clones as separate samples throughout the sequencing and assembly
process. Pooled sequencing (right) involves combining clones into one sample for sequencing and
assembly, and subsequently using previously obtained Sanger “end-tags” to retrieve speciﬁc clone
sequences. [167]
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3.4 Results and discussion
3.4.1 Pooled and barcoded sequencing results
A total of 92 cosmid clones were subjected to both pooled sequencing and barcoded se-
quencing. Of the 92 large-insert cosmid clones, I excluded 19 from subsequent analyses
due to incomplete sequencing data. Of the excluded clones, 15 clones had insuﬃcient
barcoded sequence data for successful assembly. These samples appeared to have high
contamination of E. coli genomic DNA and/or mobilizer plasmid DNA. Under my direc-
tion, Mike Hall examined the eﬀect of contamination on clone assembly. The estimated
percent E. coli contamination in each of the 92 samples ranged from 1% to nearly 50%,
and, not surprisingly, the higher the contamination, the less likely a successful assembly
(Figure 3.2).
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Figure 3.2: Fraction of clones failing assembly, binned by estimated percent
E. coli contamination. Raw sequence data from barcoded sequencing of 92 clones
were examined for E. coli contamination. [167]
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The remaining 4 of the 19 clones repeatedly failed Sanger end sequencing re-
actions, possibly due to secondary structure associated with the insert DNA. In our
lab’s experience, it is occasionally diﬃcult to obtain Sanger reads for certain clones,
which we speculate may be caused by such secondary structure eﬀects. In total, 73
clones yielded suﬃcient data for evaluation of the pooled sequencing results, using the
barcoded sequencing results as a reference.
As a result of using diﬀerent providers for the pooled and barcoded sequencing
(see Section 3.6.6 and Section 3.6.5 for details), there was unequal depth of sequencing
between the two sequencing approaches (Figure 3.3; see Table 3.3 for individual clone
depth); however, it was the barcoded strategy that had the greater depth, which was
ideal for its use as the reference data set.
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Figure 3.3: Clone sequencing read depth in barcoded sequencing versus
pooled sequencing. Values from Table 3.3 were used to compare overall read depth
for barcoded versus pooled sequencing strategies. [167]
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3.4.2 Evaluation of pooled sequencing results
Using the set of 73 clones, the accuracy and completeness of the pooled sequencing
approach was evaluated. First, contigs for each clone were retrieved from the pooled
sequencing results using that clone’s end tags (see Section 3.6.6 for details; retrieved
contigs for all clones are provided in Table 3.9). Then, for each clone, the barcoded
sequencing result (i.e., the “barcoded contig”) was the reference to which the pooled
sequencing result (i.e., the retrieved “pooled contig”) was compared. Speciﬁcally, the
retrieved pooled contig was aligned to its respective barcoded contig, using NCBI nu-
cleotide BLAST [4] running the Megablast algorithm. By aligning the pooled contig to
the barcoded contig for each clone, it was possible to quantitatively assess the pooled
sequencing approach, by obtaining values for percent identity (i.e., did pooled sequenc-
ing return the expected sequence for the clone?) and percent coverage (i.e., did pooled
sequencing return the expected length for the clone?). Katja Engel and Greg Vey
assisted me in these analyses.
Our initial reservations about a pooled sequencing strategy centred on one major
issue, which was that assembly of reads generated from a pooled sample may result in
chimeric assemblies – that is, assemblies that are derived from more than one clone.
However, when retrieved pooled contigs were aligned to barcoded contigs for each clone,
the majority of clones showed alignments of greater than 99.9% identity, with identity
values ranging from 99.4-100.0% (Figure 3.4).
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Figure 3.4: Alignment identity between pooled sequencing result and bar-
coded sequencing result. For all 73 clones, end-tags were used to retrieve contigs
from pooled sequencing results; retrieved contigs were aligned to the reference barcoded
sequencing result, and clones were binned by percent identity. [167]
Identity values showed high accuracy and little variability, indicating that the
pooled sequencing strategy is capable of generating consistently accurate sequence data.
Contrary to our concerns, the alignments showed no problems with chimeric sequences,
and that most sequences had an error rate of less than one base per thousand. Indeed,
this might be an overestimation of the error because the pooled sequencing and assembly
method may mask the presence of single nucleotide polymorphisms (discussed further
in Section 3.4.4).
The same alignments were used to determine clone coverage obtained by the
pooled method and, in contrast to identity, the sequence coverage of pooled clones
varied widely. To assess clone coverage, I ﬁrst categorized the 73 clones into Clone
Types (Type A, B, C, or D) based on whether one or both end-tags were obtained,
whether the end-tags were able to retrieve a pooled contig, and whether one or two
pooled contigs were retrieved (Figure 3.5; designations for each clone are provided in
Table 3.1).
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Figure 3.5: Percent coverage of pooled sequencing result relative to barcoded sequencing
result. Each of the 73 clones was categorized into Clone Types A, B, C, or D by the number of end-
tags obtained (one or two), whether the end-tag retrieved a contig from the pool, and the completeness
of the retrieved pooled sequencing result relative to the reference barcoded sequencing result (full or
partial coverage). Clone Type descriptions are given above. [167]
69
CHAPTER 3. EVALUATION OF POOLED ILLUMINA SEQUENCING FOR METAGENOMIC CLONES
Table 3.1: Clone type classiﬁcation for 73 clones. [167]
Count Clone Clone Type
1 BF4 B
2 BT2 A
3 Cel-1 B
4 Cel-32-1 B
5 Cel-3-22-2 B
6 Cel-60-1 B
7 CM-111 D
8 CM-123 A
9 CM-129 A
10 CM-130 A
11 CM-136 A
12 cm18 C
13 CM-18 A
14 CM-19 D
15 CM-2 C
16 Cm26 B
17 Cm3 D
18 Cm30 B
19 CM-31 D
20 CM-4 D
21 cm42 B
22 CM-69 C
23 CM-92 A
24 CX4s17 D
25 CX4s8 B
26 CX6-4 C
27 CX9-10 B
28 CX9s4 B
29 Km-1 C
30 lac-ec1 C
31 lac-ec104 D
32 lac111 C
33 lac121 B
34 lac-ec123 C
35 lac127 B
36 lac13 A
37 lac146 B
38 lac153 B
39 lac16 A
40 lac160 A
41 lac161 A
42 lac170 B
43 lac193 A
44 lac20 B
45 lac24B C
46 lac27B C
47 lac35B C
48 lac36W A
49 lac55 A
50 lac71 B
51 lac82 D
52 lac84 A
53 MEL125 B
54 MEL126 B
55 PO3 A
56 RCX18 B
57 RCX2 B
58 RCX24 A
59 RCX25 D
60 RCX28 B
61 RCX31 A
62 RCX32 B
63 RCX6 D
64 RCX7 D
65 RCX8 A
66 RCX9 D
67 RCX92 A
68 PCX9M1 A
69 PCX9M3 B
70 PCX9M5 B
71 Xyl 2 B
72 Xyl 3 B
73 Xyl 4 A
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Type A represents the ideal outcome, in which the two end-tags retrieved the
same contig from the pool; in this case, pooled sequencing resulted in ∼100% coverage
for the clone. Type B represents a scenario in which end-tags retrieved diﬀerent contigs
due to a gap in coverage in the middle of the clone. Types C and D represent cases
in which coverage was variable and likely underestimated, given that one of the two
end-tags either failed to retrieve a contig or was simply missing, respectively. Coverage
was highly variable, ranging from 0.4-100.0% over the 73 clones analyzed (Figure 3.5;
percent coverage for all clones is provided in Table 3.2).
To determine how well the pooled sequencing strategy worked overall, I used the
same coverage data (from Figure 3.5) to bin the 73 clones by coverage (Figure 3.6B).
About one-half of the clones showed a retrieved coverage of 90-100%, with an overall
average coverage of 71%. I next asked whether the retrieved coverage was an underes-
timation of the actual coverage achieved by pooled sequencing. To obtain an estimate
of the actual coverage, it was necessary to account for unretrieved clone sequences in
the pooled sequencing results, which would have occurred due to sequencing gaps, re-
sulting in multiple contigs for a single clone. A comparison of the retrieved coverage to
the actual coverage may help to determine whether increasing sequencing depth could
increase clone coverage.
Mike Hall assisted me in recovering unretrieved sequences for each clone, using
the reference barcoded sequencing result to query the pool (rather than using the end-
tags). As an example of this diﬀerence, when the speciﬁc end-tags for Lactose clone 20
are used to retrieve its sequence from the pool, we obtained a retrieved coverage of 48%
(Figure 3.6A); however, when the reference barcoded sequencing result is used instead
to query the pooled sequencing results, the coverage improved to 95%. This latter
value reﬂects the actual sequence coverage of the clone found in the pooled sequencing
results.
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This strategy was employed to correct for unretrieved sequences for all 73 clones,
using a 250-base length cut-oﬀ and 99.6% identity cut-oﬀ; after this correction, coverage
improved to an average of 85%, with over 80% of the clones showing 90-100% coverage
(Figure 3.6C; retrieved versus estimated actual coverage for each clone is provided in
Table 3.2).
Figure 3.6: Retrieved coverage and estimated actual coverage of pooled
sequencing relative to barcoded sequencing. (A) An example clone, Lactose
clone 20, shows retrieved coverage at 48% (using end-tags as queries), but an actual
coverage of 98% (using barcoded result as query). (B and C) Percent coverage for each
of the 73 clones, binned in ten-percent increments. Retrieved coverage (B) is compared
to estimated actual coverage (C). [167]
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Table 3.2: Retrieved versus estimated actual coverage for 73 clones [167]
Count Clone
1 BF4 0.7367 0.9854
2 BT2 0.9946 0.9946
3 Cel-1 0.5079 0.9289
4 Cel-32-1 0.4487 0.9404
5 Cel-3-22-2 0.4488 0.9404
6 Cel-60-1 0.4826 0.9459
7 CM-111 0.9941 0.9941
8 CM-123 0.9933 0.9933
9 CM-129 0.9917 0.9917
10 CM-130 0.9936 0.9936
11 CM-136 0.9934 0.9934
12 cm18 0.0394 0.1026
13 CM-18 0.9754 0.9754
14 CM-19 0.1214 0.9944
15 CM-2 0.4178 0.9931
16 Cm26 0.0900 0.1867
17 Cm3 0.0043 0.0911
18 Cm30 0.0789 0.1125
19 CM-31 0.9940 0.9940
20 CM-4 0.9939 0.9939
21 cm42 0.1159 0.2099
22 CM-69 0.1004 0.9856
23 CM-92 0.9947 0.9947
24 CX4s17 0.8590 0.9885
25 CX4s8 0.8417 0.8417
26 CX6-4 1.0000 1.0000
27 CX9-10 0.9908 0.9910
28 CX9s4 0.6895 0.9611
29 Km-1 0.9385 0.9619
30 lac-ec1 0.0878 0.3406
31 lac-ec104 0.1895 0.2589
32 lac111 0.1998 0.9667
33 lac121 0.8896 0.9806
34 lac-ec123 0.3211 0.3940
35 lac127 0.9922 0.9922
36 lac13 0.9937 0.9937
37 lac146 0.9794 0.9794
38 lac153 0.9875 0.9875
39 lac16 0.9865 0.9865
40 lac160 0.9941 0.9941
41 lac161 0.9941 0.9941
42 lac170 0.5329 0.9502
43 lac193 0.9940 0.9940
44 lac20 0.4826 0.9459
45 lac24B 0.0635 0.1732
46 lac27B 0.0624 0.1700
47 lac35B 0.0167 0.1278
48 lac36W 0.9938 0.9938
49 lac55 0.8491 0.8491
50 lac71 0.7695 0.9438
51 lac82 0.0204 0.8006
52 lac84 0.9817 0.9817
53 Mel-125 0.9905 0.9905
54 Mel-126 0.8557 0.9760
55 PO3 0.9782 0.9782
56 RCX18 0.9984 0.9984
57 RCX2 0.7704 0.9985
58 RCX24 0.9991 0.9991
59 RCX25 0.7666 1.0000
60 RCX28 0.9951 0.9951
61 RCX31 1.0000 1.0000
62 RCX32 0.5387 0.9968
63 RCX6 0.6946 0.9796
64 RCX7 0.2809 0.9970
65 RCX8 0.9836 0.9836
66 RCX9 0.6714 1.0000
67 RCX92 0.9853 0.9853
68 PCX9M1 1.0000 1.0000
69 PCX9M3 0.8872 0.9890
70 PCX9M5 1.0000 1.0000
71 Xyl 2 0.9692 0.9692
72 Xyl 3 0.9686 0.9686
73 Xyl 4 1.0000 1.0000
Retrieved Coverage 
(Pooled relative to Barcoded)
Estimated Actual Coverage 
(Pooled relative to Barcoded)
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These data suggest that an increase in the sequencing depth of the pooled strategy
may help to increase clone coverage, as this should reduce the occurrence of gaps that
prevent retrieval of the full clone sequence. Indeed, others have shown full recovery of
circular DNA molecules using a pooled sequencing approach in other applications. For
example, bulk sequencing of the plasmid fraction of an activated sludge metagenome
resulted in the complete assembly of forty plasmids, which were conﬁrmed to be closed
circular replicons by PCR [261], and pooled sequencing of mitochondrial genomes re-
sulted in complete assembly of each, although the authors found that de novo tran-
scriptome assemblers, designed for handling reads with diﬀerential coverage, provided
much better assembly then assemblers meant for genomes [247]. Together, these results
support our ﬁndings that a pooled strategy can be an eﬀective alternative.
3.4.3 Clones with sequence similarity may have poor recovery
To determine if factors other than depth of sequencing aﬀect clone coverage in a pooled
approach, I ﬁrst examined the sequence similarity between clones. To do this, I per-
formed an all-by-all pair-wise BLAST comparison of clones, using their barcoded ref-
erence sequences (see Section 3.6.9 for details). I found that the majority of the 73
clones had little or no sequence similarity to any other clone in the pool (Figure 3.7A).
However, some clones did have sequence similarity; furthermore, the clones that had
sequence similarity were often the same clones that had poor retrieved coverage from
pooled sequencing (Figure 3.7B). This was particularly striking when comparing to the
actual coverage (Figure 3.7C), suggesting that increasing the depth of sequencing may
improve clone coverage from pooled sequencing, but only for those clones that do not
have sequence similarity to other clones present in the pool.
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Figure 3.7: Heat map of clone sequence similarity and corresponding bar plots of clone
coverage. Pair-wise sequence similarity is shown for all 73 clones (A), juxtaposed to their pooled
sequencing coverage, showing both retrieved coverage (B) and actual coverage (C). [167]
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I next asked what the sequencing read depth was for each clone to try to under-
stand how the read depth and clone sequence similarity might be related. I asked Mike
Hall to estimate the read depth of each of the 73 clones by aligning the raw reads to the
assembled contig (see Section 3.6.8 for details; read depth for both pooled sequencing
and barcoded sequencing for each clone is provided in Table 3.3). The idea that similar
clones are problematic for a pooled sequencing strategy was corroborated using the
data from Mike Hall’s read depth analysis of each of the 73 clones. To examine the
relationship between read depth and pooled sequencing coverage, I plotted the read
depth of each clone against both its retrieved and actual coverage (Figure 3.8). I found
that for a number of clones, the estimated read depth was particularly high and yet
the coverage was unusually low; upon inspecting the identity of these clones, I found
them to be the same clones that shared sequence similarity.
Perhaps not unexpectedly, these results suggest that when clones have sequence
similarity, pooling and fragmenting the DNA for sequencing causes: (a) an overrep-
resentation of similar sequences in the pooled sequencing data, and (b) diﬃculty in
assembling the sequences, leading to lack of coverage for the clones from which the
sequences originate. There may be other factors that impact the success of pooled
sequencing and assembly, such as the presence of repetitive sequences, but this work
results suggest that sequencing depth and clone sequence similarity are two signiﬁcant
factors.
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Figure 3.8: Clone read depth plotted against clone coverage in pooled sequencing. The
overall read depth for each clone in the pooled sequencing strategy was estimated and plotted against
either the uncorrected coverage (A) or corrected coverage (B). [167]
77
CHAPTER 3. EVALUATION OF POOLED ILLUMINA SEQUENCING FOR METAGENOMIC CLONES
Table 3.3: Estimated read depth for both pooled and barcoded approaches,
ranked by depth of pooled sequencing. [167]
Barcode Clone Name
AGATAG lac55 3952 29704
GTGAAA lac27B 3196 8300
CAGATC lac35B 2616 8277
GCCAAT Cm30 2547 7716
GTCCGC Cm3 2544 9925
TTCTCC lac24B 2506 8611
AGAAGA cm18 2456 11288
AATAGG Cm26 2357 8367
CAGGCG lac-ec104 2350 10874
ATCTAT lac-ec1 2312 8384
AAAGCA cm42 2301 9909
CCTTAG lac-ec123 2020 8490
CACTCA Cel-1 1608 7606
ATGAGC lac71 1526 8087
CATGGC lac82 1314 11190
ACCCAG PO3 1263 10374
CACCGG RCX8 1142 7197
TCCCGA Cel-60-1 1117 6917
TCGAAG lac20 1117 5935
TTCGAA Km-1 1111 8388
AGCATC lac170 1093 3274
GAAACC Cel-3-22-2 1056 11067
CCGCAA Cel-32-1 1056 9250
GCAAGG CM-18 990 18870
GAGTGG RCX92 984 7952
TGGCGC CX4s8 868 16764
ACTTGA lac153 743 8880
ATCACG Xyl 2 700 27923
GATCAG Xyl 3 687 21714
GATATA lac84 663 14161
GGCACA lac111 545 7344
GTGGCC lac146 507 7717
GCTCCA lac16 491 9720
AGGTTT lac127 489 8199
CGGAAT lac121 485 10593
ACAAAC lac36W 484 8909
AGTTCC CM-69 479 10386
ACTGAT Mel-125 474 9722
TGCTGG RCX25 430 5919
CCGTCC RCX28 409 7582
CAAAAG BF4 408 11194
ATTCCT lac193 402 7991
CCCATG RCX18 400 7213
TGCCAT CM-129 397 8858
ACCGGC CM-136 391 9065
ACATCT lac161 373 10605
TACAGC CM-123 366 7313
CTTGTA RCX32 361 5984
ATCCTA Mel-126 358 10115
AACTTG CM-4 342 8342
GAATAA lac13 340 8453
ACGATA RCX6 310 7541
TGAATG CM-2 304 8761
TAGCTT CM-130 300 8133
AGCGCT BT2 297 11897
CGTACG lac160 270 5424
CAACTA CM-31 268 7539
CCACGC CM-111 267 8209
ACAGTG CX6-4 267 5986
TAATCG CM-92 256 5029
GCCGCG PCX9M3 255 5055
GCACTT RCX2 246 6884
CTCAGA RCX9 240 7227
AAACAT CX9-10 231 8804
GTAGAG CX4s17 227 5772
CTATAC CM-19 224 7553
ATAATT RCX7 218 6747
TATAAT RCX24 191 6843
CTGCTG PCX9M1 178 6976
AAGGAC CX9s4 167 7853
AACCCC Xyl 4 164 10947
TCATTC PCX9M5 163 5026
TGACCA RCX31 163 4348
Mean 881 9249
Pooled Sequencing 
Read Depth
Barcoded Sequencing 
Read Depth
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3.4.4 Consensus assemblies: a caveat of the pooled approach
Due to the nature of the pooled assembly, overlapping clones assemble into larger con-
tigs. Indeed, three clones were determined to be overlapping by the barcoded sequence
data, as well as the pooled sequence data (Figure 3.9).
Figure 3.9: Overlapping clones assemble into one contig. Three overlapping
clones as revealed by barcoded sequencing (above) and pooled sequencing (below). Lo-
cations of end-tags are indicated by vertical dashed lines. White dashed boxes indicate
gaps in the pooled sequencing data; black boxes indicate a contig. Lengths of all contigs
are given. [167]
In the latter, three contigs were retrieved from the pool using their six end-tags;
more than one contig was retrieved due to incomplete sequencing and/or assembly by
the pooled method, as discussed above (i.e., Figure 3.6 and Figure 3.7). Although
this larger contig is derived from three clones, such a contig should not be classiﬁed as
chimeric because it represents the metagenomic DNA as it would be found in nature.
Furthermore, individual clone sequences can be easily delineated from the greater contig
by alignment of clone end-tags to the contig (as illustrated in Figure 3.9).
This particular caveat of pooled sequencing can be viewed as a positive aspect
rather than a negative one, because clones from diﬀerent screens can be immediately
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identiﬁed as overlapping simply from the clone sequence retrieval process. That be-
ing said, the assembly of a consensus sequence from overlapping clones may imply
a loss of clone-speciﬁc information. It is possible that, in some cases, overlapping
clones represent diﬀerent strains of the same microorganism, or diﬀerent alleles of the
same genes(s). Through pooled assembly and depending on the assembler parameters,
such clone-speciﬁc allelic information, in the form of single nucleotide polymorophisms
(SNPs) or similar small sequence variations, may be lost – that is, the ﬁnal consensus
sequence may represent only the most frequent allele. If it should arise, the issue of in-
formation loss for allelic variations may be remedied by further analysis. For example,
if clones were determined to be overlapping from the consensus contig obtained from
pooled sequencing, it would be possible to examine the raw reads to determine if SNPs
are present. If so, sequencing primers could be designed for the target loci to determine
exactly which SNP(s) belong to which clones in the physical DNA collection.
3.4.5 Improvements and considerations
In this study, our lab investigated the quality of data obtained from pooled sequencing
because this strategy oﬀered an economical solution to the high cost of traditional
barcoded sequencing. At the time this work began, there was a large cost diﬀerence in
the two services that were available (Table 3.4 and Table 3.5). Since then, this diﬀerence
has decreased, and it is likely that it will continue to do so with further developments in
sequencing technology. At least for the time being, however, pooled sequencing remains
a more aﬀordable option for functional metagenomics research, particularly if a large
number of clones must be sequenced.
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Table 3.4: Cost of barcoded sequencing at the Genome Sciences Centre,
BC Cancer Agency, Vancouver, Canada. [167]
Traditional Barcoded Illumina
miniprep $100.00
barcoded library construction $8,700.00
sequencing $1,300.00
assembly (in-house) $0.00
total cost $10,100.00
turnaround time 6 months
average coverage per clone 100% (reference)
Table 3.5: Cost of pooled sequencing at the Beijing Genomics Institute,
Tai Po, Hong Kong. [167]
Sanger-Illumina Pooled Sequencing
miniprep $100.00
Sanger end-sequencing $1,000.00
library construction $400.00
pooled sequencing $300.00
assembly and annotation $400.00
total cost $2,200.00
turnaround time 4 months
average coverage per clone, uncorrected 71%
average coverage per clone, corrected 85%
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In our workﬂow, the lab concurrently had clones analyzed by pooled sequencing
and by Sanger sequencing (for the generation of end-tags); this was done concurrently
due to anticipation of a lengthy turnaround time for the Illumina sequencing results,
which is typically (and was in fact) the case. However, given our experience, I recom-
mend obtaining end sequences for all clones before carrying out pooled sequencing, due
to the unexpected diﬃculty of Sanger-sequencing certain clones. Without two end-tags
for each clone, it becomes diﬃcult to retrieve the corresponding contig from the pool
without further work, such as subcloning and sequencing fragments of the insert (which
would negate the ease and economy of the pooled sequencing strategy).
Assembly for both the barcoded and the pooled sequencing strategies revealed
contamination with E. coli genomic DNA sequences, indicating that minipreps of cos-
mid clones contained host DNA. Similar results were reported for genomic library BAC
clones isolated for pooled sequencing [193]. Such contamination adds undesired DNA
template to the sequencing reaction, aﬀecting required-depth-of-coverage calculations,
and possibly leading to insuﬃcient sequencing and poor clone sequence recovery. This
may have been a problem in our own incomplete recovery for the pooled strategy. We
recommend removing contaminating genomic DNA by cesium chloride density puriﬁ-
cation or pre-treatment of samples with Plasmid-Safe DNase (Epicentre), which may
help reduce genomic contamination up to ten-fold [16]. Clone sequence recovery was
not problematic in the barcoded sequencing strategy because the sequencing depth
was extremely high for the purpose of generating high-quality reference sequence data
(Figure 3.3).
Another consideration for pooled sequencing relates to the problem of sequence
similarity (Figure 3.7). These results indicate that clones that have sequence similarity
are problematic in a pooled strategy, likely due to diﬃculties in assembling the similar
reads and resulting in poor clone sequence recovery. The simple solution would be to
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avoid pooling clones that share sequence similarity, but this remains a diﬃcult, if not
impossible, task without prior knowledge of the clone sequence. A possible way to
reduce the potential for sequence similarity may be to assemble pools of clones such
that the diversity of functional screens represented is maximized within a pool. In this
way, the presence of homologous genes may be reduced.
One other consideration for the pooled sequencing strategy relates to the issue of
consensus assemblies, which may occur for overlapping clones during assembly process
(Figure 3.9). Since overlapping clones likely (though not always) result from the same
functional screen, it is possible for the experimental biologist to minimize their pres-
ence by doing restriction proﬁle comparisons prior to selecting clones for pooling and
sequencing. It may also be possible to reduce loss of clone-speciﬁc sequence variation by
using combinatorial or overlapping clone pooling approaches, which have been used by
others for strategic sequencing of BAC clones from genomic libraries [30,193] as well as
plasmid-based oligonucleotide libraries [79]. In such an approach, a large set of clones
is divided into subpools such that each clone is present in multiple subpools, but no
two clones are in the same subpool more than once, which can help resolve ambiguity
in the case that clones in one pool have sequence similarity. In the simplest approach
for combining the barcoded and pooled sequencing strategies, a large pool of clones
could be split into smaller subpools, each of which gets barcoded. By strategically
using a mixture of barcoding, pooling, and/or duplicate sequencing, one can strike a
balance between making use of sequencing power and being able to recover accurate
and complete clone sequence information.
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3.5 Conclusions
We explored a more economical sequencing strategy than barcoded sequencing by using
a pooled sequencing method that successfully obtained sequence information for a set of
large-insert clones. In particular, we validated this method by comparing the sequence
data to reference data generated from barcoded sequencing of the same set of clones.
By observing identity and coverage between the two datasets for 73 clones, I have
demonstrated high quality assemblies from the pooled sequencing dataset. Using the
pooled strategy, retrieved clone sequences showed high accuracy, with identity at 99.9-
100% for the majority of clones. The amount of sequence recovered for each clone,
however, was variable; averaged across 73 clones, the retrieved coverage was 71%, with
some clones showing full coverage, and others with minimal coverage. Correcting for
sequencing gaps, the average coverage increased to 85%. These results suggest that
increasing sequencing depth can improve clone coverage, but that clones that have
sequence similarity are problematic in a pooled strategy regardless. Though pooled
sequencing has generated promising results, reﬁnement of the method is required: se-
quencing depth will need to be optimized to obtain maximum recovery of clone se-
quence, and the choice of clones to pool will also need consideration, to minimize the
presence of clones with sequence similarity.
These results demonstrate that, with further optimization, a pooled sequencing
approach could become the preferred method of generating clone sequence data, as its
cost is a fraction of that of barcoded sequencing. It is important to note that clone
sequence recovery may not be complete or even possible for all clones that have been
pooled for sequencing; however, until the cost of barcoding many samples becomes
aﬀordable in the way that Sanger sequencing has become aﬀordable, pooled sequencing
of large sets of clones remains a relevant and reasonable strategy.
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3.6 Specific materials and methods
3.6.1 Ethics Statement
Approval for the collection of human fecal samples was obtained from the Oﬃce of
Research Ethics of the University of Waterloo in Waterloo, Canada, and written consent
was obtained from the volunteers. No identiﬁcation was attached to the collected
samples and samples were pooled prior to use.
3.6.2 Isolation of HMW DNA
Soil samples were obtained from diverse environments across Canada [222]. Information
regarding the metagenomic libraries constructed from Canadian soil samples is available
online through the Canadian MetaMicrobiome Project website (http://www.cm2bl.org).
The isolation of high-molecular-weight DNA was previously described for fecal
samples (Section 2.4.5) and for pure bacterial cultures (Section 2.4.6). Extracted DNA
was either cloned directly or puriﬁed further by synchronous coeﬃcient of drag al-
teration (SCODA) using the Aurora (Boreal Genomics) according to an established
protocol [75]. Crude or SCODA-puriﬁed DNA was quantiﬁed by gel electrophoresis,
using bacteriophage λ DNA as a standard.
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3.6.3 Construction of large-insert metagenomic cosmid libraries
The cosmid vector pJC8 (Genbank accession KC149513; [43]) formed the backbone
of all metagenomic libraries constructed in this study. In addition to constructing
new libraries, existing metagenomic clones were used from previous libraries [320],
constructed in the cosmid vector pRK7813 (Genbank accession KC442292; [139]). All
libraries have entries in the NCBI BioSample database [13], and details regarding the
libraries used in this study are summarized in Table 3.6.
Table 3.6: Metagenomic and genomic libraries screened.
Library
name
NCBI
BioSample
DNA source No.
clones
Vector Ref.
12AC SAMN02324088 soil (agricultural) 80,000 pJC8 [43]
BF1 SAMN02324093 Bacteroides fragilis 18,000 pJC8 this study
BT1 SAMN02324089 Bacteroides thetaiotaomicron 8,000 pJC8 this study
CLGM1 SAMN02324081 human feces 42,000 pJC8 this study
CX3 SAMN02324235 activated sludge (pulp and
paper)
2,500 pRK7813 [320]
CX4 SAMN02393652 activated sludge (pulp and
paper)
3,900 pRK7813 [320]
CX6 SAMN02393657 activated sludge (municipal) 3,300 pRK7813 [320]
CX9 SAMN02393684 soil (creek) 22,000 pRK7813 [320]
CX10 SAMN02393686 soil (creek) 8,700 pRK7813 [320]
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Libraries were constructed as previously described [43]. Brieﬂy, the vector pJC8
was digested with Eco72I/PmlI to produce blunt ends and then dephosphorylated. The
backbone was puriﬁed from the 0.8 kb gentamicin resistance gene stuﬀer, either with
an EZ-10 Spin Column DNA Gel Extraction Kit (BioBasic) or by electroelution. The
high-molecular-weight DNA extracted from either environmental samples or pure cul-
ture (up to 25 ➭g of either crude or puriﬁed DNA) was size-selected by pulsed-ﬁeld
gel electrophoresis (PFGE) using a CHEF MAPPER Pulsed Field Gel Electrophore-
sis System (Bio-Rad). The gel fragment containing DNA of approximately 40-70 kb
was excised, then electroeluted and concentrated using an Amicon Ultra Centrifugal
Filter with 30 kDa MWCO (Millipore). Puriﬁed DNA (2.5 ➭g) was end-repaired using
the End-It DNA End-Repair Kit (Epicentre). A phenol:chloroform extraction was per-
formed to remove T4 polynucleotide kinase, and DNA was precipitated, resuspended in
TE, and quantiﬁed by gel electrophoresis, using bacteriophage λ DNA as a standard.
The puriﬁed and blunt-ended DNA was then ligated to the linearized cosmid vector.
Ligations were carried out at 14❽ overnight with Fast-Link DNA Ligase (Epicentre),
using 500 ng of end-repaired insert DNA and a vector-to-insert molar ratio of 10:1.
Ligations were packaged into λ phage heads using Gigapack III XL Packaging Extract
(Stratagene 200209) according to the manufacturer’s instructions, and the ﬁnal phage
suspension was stored at 4❽.
To prepare cells for transduction, E. coli HB101 was streaked from frozen stock
onto LB agar, and a single colony was then inoculated into 5ml of LB. The culture
was grown overnight at 37➦C, and was subcultured 1:200 in 5ml of LB supplemented
with 0.2% maltose and 10mM MgSO4. The culture was grown to an OD600 of 0.8
(Spectronic Spec 20D). Cells were pelleted by centrifugation, resuspended in 2.5ml
of LB supplemented with 10mM MgSO4, and held on ice. For an estimate of phage
concentration, 10 ➭l phage were mixed with 90 ➭l cells, and the mixture was incubated
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at room temperature for 30 minutes, and moved to 37❽ for 30 minutes. Cells were
pelleted by centrifugation and plated on LB with 20 ➭g/ml tetracycline to select for
transductants. Plates were incubated overnight at 37❽ and colonies were counted to
estimate phage concentration in the suspension. Finally, the transduction was scaled
up to achieve approximately 1000 colonies per plate. Several plates were counted for
an estimate of metagenomic library size, and then pooled and stored at -80❽. For
regular use, libraries were propagated from the original frozen stock. For an estimate
of average insert size, library stocks were streaked onto LB with 20 ➭g/ml tetracycline,
and colonies were selected at random for restriction analysis.
3.6.4 Functional screens and positive clones
Various function-based screens were performed in our laboratory, including screens for
antibiotic resistance genes, conjugation genes, and carbohydrate utilization genes. Tens
to hundreds of positive clones were isolated from each screen although 92 distinct clones
(based on restriction enzyme digestion patterns) were chosen for full sequencing. The
list of clones and the screens from which they were isolated are provided (Table 3.7).
Cosmid clone DNA was isolated from either E. coli HB101 or DH5α.
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Table 3.7: Functional screens from which cosmid clones were isolated; bolded clone
names indicate those excluded from analyses. [167]
Count Clone Name Functional Screen Library Name Vector Backbone
1 BF4 random clone Bacteroides fragilis cosmid library BF1 pJC8
2 BT2 random clone Bacteroides theta cosmid library BT1 pJC8
3 Cel-1 cellobiose utilization 12AC pJC8
4 Cel-32-1 cellobiose utilization 12AC pJC8
5 Cel-3-22-2 cellobiose utilization 12AC pJC8
6 Cel-3-24-2 cellobiose utilization 12AC pJC8
7 Cel-60-1 cellobiose utilization 12AC pJC8
8 CM-10 conjugation 12AC pJC8
9 CM-110 conjugation 12AC pJC8
10 CM-111 conjugation 12AC pJC8
11 CM-123 conjugation 12AC pJC8
12 CM-129 conjugation 12AC pJC8
13 CM-130 conjugation 12AC pJC8
14 CM-131 conjugation 12AC pJC8
15 CM-135 conjugation 12AC pJC8
16 CM-136 conjugation 12AC pJC8
17 CM-15 conjugation 12AC pJC8
18 cm18 chloramphenicol resistance 12AC pJC8
19 CM-18 conjugation 12AC pJC8
20 CM-19 conjugation 12AC pJC8
21 CM-2 conjugation 12AC pJC8
22 CM-20 conjugation 12AC pJC8
23 Cm26 chloramphenicol resistance 12AC pJC8
24 Cm3 chloramphenicol resistance 12AC pJC8
25 Cm30 chloramphenicol resistance 12AC pJC8
26 CM-31 conjugation 12AC pJC8
27 CM-4 conjugation 12AC pJC8
28 cm42 chloramphenicol resistance 12AC pJC8
29 CM-45 conjugation 12AC pJC8
30 CM-56 conjugation 12AC pJC8
31 CM-64 conjugation 12AC pJC8
32 CM-69 conjugation 12AC pJC8
33 CM-92 conjugation 12AC pJC8
34 CX4s17 PHB synthesis CX4 pRK7813
35 CX4s8 PHB synthesis CX4 pRK7813
36 CX6-4 PHB synthesis CX6 pRK7813
37 CX9-10 PHB synthesis CX9 pRK7813
38 CX9s4 PHB synthesis CX9 pRK7813
39 jac97W lactose utilization 12AC pJC8
40 Km-1 kanamycin resistance 12AC pJC8
41 lac-ec1 lactose utilization 12AC pJC8
42 lac100B lactose utilization 12AC pJC8
43 lac-ec104 lactose utilization 12AC pJC8
44 lac111 lactose utilization 12AC pJC8
45 lac121 lactose utilization 12AC pJC8
46 lac112W lactose utilization 12AC pJC8
47 lac-ec123 lactose utilization 12AC pJC8
48 lac127 lactose utilization 12AC pJC8
49 lac13 lactose utilization 12AC pJC8
50 lac146 lactose utilization 12AC pJC8
51 lac153 lactose utilization 12AC pJC8
52 lac16 lactose utilization 12AC pJC8
53 lac160 lactose utilization 12AC pJC8
54 lac161 lactose utilization 12AC pJC8
55 lac170 lactose utilization 12AC pJC8
56 lac193 lactose utilization 12AC pJC8
57 lac20 lactose utilization 12AC pJC8
58 lac224 lactose utilization 12AC pJC8
59 lac24B lactose utilization 12AC pJC8
60 lac27B lactose utilization 12AC pJC8
61 lac35B lactose utilization 12AC pJC8
62 lac36B lactose utilization 12AC pJC8
63 lac36W lactose utilization 12AC pJC8
64 lac55 lactose utilization 12AC pJC8
65 lac71 lactose utilization 12AC pJC8
66 lac82 lactose utilization 12AC pJC8
67 lac84 lactose utilization 12AC pJC8
68 Mel-125 melibiose utilization 12AC pJC8
69 Mel-126 melibiose utilization 12AC pJC8
70 PO3 random clone human gut library CLGM1 pJC8
71 RCX11 3-hydroxybutyrate utilization CX4 pRK7813
72 RCX12 3-hydroxybutyrate utilization CX4 pRK7813
73 RCX13 3-hydroxybutyrate utilization CX4 pRK7813
74 RCX15 3-hydroxybutyrate utilization CX4 pRK7813
75 RCX18 3-hydroxybutyrate utilization CX9 pRK7813
76 RCX2 3-hydroxybutyrate utilization CX3 pRK7813
77 RCX24 3-hydroxybutyrate utilization CX9 pRK7813
78 RCX25 3-hydroxybutyrate utilization CX9 pRK7813
79 RCX28 3-hydroxybutyrate utilization CX9 pRK7813
80 RCX31 3-hydroxybutyrate utilization CX9 pRK7813
81 RCX32 3-hydroxybutyrate utilization CX10 pRK7813
82 RCX6 3-hydroxybutyrate utilization CX4 pRK7813
83 RCX7 3-hydroxybutyrate utilization CX9 pRK7813
84 RCX8 3-hydroxybutyrate utilization CX9 pRK7813
85 RCX9 3-hydroxybutyrate utilization CX10 pRK7813
86 RCX92 3-hydroxybutyrate utilization CX9 pRK7813
87 PCX9M1 3-hydroxybutyrate utilization CX9 pRK7813
88 PCX9M3 3-hydroxybutyrate utilization CX9 pRK7813
89 PCX9M5 3-hydroxybutyrate utilization CX9 pRK7813
90 Xyl 2 xylose utilization CX9 pRK7813
91 Xyl 3 xylose utilization CX9 pRK7813
92 Xyl 4 xylose utilization CX9 pRK7813
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3.6.5 Barcoded sequencing
Cosmid DNA was prepared from E. coli DH5α using a GeneJET Plasmid Miniprep
Kit (Thermo Scientiﬁc), and 1-2 ➭g of DNA from each of the 92 samples was adjusted
to ¿25 ng/➭l. Samples were submitted to the BC Cancer Agency at the Michael Smith
Genome Sciences Centre for individual barcoding and 75-base paired-end sequencing
on the Illumina HiSeq 2000 platform, using in-house protocols and reagents for library
construction. Clones were sequenced to a read depth of approximately 9000-fold, on
average (Figure 3.3 and Table 3.3). This high coverage was ideal for a high-quality
reference data set. Vector sequences were subtracted from the raw data by comparing all
reads against the vector backbone using BLAST (with a requirement for 100% identity),
and the data were assembled using ABySS version 1.3.2 [272]; default settings were
used, with the exception of a k -mer length of 64. At the time of assembly, the complete
sequence of the cosmid vector pJC8 was not yet available; as a result, vector subtraction
used the closely related parent vector pRK404 (Genbank accession AY204475; [63]), and
assemblies were checked subsequently for remaining vector sequences.
After assembly, the barcoded sequencing data were prepared in order to use as
a reference for evaluation of the pooled sequencing data. For the majority of clones,
assembly resulted in a single contig, usually exceeding 30 kb, as expected. For cases
in which assembly resulted in more than one contig, contigs were manually checked
for sequences from contaminating E. coli genomic DNA, helper plasmids, and cloning
vectors, and those contigs were removed. For 3 clones, multiple contigs remained,
indicating the samples may have been insuﬃciently sequenced, resulting in gaps. Ac-
cordingly, we concatenated the multiple large contigs and treated them as one contig.
Using the described strategy, reference contigs were obtained for 77 out of 92 clones.
The average contig length was 33.5 kb, with the largest being 47.2 kb and the smallest
1.8 kb. Though our cloning strategy enriches for high-insert clones, we have occasion-
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ally observed smaller inserts after carrying out functional screening. These smaller
inserts may have arisen from recombination and subsequent loss of cloned DNA after
the library construction process. Sequence data have been made available for download
(see below). Barcodes are provided in Table 3.8.
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Table 3.8: Barcodes corresponding to each clone for Illumina sequencing. [167]
Count Clone Name Barcode
1 BF4 CAAAAG
2 BT2 AGCGCT
3 Cel-1 CACTCA
4 Cel-32-1 CCGCAA
5 Cel-3-22-2 GAAACC
6 Cel-3-24-2 GCCTTA
7 Cel-60-1 TCCCGA
8 CM-10 AAGACT
9 CM-110 CTAGCT
10 CM-111 CCACGC
11 CM-123 TACAGC
12 CM-129 TGCCAT
13 CM-130 TAGCTT
14 CM-131 GGCTAC
15 CM-135 TTAGGC
16 CM-136 ACCGGC
17 CM-15 CGATGT
18 cm18 AGAAGA
19 CM-18 GCAAGG
20 CM-19 CTATAC
21 CM-2 TGAATG
22 CM-20 ATGTCA
23 Cm26 AATAGG
24 Cm3 GTCCGC
25 Cm30 GCCAAT
26 CM-31 CAACTA
27 CM-4 AACTTG
28 cm42 AAAGCA
29 CM-45 CCAACA
30 CM-56 AGGCCG
31 CM-64 GATGCT
32 CM-69 AGTTCC
33 CM-92 TAATCG
34 CX4s17 GTAGAG
35 CX4s8 TGGCGC
36 CX6-4 ACAGTG
37 CX9-10 AAACAT
38 CX9s4 AAGGAC
39 jac97W CGAGAA
40 Km-1 TTCGAA
41 lac-ec1 ATCTAT
42 lac100B GACGGA
43 lac-ec104 CAGGCG
44 lac111 GGCACA
45 lac121 CGGAAT
46 lac112W TCGGCA
47 lac-ec123 CCTTAG
48 lac127 AGGTTT
49 lac13 GAATAA
50 lac146 GTGGCC
51 lac153 ACTTGA
52 lac16 GCTCCA
53 lac160 CGTACG
54 lac161 ACATCT
55 lac170 AGCATC
56 lac193 ATTCCT
57 lac20 TCGAAG
58 lac224 CATTTT
59 lac24B TTCTCC
60 lac27B GTGAAA
61 lac35B CAGATC
62 lac36B AAATGC
63 lac36W ACAAAC
64 lac55 AGATAG
65 lac71 ATGAGC
66 lac82 CATGGC
67 lac84 GATATA
68 Mel-125 ACTGAT
69 Mel-126 ATCCTA
70 PO3 ACCCAG
71 RCX11 AAGCGA
72 RCX12 ACTCTC
73 RCX13 ATACGG
74 RCX15 CACGAT
75 RCX18 CCCATG
76 RCX2 GCACTT
77 RCX24 TATAAT
78 RCX25 TGCTGG
79 RCX28 CCGTCC
80 RCX31 TGACCA
81 RCX32 CTTGTA
82 RCX6 ACGATA
83 RCX7 ATAATT
84 RCX8 CACCGG
85 RCX9 CTCAGA
86 RCX92 GAGTGG
87 PCX9M1 CTGCTG
88 PCX9M3 GCCGCG
89 PCX9M5 TCATTC
90 Xyl 2 ATCACG
91 Xyl 3 GATCAG
92 Xyl 4 AACCCC
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3.6.6 Sanger end-sequencing and pooled sequencing
Cosmid DNA was prepared from E. coli DH5α using a GeneJET Plasmid Miniprep
Kit (Thermo Scientiﬁc). Aliquots of 100 ng from each of the 92 samples were pooled
and concentrated to 125 ng/➭l. The pooled samples were sequenced by the Beijing
Genomics Institute (BGI) using 90-base paired-end sequencing on the Illumina HiSeq
2000 platform, using in-house protocols and reagents for library construction. Clones
were sequenced to a read depth of approximately 900-fold on average (Figure 3.3),
upon recommendation of >100-fold coverage. The service provider subtracted vector
sequences using SOAPaligner version 2.21 [184] (again, using pRK404), and completed
assembly using SOAPdenovo version 1.05 [185], using a k -mer size of 31, and BWA
version 0.5.8 [181]. This resulted in 563 contigs ranging between 0.5 kb to 97.7 kb,
with a mean contig length of 11.7 kb. Contigs exceeding the expected insert size were
determined to be E. coli genomic DNA contamination, the presence of which did not
interfere with clone sequence retrieval, as retrieval is done using clone end sequences.
Concurrent to pooled sequencing, samples were end-sequenced by Sanger sequenc-
ing at BioBasic Inc., Lucigen Corporation, or The Centre for Applied Genomics, to
generate end-tags. One or both end sequences were obtained for 83 out of 92 clones.
Sequencing primers used were standard M13 forward and M13 reverse from the se-
quencing facility, or custom primers JC102 (5’TAACAATTTCACACAGGAAACAGCTATGAC) and
JC103 (5’GCGATTAAGTTGGGTAACGCCAGGGTTTTC). The obtained end-tags were then used
to query the pooled sequencing results, using NCBI nucleotide BLAST [4] running the
Megablast algorithm. In this manner, contigs were retrieved from the pool for each
clone; see Table 3.9 for details. Pooled sequence data and end sequence data have been
made available for download (see Section 3.6.10).
93
CHAPTER 3. EVALUATION OF POOLED ILLUMINA SEQUENCING FOR METAGENOMIC CLONES
Table 3.9: Summary of retrieved contigs for the pooled sequencing approach. [167]
Count Clone
Forward End-Tag (M13F/JC103) Reverse End-Tag (M13R/JC102)
End Tag? Tag Len Retrieved Contig ID Contig Len Align. Identity End Tag? Tag Len Retrieved Contig ID Contig Len Align. Identity
1 BF4 Y 661 scaffold196_1 9979 0.9847457627 Y 720 scaffold199_1 16126 0.9984802432
2 BT2 Y 517 scaffold258_1 39283 0.9712389381 Y 510 scaffold258_1 39283 0.9841986456
3 Cel-1 Y 1000 scaffold10_1 3594 0.9804347826 Y 563 scaffold7_1 17578 0.9936708861
4 Cel-32-1 Y 559 scaffold10_1 3594 0.9810526316 Y 561 scaffold7_1 17578 0.9977728285
5 Cel-3-22-2 Y 559 scaffold10_1 3594 0.9810526316 Y 561 scaffold7_1 17578 0.9977728285
6 Cel-60-1 Y 545 scaffold15_1 24084 0.9838337182 Y 1042 scaffold26_1 13528 0.9873817035
7 CM-111 Y 761 scaffold146_1 36324 0.9352226721 N
8 CM-123 Y 805 scaffold155_1 32613 0.9955686854 Y 886 scaffold155_1 32613 0.982278481
9 CM-129 Y 633 scaffold213_1 25538 0.962745098 Y 759 scaffold213_1 25538 0.987933635
10 CM-130 Y 607 scaffold248_1 33740 0.987933635 Y 764 scaffold248_1 33740 1
11 CM-136 Y 602 scaffold63_1 31929 1 Y 402 scaffold63_1 31929 0.9765886288
12 cm18 Y 567 no hit Y 844 scaffold151_1 3127 0.9943582511
13 CM-18 Y 995 scaffold126_1 8660 0.9836448598 Y 525 scaffold126_1 8660 1
14 CM-19 Y 564 scaffold260_2 4083 0.9953379953 N
15 CM-2 Y 882 no hit Y 519 scaffold185_1 13797 0.9976470588
16 Cm26 Y 747 scaffold151_1 3127 1 Y 1114 scaffold73_1 1676 0.9953488372
17 Cm3 Y 720 scaffold116_1 629 1 N
18 Cm30 Y 1166 scaffold116_1 629 1 Y 763 scaffold127_1 2108 0.9906542056
19 CM-31 N Y 343 scaffold246_1 34863 1
20 CM-4 Y 522 scaffold223_1 35472 0.9797979798 N
21 cm42 Y 1039 scaffold151_1 3127 0.9855715871 Y 770 scaffold73_1 1676 0.9910979228
22 CM-69 Y 763 no hit Y 921 scaffold110_1 2278 0.9875466999
23 CM-92 Y 1043 scaffold242_1 37050 0.9953271028 Y 641 scaffold242_1 37050 0.9811320755
24 CX4s17 N Y 562 scaffold65_1 35609 0.9945454545
25 CX4s8 Y 766 scaffold35_2 3907 0.9957627119 Y 1121 scaffold54_1 2383 0.9465478842
26 CX6-4 Y 844 scaffold118_1 40976 0.9927971188 Y 688 no hit
27 CX9-10 Y 927 scaffold13_1 7483 0.9812981298 Y 611 scaffold74_1 27257 0.995
28 CX9s4 Y 1184 scaffold234_1 12189 0.969273743 Y 681 scaffold210_1 12971 0.9910313901
29 Km-1 Y 687 scaffold56_1 32939 0.9963702359 Y 810 no hit
30 lac-ec1 Y 743 no hit Y 524 scaffold85_1 3220 0.9900497512
31 lac-ec104 N Y 521 scaffold24_1 12023 0.9974811083
32 lac111 Y 561 scaffold45_5 6060 0.9946380697 Y 247 no hit
33 lac121 Y 1166 scaffold128_1 22461 0.983463035 Y 598 scaffold134_1 3736 0.9940944882
34 lac-ec123 Y 813 scaffold24_1 12023 0.9897510981 Y 348 no hit
35 lac127 Y 607 scaffold75_1 14099 0.9957983193 Y 841 scaffold109_1 17771 0.9919354839
36 lac13 Y 684 scaffold259_1 34172 0.9910394265 Y 762 scaffold259_1 34172 0.9864253394
37 lac146 Y 768 scaffold52_1 15507 0.9968652038 Y 727 scaffold249_1 10025 0.9920760697
38 lac153 Y 640 scaffold11_1 17026 0.9872881356 Y 1076 scaffold11_2 18778 0.9969325153
39 lac16 Y 920 scaffold84_2 32539 0.9849812265 Y 601 scaffold84_2 32539 0.9943019943
40 lac160 Y 603 scaffold243_1 36291 0.9978991597 Y 645 scaffold243_1 36291 0.9981751825
41 lac161 Y 641 scaffold77_1 35961 0.9902534113 Y 919 scaffold77_1 35961 0.9879951981
42 lac170 Y 445 scaffold15_1 24084 0.9860627178 Y 634 scaffold26_1 13528 0.9941634241
43 lac193 Y 601 scaffold135_1 35915 1 Y 679 scaffold135_1 35915 0.9982905983
44 lac20 Y 734 scaffold15_1 24084 0.9918032787 Y 962 scaffold26_1 13528 0.9844074844
45 lac24B Y 653 no hit Y 569 scaffold27_2 5893 0.9857397504
46 lac27B Y 570 no hit Y 809 scaffold27_2 5893 0.9937578027
47 lac35B Y 855 scaffold97_1 1604 1 Y 686 no hit
48 lac36W Y 723 scaffold58_1 34351 0.9461325967 Y 467 scaffold58_1 34351 0.9892933619
49 lac55 Y 1096 scaffold150_1 1502 0.9657407407 Y 810 scaffold150_1 1502 0.9888888889
50 lac71 Y 501 scaffold23_2 3999 0.9893333333 Y 814 scaffold15_1 24084 0.9926199262
51 lac82 Y 493 scaffold71_1 701 0.9909090909 N
52 lac84 Y 575 scaffold107_1 15739 0.9808362369 Y 406 scaffold107_1 15739 0.9971346705
53 Mel-125 Y 847 scaffold138_1 11638 0.9847645429 Y 436 scaffold138_3 21002 0.9794721408
54 Mel-126 Y 479 scaffold100_1 24125 0.9971590909 Y 516 scaffold205_1 7863 0.9926289926
55 PO3 Y 570 scaffold42_1 32512 0.994011976 Y 421 scaffold42_1 32512 1
56 RCX18 Y 961 scaffold6_1 5837 0.9853095488 Y 1047 scaffold39_1 28772 0.9912790698
57 RCX2 Y 1075 scaffold194_1 6764 0.9704433498 Y 574 scaffold194_4 19345 0.9891304348
58 RCX24 Y 811 scaffold108_1 43364 0.9899874844 Y 956 scaffold108_1 43364 0.9957805907
59 RCX25 N Y 1039 scaffold25_1 31529 0.9889558233
60 RCX28 Y 561 scaffold43_1 35659 0.9746835443 Y 1076 scaffold43_2 3459 0.9885167464
61 RCX31 Y 840 scaffold32_1 39632 0.9401197605 Y 1213 scaffold32_1 39632 0.9634042553
62 RCX32 Y 538 scaffold206_1 3977 0.9961759082 Y 1045 scaffold88_1 15979 0.9884281581
63 RCX6 Y 602 scaffold31_2 26136 0.9956709957 N
64 RCX7 Y 803 scaffold201_3 10607 0.9936788875 N
65 RCX8 Y 801 scaffold30_1 33899 0.9885931559 Y 1005 scaffold30_1 33899 0.9867617108
66 RCX9 N Y 643 scaffold46_1 23784 0.9919614148
67 RCX92 Y 1169 scaffold2_1 34796 0.9759572573 Y 1039 scaffold2_1 34796 0.982230997
68 PCX9M1 Y 526 scaffold181_1 37968 0.9633204633 Y 1228 scaffold181_1 37968 0.9885462555
69 PCX9M3 Y 524 scaffold55_2 7811 0.9595375723 Y 970 scaffold21_1 22427 0.9823651452
70 PCX9M5 Y 805 scaffold239_1 19889 0.9874529486 Y 1012 scaffold244_1 17171 0.9791459782
71 Xyl 2 Y 218 scaffold188_1 1491 0.9770642202 Y 209 scaffold61_1 1834 0.9959349593
72 Xyl 3 Y 683 scaffold87_1 4981 0.9939577039 Y 924 scaffold14_1 3665 0.9869423286
73 Xyl 4 Y 641 scaffold177_1 32570 0.9789644013 Y 180 scaffold177_1 32570 0.975
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3.6.7 E. coli genomic DNA contamination analysis
Because contamination of samples with E. coli genomic DNA was found to aﬀect down-
stream assembly of barcoded samples, raw data were used to estimate percent contam-
ination. The genome of E. coli DH1 (Genbank accession CP001637) was used as a
reference, being the parent of DH5α, the strain used in the lab for cosmid propagation.
All sequence reads were examined for similarity to the DH1 genome, using a criterion of
100% identity. Contamination ranged from 1% to approximately 50% in the barcoded
samples (Figure 3.2) and 5% in the pooled sample (data not shown).
3.6.8 Read depth analysis
Read depth was estimated for each clone, for both barcoded sequencing and pooled
sequencing. In both cases, the barcoded clone sequence was used as the reference
sequence; raw reads were aligned to the reference sequence using BWA version 0.7.6a
[180] and depth at each base was counted using SAMtools version 0.1.18 [181]. Average
read depth for each clone was calculated (Figure 3.3) as well as read depth at every
base across each clone (Appendix B.1).
3.6.9 Clone sequence similarity analysis
Sequence similarity was estimated for all clones using BLAST [4] on the barcoded
reference sequences, speciﬁcally blastn with an e-value cut-oﬀ of 0.001. In each pair-
wise comparison, the total alignment length was divided by the shorter clone length
to obtain a similarity value between 0 and 1. Clones with no sequence similarity
identiﬁable by BLAST were assigned a similarity value of 0.
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3.6.10 Data availability
Raw sequence data are available at the NCBI Sequence Read Archive under Study
SRP031898. Accession numbers for all SRA Experiments are provided (Table 3.10) as
are Sanger end sequences for the pooled sequencing strategy (http://www.cm2bl.org/
~data) and barcode information for the barcoded sequencing strategy (Table 3.8). In
addition, raw data and relevant information for both barcoded and pooled sequencing
may be accessed online: http://www.cm2bl.org/~data
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Table 3.10: Accession numbers for datasets uploaded to NCBI SRA. [167]
NCBI Experiment Title NCBI SRA Experiment Accession Number
Pooled sequencing of cosmid clones from metagenomic libraries SRX367531
MetaMicrobiome-AAACAT SRX375037
MetaMicrobiome-AAAGCA SRX375038
MetaMicrobiome-AAATGC SRX375039
MetaMicrobiome-AACCCC SRX375040
MetaMicrobiome-AACTTG SRX375041
MetaMicrobiome-AAGACT SRX375042
MetaMicrobiome-AAGCGA SRX375043
MetaMicrobiome-AAGGAC SRX375044
MetaMicrobiome-AATAGG SRX375045
MetaMicrobiome-ACAAAC SRX375046
MetaMicrobiome-ACAGTG SRX375047
MetaMicrobiome-ACATCT SRX375048
MetaMicrobiome-ACCCAG SRX375049
MetaMicrobiome-ACCGGC SRX375050
MetaMicrobiome-ACGATA SRX375051
MetaMicrobiome-ACTCTC SRX375052
MetaMicrobiome-ACTGAT SRX375053
MetaMicrobiome-ACTTGA SRX375054
MetaMicrobiome-AGAAGA SRX375055
MetaMicrobiome-AGATAG SRX375056
MetaMicrobiome-AGCATC SRX375057
MetaMicrobiome-AGCGCT SRX375058
MetaMicrobiome-AGGCCG SRX375059
MetaMicrobiome-AGGTTT SRX375060
MetaMicrobiome-AGTTCC SRX375061
MetaMicrobiome-ATAATT SRX375062
MetaMicrobiome-ATACGG SRX375063
MetaMicrobiome-ATCACG SRX375064
MetaMicrobiome-ATCCTA SRX375065
MetaMicrobiome-ATCTAT SRX375066
MetaMicrobiome-ATGAGC SRX375067
MetaMicrobiome-ATGTCA SRX375068
MetaMicrobiome-ATTCCT SRX375069
MetaMicrobiome-CAAAAG SRX375070
MetaMicrobiome-CAACTA SRX375071
MetaMicrobiome-CACCGG SRX375072
MetaMicrobiome-CACGAT SRX375073
MetaMicrobiome-CACTCA SRX375074
MetaMicrobiome-CAGATC SRX375075
MetaMicrobiome-CAGGCG SRX375076
MetaMicrobiome-CATGGC SRX375077
MetaMicrobiome-CATTTT SRX375078
MetaMicrobiome-CCAACA SRX375079
MetaMicrobiome-CCACGC SRX375080
MetaMicrobiome-CCCATG SRX375081
MetaMicrobiome-CCGCAA SRX375082
MetaMicrobiome-CCGTCC SRX375083
MetaMicrobiome-CCTTAG SRX375084
MetaMicrobiome-CGAGAA SRX375085
MetaMicrobiome-CGATGT SRX375086
MetaMicrobiome-CGGAAT SRX375087
MetaMicrobiome-CGTACG SRX375088
MetaMicrobiome-CTAGCT SRX375089
MetaMicrobiome-CTATAC SRX375090
MetaMicrobiome-CTCAGA SRX375091
MetaMicrobiome-CTGCTG SRX375092
MetaMicrobiome-CTTGTA SRX375093
MetaMicrobiome-GAAACC SRX375094
MetaMicrobiome-GAATAA SRX375095
MetaMicrobiome-GACGGA SRX375096
MetaMicrobiome-GAGTGG SRX375097
MetaMicrobiome-GATATA SRX375098
MetaMicrobiome-GATCAG SRX375099
MetaMicrobiome-GATGCT SRX375100
MetaMicrobiome-GCAAGG SRX375101
MetaMicrobiome-GCACTT SRX375102
MetaMicrobiome-GCCAAT SRX375103
MetaMicrobiome-GCCGCG SRX375104
MetaMicrobiome-GCCTTA SRX375105
MetaMicrobiome-GCTCCA SRX375106
MetaMicrobiome-GGCACA SRX375107
MetaMicrobiome-GGCTAC SRX375108
MetaMicrobiome-GTAGAG SRX375109
MetaMicrobiome-GTCCGC SRX375110
MetaMicrobiome-GTGAAA SRX375111
MetaMicrobiome-GTGGCC SRX375112
MetaMicrobiome-TAATCG SRX375113
MetaMicrobiome-TACAGC SRX375114
MetaMicrobiome-TAGCTT SRX375115
MetaMicrobiome-TATAAT SRX375116
MetaMicrobiome-TCATTC SRX375117
MetaMicrobiome-TCCCGA SRX375118
MetaMicrobiome-TCGAAG SRX375119
MetaMicrobiome-TCGGCA SRX375120
MetaMicrobiome-TGAATG SRX375121
MetaMicrobiome-TGACCA SRX375122
MetaMicrobiome-TGCCAT SRX375123
MetaMicrobiome-TGCTGG SRX375124
MetaMicrobiome-TGGCGC SRX375125
MetaMicrobiome-TTAGGC SRX375126
MetaMicrobiome-TTCGAA SRX375127
MetaMicrobiome-TTCTCC SRX375128
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4.2 Abstract
Background: Clone libraries provide researchers with a powerful resource to study
nucleic acid from diverse sources. Metagenomic clone libraries in particular have aided
in studies of microbial biodiversity and function, and allowed the mining of novel en-
zymes. Libraries are often constructed by cloning large inserts into cosmid or fosmid
vectors. Recently, there have been reports of GC bias in fosmid metagenomic libraries,
and it was speculated to be a result of fragmentation and loss of AT-rich sequences dur-
ing cloning. However, evidence in the literature suggests that transcriptional activity
or gene product toxicity may play a role.
Results: To explore possible mechanisms responsible for sequence bias in clone li-
braries, I constructed a cosmid library from a human microbiome sample and sequenced
DNA from diﬀerent steps during library construction: crude extract DNA, size-selected
DNA, and cosmid library DNA. I conﬁrmed a GC bias in the ﬁnal cosmid library, and
provide evidence that the bias is not due to fragmentation and loss of AT-rich sequences
but is likely occurring after DNA is introduced into E. coli . To investigate the inﬂu-
ence of strong constitutive transcription, I searched the sequence data for consensus
promoter sequences and found that rpoD/σ70 promoter sequences were underrepre-
sented in the cosmid library. Furthermore, when I examined the genomes of taxa that
were diﬀerentially abundant in the cosmid library relative to the original sample, I
found the bias to be more correlated with the number of rpoD/σ70 consensus sequences
in the genome than with simple GC content.
Conclusions: The GC bias of metagenomic libraries does not appear to be due to DNA
fragmentation. Rather, analysis of promoter sequences provides support for the hy-
pothesis that strong constitutive transcription from sequences recognized as rpoD/σ70
consensus-like in E. coli may lead to instability, causing loss of the plasmid or loss of
the insert DNA that gives rise to the transcription. Despite widespread use of E. coli to
propagate foreign DNA in metagenomic libraries, the eﬀects of in vivo transcriptional
activity on clone stability are not well understood. Further work is required to tease
apart the eﬀects of transcription from those of gene product toxicity.
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4.3 Introduction
Clone libraries can be generated using a range of source material, from the DNA of
a single organism to the DNA from environmental sources representing often com-
plex microbial communities. Libraries generated from microbial communities are called
metagenomic libraries, and they have been central to a powerful methodology contribut-
ing to understanding the diversity of microbial communities, expanding the knowledge
of gene function, and mining for novel sequences encoding functions of interest. These
activities all fall under the umbrella of functional metagenomics and require cloning
the DNA, typically using low-copy vectors such as cosmids or fosmids. Cloned DNA
is typically propagated in E. coli , and if the vector host range allows, the DNA can
subsequently be transferred to other surrogate hosts that may be more suitable for
heterologous expression.
4.3.1 Possible causes of sequence bias in metagenomic libraries
The general assumption in cloning-based metagenomic approaches is that foreign DNA
can be stably maintained in E. coli and that the cloned DNA is a fair representation
of the original sample. However, it has been previously observed that fosmid libraries
exhibit a GC bias [54, 101, 304]. In general, such cloning biases may aﬀect conclusions
derived from analysis of the clone libraries. The observed GC bias of fosmid libraries
was suggested to be due to fragmentation and subsequent loss of AT-rich sequences
during the cloning process, purportedly because AT-rich sequences have fewer hydro-
gen bonds which makes them more vulnerable to non-perpendicular shear forces [304].
Other possible reasons for the bias in libraries include transcriptional activity of the
cloned DNA [41] as well as toxicity from expressed genes [84, 287]. Though the exact
mechanism(s) by which GC bias occurs has not yet been fully elucidated, the fragmenta-
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tion explanation has been echoed by others [110, 192] despite being purely speculative
and lacking experimental support. Indeed, in my own experience, extracting high-
molecular-weight genomic DNA from low-GC organisms is no more diﬃcult than from
E. coli . I have previously constructed genomic libraries in cosmid vectors using DNA
from Bacteroides thetaiotaomicron and Bacteroides fragilis (Table 2.12; both ∼43%
GC) with no diﬃculties obtaining high-quality DNA (Figure 4.1) [167].
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Figure 4.1: Pulsed-field gel electrophoresis of extracted Bacteroides ge-
nomic DNA. Genomic DNA extracted from Bacteroides thetaiotaomicron, Bac-
teroides fragilis, and Bacteroides ovatus was found to be high-molecular-weight by
pulsed-ﬁeld gel electrophoresis. For more details on the molecular markers, see Sec-
tion 2.5.9.
103
CHAPTER 4. ANALYSIS OF CLONING BIAS IN METAGENOMIC LIBRARIES
Furthermore, in the Charles laboratory, we have observed that on occasion, cosmid
clones from metagenomic libraries appear to have suﬀered insert loss, which is discussed
in greater detail in the “Results and discussion” section below. Therefore, it seemed
that the suggestion by Temperton et al. [304] that the GC bias in cosmid/fosmid
libraries might be due to fragmentation of AT-rich sequences was unlikely to be true;
rather, events occurring in vivo may be contributing substantially to the sequence bias
of libraries.
4.3.2 Aims of this work
I investigated the nature of this GC bias, to characterize whether, and by what mech-
anism, biases may be introduced into the lab’s own cosmid libraries. In particular, I
wished to determine if fragmentation was a major cause of bias, or if there is evidence
that the bias was indeed occurring in vivo. To answer this question, I constructed a
cosmid library using DNA isolated from pooled human fecal samples, saving a portion
of the DNA from three steps of the library construction process: (1) the crude extract
DNA, (2) the size-selected DNA, and (3) the cloned DNA from the constructed cosmid
library (Figure 4.2). The DNA samples were sequenced and the resulting datasets were
analyzed to investigate if, where, and how any bias may have been introduced. Con-
sistent with the aforementioned studies, I observed GC bias in the constructed cosmid
library. However, the results indicate that fragmentation of DNA does not cause any
signiﬁcant bias; rather, the results are consistent with the hypothesis that the bias
occurs after DNA is introduced into the E. coli host.
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Figure 4.2: Overview of the experimental design for this library bias study. A pooled
human fecal sample was used to construct a metagenomic cosmid library, during which DNA from
three distinct steps was collected and sequenced in order to investigate possible sequence biases and
at what steps the biases were introduced. [165]
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4.4 Results and discussion
4.4.1 DNA sampling and sequencing results
I collected DNA at the three main steps of cosmid library construction: the crude
extract DNA, the size-selected DNA, and the ﬁnal cosmid library DNA (Figure 4.2).
Before sequencing, I ﬁrst checked the quality of each sample by gel electrophoresis
(Figure 4.3). As expected, the crude extract was the only sample that contained a heavy
smear of fragmented DNA; the selection for high-molecular-weight DNA greatly reduced
fragmented DNA, as evidenced by its absence from the size-selected sample. The cosmid
library sample exhibited the characteristic multiple banding pattern representing the
various possible conformations of uncut circular DNA.
Figure 4.3: Gel electrophoresis of crude extract, size-selected, and cosmid
library DNA samples. Diluted and undiluted amounts of each sample were gel
electrophoresed for quality control check of DNA prior to Illumina sequencing. [165]
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After conﬁrming DNA quality, the samples were paired-end sequenced on an
Illumina HiSeq 2000 platform, generating ∼1.2 Gb of DNA sequence per sample. It
was expected that the cosmid library would be contaminated with E. coli genomic
DNA and cosmid vector DNA as a result of (1) isolating cosmid DNA from E. coli
cells and (2) the fact that each and every cosmid clone sequenced included its vector
backbone. Thus, for fair treatment, I subtracted E. coli and pJC8 sequences from all
samples (see “Methods” section). For E. coli and pJC8, respectively, 6701 and 164
reads were removed from crude extract data (∼0.05% of all reads); 9273 and 2410 from
size-selected data (∼0.09%); and 851,410 and 2,130,004 from the cosmid library DNA
(∼23%). As expected, the dataset originating from the cosmid library sample had
the highest number of reads subtracted. Though the crude extract and size-selected
samples contained a small amount, these likely represent true environmental sequences;
however, their subtraction was necessary for equal treatment of all samples, and the
small fraction removed should not aﬀect overall conclusions from the data.
After host and vector sequence subtraction, I used Nonpareil [243] to estimate the
overall sequencing coverage of the samples, which was ∼85% for the crude extract and
size-selected samples and ∼95% for the cosmid library sample (Figure 4.4). Interest-
ingly, despite one-quarter of reads in the cosmid library sample being from E. coli or
pJC8, this sample appeared to have the best sequencing coverage, suggesting that the
cosmid library suﬀered a decrease in diversity as a result of cloning bias. Overall, the
relatively high sequencing coverage for all three samples was suﬃcient for the down-
stream comparative sequence analyses; for all subsequent results discussed here, the
forward and reverse sequencing reads for the three samples were analyzed separately.
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Figure 4.4: Estimate of sample sequencing coverage using Nonpareil. The software Non-
pareil was used to estimate sequencing coverage for each of the three samples. The software takes a
sequence data ﬁle as input and, based on the redundancy of the reads, calculates curves of coverage
versus sequencing eﬀort. [165]
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4.4.2 GC bias is not caused by fragmentation of AT-rich DNA
The experimental design (Figure 4.2) was such that I could address whether the bias
in the metagenomic library was due to fragmentation of DNA during cloning. Because
both crude extract and size-selected samples were sequenced, I could determine whether
the removed fragmented DNA from the crude extract (visible in Figure 4.3) led to a
bias in the size-selected DNA sample. I calculated the percent GC in each of the three
datasets and found that the GC bias was only present in the ﬁnal cosmid library and
not the size-selected sample (Table 4.1), eﬀectively ruling out fragmentation as the
mechanism for cosmid library bias.
Table 4.1: Percent GC of crude extract, size-selected, and cosmid library
datasets. GC content was calculated after subtraction of E. coli and vector
DNA from all samples. [165]
Sample/dataset No. reads No. Mb %GC
Crude extract F 6,654,484 599 47.7
Crude extract R 6,654,567 599 47.8
Size-selected F 6,645,306 598 46.9
Size-selected R 6,645,817 598 46.9
Cosmid library F 5,134,020 462 53.0
Cosmid library R 5,191,538 467 53.1
After conﬁrming that the bias occurs post size selection, I next asked if certain
taxa were diﬀerentially represented across the samples to see if this would point to a
possible reason for library sequence bias. I used Taxy [209] as well as Taxy-Pro [154]
as part of the CoMet web server [189] to do a fast preliminary comparison of taxa
abundance across the three diﬀerent samples. Taxy calculates k -mer frequencies for the
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dataset and then uses mixture modeling of k-mer frequencies of sequenced genomes to
obtain a proﬁle similar to that of the sample, whereas Taxy-Pro has a similar modeling
approach but uses protein domains rather than k -mer frequencies. Both tools generated
very similar proﬁles for the crude extract and the size-selected DNA but a very diﬀerent
proﬁle for the cosmid library DNA (see Figure 4.5 for Taxy results), supporting the
percent GC results.
Figure 4.5: Distribution of bacterial phyla predicted by Taxy. The software
Taxy was used to estimate the distribution of bacterial phyla in each of the three
samples, using a k -mer length of 7.
With positive results from this preliminary work, I then performed more thorough
taxonomic analyses using two diﬀerent approaches; in the ﬁrst, all sequencing reads were
used, and in the second, only the 16S rRNA gene-containing reads were used.
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In the ﬁrst approach, I used the Metagenome Phylogenetic Analysis (MetaPhlAn)
tool, a proﬁling tool that maps reads against clade-speciﬁc marker sequences [258] to
estimate sample composition down to the species level (see Appendix C.1 for summary
table of MetaPhlAn output). I examined the abundance of the top four most common
phyla in human gut metagenomes to see whether there were large overall changes in taxa
abundance across the samples (Figure 4.6). The crude extract and size-selected samples
showed high Firmicutes and Bacteroidetes content with lower levels of Actinobacteria
and Proteobacteria, compositions that are typical of gut-derived samples [72,197,288].
Notably, these results indicated that that DNA from the Firmicutes was nearly absent
in the cosmid library sample, accompanied by an equivalent increase in the Actinobac-
teria. These results were consistent with the percent GC analysis, as members of the
Firmicutes phylum are generally known to be low-GC, and those of the Actinobacteria,
high-GC [97,188].
Figure 4.6: Histogram of abundance of the top four phyla in crude extract,
size-selected, and cosmid library samples. Abundance of the Actinobacteria,
Bacteroidetes, Firmicutes, and Proteobacteria phyla in each sample, as determined
using MetaPhlAn. [165]
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I also examined the MetaPhlAn results at the species level to see which genomes
may be under- or overrepresented in the cosmid library, choosing to examine the top
50 most diﬀerentially abundant species (Figure 4.7). Several members of the Biﬁ-
dobacterium genus were substantially overrepresented in the cosmid library while many
members of the Firmicutes were completely or very nearly lost; for example, Eubac-
terium rectale, Ruminococcus bromii, and Faecalibacterium prausnitzii were all highly
abundant in the original sample.
Figure 4.7: Heatmap of 50 species with differential abundance across crude
extract, size-selected, and cosmid library samples. Abundance in each sample
of the top 50 species determined to be diﬀerentially abundant using MetaPhlAn. Abun-
dance is depicted on a log scale. [165]
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In the second approach, I identiﬁed reads in the datasets that were from the 16S
rRNA gene, and used the RDP classiﬁer to classify these to the genus level (Figure 4.8).
I found that analyses using only 16S rRNA gene-containing reads showed high agree-
ment with analyses carried out using all reads (i.e., Figure 4.6), indicating that 16S
rRNA gene content tracks well with genomic content in large-insert cosmid libraries.
Both approaches – using all reads or only reads from the 16S rRNA gene – provided
similar results, and both were in agreement with percent GC, Taxy, and Taxy-Pro re-
sults, all of which provide compelling evidence that cosmid library biases are not due
to fragmentation of AT-rich sequences during the cloning process.
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Figure 4.8: 16S rRNA gene analysis results using Infernal for identification of 16S-
containing reads, RDP classifier to classify reads, and MEGAN for visualization of results.
16S rRNA sequences from forward and reverse datasets were classiﬁed for all three samples. [165]
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4.4.3 GC content may be a proxy for E. coli σ70
promoter content
From these results, our laboratory’s own experiences, and what was previously known
in the literature, there was reason to suspect that the cause of the bias occurred in
vivo. I wondered whether these AT-rich sequences might have a regulatory role in vivo
and noticed that they may resemble the constitutive E. coli promoter, and in fact, I
am not the ﬁrst to suggest this resemblance [64, 218], particularly of the ❂10 Pribnow
box (Figure 4.9).
Figure 4.9: Sequence logo of rpoD/σ70 promoter consensus. The consensus
sequence for rpoD/σ70 promoters is AT-rich. Adapted from [262]
To investigate whether transcription of the insert may be having a negative eﬀect
on its maintenance by the host cell, I analyzed the sequence data from the three samples
for E. coli consensus promoter sequences; in particular, I was interested in examining
the data for diﬀerential abundance of the rpoD/σ70 consensus sequence, as σ70 is the
“house-keeping” sigma factor whose promoters are constitutive.
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In my analysis, I used the known promoter consensus sequence for rpoD/σ70
[262], and, as negative controls, I used the consensus sequence for: rpoE/σ24 [241];
rpoH /σ32 [224]; rpoN /σ54, which has a GC-rich consensus [346]; as well as the primary
sigma factor of Bacteroides , σABfr [15], because the Bacteroides genus had comparable
abundance across the three samples (Figure 4.8) and because Bacteroides constitutive
promoters are not recognized by E. coli [206]. I examined each of the three samples for
relative abundance of these ﬁve consensus sequences; consensus sequences are provided
in Table 4.2.
Table 4.2: Consensus promoter sequences for selected sigma factors.
Sigma factor Consensus sequence Ref.
rpoD (σ70) TTGACAN15-19TATAAT [262]
rpoE (σ24) GGAACTTN15-19TCAAA [241]
rpoH (σ32) TTG[A/T][A/T][A/T]N13-14CCCCAT[A/T]T [224]
rpoN (σ54) TGGCAN7TGC [346]
Bacteroides (σABfr) TTTGN19-21TAN2TTTG [15]
The results showed that while the crude extract and size-selected samples had
similar promoter content proﬁles, the cosmid library exhibited a deviation (Figure 4.10).
Supporting the hypothesis, only the rpoD consensus content was considerably diﬀerent
in abundance, by about an order of magnitude when compared to either the crude
extract or size-selected sample.
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Figure 4.10: Histogram of sigma factor consensus sequence content in
crude extract, size-selected, and cosmid library samples. Bars indicate the
number of consensus sequences in each sample, for select E. coli sigma factors and the
Bacteroides primary sigma factor, normalized to the amount of sequence data for that
sample. Consensus content is depicted on a log scale. [165]
The loss of these speciﬁc sequences from the cosmid library suggests that the
widely used cloning host E. coli may be problematic for cosmid-cloned fragments of
DNA that incidentally contain constitutively active rpoD promoter sequences; indeed,
these ﬁndings are supported by previous reports in the literature, which is discussed in
more detail in the following section. If E. coli does in fact exclude constitutively active
rpoD promoter-containing sequences, simply switching to a diﬀerent cloning/library
host (even if it were possible) would likely alleviate one problem only to introduce
another, as all organisms have sequences from which constitutive transcription arises.
It may be that multiple backgrounds, with diﬀerent constitutively active sequences, are
required for the maintenance of metagenomic libraries in an eﬀort to increase sample
representativeness.
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Given that rpoD promoter sequences were underrepresented in the cosmid library
and that certain species appear to be over- or underrepresented, I next asked whether
a species’ abundance in the cosmid library could be predicted from the rpoD consensus
content of its genome. And in particular, is rpoD consensus content more predictive of
library abundance than simple GC content?
To answer these questions, I turned to the results of the MetaPhlAn analysis,
which gave me a list of the top 50 most diﬀerentially abundant species (Figure 4.7).
To analyze the genomes of these species for possible sequence determinants of library
abundance, I used the NCBI Genome database to ﬁnd sequenced representatives of each
species where possible and was able to retrieve 46 genomes (complete, draft, or whole
genome shotgun sequences; see Section 4.6.6 for details); for each genome, I calculated
the percent GC as well as the number of rpoD consensus promoter sequences present
(Table 4.3).
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Table 4.3: Length, percent GC, and rpoD consensus content of the 46 genomes. [165]
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Next, to quantify bias in the cosmid library relative to the original sample (the
crude extract), I calculated the change in abundance of the 46 species (using the average
abundance of the forward and reverse datasets). I then plotted the change in abundance
ﬁrst against genome percent GC (Figure 4.10A) and second against rpoD consensus
content, normalizing to genome size (Figure 4.10B). The results show that while library
bias only generally correlates with GC content, library bias correlates surprisingly well
with the rpoD consensus content of the genome.
Figure 4.11: Bias in cosmid library relative to crude extract, against
GC content or rpoD consensus content. Species abundance was obtained from
MetaPhlAn analysis of the crude extract and cosmid library samples. Bias is calculated
as change in percent abundance (cosmid library abundance / crude extract abundance)
plotted against GC content (a) or rpoD consensus content (b). Change in abundance is
depicted on a log scale; CE0 values indicate zero abundance in the crude extract sample
and CL0 values indicate zero abundance in the cosmid library sample, as predicted by
MetaPhlAn. [165]
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These results suggest that GC content may be only a rough proxy for rpoD con-
sensus content (as rpoD consensus sequences are AT-rich), but GC content itself may
not be an accurate predictor of library presence/abundance; indeed, in some cases, a
genome may have a moderate or relatively high percent GC but also possess an un-
usually high rpoD consensus content, leading to an underrepresentation in the cosmid
library that could not have been predicted from GC content alone (Figure 4.10). These
results are also consistent with the previous observation that library bias was more
obvious among organisms with low GC content [54] because AT-rich genomes would
have an increased number of rpoD promoter-like sequences simply by chance [219].
4.4.4 Examining the published literature: evidence for tran-
scriptional activity of cloned AT-rich DNA interfering
with stability of circular vectors
This chapter describes analyses concerning metagenomic DNA. However, if there are
rpoD consensus-like sequences that are interfering with the maintenance of foreign DNA
in E. coli , then the scope of the problem extends beyond metagenomics applications.
Curious about the extent of the problem, I performed literature searches to ﬁnd re-
ports of experienced diﬃculties cloning AT-rich DNA and/or investigations of possible
mechanisms for those diﬃculties. My search was fruitful, leading us to literature that
spans the past three decades.
It was reported that there are diﬃculties associated with cosmid cloning of very
AT-rich genomic DNA [99, 106], and even when genomic libraries can be constructed,
cosmid clones may be unstable [27, 120, 240, 265], which simply means that foreign
DNA fragments are not able to be maintained in the E. coli library host. Thus, if
selection is applied for a marker present on the vector, then in vivo events may lead
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to insert deletion, which has been observed by our lab as well as others, despite using
a host that is a recA mutant [265]. This is particularly evident when the library is
constructed using a high-copy number vector (e.g., one containing a ColE1-type origin
of replication), which has been experienced by our lab (Figure 5.10) and others [40]
and is in agreement with the observation that F-based, single-copy fosmids perform
better than multi-copy cosmids at stably maintaining insert DNA [148]. Loss of cloned
sequence is even more widespread for inserts that have repetitive DNA sequences [33],
as such sequences may be conducive to recombination. One way to combat insert loss
is by minimizing outgrowth of the library-containing cells as much as possible [265],
though this is not always feasible for shared cosmid libraries such as the Canadian
MetaMicroBiome Library collection [222], which require outgrowth to generate stocks
for sharing with the scientiﬁc community.
But what is the mechanism for plasmid instability? It was previously shown that
transcriptional activity from a cloned strong promoter could aﬀect plasmid stability by
(1) interfering with the origin of replication via transcriptional read-through into the
vector as well as (2) changing the abundance of protein products involved in plasmid
copy number. Furthermore, plasmid instability was alleviated by placing transcriptional
terminator sequences that ﬂank the multiple cloning site [291]. It was also observed that
strong phage promoters could only be cloned into plasmids that possess a downstream
termination signal [100, 162]. Similarly, AT-rich pneumococcal DNA was found to
contain a high incidence of E. coli strong promoter sequences, and that cloning of
the DNA was improved by using a vector with eﬃcient transcriptional terminators
[40,41,289], although analysis of a set of pneumococcal promoter-containing sequences
indicated that transcription strong enough to interfere with plasmid stability may be
relatively rare and that other factors could be contributing to cloning diﬃculty [61].
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Another consideration is that eﬃcient transcription of poly-dT (as well as poly-
dG) DNA tracts may cause the DNA to form a stable complex with its own accumulated
transcription products, leading to transcriptional stalling that may interfere with the
replication fork [152, 153, 160]. One particularly interesting observation that has sur-
prisingly not attracted more interest is that linear cloning vectors with transcriptional
terminators provide even more stability than circular vectors with transcriptional ter-
minators [106, 107]. The advantage of these vectors is increased stability due to their
linear conformation, but intriguingly, the mechanism remains unclear, although DNA
supercoiling of plasmids is thought to play a role (Ronald Godiska, personal communi-
cation).
Our ﬁndings along with the aforementioned facts suggest that multiple, distinct
mechanisms may be at play to cause cloning bias in E. coli , but that there is evidence
that transcriptional activity of cloned DNA may be contributing to the sequence bias
observed in metagenomic libraries. It is often assumed that toxicity of gene products
may inﬂuence the stable maintenance or “clonability” of DNA in E. coli [84, 287,302],
but it is currently unclear whether gene product toxicity is a major factor in the bias
of typical clone libraries constructed using circular vectors. It is interesting to consider
that cloning bias could be due primarily to purely transcriptional activity rather than
the often-blamed protein toxicity.
4.4.5 Cloning bias in a soil metagenomic library
The previous sections discuss the results of using shotgun sequencing to examine bias
in a human fecal library (CLGM1 library; NCBI BioSample SAMN02324081). This
section also discusses the results of 16S rRNA gene sequencing to examine bias in
a corn ﬁeld soil library (12AC library; NCBI BioSample SAMN02324088) [43]. Both
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libraries were constructed using the same vector, the RK2-based cosmid pJC8 (Genbank
accession KC149513). To examine possible bias in the soil library, I compared the
16S rRNA gene sequences from the original DNA that was extracted from the sample
to the 16S rRNA gene sequences from the ﬁnal cloned library DNA isolated from
E. coli . Figure 4.12A summarizes analysis at the phylum level for both the fecal and
soil samples.
At the phylum level, the fecal library diﬀers substantially in the relative abun-
dance of phyla compared to its corresponding extract, as discussed in the previous
section. On the contrary, the relative abundance of phyla in the corn ﬁeld soil library
seemed similar to its extract (Figure 4.12A), although some caution should be exercised
in their interpretation. Unfortunately, the majority of 16S rRNA gene sequences from
the library sample were E. coli contamination, despite treating the library cosmid DNA
preparation with Plasmid-Safe DNase to remove host genomic DNA prior to PCR, as
well as obtaining on the order of millions of sequences from Illumina sequencing; after
subtracting E. coli host sequences, I was left with approximately 30,000 sequences to
represent the metagenomic library (see Section 4.6.7 for details). This high level of
host contamination could be due to preferential ampliﬁcation of template during PCR
based on diﬀerences in DNA conformation: though present in very small quantities,
linear DNA may be more eﬃciently ampliﬁed over supercoiled or closed circular plas-
mid DNA [39]. The issue of E. coli host contamination in 16S rRNA gene analysis
needs to be addressed for future examination of bias in metagenomic libraries.
When I examined the soil samples more closely, I found that the similarity of the
library and extract at the phylum level does not extend to the “species” level: examina-
tion of the individual OTUs in each sample revealed that only a small fraction of OTUs
are shared between the library and original sample (Figure 4.12B). Interestingly, this
analysis indicated that there were a number of OTUs in the library that were not iden-
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Figure 4.12: Metagenomic libraries exhibit cloning bias when compared to the original
environmental sample. (A) Relative abundance of bacterial phyla from two previously constructed
metagenomic libraries, a human fecal library [165] and a corn ﬁeld soil library [43], compared to their
original sample DNA extracts. (B) Number of OTUs identiﬁed from corn ﬁeld soil DNA extract and
library, and whether the OTUs were present in the library sample only, the extract sample only, or
present in both. (C) Examination of cloning bias by comparing the relative abundance of OTUs that
were present in both the DNA extract and the cosmid library, shown on a log scale; horizontal line at
1 denotes equal relative abundance in both samples.
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tiﬁed in the extract sample (Figure 4.12B) and although this number is halved when
the library data are compared to extract data that have not been rareﬁed (data not
shown), they nevertheless remain, indicating that these OTUs are either extremely rare
in the original sample and their DNA is preferentially cloned or that the identiﬁcation
of these OTUs is due to sequencing errors. A further analysis of the OTU fraction that
is shared between extract and library samples shows a large range in the bias in relative
abundance of each OTU, with some OTUs exhibiting a 1000-fold overrepresentation
and others a 1000-fold underrepresentation in the library (Figure 4.12C). While there
may be concern that 16S rRNA gene proﬁles of libraries compared to extracts may
not provide an accurate comparison of cloned DNA content in general, I have shown
in a previous section that for large-insert RK2 oriV -based cosmid libraries, 16S rRNA
gene tracks well with genomic content (Figure 4.4.2). The analysis of the corn ﬁeld
DNA extract and corresponding metagenomic library suggests that though the overall
relative abundance of phyla may remain similar, bias is occurring on the level of indi-
vidual OTUs. This indicates that when trying to understand bias, using the popular
representation of samples as barplots of bacterial phyla may be inappropriate; rather
an OTU-level analysis may be required (Figure 4.12B versus Figure 4.12C). For mining
purposes, the fact that certain taxa are under- or overrepresented might not pose a
barrier to screening, but it may be useful to know from the beginning what sequences
are not likely to be captured in libraries.
4.5 Conclusions
The results presented in this chapter and what was already known from the literature
together support the hypothesis that GC bias in typical clone libraries (that is, using
circular vectors) is related to constitutive promoter activity of the insert in E. coli ,
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although DNA topology as well as toxic protein eﬀects may also inﬂuence insert and
plasmid maintenance. In this analyses, I have focused only on would-be strong consti-
tutive promoters in E. coli (rpoD/σ70 consensus sequences) because there is evidence
that high-level transcription may have negative eﬀects. It is important to acknowledge,
however, that functional metagenomic approaches rely on E. coli (or other hosts) being
able to transcribe and translate foreign DNA, in order to identify fragments encoding
functions of interest. This ability of E. coli to initiate low-level transcription from
diverse sources [214] and to be able to produce foreign proteins has been immensely
advantageous for functional metagenomics and likely has contributed to the general
assumption that E. coli is tolerant of foreign DNA, whether it expresses it or not. Our
work, however, suggests that more careful consideration of cloning strategies may be
required.
The stability of foreign DNA in E. coli is inﬂuenced by the copy number of its
host plasmid and, as a result, single-copy fosmids may be ideal as the library back-
bone [148], although the success of some functional screens may be dependent on a
higher gene dose. Possible alternatives to fosmid vectors include BACs [142] as well as
linear vectors, which may provide exceptional stability [106]. However, cos-based vec-
tors are likely to remain popular for their advantages: the availability of high-quality
commercial packaging extracts, the eﬃciency of transduction over transformation, and
the decreased probability of insert concatemers due to the phage head upper size limit.
Though there exists variety in library cloning vectors, further work is required to un-
derstand how and to what extent cloning vector choice impacts library sequence bias.
Currently, there are three outstanding questions: (1) to what extent does tran-
scription contribute to metagenomic library bias, (2) what factors aﬀect whether tran-
scription will be problematic, and (3) how can transcriptional eﬀects be minimized so
that DNA can be faithfully maintained in E. coli . An important consideration may
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be the likelihood of an rpoD consensus sequence being cloned on any given fragment
from a genome or metagenome. As an example, let us consider Ruminococcus bromii,
which was one of the most highly abundant species in the original sample but became
nearly absent in the cosmid library according to our analyses (∼7% versus ∼0.01%, re-
spectively; see Section C.1). R. bromii has a genome size of 2.25 Mb; theoretically, its
genome can be represented in ∼80 fragments if we consider that the average fragment
in the particular cosmid library discussed here is ∼28 kb (data not shown). Given that
there were 77 rpoD consensus sequences identiﬁed in its genome (Table 4.3), poten-
tially many fragments could include a sequence that behaves as a strong, constitutive
promoter in E. coli . I acknowledge that although this work supports the hypothesis
that constitutive transcription contributes to library bias, more concrete evidence is
required to conﬁrm this hypothesis.
If strong transcription from the insert into the vector backbone contributes in part
to the observed cloning bias—aﬀecting the origin of replication, for example—it may
be helpful to use vectors that include transcriptional terminators ﬂanking the cloning
site. Our lab is currently investigating the extent to which transcriptional termina-
tors alleviate the cosmid library sequence bias, which may help tease apart the issue
of transcription from that of gene product toxicity. While it is generally recognized
that diﬀerent expression hosts are needed for functional screening (discussed in Sec-
tion 1.6.3), it is not as widely acknowledged that using E. coli as the sole cloning host
for metagenomic DNA itself may be quite limiting due to the potential lack of sample
representativeness from the outset. It is interesting that despite decades of using E. coli
as “the workhorse of molecular biology,” there is still much left to discover about how it
tolerates exogenous DNA, which should serve as a reminder to us of how necessary it is
to continually re-evaluate even our most basic methodological assumptions, particularly
when they concern the inner workings of the cell.
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4.6 Specific materials and methods
4.6.1 Sampling of DNA during fecal library construction
Methods for the construction of cosmid libraries, including the speciﬁc human gut
metagenomic library discussed here (NCBI BioSample ID SAMN02324081), have been
previously described in detail [167]. Brieﬂy, DNA was extracted from pooled human
fecal samples using freeze-grinding with liquid nitrogen followed by gentle lysis. Crude-
extracted DNA was then size-selected by pulsed ﬁeld gel electrophoresis using a CHEF
Mapper Pulsed Field Gel Electrophoresis System (Bio-Rad), followed by electroelution,
retaining fragments between approximately 40 and 70 kb. The size-selected DNA was
end-repaired, puriﬁed, and ligated into the Eco72I site of linearized dephosphorylated
pJC8 vector DNA (Genbank accession KC149513). The ligation product was packaged
into λ phage heads using Gigapack III XL Packaging Extract (Stratagene 200209),
followed by transduction of E. coli HB101. Transductants were recovered on LB agar
supplemented with tetracycline (20 ➭g/ml) and incubated overnight at 37❽. Resulting
colonies were enumerated to estimate library size (∼42,000 clones), and colonies were
resuspended, pooled, and frozen at -80❽ to form the cosmid library stock.
During construction of the cosmid library, DNA was sampled from three steps:
(1) the crude extract DNA, (2) the size-selected DNA, and (3) the ﬁnal cosmid library
DNA, prepared from the frozen stock using a GeneJET Plasmid Miniprep Kit (Thermo
Scientiﬁc K0502).
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4.6.2 Purification, quantification, and Illumina sequencing of
DNA
Two of the three DNA samples, the cosmid library DNA and the size-selected DNA,
were suﬃciently pure for Illumina sequencing, as gauged by 260/280 and 260/230-
nm ratios (Nanodrop ND-1000 Spectrophotometer); however, the crude extract DNA
required further puriﬁcation. Crude extract DNA concentration was estimated by gel
electrophoresis, using bacteriophage λ DNA as a standard; ∼150 ➭g in 1ml was puriﬁed
and concentrated on the synchronous coeﬃcient of drag alteration (SCODA) instrument
(Boreal Genomics), using an established protocol [75].
All samples were re-quantiﬁed by gel electrophoresis, using bacteriophage λ DNA
as a standard, and >2 ➭g of each sample was sent to the Beijing Genomics Institute
(BGI, Hong Kong) for 90-base paired-end sequencing on the Illumina HiSeq 2000 plat-
form, using their in-house protocols and reagents for 350-bp fragment library construc-
tion. Approximately 6.7 million reads were obtained in both the forward and the
reverse direction, generating ∼1.2Gb of sequence data per sample. All sequence data
have been made publicly available (see “Data” section).
4.6.3 Subtraction of E. coli and vector DNA from fecal se-
quence data
The fecal cosmid library sequence data were expected to have substantial contamination
with E. coli genomic DNA and pJC8 vector sequences. Sequence data were cleaned
of contaminating E. coli genomic DNA and vector DNA, using BLAT [146] with a
conservative criterion of 100% identity. To remove E. coli contamination, I used the
genome of E. coli K12 MG1655 (Genbank accession U00096.3), which to our knowledge
130
CHAPTER 4. ANALYSIS OF CLONING BIAS IN METAGENOMIC LIBRARIES
is currently the closest sequenced relative of HB101, the library host strain. To remove
vector contamination, I used the sequence of pJC8 (Genbank accession KC149513), for-
matted to simulate Eco72I-cut, cloning-ready vector by removing the 0.8-kb gentamicin
resistance gene stuﬀer present between the two Eco72I sites.
4.6.4 Taxonomic analysis
To examine taxonomy based on only the 16S rRNA gene sequences present in the data,
I identiﬁed 16S-containing reads using Infernal version 1.1 [220] and classiﬁed them
using the RDP Classiﬁer version 2.8 [323]. The classiﬁer output was visualized using
the MEtaGenome ANalyzer (MEGAN) version 5.6 [132]. To examine taxonomy using
all sequence reads (i.e., not only those identiﬁed as 16S reads), I used the MetaPhlAn
tool version 2.0, along with its built-in scripts for visualization [258].
4.6.5 Promoter analysis
To estimate promoter content in the data, I searched for known sigma factor consensus
sequences for the E. coli sigma factors, rpoD/σ70, rpoE/σ24, rpoH /σ32, rpoN /σ54, as
well as for the Bacteroides primary sigma factor, σABfr. To do this, I used regular
expression pattern matching with Python version 2.7.3; consensus promoter sequences
and literature references were provided in Table 4.2 and regular expressions are provided
in Table 4.4.
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Table 4.4: Regular expressions used for selected promoter consensus sequences.
Sigma factor Regular expression
rpoD (σ70) TTGACA.{15,19}TATAAT
rpoE (σ24) GGAACTT.{15,19}TCAAA
rpoH (σ32) TTG[AT][AT][AT].{13,14}CCCCAT[AT]T
rpoN (σ54) TGGCA.{7}TGC
Bacteroides (σABfr) TTTG.{19,21}TA.{2}TTTG
4.6.6 Analysis of reference genomes
Genome sequences were downloaded from the NCBI Genbank database as complete
genomes, draft genomes, or from whole genome shotgun sequencing projects. Organ-
ism names and accession numbers, as well as other relevant information, are provided
(Table 4.5).
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Table 4.5: NCBI accession numbers for genome sequences of the 46 species selected for percent
GC and rpoD consensus content analysis. [165]
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4.6.7 16S rRNA analysis for soil extract and library
Construction of the 12AC library was previously described [43]. Crude DNA extract
of corn ﬁeld soil was puriﬁed using the SCODA method [75]. Cosmid library DNA
was miniprepped from E. coli HB101 using a GeneJet Plasmid Miniprep kit (Thermo
Scientiﬁc K0502). Cosmid DNA was treated with Plasmid-Safe ATP-dependent DNase
according to the supplier’s recommendations (Epicentre Biotechnologies E3101K). PCR
was carried out on the samples as previously described, using bacterial V3-speciﬁc
primers 5’CCTACGGGAGGCAGCAG and 5’ATTACCGCGGCTGCTGG [14]. Amplicons were se-
quenced at the NRC-PBI Saskatoon Research Facility (Saskatoon, Canada) using the
Illumina GAIIx platform. Paired-end sequences were assembled using PANDAseq ver-
sion 2.8 [205] using default parameters; 1,823,112 and 1,886,370 sequences were assem-
bled for the extract and cosmid library sample, from an input of 1,960,793 and 2,035,138
paired-end sequences, respectively. E. coli sequences were ﬁltered out, using a crite-
rion of 100% identity to E. coli MG1655 (the closest sequenced relative of HB101),
resulting in 233 sequences removed from the extract sample and 1,453,806 sequences
removed from the cosmid library sample. Sequences were subsequently processed via
AXIOME2 [195] running QIIME version 1.9, specifying UPARSE (USEARCH version
7.0) to cluster the sequences using default parameters and the RDP classiﬁer version 2.2
trained with the Greengenes database version 13.8 to classify deﬁned OTUs. From the
resulting OTU table, E. coli was ﬁltered a second time by manually removing OTUs
classiﬁed as Enterobacteriaceae, which consisted of 109 sequences from the extract sam-
ple and 335,994 sequences from cosmid library sample. The extract sample was then
rareﬁed using QIIME to match the cosmid library, retaining ∼30,000 sequences for each
sample, altogether comprising ∼4000 OTUs.
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4.6.8 Data availability
Raw Illumina sequence data for the CLGM1 human gut cosmid library (NCBI BioSam-
ple SAMN02324081), size-selected, and crude extract DNA samples are available at the
NCBI Sequence Read Archive under Study SRP031898. Accession numbers for SRA
Experiments are: SRX683591 for the crude extract, SRX683589 for the size-selected,
and SRX683586 for the cosmid library. Sequence data for the 12AC corn ﬁeld DNA
extract and corresponding metagenomic library (NCBI BioSample SAMN02324088)
previously constructed [43] have been deposited at NCBI SRA; accession numbers are
SRX1015944 and SRX1015946 for the extract and cosmid library, respectively. In
addition, raw data and other relevant data for this study may be accessed online:
http://www.cm2bl.org/~data
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5.2 Abstract
Functional metagenomic approaches are becoming increasingly important in this age of
relatively inexpensive high-throughput sequencing, in which obtaining sequence data
from metagenomes is widely accessible but lack of knowledge of gene function makes
annotation of those datasets incomplete. Function-based approaches can help to ﬁll
this gap in knowledge by providing information about gene function for as-yet unchar-
acterized sequences through the cloning, expression, and functional screening/selection
of DNA from metagenomes. Importantly, this process is dependent on the ability to ex-
press the cloned DNA in a surrogate host; though E. coli is a popular host for screening
of metagenomic libraries, it may not be ideal.
Regarding human gut metagenomic DNA in particular, the Gammaproteobacte-
ria E. coli may be inadequate due to barriers in transcription and/or translation. The
bacterial community that inhabits the human distal gut is composed predominantly of
members of the Bacteroidetes and Firmicutes phyla; though there are Proteobacteria
present, they are usually vastly outnumbered. For one dominant member of the Bac-
teroidetes phylum, Bacteroides thetaiotaomicron (B. theta), it has been shown that the
E. coli σ70 sigma factor is unable to substitute the function of the Bacteroides sigma
factor in vivo and is therefore unable to transcribe Bacteroides DNA, although spurious
transcription is possible.
With growing interest in the human gut microbiome, B. theta is attracting the
attention of researchers interested in understanding its dominance and stability in the
gut environment as well as those interested in harnessing these properties for micro-
biome engineering. In this chapter, I discuss how B. theta might be useful for functional
metagenomics as a screening host, to express DNA present in gut-derived metagenomic
libraries. B. theta is a good candidate because it already has reasonably well-developed
molecular genetic methods, including methods for conjugation and mutant construc-
tion. In addition, it has inherent advantages such as aerotolerance and the ability to
degrade various complex polysaccharides, which make it relatively easy to manipulate
in a typical laboratory setting and provides potential phenotypes for functional comple-
mentation, respectively. Here, I present the results of developing B. theta VPI-5482 as a
surrogate host for functional screening, through the construction of B. theta-compatible
cos-based cloning vectors, generation of human gut metagenomic libraries, and attempt
to complement B. theta mutants. In my ﬁrst unsuccessful attempt, I constructed a high-
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copy cosmid vector called pKL3, based on an existing E. coli -B. theta shuttle vector,
but found after generating libraries that metagenomic DNA inserts maintained at high
copy number were unstable and led to diﬃculty conjugating into B. theta. In my sec-
ond attempt, I constructed a fosmid vector called pKL13, based on the commerical
pCC1FOS, and found that metagenomic libraries were both more stable and exhibited
suﬃcient conjugation eﬃciency for attempting functional screens in B. theta.
For B. theta mutant strains to use in complementation screens, I constructed
amino acid auxotrophs using single recombination of a suicide vector to disrupt genes
in either the threonine or tryptophan biosynthesis operons. Unfortunately, complemen-
tation of single recombinants proved unsuccessful as the recombinants had a tendency
to revert to wild-type. Instead, I tried to complement an existing B. theta deletion mu-
tant, a mutant missing the chuR gene that is required for growth on chondroitin sulfate
as sole carbon source. This screen was successful, leading to the isolation and analysis
of several complementing clones from the human gut metagenomic library, including
one chuR gene exhibiting 97% nucleotide sequence identity to the wild-type VPI-5482
sequence. Unfortunately, however, this analysis also led to the discovery that fosmid
clone DNA appeared to have recombined into the B. theta chuR mutant host genome.
The inability to retrieve fosmid clone DNA poses a barrier to screening of pooled
metagenomic libraries; to tackle this problem, it was necessary to track individual
clones being conjugated into B. theta. In a proof-of-principle experiment, I generated
an arrayed collection using a subset of clones from the pKL13-based metagenomic
library, and performed a two-step screening strategy to identify which clones in the
array led to complementation of the chuR phenotype. Results from this attempt show
that the method is promising, although mating conditions need to be reﬁned to achieve
the high throughput required for screening hundreds of thousands of clones in this
manner. Based on the results presented here, B. theta has potential for use as a host
in functional screening of gut-derived metagenomic DNA.
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5.3 Introduction
Bacteroides thetaiotaomicron, or B. theta, is a microbe that is frequently a dominant
member of the human gut, speciﬁcally the distal intestine [12, 339]. It is a Gram-
negative anaerobe whose genome sequence was made available in 2003 [339]. The
sequenced representative is the type strain from the Virginia Polytechnic Institute,
VPI-5482; an alternative name for the same strain from the American Type Culture
Collection is ATCC 29148 [339]. The type strain has one 6.3-Mb chromosome and one
33-kb plasmid called p5482.
As research interest concerning the role of the human-associated microbiota in
human health has grown, and particularly of the human gut microbiota, so too has
the interest in B. theta grown. Its dominance in the gut, its ability to break down
complex polysaccharides from both the host as well as the host dietary intake, and its
tractability in bacterial genetics has brought it to the forefront of human microbiota
studies. This introduction will discuss B. theta’s role and functions in its symbiosis with
the host, give an overview of molecular genetic methods used to work with B. theta
in the laboratory, and ﬁnally, touch on the reasons that B. theta would be a suitable
expression host for functional metagenomics.
5.3.1 Mutualistic role and polysaccharide utilization abilities
The digestion of complex polysaccharides in the gut requires the action of glycoside
hydrolases (GHs) and polysaccharide lyases (PLs), enzymes which are able to hydrolyze
glycosidic bonds and cleave carbohydrates using an elimination mechanism, respectively
[56]. Interestingly, compared to the microbes that reside in our gastrointestinal tract,
humans have no PLs and only a relatively small number of GHs, with only a handful of
these participating in digestion, speciﬁcally of starch, sucrose, and lactose (Figure 5.1).
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Other GHs:
Lysosomal GHs
GHs for processing of host N -glycans
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Possibly digestive
Figure 5.1: Classiﬁcation of glycoside hydrolases encoded by the human genome.
Adapted from [72].
In general, the gut microbiota allow energy to be harvested from many complex
polysaccharides in the common human diet that would otherwise be undigestable, such
as pectin, cellulose, and hemicellulose [12]. Our resident microbiota produce short chain
fatty acids from fermentation of these polysaccharides, which are then taken up by our
colonocytes [48], particularly butyrate [67]; in this manner, our microbiota have been
estimated to produce between 5-10% of our energy requirements [207]. An assessment
of a fraction of these bacteria whose genomes are sequenced reveals that many species
possess GHs and PLs; in particular though, members of the Bacteroidetes have both a
large number as well as diverse members of GHs and PLs, with B. theta close to the
top (Figure 5.2).
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Figure 5.2: Total number and number of diﬀerent GH and PL genes in gut bacterial
genomes. Adapted from [72].
That B. theta would possess both a large number and diverse members of these
enzymes is perhaps not surprising, as it has been characterized as a “generalist” with
the ability to degrade a broad range of polysaccharides in the gut, in contrast to “spe-
cialists” that can only degrade one or a few polysaccharides [158]. Its relatively large
genome size of ∼6.3 Mb has been attributed to this generalist lifestyle in the “use-it-
or-lose-it” hypothesis of gene retention [221].
The Starch Utilization System (SUS) in B. theta is a canonical example of an
operon devoted to the degradation of a particular polysaccharide (Figure 5.3). The
system was ﬁrst studied in the 1980s in the laboratory of the late Abigail Salyers. Using
transposon mutagenesis, it was found that starch utilization mutants had insertions
clustered within an 18-kb region of the chromosome [297]. Biochemical and genetic
analyses of B. theta revealed that cells did not secrete extracellular enzymes, but instead
bound starch for eventual degradation in the periplasm or cytoplasm [5, 6]. Later
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work in the Salyers lab identiﬁed all 8 members of the sus locus, susRABCDEFG
[57, 58, 238, 239]. Brieﬂy, outer membrane proteins SusE, SusF, and SusD bind the
starch molecule allowing it to be degraded into smaller oligosaccharides by the amylase
SusG; SusE and SusF were shown to be not required for growth on starch [45] though
they are involved in enhancing starch binding [32,263]. SusG-generated oligosaccharides
are transported via the transporter SusC to the periplasm where SusA and SusB cleave
them to form smaller mono- and disaccharides, which are ﬁnally transported into the
cytoplasm for use by the cell. SusR is involved in activation of the locus and its
expression is induced by maltose.
Monosaccharide import
Oligosaccharides
Starch
Amylases
Inner membrane
SusR
SusD
SusC
SusFSusE
Maltose sensor and regulator:
transcriptional activation of the sus operon
TonB
SusG
(GH13)
SusA
(GH13)
SusB
(GH97)
Outer membrane
Figure 5.3: Overview of the canonical Starch Utilization System (SUS). Adapted
from [158]
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The sus locus is one example of an operon that encodes an entire membrane-
associated multi-protein system for tackling the degradation of a speciﬁc polysaccharide,
namely starch. B. theta uses similar operons to degrade other carbohydrates, called
SUS-like systems or polysaccharide utilization loci (PULs) [202]. Remarkably, B. theta
is estimated to have a total of 88 of these PULs, which comprise 18% of its genome
and 866 of its genes, enabling it to degrade a wide range of glycans, from host-derived
glycans such as mucin O-glycans and chondroitin sulfate to plant-derived glycans such
as amylopectin and inulin [200,202], although the majority of its 88 PULs are thought
to be involved in the breakdown of plant polysaccharides [331].
These systems are interesting in that they aﬀord members of the Bacteroidetes
a competitive advantage, but each species may have its own micro-habitat or niche
depending on the array of PULs its genome possesses. For example, B. theta seems
well-suited for growth on host mucins while a related species, Bacteroides ovatus , may
thrive on plant cell wall hemicellulose [158]. The SUS and SUS-like systems are of
particular interest because Bacteroides mutants deﬁcient in these systems may be good
candidates for use as hosts in functional complementation screening.
5.3.2 Overview of molecular methods for B. theta
Over the past few decades, research interest in members of the Bacteroides has grown,
leading to the development of molecular methods for use with these organisms, specif-
ically with B. theta. Work in the Salyers’ lab led to the development of Bacteroides as
a genetic system, as well as the related Porphyromonas and Prevotella. Abigail Salyers
was interested in the Bacteroides and related organisms for both their environmental
and clinical signiﬁcance. As mentioned, her lab did the initial studies on the sus locus
in B. theta, but her lab also studied antibiotic resistance in B. theta, mediated by
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mobile elements, which include conjugative transposons [250] and mobilizable insertion
elements [182]. Their work developing genetic methods in B. theta culminated in the
publication of two important reviews of genetic techniques in B. theta, one in 1999
called “Genetic Methods for Bacteroides Species” [249] and another in 2000, called
“Starting a new genetic system: lessons from Bacteroides” [248]. In the following sec-
tions, I will attempt to summarize the microbiology and molecular genetic methods
used to work with B. theta, both those that stem from early work and those that have
been developed since then.
Vectors
All of the B. theta-compatible vectors in use today appear to use origins of replication
that can be traced back to just a few native plasmids originally isolated from Bacteroides
species. From the literature, the two most common originate from the 4.4-kb plasmid
pB8-51 isolated from Bacteroides eggerthii B8-51 [268] and the 2.7-kb plasmid pBI143
isolated from Bacteroides fragilis IB143 [274]. Both plasmids have a copy number of
approximately 10 to 20 in Bacteroides and, interestingly, the two origins have been
shown to be compatible [290], although pB8-51 appears to have a broader host range
and can replicate in Prevotella and Porphyromonas species in addition to Bacteroides
species. The plasmid pBI143 was sequenced in 1995 [278], about one decade after its
isolation.
A range of B. theta vectors have been developed: shuttle vectors and suicide
vectors, many of which have been previously reviewed by Salyers et al. [249], and
even expression vectors are available for use in Bacteroides [277]. Nucleotide sequence
data available for some B. theta plasmids (native plasmids or cloning vectors) are
summarized in Table 5.1.
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Table 5.1: Plasmids relevant for genetics in B. theta, with available sequence
Vector Source Ref.
pBI143 Genbank U30316 (1995) [278]
pFD288 Genbank U30830 (1995) [278]
pBA Genbank AF203972 (2006) [336]
pFD1146 Genbank JQ776640 (2012) [228]
pBUN24 Genbank EU818711 (2013) [264]
pVAL-1 Genbank AB775653 (2014) [314]
pTIO-1 Genbank AB775804 (2014) [296]
pKNOCK-bla-ermG https://gordonlab.wustl.edu/plasmids/ [159]
pKNOCK-bla-tetQ https://gordonlab.wustl.edu/plasmids/ [200]
pNBU2-bla-ermG https://gordonlab.wustl.edu/plasmids/ [159]
pNBU2-bla-tetQ https://gordonlab.wustl.edu/plasmids/ [200]
There have not been many cosmid vectors constructed for use in the Bacteroides ,
however, as searches of the literature have turned up only two cosmids, both constructed
in the late 1980s:
❼ pNJR1/pNJR5 [265] was constructed in Abigail Salyers’ lab and employs the
Bacteroides pB8-51 origin and the E. coli RSF1010 origin (IncQ).
❼ pOA10 [112] was constructed at UCSD and uses the less popular Bacteroides
pCP1/pBFTM10 origin and the E. coli pBR322 origin.
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Selectable markers and reporters
There are two antibiotic selectable markers that appear to be favoured for use in
B. theta, erythromycin and tetracycline. Other antibiotics have been used successfully
in B. theta in the literature, however, and a summary of the possibilities is presented
in Table 5.2.
Table 5.2: Antibiotic markers in B. theta.
Antibiotic Concentration Reference
erythromycin (ermF, ermG) 10-25 ➭g/ml [32,268]
tetracycline (tetQ✯) 3 ➭g/ml [265]
clindamycin (ermF, ermG) 5-20 ➭g/ml [268,274]
ampicillin (cfxA) 25-50 ➭g/ml [182]
chloramphenicol (cat) 10-15 ➭g/ml [277,290]
Additionally, reporter systems that have been used successfully in B. theta or
closely related species include:
❼ β-glucoronidase (uidA) [249]
❼ β-xylosidase (xyaA) [249]
❼ chloramphenicol acetyl transferase (cat) [15]
❼ catechol 2,3-dioxygenase (xylE ) [38]
❼ luciferase, including lux and [206] and Nanoluc [215]
✯distinct from E. coli tetracycline resistance
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Conjugation
The native plasmids isolated from Bacteroides species – pBI143, pB8-51, and pBFTM10
– all have mob regions and can be mobilized by R751 or RP4/RK2 [267, 276] though
these helper plasmids cannot replicate in the recipient [250]. Interestingly, despite the
fact that R751 does not recognize the RK2 oriT , most or all of the B. theta plasmids
can be mobilized by both R751 and RK2 [248].
Conjugations from an E. coli donor into a B. theta recipient can be done anaer-
obically on nitrocellulose ﬁlters placed on TYG agar plates [268, 279] or aerobically as
a lawn on brain-heart-infusion blood plates [159]; in the latter method, anaerobic in-
cubation is not required likely because the initial growth of E. coli sets up a barrier to
the oxygen, allowing the anaerobic B. theta to grow between the agar surface and the
E. coli lawn. Conjugations from a B. theta donor into an E. coli recipient are possible
but require that the the Bacteroides strain express transfer genes, such as those from
a conjugative transposon, as it has been shown that R751 integrated into the genome
of B. theta was not able to mobilize out on its own, likely because R751 transfer genes
are not expressed in Bacteroides [250,269].
Conjugations require counter-selection. For conjugations from B. theta into E. coli ,
selection via aerobic incubation of plates is obviously suﬃcient, although transconju-
gants must be streaked for purity because B. theta can co-culture with E. coli [267].
Conjugations from E. coli into B. theta on the other hand require the use of antibiotics
against the E. coli donor because it is a facultative anaerobe that is able to grow in the
absence of oxygen. The B. theta type strain VPI-5482 has been reported to be naturally
resistant to all aminoglycosides [268], up to 1 mg/ml [266] as well as nalidixic acid [306].
The antibiotics that can be used and their concentrations are listed in Table 5.3.
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Table 5.3: Counter-selection against E. coli .
Antibiotic Concentration Reference
gentamicin 200 ➭g/ml [314]
geneticin (G418) 400 ➭g/ml [267]
nalidixic acid 100 ➭g/ml [268,306]
cefoxitin 50 ➭g/ml [133]
streptomycin 200 ➭g/ml this study
kanamycin 200 ➭g/ml this study
Transduction
There is currently no transducing phage for Bacteroides [248]. A transducing phage
would provide a means to isolate the genetic background of mutant strains to ensure
the absence of other mutations, or to combine two mutations into a single background.
However, the search for a transducing phage can be diﬃcult and time-consuming [248],
which is probably why such a tool for the Bacteroides remains elusive.
Electroporation
Wild-type Bacteroides strains are typically recalcitrant to the introduction of heterolo-
gous DNA, possibly due to the presence of restriction-modiﬁcation systems. However,
it has been shown that E. coli -derived DNA can be electroporated into some Bac-
teroides species [275], with especially high eﬃciency into B. fragilis [133]. The same
group has reported being able to successfully electroporate E. coli HB101-derived DNA
into B. theta VPI-5482 [133]. Interestingly, the Salyers group was not able to achieve
this, but they have published that B. theta-derived DNA can be re-introduced into
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B. theta via electroporation at high frequencies [182], both observations that I can
conﬁrm (unpublished data).
Mutant construction
B. theta mutant construction is fairly straightforward as suicide vectors and conjuga-
tion strategies are available. Single recombinants can be made using a suicide vector,
such as pKNOCK-bla-ermG (Figure 5.15A) [159], which carries the ori R6K origin
of replication that requires the use of λ-pir strains. Conveniently, constructs can be
mated from E. coli S17-1 λ-pir in biparental conjugations [201] that are more eﬃcient
that triparental conjugations using a mobilizer strain .
Double crossover-based methods allow for the construction of clean deletions (e.g.,
the removal of a speciﬁc open reading frame), and can be generated using the suicide
vector pExchange-tdk [159], a derivative of pKNOCK-bla-ermG that carries the B. theta
tdk gene. The tdk gene provides the counter-selection that is required to make a clean
deletion and must be used in combination with a B. theta tdk deletion mutant. In the
presence of Tdk, B. theta becomes sensitive to the nucleotide analog 5-ﬂuoro-2-deoxy-
uridine (FUdR) [159]. Thus, mutant construction involves the following steps:
❼ cloning the ORF’s upstream and downstream regions into the vector, generating
the deletion construct
❼ conjugating the new construct into the tdk mutant, selecting with erythromycin
for integration of the suicide plasmid into the genome at the location of the ORF
❼ selecting with FUdR for loss of the integrated plasmid, followed by screening
FUdR-resistant, erythromycin-sensitive clones for loss of the ORF, using PCR
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5.3.3 Use of B. theta in systems biology and synthetic biology
Since this project began, there have been studies in systems biology and synthetic bi-
ology making use of B. theta. In a recent study, a functional genomic approach was
used to explore which B. theta genes contribute to ﬁtness in the gut: small fragments
of B. theta genomic DNA were cloned into an E. coli expression vector to drive ex-
pression of B. theta genes, forgoing the requirement for E. coli to recognize native
B. theta elements for transcription and translation [341]. The researchers introduced
this library into mice; then, by sampling mouse feces that was shed and sequencing
the DNA present, they were able to identify which B. theta genes were carried by the
clones that dominated the population in the mouse gut as time progressed. Perhaps
unsurprisingly, the two genes that dominated by far (>90% by sequencing) were ones
involved in carbohydrate utilization: BT 1759 encodes a periplasmic glycoside hydro-
lase involved in hydrolyzing fructo-oligosaccharides and sucrose [285] and the adjacent
BT 1758 encodes a glucose/galactose transporter. This experiment illustrates the po-
tential of using functional genomics to understand how speciﬁc genes might contribute
to a microbe’s ﬁtness in the host gut. Although this experiment was done in E. coli
and using only B. theta genomic DNA, the next step would be to use larger inserts
for cloning, metagenomic DNA from the whole gut community, or even a diﬀerent
surrogate host [81].
In another study, B. theta was engineered to respond to environmental cues
present in the mouse gut by expressing a luciferase reporter gene as well as recording
this encounter through the modiﬁcation of its own DNA [215]; this is often described
as equipping the organism with “synthetic genetic memory”. First, as a foundation for
their work, the researchers developed a repertoire of genetic parts to use in B. theta, in-
cluding promoters and RBSs that together allow gene expression to be controlled over a
104-fold range. They also develop inducible systems based on E. coli ’s IPTG-inducible
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lac system as well as on B. theta’s previously characterized natural polysaccharide uti-
lization systems, which encode hybrid two-component transcriptional regulators that
sense and respond to the presence of carbohydrates such as rhamnose, chondroitin sul-
fate, and arabinogalactan [200,203,231]. Next, they design the responsive genetic mem-
ory by coupling the rhamnose utilization regulator to expression of serine integrases for
unidirectional inversion of DNA at a designed “memory array” located on the chromo-
some. Another important contribution by the authors to the B. theta genetics toolbox
is the development an inducible system for knocking down gene expression in B. theta
by using CRISPR interference (CRISPRi) and they demonstrate that CRISPRi can
be used to down-regulate gene expression in B. theta cells colonizing the mouse gut.
These exciting developments in synthetic biology will hopefully spur eﬀorts in micro-
biome engineering that may be important for the development of therapeutics to treat
gastrointestinal diseases [286].
These examples in the recent literature illustrate B. theta’s potential in both pure
and applied research and its utility as a model for both studying the adaptive functions
of the microbiota in the gut as well as for manipulating the microbiota for the beneﬁt
of the host.
5.3.4 Suitability as a host for screening human gut metage-
nomic DNA
Functional metagenomics is dependent on the ability to eﬀectively screen libraries for
gene function, therefore requiring that the cloned fragments be expressed in the surro-
gate host. The human gut microbial community is dominated by members of the Bac-
teroidetes phylum, suggesting that human gut-derived libraries contain a large portion
of Bacteroidetes genes. However, previous studies suggest a barrier to the expression
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of Bacteroides-derived genes in the popular Proteobacteria host E. coli at the level of
transcription due to lack of promoter recognition [206]. B. theta’s primary sigma factor
recognizes a consensus sequence markedly diﬀerent from E. coli ’s σ70 (Figure 4.9); the
consensus has been identiﬁed and comprises two elements situated at -33 and -7 from
the start of transcription, separated by 19-21 nucleotides: TTTGN19-21TAN2TTTG [15,317].
Most interestingly, though this would appear to be a contradiction of the above
facts, there are at least several examples in the literature where functional screens
of metagenomic libraries in an E. coli surrogate host have turned up positive clones
carrying DNA that appears to be from Bacteroides :
❼ A metagenomic fosmid libary constructed from the fecal samples of patients with
Crohn’s Disease was screened for ability to modify NF-κB expression in human
intestinal epithelial cells using a reporter system. NF-κB is a transcription factor
that is involved in immune and inﬂammatory responses in the gut. This led to
the identiﬁcation of a clone whose insert’s closest match was Bacteroides vulgatus
[164,196].
❼ A metagenomic fosmid libary constructed from the fecal sample of a healthy
pescatarian was screened for carbohydrate-active enzymes able to degrade resis-
tant substrates and/or able to withstand high temperature or extreme pH. Of
the 26 clones sequenced, 9 were taxonomically assigned to members of the Bac-
teroidetes with 7 in the Bacteroides genus, on the basis of sequence similarity of
predicted ORFs to known protein sequences [299].
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❼ Fosmid libraries were generated from the foregut contents of Tammar wallabies
and screened for ability to degrade cellulose or xylan. Sequencing and assembly
of 33 fosmids resulted in contigs for which the majority were assigned to the order
Bacteroidiales and half possessed homologs of genes present in Bacteroides PULs,
including susC and susD [235].
❼ A BAC library constructed from a dairy cow rumen sample was screened for
hydrolase activity. Subcloning and sequencing of positive clones revealed that
that the endoglucanase genes from two of the clones had blastx best hits to
Bacteroides species [108].
❼ A BAC library was constructed using whole intestinal samples from mice, and
the library was screened for enhanced adherence to surfaces via bioﬁlm. The two
clones isolated were additionally tested for increased intestinal colonization in
vivo in the mouse gut. The clones were sequenced and both blastn analysis and
tetranucleotide frequency analysis revealed best hits to Bacteroides species [342].
I think that the most likely explanation for the successful isolation of Bacteroidetes-
derived DNA from screening in E. coli is that the expression was due to spurious
transcription at incidental E. coli σ70 consensus promoter-like sequences. Spurious
transcription has been discussed in detail in Chapter 4 and simply means that tran-
scription begins at a place on the DNA that is not at the native promoter of a gene.
Bacteroidetes DNA could be expressed if transcription were to initiate spuriously and
if E. coli were able to translate ORFs by recognizing RBSs present on the transcript.
This scenario is plausible as E. coli has been demonstrated to recognize the RBS of the
B. theta 16S rRNA operon despite not recognizing its promoter [206].
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It is important to note that though this spurious transcription may have facili-
tated functional screening in the above cases, it cannot be relied on in general because
stretches of cloned DNA may lack the sequences that give rise to such transcription in
E. coli . There is currently a lack of suitable surrogate hosts for systematic functional
screening of Bacteroidetes-derived DNA from the human gut metagenome. Given that
Bacteroides are dominant members of the gut microbial community and some species
are well-developed as genetic models, the development of a Bacteroides species as a host
is a natural choice. In particular, the described genetic tools available for B. theta and
its genetic tractability make it an ideal candidate for development as a surrogate host
for functional metagenomics. This section further discusses the practical and technical
aspects of this proposed development.
To use B. theta as a host for screening requires constructing a library using a
cloning vector that is capable of replicating in both E. coli and B. theta. The library
is constructed and maintained in E. coli as usual and subsequently transferred into a
recipient B. theta strain in a triparental conjugation with the help of a mobilizer strain
(Figure 5.4A). The B. theta transconjugants can then be plated on media selecting for
functional complementation, that is, colonies of B. theta carrying cloned environmental
DNA able to confer the desired phenotype upon the recipient; for example, wild-type
B. theta can be selected on media containing an antibiotic to isolate library clones
harbouring resistance genes (Figure 5.4B).
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Figure 5.4: Overview of using B. theta as a host for functional metagenomics (A) Li-
braries from E. coli are conjugated into a B. theta mutant strain using a triparental mating and (B)
functionally complemented B. theta transconjugants are grown on selective media.
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Oxygen tolerance and laboratory culture
The culture of an obligate anaerobe requires growth in the absence of oxygen. B. theta
is an obligate anaerobe but unlike other organisms that are highly sensitive to the pres-
ence of oxygen, it is able to survive for a limited time upon exposure to oxygen, making
it convenient to work with in a laboratory setting. B. theta possesses enzymes that
protect it from both superoxide- and hydrogen peroxide-induced damage to biological
molecules, such as superoxide dismutase (SOD) [49], and catalase and other scavenging
enzymes [216], respectively. Being an anaerobe, B. theta has a central metabolism that
is blocked in the presence of oxygen. Its central metabolism has two iron-sulphur clus-
ter enzymes that are sensitive to superoxide or molecular oxygen, which render them
inactive; however, both can be repaired rapidly upon return to anaerobic conditions
without new protein synthesis, explaining how B. theta can recover quickly after expo-
sure to oxygen in the lab [227]. Outside of its central metabolism, B. theta has other
iron-sulphur proteins that may also be aﬀected by oxygen.
This ability to rapidly repair oxygen-induced damage makes it possible to culture
B. theta without the use of an expensive anaerobic chamber. B. theta can be cultured in
liquid using the pyrogallol method to create anerobic conditions inside a typical culture
and the indicator dye resazurin can be used to to determine whether this has been done
successfully (Figure 5.5 and Section 5.6.2). Culture on solid media in the absence of
an anaerobic chamber can be done with the aid of a GasPak jar used in conjunction
with one-time-use GasPak sachets that deplete oxygen inside the jar (Figure 5.6A);
an even more cost-eﬀective solution is to use inexpensive air-tight containers that can
eﬀectively replace GasPak jars (Figure 5.6B and C; Section 5.6.2).
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Figure 5.5: Resazurin as an indicator dye for oxidizing/reducing envi-
ronments The dye resazurin is initially blue-purple in oxidizing conditions (left-most
tube), turns irreversibly pink in reducing conditions (right-most tube), and reversibly
colourless in anaerobic conditions (centre tube).
Figure 5.6: Anaerobic jars used in the culture of B. theta. (A) GasPak 100
System anaerobic jar, ∼✩500; (B) Anchor Hocking stainless steel canister, ✩20; (C)
Lock & Lock glass container, ✩7.
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Stability of cloned Bacteroides DNA in E. coli
Although I have shown in Chapter 4 that major cloning bias can occur when construct-
ing human gut metagenomic libraries, likely as a result of selection against AT-rich,
rpoD consensus-containing sequence in vivo by the E. coli host, this appears to aﬀect
members of the Firmicutes to a much greater extent than members of the Bacteroidetes
(Figure 4.5 and Figure 4.6). Although a previous study found large segments of Bac-
teroides DNA to be unstable in E. coli [265], I have found that using the low-copy
cosmid vector pJC8, Bacteroides-derived content appears to be similar between the
crude extracted DNA and the ﬁnal cosmid library (Figure 4.7).
Again, the factors aﬀecting the stability of cloned DNA are not well understood;
however, my own observations support the notion that there is good representation of
metagenomic DNA from the human gut that is likely to be expressed in B. theta. It is
anticipated that Bacteroides DNA will be relatively stable in a low-copy IncP cosmid
vector or single-copy fosmid vector, thereby facilitating functional screens in a B. theta
host.
Functional complementation of Bacteroides mutant phenotypes
Though E. coli does not recognize B. theta promoters, it does recognize B. theta RBSs.
One might be inclined to suggest that functional screening in E. coli could be improved
by heterologous expression of the B. theta housekeeping sigma factor in E. coli ; however,
although the B. theta sigma factor has been shown to be able to interact with the E. coli
RNA polymerase in vitro, the complex is unable to initiate transcription [317]. But
even if this were possible, there is another reason why screening in B. theta would
be more advantageous: B. theta’s various polysaccharide degradation abilities provide
a range of phenotypes that can potentially be complemented on selective media, if
159
CHAPTER 5. DEVELOPMENT OF BACTEROIDES THETAIOTAOMICRON AS A SCREENING HOST
the appropriate B. theta mutant strains were available. Cosmid or fosmid libraries
in particular may be very powerful for functional screening as the large DNA inserts
of these libraries would capture the large operons that encode multi-protein systems
characteristic of PULs (Figure 5.3).
5.3.5 Aims of this work
The objective of this work was to develop B. theta VPI-5482 as a surrogate host to
use in functional screening of human gut metagenomic libraries. This required the
construction of a library cloning vector with an origin of replication for B. theta, and
generation of a metagenomic clone library using this vector. The library was used
to attempt functional complementation of B. theta mutants possessing a suitable and
relevant phenotype such as deﬁciency in the utilization of a particular polysaccharide
as compared to wild-type. The goal was to isolate and sequence complementing clones
with the hope of ﬁnding either novel complementing genes or at least genes diﬀerent in
sequence from the wild-type, thereby demonstrating the eﬀectiveness and potential of
using B. theta as a host.
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5.4 Results and discussion
5.4.1 Problems arising from pUC-based cosmid libraries
Construction of a B. theta-compatible pUC-based cosmid pKL3
To be able to screen a library in a B. theta host, the library must be constructed using
a vector that is able to replicate in B. theta. To generate a suitable cloning vector, I
ﬁrst started with the E. coli -B. theta shuttle vector pAFD1 (Figure 5.7).
Figure 5.7: Bacteroides shuttle vector, pAFD1. Constucted in Abigail Salyers
lab [249], this vector was generously shared by Nadja Shoemaker. Unique restriction
sites in MCS: EcoRI, SstI, KpnI, SmaI/XmaI, BamHI, SalI, AccI, BspMI, PstI, SphI.
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pAFD1 was constructed by ligating the native Bacteroides plasmid pBI143 [278]
to the E. coli vector pUC19 [340], followed by introducing the ermF gene for ery-
thromycin resistance in B. theta. To this base vector, I added the following elements,
which are also summarized in Figure 5.8:
❼ A cos site, by cloning in the BglII fragment from the cosmid pHC79 into the
compatible BamHI site of pAFD1 (Figure 5.8A), generating pKL1. The cos site
enables packaging of DNA into λ phage heads.
❼ A polylinker (or multiple cloning site) to introduce the Eco72I restriction site
(Figure 5.8B), generating pKL2. The Eco72I site was desired because this par-
ticular blunt-end restriction site has been used to successfully generate cos-based
libraries and the preparation of digested, desphosphorylated vector DNA has be-
come routine. The polylinker fragment was generated by phosphorylating and
annealing two complementary oligos, KL10 and KL11 (see Section 5.6.4).
❼ The gentamicin resistance stuﬀer, as an Eco72I fragment from pJC8 into the
Eco72I site of pKL2 (Figure 5.8C), generating pKL3. The stuﬀer is routinely
included in vectors constructed in our laboratory to aid in restriction enzyme
cleavage because we ﬁnd that without a stuﬀer, digestion does not progress to
completion or near-completion.
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Figure 5.8: Construction of pUC-based B. theta-compatible cosmid vector pKL3. The
shuttle vector pAFD1 (A) was modiﬁed by adding: the cos site from pHC79 as a BglII fragment,
generating pKL1 (B); a polylinker carrying Eco72I, generating pKL2 (C); the gentamicin resistance
stuﬀer from pJC8, generating pKL3 (D). Note that these are stylized diagrams and are not to scale.
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Confirmation of pKL3 functionality; generation of clone libraries using pKL3
After constructing pKL3 (Figure 5.8D) from pAFD1, I then checked that the addition
of the cos site and polylinker did not interfere with the vector’s ability to replicate in
B. theta. To do this, pKL2 was conjugated from E. coli S17-1 into B. theta, while
pAFD1 was also conjugated as a positive control (Figure 5.9); note that pKL3 was
not used because the presence of the gentamicin resistance gene stuﬀer would have
interfered with the gentamicin used as E. coli counter-selection in this experiment.
The results indicated that the constructed derivative was still functional in B. theta
and that pKL3 could be used as a library backbone.
I then used this new pUC-based cosmid to construct a metagenomic library from
a human fecal sample for screening in B. theta. The library was constructed in E. coli
HB101 and named Charles Lab Gut Microbiome 2 (CLGM2; Figure 5.10A) because it
was the second library to be constructed from the pooled stool samples of anonymous
donors of the Charles Lab. I also constructed a library using B. theta genomic DNA
for use as a control in selection experiments (Table 2.12).
Figure 5.9: Conjugation of positive control pAFD1 and constructed deriva-
tive pKL2 into B. theta. pAFD1 and pKL2 were separately conjugated into B. theta
to determine functionality of pKL2. Growth media: BHIH Em10 Gm200
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Instability of metagenomic insert DNA in high-copy vector
After the library was constructed, colonies were pooled from all the plates (Figure 5.10A)
and frozen in aliquots as libraries typically are in the Charles Lab. One aliquot was
used to plate isolated colonies from which random clones were selected for examination
of insert size: cosmid DNA was miniprepped and subjected to an EcoR1-KpnI double
digest to simultaneously release and digest the cloned insert DNA (Figure 5.10B).
Figure 5.10: Random clones from CLGM2 library exhibit insert loss Ran-
domly selected clones from CLGM2 library were miniprepped, ordered by DNA con-
centration, and subjected to EcoRI-KpnI double digest, revealing that nearly half have
insert sizes much smaller than expected.
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The diagnostic digest of 22 random clones yielded an unexpected result: while
clones #10 to #22 exhibited restriction patterns typical of large cosmid DNA in-
serts, clones #1 to #9 had noticeably smaller or even non-existent DNA inserts (Fig-
ure 5.10B). This result suggested that a sizeable portion of the library was unstable;
the possible causes of this instability that lead to cloning bias were previously discussed
in Chapter 4 (see Section 4.4.4). Despite the observed instability, I decided to try to
use this library due to time constraints.
Difficulty conjugating CLGM2 metagenomic library
To use the library and attempt to carry out functional screening in a B. theta host, the
library requires transfer from E. coli to B. theta via conjugation. To do this, I carried
out a triparental conjugation using the library strain HB101(CLGM2) as donor, B. theta
as recipient, and J53(R751) as helper (Figure 5.11A); I also simultaneously conjugated
the empty vector from HB101(pKL2) into B. theta as a control. It was necessary to
use R751 as the helper plasmid instead of the commonly used pRK600 or pRK2013
to avoid plasmid incompatibility issues as pKL2/pKL3 and pRK600/pRK2013 are all
ColE1-related plasmids.
The conjugation was plated on media selecting for the transconjugant, B. theta
carrying the conjugated cosmids; recall that B. theta has natural resistance to nalidixic
acid and aminoglycosides, such as kanamycin. While the empty vector showed an
acceptable conjugation eﬃciency, the eﬃciency of the CLGM2 library was poor (Fig-
ure 5.11B). This poor transfer of the library was not speciﬁc to the B. theta recipient,
as conjugation was also poor for an E. coli recipient when tested (data not shown).
The reason for the library’s poor transfer is not clear, although it maybe be related to
the high-copy number of the vector backbone in combination with maintaining large
DNA inserts that may be transcriptionally active.
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Recipient:  B. theta
Donor: HB101 (CLGM2) Mobilizer: J53 (R751)A
B
vector only
100 dilution
CLGM2 library
100 dilution
Figure 5.11: Triparental conjugation of CLGM2 library into B. theta. (A)
Overview of triparental conjugation experiment for transfer of CLGM2 library from
E. coli HB101 donor to B. theta recipient. (B) Result of conjugation into B. theta of
vector alone (left) or CLGM2 library (right). Growth media: BHIH Em25 NA25 Km200
A poor eﬃciency of conjugation into B. theta severely hinders the success of
functional screens because library clone DNA cannot be transferred to the recipient in
order to undergo selection. In combination, the instability of insert DNA in the library
and the poor transfer of the library into recipient cells rendered the CLGM2 library
eﬀectively unuseable. Therefore, I decided to re-build the system, using a single-copy
vector backbone to avoid possible high copy number-related problems.
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5.4.2 Efficient conjugation of fosmid-based libraries into B. theta
Construction of a B. theta-compatible fosmid pKL13
For the backbone of the new library cloning vector, I decided to use the commercial
vector pCC1FOS (Figure 5.12A). The properties, advantages, and disadvantages of this
vector are discussed in greater detail in Section 6.3.2 of the following Chapter 6.
Brieﬂy, pCC1FOS replicates as a single-copy fosmid in E. coli strains as it carries
the F plasmid origin of replication. In addition, it carries the RK2 origin of replication
which, combined with the trfA gene product, increases copy number in members of the
Proteobacteria. For example, the commercial strain E. coli EPI300 has been designed
for use with pCC1FOS: EPI300 carries trfA under the control of an arabinose-inducible
promoter, which allows the fosmid to be maintained at single-copy but induced to a
higher copy number when desired. The vector also carries the chloramphenicol resis-
tance gene for selection in E. coli .
pCC1FOS is used widely for the construction of fosmid libraries; both the pop-
ularity and the properties of pCC1FOS made it an attractive choice for use as a base
vector for construction of B. theta-compatible libraries. The following points below
describe the step-by-step construction of the pCC1FOS B. theta-compatible derivative
pKL13; the steps are also summarized graphically (Figure 5.12):
❼ The gentamicin resistance stuﬀer was added, as an Eco72I fragment from pJC8
into the Eco72I site of pCC1FOS, generating pKL4 (Figure 5.12B). As previously,
the stuﬀer was added to aid digestion of the vector for library cloning.
❼ An oriT sequence was added to allow the vector to be conjugated between strains,
particularly between E. coli and B. theta. The sequence was PCR-ampliﬁed as
an ∼800-bp fragment from pJC8 using primers KL12 and KL13 with HindIII
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adapters, and ligated into the unique HindIII site of pKL4, generating pKL5
(Figure 5.12C). Though the actual functional oriT sequence is only ∼100 bp,
including the surrounding region reportedly improves transfer frequency by two
orders of magnitude [113].
❼ A fragment from pAFD1 was added, which includes (a) the ermF gene encoding
erythromycin resistance as a selectable marker for B. theta and (b) the repA gene
and internal ori for replication in B. theta. The fragment was PCR-ampliﬁed
as an ∼4-kb fragment from pAFD1 using primers KL14 and KL15 with EcoRI
adapters, ligated into pJET1.2 forming pKL8, and subcloned as an EcoRI frag-
ment from pKL8 into the unique EcoRI site of pKL5, generating pKL6 (Fig-
ure 5.12D). Note that because the sequence of pAFD1 was not known, I deduced
the fragment’s probable sequence and designed PCR primers based on related
vectors that have been sequenced: the sequence of repA was determined from the
native B. fragilis plasmid pBI143 [278]; the sequence of ermF was determined
from the vectors pFD288 and pFD1146 [228, 278], which are related to pAFD1
through the shared ermF marker that was originally from pBF4 [326]. I was
uncertain about the sequence for the portion between the ermF and repA el-
ements, so to obtain the complete sequence, I carried out primer walking (see
Section 5.6.6).
❼ Deletion of the gentamicin resistance gene stuﬀer, generating pKL7 (Figure 5.12E).
At this time, I was ﬁnishing my work on Chapter 4, and decided to include tran-
scriptional terminators that ﬂank the cloning site in my new vector (see next
point), which required removing this stuﬀer.
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❼ In place of the gentamicin resistance stuﬀer, I cloned in what I called the “tran-
scriptional terminator” fragment. The elements of this fragment are discussed in
detail in Section 6.4.1. The fragment includes: two unidirectional transcriptional
terminators that stop potential insert-initiated transcription from going into the
vector backbone, and a stuﬀer comprising a gentamicin resistance gene as well as
a Ptac promoter for terminator testing purposes (see Section 6.4.3). The fragment
was cloned as a blunt SwaI fragment from pKL9 into the blunt Eco72I site of
pKL7, terminating the existing Eco72I sites but reintroducing new Eco72I sites,
which ﬂank the stuﬀer (Figure 5.12F).
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Figure 5.12: Construction of B. theta-compatible fosmid vector pKL13. The commerical vector pCC1FOS (A) was
modiﬁed by adding the gentamicin resistance stuﬀer from pJC8, generating pKL4 (B); the fragment carrying the oriT from pJC8
with BamHI adapters, generating pKL5 (C); the fragment from pAFD1 carrying ermF and repA-ori with EcoRI adapters, generating
pKL6 (D); deleting the gentamicin resistance stuﬀer, generating pKL7 (E); adding the transcriptional terminator fragment, generating
pKL13 (F). Note that these are stylized diagrams and are not to scale.
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Analysis of new vector passaged through B. theta ; generation of clone li-
braries using pKL13
After constructing the new vector, I performed a check to see that the vector was
behaving as expected. Because the pCC1FOS backbone is not a vector that is normally
used in the Bacteroides , the check was important to make sure that the new vector is
stable in B. theta and was therefore appropriate to use as a library cloning vector.
To perform the check, I used pK11; note that pKL11 is identical to pKL13 except
for a point mutation in one of the transcriptional terminators and the removal of the
stuﬀer between the Eco72I sites (see Table 2.2). I carried out a triparental mating
to conjugate pKL11 from E. coli HB101 to B. theta, using DH5α(pRK600) as helper;
following this, six clones of B. theta carrying pKL11 were selected and streak-puriﬁed,
fosmid DNA was isolated from the clones, and the DNA was re-introduced into E. coli
for subsequent isolation and restriction analysis (Figure 5.13A). Note that plasmid
miniprepped DNA from B. theta cannot be analyzed directly because it contains DNA
from B. theta’s own native plasmid (see Section 5.3), which complicates restriction
digest analyses.
The B. theta-passaged fosmid DNA isolated from E. coli was digested and com-
pared to digested pKL11 from E. coli that had not been passaged through B. theta
(Figure 5.13B). From the results, it can be seen that the passaged vector DNA is the
same size as the original vector, meaning undesired recombination events that may
have increased or decreased the vector size did not occur. Importantly, this experiment
demonstrates that the vector is stable and can be isolated intact by plasmid miniprep
from B. theta; this point will returned later in Section 5.4.4 where I encounter diﬃcul-
ties isolating plasmid DNA.
172
CHAPTER 5. DEVELOPMENT OF BACTEROIDES THETAIOTAOMICRON AS A SCREENING HOST
Recipient:  B. theta
Donor: HB101 (pKL11) Helper: DH5α (pRK600)A
B
23.1 kb
9.4 kb
Bt-passaged pKL11
1 2 3 4 5 6 pKL11
Ec
6.6 kb
4.4 kb
2.3 kb
2.0 kb
Figure 5.13: Analysis of fosmid vector DNA passaged through B. theta and re-
introduced into E. coli . (A) pKL11 was conjugated from E. coli to B. theta in a triparental mating;
plasmid DNA was isolated from six B. theta clones carrying pKL11, re-introduced into E. coli , and
isolated from E. coli for analysis (B) Gel electrophoresis of Eco72I-digested B. theta-passaged pKL11,
against a control preparation of pKL11 from E. coli .
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After making sure the fosmid vector was stable in B. theta, I used pKL13 to gen-
erate clone libraries. Library construction was carried out using a protocol as described
earlier with the exception that the Eco72I stuﬀer was not separated from the vector
preparation prior to ligation to the genomic/metagenomic DNA (see Section 5.6.9 for
technical details). As before, I generated two libraries to use in selection experiments:
a B. theta genomic library named BT3, and human gut metagenomic library named
CLGM3 (see Table 2.12). Both libraries were constructed in an EPI300 background,
because EPI300 oﬀers copy-number inducibility and I found that it transduces at least
as well as HB101 (Table 5.4).
Table 5.4: Transduction eﬃciency using HB101, S17-1, or EPI300.
Strain used
Number of transductants
Trial 1 count Trial 2 count
HB101 162 413
S17-1 34 61
EPI300 592 430
Conjugation of CLGM3 metagenomic library into B. theta host
Hoping that using new single-copy vector backbone would resolve the conjugation prob-
lems encountered, I performed a triparental mating to transfer the library from EPI300
to B. theta, using HB101(pRK2013) as helper (Figure 5.14A). A similar mating us-
ing the pKL13 vector alone was done alongside as a control. Note that the pRK2013
helper is a ColE1 plasmid, and is compatible with pKL13, which carries the F and RK2
origins.
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The mating was plated on media selecting for B. theta transconjugants (Fig-
ure 5.14B). Comparing the dilution plate giving rise to colonies between Figure 5.11B
and Figure 5.14B, it can be seen that the conjugation eﬃciency of the vector alone is
improved using the single-copy fosmid, but more importantly, the eﬃciency of CLGM3
is showing an improvement of easily one thousand-fold. The marked improvement in
transfer of the library meant that it was well-suited for functional screening in B. theta.
Before proceeding to a screen, however, I ﬁrst wanted to more quantitatively assess the
conjugation eﬃciencies.
vector only
10-2 dilution
CLGM3 library
10-2 dilution
A
B
Recipient:  B. theta
Donor: EPI300 (CLGM3) Mobilizer: HB101 (pRK2013)
Figure 5.14: Triparental conjugation of CLGM3 library into B. theta. (A)
Overview of triparental conjugation experiment for transfer of CLGM3 library from
E. coli EPI300 donor to B. theta recipient. (B) Result of conjugation into B. theta of
vector alone (left) or CLGM3 library (right). Growth media: BHIH Em25 NA25 Km200
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Conjugation efficiencies
To calculate the eﬃciency of conjugation of both empty pKL13 and the CLGM3 library
into B. theta, I repeated the triparental conjugations as depicted in Figure 5.14A. The
matings were serially diluted and plated on media with diﬀerent antibiotics to select
for the donor, recipient, or transconjugant:
❼ Donor: E. coli EPI300 (pKL13/CLGM3), on LB Cm10
❼ Recipient: B. theta, on BHIH NA25 Km200
❼ Transconjugant: B. theta (pKL13/CLGM3), on BHIH Em25 NA25 Km200
From counting the number of colonies arising on the plates for each of the donor,
recipient, and transconjugant dilutions, it was possible to determine the conjugation ef-
ﬁciency with respect to the donor as well as the recipient, which is simply the number of
transconjugants divided by the number of donors or recipients, respectively (Table 5.5).
Table 5.5: Conjugation eﬃciency of pKL13 vector and CLGM3 library into B. theta.
pKL13 vector only CLGM3 library
relative to donor 2.1× 10−5 8.2× 10−6
relative to recipient 2.6× 10−2 1.1× 10−2
For matings in which B. theta is the recipient, it would be most useful to refer
to the conjugation eﬃciency with respect to the recipient as this is the limiting factor;
this is because conjugations are performed aerobically where B. theta growth can only
occur after the E. coli cells have formed a lawn, thereby protecting B. theta from
atmospheric oxygen (see Section 5.6.8 for details on methods); hence, the recipient cell
count is much lower than the donor cell count.
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The conjugation eﬃciency was calculated to be 2.6×10−2 for pKL13 and 1.1×10−2
for the CLGM3 library (Table 5.5). This means that 2-3% of B. theta cells present in
the pKL13 conjugation will receive the vector; for the library, this number is closer to
1%. Though the fraction of transconjugants obtained from a mating is not as high as,
for example, matings involving Sinorhizobium meliloti as recipient [94], the frequency
of transfer was suﬃciently high to move forward and try functional screening using
B. theta as an expression host.
5.4.3 Functional complementation using a B. theta host
Construction of B. theta single recombinant amino acid auxotrophs and
attempt at complementation
To execute a functional screen as described in Figure 5.4, a prerequisite is having a
B. theta mutant whose phenotype can be complemented and, ideally, the complemen-
tated mutant can be selected rather than screened for. During my visit to laboratory of
Eric Martens at the University of Michigan, I constructed two mutants for this purpose;
both were mutants in amino acid biosynthesis: the ﬁrst was a threonine auxotroph and
the second, a tryptophan auxotroph.
For a quick construction, rather than making clean deletions, I settled for generat-
ing single recombinant mutants by disrupting the thrC (BT 2401) and trpD (BT 0530)
genes. To do this, I PCR-ampliﬁed and cloned an internal fragment from either the thrC
or trpD gene into B. theta suicide vector pKNOCK-bla-tetQ (Figure 5.15A), generating
pKL21 and pKL22, respectively. The constructed plasmids were then mated into wild-
type B. theta; pKNOCK-bla-tetQ is unable to replicate in B. theta and thus selection
for tetracycline resistance allows isolation of single recombinants in which the plasmid
has integrated into the genome at the locus speciﬁed by the cloned fragment. I isolated
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threonine and tryptophan auxotrophs and checked their phenotype on minimal media;
as expected, the thr mutant could not grow unless threonine was supplemented and
the trp mutant could not grow unless tryptophan was supplemented (Figure 5.15B).
Figure 5.15: Construction of B. theta single recombinant amino acid aux-
otrophs. (A) A fragment of either thrC or trpD was PCR-ampliﬁed and cloned into the
B. theta suicide vector pKNOCK-bla-tetQ ; adapted from [200] (B) Phenotypic check of
constructed mutants on minimal media; WT: wild-type, trp1: tryptophan auxotroph,
thr1: threonine auxotroph.
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Out of the two mutants, I decided to use the B. theta tryptophan auxotroph in
the ﬁrst functional screen of the CLGM3 library. I mated the CLGM3 library from
E. coli EPI300 into the B. theta tryptophan auxotroph, and selected for complemented
transconjugants on minimal media with no supplemented amino acids; as negative and
positive controls, I also mated the vector, pKL13, as well as the B. theta genomic
library, BT3, respectively (Figure 5.16). Unfortunately, though the CLGM3 metage-
nomic library and BT3 genomic library matings gave rise to colonies on the selective
media, the vector-only control did as well – at an even greater frequency. It was most
likely that the single recombinant mutant was unstable and the vector was recombining
out of the chromosome, despite the inclusion of tetracycline as selection; that is, the
mutant was reverting to wild-type phenotype under the selection for functional trypto-
phan biosynthesis genes. The greater frequency of reversion seen for the vector over the
two libraries can likely be attributed to a greater eﬃciency of conjugation for smaller
plasmids; this was also evident in Figure 5.14B.
Figure 5.16: Results of functional screen for tryptophan biosynthesis genes
in B. theta single recombinant. The vector-only control, pKL13 (left), the BT3
genomic library (centre), and the CLGM3 metagenomic library (right) were mated into
the B. theta tryptophan auxotroph and conjugations were plated on media selecting
for complementation. Growth media: MM glucose Tc2 Em25 NA25 Km200
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It was most regrettable that I did not construct deletion mutants instead of single
recombinant mutants: if the trpD gene were deleted instead of simply interrupted, there
would be no possibility of reversion to wild-type phenotype. Given the time constraints,
however, it was not feasible to begin the construction of clean deletions of the thrC or
trpD genes; rather, as Eric Martens suggested, I made use of a B. theta deletion mutant
that had been previously constructed and characterized.
Successful complementation of the B. theta chuR / anSME mutant
The mutant chosen for the next attempt at functional complementation was B. theta
∆chuR, also called ∆anSME [17]. The chuR/anSME gene (BT 0238) was ﬁrst iden-
tiﬁed by Abigail Salyers’ group through transposon mutagenesis as a regulator of
chondroitin sulfate and heparin utilization [44]. Knocking out this single gene renders
B. theta unable to grow on chondroitin sulfate or heparin as sole carbon source, as
shown in Figure 5.17 ❸.
Figure 5.17: Phenotype of B. theta wild-type and ∆chuR mutant. Pheno-
type of the B. theta wild-type (top half) and ∆chuR mutant (bottom half) on BHIH
complex media (A) or minimal media with chondroitin sulfate as sole carbon source
(B).
❸Note that the strain isogenic to ∆chuR is ∆tdk, which is in turn isogenic to the wild-type. The
wild-type and ∆tdk exhibit comparable growth on chondroitin sulfate; see Appendix D.1
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Chondroitin sulfate is a polysaccharide that is composed of alternating N-acetyl-
galactosamine and glucuronic acid residues, with the sugar residues carrying sulfate
groups at certain positions [80]. The breakdown of this polysaccharide requires the
action of sulfatase enzymes, of which B. theta may encode up to 28 [17]; however, the
sulfatases must be modiﬁed post-translationally by the product of the chuR/anSME
gene, an anaerobic sulfatase maturase enzyme [18]; without the post-translational
modiﬁcation, the sulfatases are not active. The 1.2-kb chuR/anSME gene is part of a
three-gene operon but is currently the only characterized member (Figure 5.18). The
phenotype being dependent on the single chuR gene, as well as the clean phenotype of
the B. theta ∆chuR mutant on chondroitin sulfate as sole carbon source (Figure 5.17B),
make it a very good candidate for functional complementation.
Figure 5.18: Genomic region of the B. theta chuR (anSME ; BT 0238)
gene. The 1.2-kb chuR gene (underlined in red) of the B. theta genome and its
surrounding region. Adapted from the KEGG Genome Database [143]
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To screen the CLGM3 library for chuR/anSME genes, I once again performed
a triparental conjugation, mating the CLGM3 library from E. coli EPI300 into the
B. theta ∆chuR strain, selecting on minimal media with chondroitin sulfate. Also
as before, for negative and positive controls, respectively, I performed matings of the
vector, pKL13, as well as the B. theta genomic library, BT3. Each of the three conju-
gations was plated on multiple plates to select for transconjugants with ability to use
chondroitin sulfate as sole carbon source; one of each is shown in Figure 5.19.
A B C
Figure 5.19: Results of functional screen for chuR/anSME genes using
B. theta ∆chuR background. Selection plates onto which conjugations were spread,
using as donor: pKL13 vector only (A), BT3 genomic library (B), and CLGM3 metage-
nomic library (C). Black arrows indicate several examples of isolated colonies. Growth
media: MM chondroitin sulfate
Unlike my ﬁrst attempt at complementation, the negative control had no colonies
(Figure 5.19A). The positive control, using B. theta’s own genomic DNA to complement
the mutant, resulted in colonies, as was expected (Figure 5.19B). Most importantly, the
experimental mating using the CLGM3 metagenomic library also yielded colonies (Fig-
ure 5.19C). This result indicates that the B. theta ∆chuR mutant can be complemented
using cloned metagenomic DNA from the human gut, although the phylogenetic origin
of the complementing DNA remained to be determined. From the BT3 and CLGM3
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plates, I streak-puriﬁed colonies to conﬁrm the restored phenotype and to purify the
clone in the case that one colony arose from more than one complemented cell. The
positive clones from the streak-puriﬁcation provide clear evidence that the mutant’s
ability to grow on chondroitin sulfate has been restored (Figure 5.20). After the dif-
ﬁculties that I encountered, that the functional screen seemed to be working well was
promising. The next step was to isolate the complementing fosmids from B. theta for
eventual restriction analyses and DNA sequencing.
A B C
Figure 5.20: Streak purification of complementing chuR/anSME clones.
Control streaks of wild-type and ∆chuR (A), four complementing clones from the BT3
library (B), and one complementing clone from the CLGM3 library (C). Growth media:
MM chondroitin sulfate
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5.4.4 DNA of positive clones appears to be integrated into the
host genome
In Section 5.4.2, I showed that the fosmid vector could be isolated from B. theta and
re-introduced into E. coli . Now, with streak-puriﬁed complementing clones from the
successful chuR/anSME screen of both the BT3 library and the CLGM3 library, I
needed to employ the same method to isolate the clone DNA from the B. theta ∆chuR
host. I inoculated the clones in liquid media for a plasmid miniprep, and included the
antibiotic erythromycin in the media to ensure that the fosmid backbone was present.
The ﬁrst clue that something was amiss was when only about half of the clones grew up
in the liquid media containing the antibiotic. I proceeded to do the plasmid miniprep
for those clones that grew; when I attempted to transform E. coli with the preparation,
however, I did not obtain transformants for any of the samples, which indicated that
there was no fosmid DNA isolated from B. theta.
At this point, I hypothesized that the fosmid DNA may have integrated into
the host genome. If the DNA were in fact integrated into the genome, this would be
unfortunate as the functional metagenomic method employed in our lab hinges on being
able to retrieve the DNA for sequence analysis. With this hypothesis in mind, I isolated
genomic DNA from the same clones to analyze, that is, from the clones that did grow in
the presence of erythromycin. Genomic DNA was prepared from the following strains
for analysis:
❼ BT3 library: chuR clones #2, 5, 6, 9, 10, in B. theta ∆chuR background
❼ CLGM3 library: chuR clones #1, 2, 3, 4, 5, 8, 9, in B. theta ∆chuR background
❼ B. theta ∆chuR, as a control
❼ wild-type B. theta, as a control
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To establish whether the genomic DNA contained integrated fosmid DNA, I per-
formed a PCR to test for the presence of the fosmid’s oriT sequence, and I included
pKL13 as a positive control (Figure 5.21A). As suspected, all of the clones from the
BT3 and CLGM3 library were positive for the oriT while the wild-type and ∆chuR
controls were negative. This suggested that the fosmid DNA was integrated into the
genome of the ∆chuR background; the location of integration is uncertain but recom-
bination would theoretically be possible anywhere along shared homologous tracts of
DNA, which would likely be present on the complementing chuR fosmid clone.
Following that line of thought, if the fosmid DNA had recombined into the genome
for so many clones, could it be that most or even all of the fosmid clones were carry-
ing DNA from B. theta strains (rather than other species) present in the pooled fecal
samples? This scenario could explain the clones’ propensity for homologous recombi-
nation. To see if this was the case, I designed PCR primers for the ORF of the B. theta
chuR gene; these primers are likely to amplify only exact or very close matches to the
B. theta VPI-5482 wild-type sequence (primers KL61 and KL62 were 35 and 40 bases
in length, respectively; see Table 2.3). I carried out this PCR, using the pKL13 plas-
mid DNA and ∆chuR genomic DNA as negative controls (Figure 5.21B). As expected,
all of the clones from the BT3 library were positive; and from the CLGM3 library,
all but one clone (chuR clone #2) showed ampliﬁcation using primers based on the
B. theta chuR sequence. I tried reducing the annealing temperature of the PCR in an
attempt to amplify the chuR ORF from CLGM3 clone #2, but a PCR product was
not obtained even when using an annealing temperature as low as 45❽. This suggests
that this clone may be carrying a copy of chuR that is quite diﬀerent in sequence from
B. theta; unfortunately, such sequences are the ones desired in a functional metage-
nomics approach and the problem of recombination prevented the retrieval of the clone’s
chuR-complementing sequence.
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Figure 5.21: PCR analysis supporting the hypothesis that complementing fosmid DNA
is integrated into the genome of B. theta ∆chuR host. PCR for: (A) the oriT sequence on
the pKL13 vector backbone; (B) chuR ORF based on B. theta wild-type sequence; (C) fragment 300
bp upstream to 300 bp downstream of the chuR ORF; (D) chuR ORF plus −300 bp downstream; (E)
chuR ORF plus 300 bp upstream.
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From Figure 5.21B, it appeared that all but one clone from the CLGM3 library
had a chuR gene exactly or very similar to the B. theta VPI-5482 wild-type, because
PCR using B. theta-speciﬁc primers was successful. However, before I proceeded to
analyze the sequences for these ampliﬁed ORFs, I ﬁrst wanted to perform another
check to support the hypothesis that the fosmid clones had integrated into the genome
of the ∆chuR background. This deletion strain carries a clean removal of the 1,200-bp
chuR ORF, and primers designed to +300 bp upstream and −300 bp downstream of the
ORF would amplify only 600 bp from the mutant versus 1,800 bp from the wild-type.
I used such primers to conﬁrm that indeed the chuR 600-bp deletion fragment in the
host genome was still intact for all BT3 and CLGM3 library clones (Figure 5.21C).
The result of this last PCR was somewhat surprising, however, for another reason.
I had expected the BT3 library clones (and perhaps some of the CLGM3 clones as well)
to exhibit both the 600-bp and 1800-bp bands – the prior from the B. theta ∆chuR
background and the latter from the complementing fosmid DNA carrying the B. theta
chuR gene. That all of the BT3 clones from Figure 5.21C were exhibiting just the 600-
bp band suggested that the smaller product may be preferred in the PCR. To determine
if this was the case, I used primer combinations such that the smaller PCR product
was not a possibility: amplifying either the chuR ORF plus 300 bp downstream or
amplifying the chuR ORF plus 300 bp upstream (Figure 5.21D and E, respectively).
The results of this PCR conﬁrmed that indeed the smaller PCR product was preferred
and that the wild-type complementing DNA was present in the clones originating from
the BT3 genomic library. Interestingly, 6 of the 7 clones from the CLGM3 human
gut library also showed ampliﬁcation (Figure 5.21D), supporting my hypothesis that
these gut clones likely carried B. theta DNA – although CLGM3 clone #9 did not
produce a PCR product in the ampliﬁcation that included the 300-bp upstream of the
ORF (Figure 5.21E), a result that suggests this particular complementing fosmid may
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simply not be carrying a fragment that includes this 300-bp upstream region.
Consistent with a lack of ampliﬁcation of the chuR ORF for CLGM3 clone #2
in Figure 5.21B, this clone did not produce PCR products in either Figure 5.21D or
Figure 5.21E. For the 6 other clones isolated from the CLGM3 human gut library,
however, the successful ampliﬁcation of the chuR ORF (Figure 5.21B) meant that
sequence analysis of the complementing ORF on the metagenomic DNA was possible.
5.4.5 Sequence analysis of positive clones isolated from com-
plementation of B. theta reveals a chuR variant
Of the 6 metagenomic chuR ORFs that were ampliﬁed (Figure 5.21B), I suspected
that all or most of them would be near or exact matches to the B. theta VPI-5482
chuR ORF. To analyze the sequence of these ORFs, the PCR products from CLGM3
chuR clones #1, 3, 4, 5, 8, and 9 were puriﬁed and submitted for Sanger sequencing.
As a control, I also sequenced a PCR product originating from the B. theta genomic
libary, BT3 chuR clone #2; this sequence should be the wild-type B. theta sequence,
consistent with the source DNA used to make the BT3 library.
After Sanger sequencing, the single BT3 and 6 CLGM3 chuR sequences were
aligned (Figure 5.22). All but one of the metagenomic chuR sequences were an exact
match to the B. theta wild-type chuR sequence. To reiterate, this result was not
surprising if homologous recombination occurred for all of these clones, suggesting that
there was signiﬁcant sequence similarity between the host genome and the DNA carried
on the fosmid clones.
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. . . . : . . . . 1 . . 120
1 CLGM3_chuR5_KL61 AAGCTGC-WTGTYMT-GGTAAGCCCGTGGGAGCCGTATGTAATCTCGCATGCGAATACTGCTATTATTTGGAAAAGGCGAACCTATACAAAGAAAACCCCAAACATGTAATGAGCGATGA
2 CLGM3_chuR1_KL61 GAGCTCYAYYGTYMWGGGTAAGCCCGTGGGAGCCGTATGCAACCTCGCATGCGAATACTGCTATTATTTGGAAAAGGCGAATCTATACAAAGAAAACCCGAAACATGTAATGAGCGATGA
3 CLGM3_chuR3_KL61 GAGCTGC-WTGTYMT-GGTAAGCCCGTGGGAGCCGTATGCAACCTCGCATGCGAATACTGCTATTATTTGGAAAAGGCGAATCTATACAAAGAAAACCCGAAACATGTAATGAGCGATGA
4 BT3_chuR2_KL61 GAGCTG--AYGTYMT-GGTAAGCCCGTGGGAGCCGTATGCAACCTCGCATGCGAATACTGCTATTATTTGGAAAAGGCGAATCTATACAAAGAAAACCCGAAACATGTAATGAGCGATGA
5 CLGM3_chuR8_KL61 AAGCTCC-WYGTYMT-GGTAAGCCCGTGGGAGCCGTATGCAACCTCGCATGCGAATACTGCTATTATTTGGAAAAGGCGAATCTATACAAAGAAAACCCGAAACATGTAATGAGCGATGA
6 CLGM3_chuR4_KL61 GAGCTGCAYTGTYMT-GGTAAGCCCGTGGGAGCCGTATGCAACCTCGCATGCGAATACTGCTATTATTTGGAAAAGGCGAATCTATACAAAGAAAACCCGAAACATGTAATGAGCGATGA
7 CLGM3_chuR9_KL61 TAGCTG--AWGTTMT-GGTAAGCCCGTGGGAGCCGTATGCAACCTCGCATGCGAATACTGCTATTATTTGGAAAAGGCGAATCTATACAAAGAAAACCCGAAACATGTAATGAGCGATGA
. . : . . . . 2 . . . . 240
1 CLGM3_chuR5_KL61 ACTACTGGAAAAGTTTATCGACGAGTATATCAGTTCTCAAACCATGCCTCAAGTGCTTTTTACCTGGCACGGTGGAGAAACGCTGATGCGTCCGCTTTCTTTTTATAAAAAGGCGATGGA
2 CLGM3_chuR1_KL61 GCTACTGGAAAAGTTTATCGACGAGTATATCAACTCTCAAACCATGCCTCAAGTGCTTTTTACCTGGCACGGTGGAGAAACGCTGATGCGTCCGCTTTCTTTTTATAAAAAGGCGATGGA
3 CLGM3_chuR3_KL61 GCTACTGGAAAAGTTTATCGACGAGTATATCAACTCTCAAACCATGCCTCAAGTGCTTTTTACCTGGCACGGTGGAGAAACGCTGATGCGTCCGCTTTCTTTTTATAAAAAGGCGATGGA
4 BT3_chuR2_KL61 GCTACTGGAAAAGTTTATCGACGAGTATATCAACTCTCAAACCATGCCTCAAGTGCTTTTTACCTGGCACGGTGGAGAAACGCTGATGCGTCCGCTTTCTTTTTATAAAAAGGCGATGGA
5 CLGM3_chuR8_KL61 GCTACTGGAAAAGTTTATCGACGAGTATATCAACTCTCAAACCATGCCTCAAGTGCTTTTTACCTGGCACGGTGGAGAAACGCTGATGCGTCCGCTTTCTTTTTATAAAAAGGCGATGGA
6 CLGM3_chuR4_KL61 GCTACTGGAAAAGTTTATCGACGAGTATATCAACTCTCAAACCATGCCTCAAGTGCTTTTTACCTGGCACGGTGGAGAAACGCTGATGCGTCCGCTTTCTTTTTATAAAAAGGCGATGGA
7 CLGM3_chuR9_KL61 GCTACTGGAAAAGTTTATCGACGAGTATATCAACTCTCAAACCATGCCTCAAGTGCTTTTTACCTGGCACGGTGGAGAAACGCTGATGCGTCCGCTTTCTTTTTATAAAAAGGCGATGGA
: . . . . 3 . . . . : . 360
1 CLGM3_chuR5_KL61 ACTGCAAAAGAAATACGCCCGCGGACGTACGATTGACAATTGTATCCAGACGAATGGGACCTTACTCACAGACGAATGGTGCGAGTTCTTCCGTGAAAACAACTGGCTGGTAGGGGTTTC
2 CLGM3_chuR1_KL61 GCTGCAAAAGAAATACGCCCGCGGACGTACGATTGACAATTGTATCCAGACGAATGGAACCTTGCTTACAGACGAATGGTGCGAGTTCTTCCGTGAAAACAACTGGCTGGTAGGGGTTTC
3 CLGM3_chuR3_KL61 GCTGCAAAAGAAATACGCCCGCGGACGTACGATTGACAATTGTATCCAGACGAATGGAACCTTGCTTACAGACGAATGGTGCGAGTTCTTCCGTGAAAACAACTGGCTGGTAGGGGTTTC
4 BT3_chuR2_KL61 GCTGCAAAAGAAATACGCCCGCGGACGTACGATTGACAATTGTATCCAGACGAATGGAACCTTGCTTACAGACGAATGGTGCGAGTTCTTCCGTGAAAACAACTGGCTGGTAGGGGTTTC
5 CLGM3_chuR8_KL61 GCTGCAAAAGAAATACGCCCGCGGACGTACGATTGACAATTGTATCCAGACGAATGGAACCTTGCTTACAGACGAATGGTGCGAGTTCTTCCGTGAAAACAACTGGCTGGTAGGGGTTTC
6 CLGM3_chuR4_KL61 GCTGCAAAAGAAATACGCCCGCGGACGTACGATTGACAATTGTATCCAGACGAATGGAACCTTGCTTACAGACGAATGGTGCGAGTTCTTCCGTGAAAACAACTGGCTGGTAGGGGTTTC
7 CLGM3_chuR9_KL61 GCTGCAAAAGAAATACGCCCGCGGACGTACGATTGACAATTGTATCCAGACGAATGGAACCTTGCTTACAGACGAATGGTGCGAGTTCTTCCGTGAAAACAACTGGCTGGTAGGGGTTTC
. . . 4 . . . . : . . . 480
1 CLGM3_chuR5_KL61 TATTGATGGCCCGCAAGAGTTTCATGACGAATACCGCAAGAACAAAATGGGCAAACCTTCTTTCGTCAAAGTGATGCAAGGGATTAATCTCCTGAAAAAACATGGAGTAGAATGGAACGC
2 CLGM3_chuR1_KL61 CATTGATGGCCCGCAAGAGTTTCATGACGAATATCGCAAAAATAAGATGGGCAAACCTTCTTTCGTCAAAGTGATGCAAGGGATCAATCTCCTGAAAAAACATGGAGTAGAATGGAACGC
3 CLGM3_chuR3_KL61 CATTGATGGCCCGCAAGAGTTTCATGACGAATATCGCAAAAATAAGATGGGCAAACCTTCTTTCGTCAAAGTGATGCAAGGGATCAATCTCCTGAAAAAACATGGAGTAGAATGGAACGC
4 BT3_chuR2_KL61 CATTGATGGCCCGCAAGAGTTTCATGACGAATATCGCAAAAATAAGATGGGCAAACCTTCTTTCGTCAAAGTGATGCAAGGGATCAATCTCCTGAAAAAACATGGAGTAGAATGGAACGC
5 CLGM3_chuR8_KL61 CATTGATGGCCCGCAAGAGTTTCATGACGAATATCGCAAAAATAAGATGGGCAAACCTTCTTTCGTCAAAGTGATGCAAGGGATCAATCTCCTGAAAAAACATGGAGTAGAATGGAACGC
6 CLGM3_chuR4_KL61 CATTGATGGCCCGCAAGAGTTTCATGACGAATATCGCAAAAATAAGATGGGCAAACCTTCTTTCGTCAAAGTGATGCAAGGGATCAATCTCCTGAAAAAACATGGAGTAGAATGGAACGC
7 CLGM3_chuR9_KL61 CATTGATGGCCCGCAAGAGTTTCATGACGAATATCGCAAAAATAAGATGGGCAAACCTTCTTTCGTCAAAGTGATGCAAGGGATCAATCTCCTGAAAAAACATGGAGTAGAATGGAACGC
. 5 . . . . : . . . . 6 600
1 CLGM3_chuR5_KL61 TATGGCTGTTGTGAACGATTTCAATGCCGAATATCCATTAGACTTTTATAATTTCTTCAAAGAAATAGATTGCCATTATATCCAGTTCGCCCCGATTGTTGAACGCATTGTTTCACATCA
2 CLGM3_chuR1_KL61 TATGGCTGTTGTGAACGATTTCAATGCCGAATATCCATTAGACTTTTATAATTTCTTCAAAGAAATAGATTGCCATTATATTCAGTTCGCTCCGATTGTTGAACGCATTGTTTCACATCA
3 CLGM3_chuR3_KL61 TATGGCTGTTGTGAACGATTTCAATGCCGAATATCCATTAGACTTTTATAATTTCTTCAAAGAAATAGATTGCCATTATATTCAGTTCGCTCCGATTGTTGAACGCATTGTTTCACATCA
4 BT3_chuR2_KL6 TATGGCTGTTGTGAACGATTTCAATGCCGAATATCCATTAGACTTTTATAATTTCTTCAAAGAAATAGATTGCCATTATATTCAGTTCGCTCCGATTGTTGAACGCATTGTTTCACATCA
5 CLGM3_chuR8_KL61 TATGGCTGTTGTGAACGATTTCAATGCCGAATATCCATTAGACTTTTATAATTTCTTCAAAGAAATAGATTGCCATTATATTCAGTTCGCTCCGATTGTTGAACGCATTGTTTCACATCA
6 CLGM3_chuR4_KL61 TATGGCTGTTGTGAACGATTTCAATGCCGAATATCCATTAGACTTTTATAATTTCTTCAAAGAAATAGATTGCCATTATATTCAGTTCGCTCCGATTGTTGAACGCATTGTTTCACATCA
7 CLGM3_chuR9_KL61 TATGGCTGTTGTGAACGATTTCAATGCCGAATATCCATTAGACTTTTATAATTTCTTCAAAGAAATAGATTGCCATTATATTCAGTTCGCTCCGATTGTTGAACGCATTGTTTCACATCA
. . . . : . . . . 7 . . 720
1 CLGM3_chuR5_KL61 GGACGGTCGTCATCTTGCCTCTCTGGCAGAAGGTAAAGAAGGAGCATTGGCTGATTTCTCCATAAGTCCGGAACAATGGGGTAACTTTCTCTGTACAATTTTTGATGAATGGGTAAAAGA
2 CLGM3_chuR1_KL61 GGACGGTCGTCATCTTGCCTCTCTGGCAGAAGGTAAAGAAGGGGCATTGGCTGATTTTTCCGTAAGTCCGGAACAATGGGGTAACTTTCTCTGTACAATTTTTGATGAATGGGTAAAAGA
3 CLGM3_chuR3_KL61 GGACGGTCGTCATCTTGCCTCTCTGGCAGAAGGTAAAGAAGGGGCATTGGCTGATTTTTCCGTAAGTCCGGAACAATGGGGTAACTTTCTCTGTACAATTTTTGATGAATGGGTAAAAGA
4 BT3_chuR2_KL61 GGACGGTCGTCATCTTGCCTCTCTGGCAGAAGGTAAAGAAGGGGCATTGGCTGATTTTTCCGTAAGTCCGGAACAATGGGGTAACTTTCTCTGTACAATTTTTGATGAATGGGTAAAAGA
5 CLGM3_chuR8_KL61 GGACGGTCGTCATCTTGCCTCTCTGGCAGAAGGTAAAGAAGGGGCATTGGCTGATTTTTCCGTAAGTCCGGAACAATGGGGTAACTTTCTCTGTACAATTTTTGATGAATGGGTAAAAGA
6 CLGM3_chuR4_KL61 GGACGGTCGTCATCTTGCCTCTCTGGCAGAAGGTAAAGAAGGGGCATTGGCTGATTTTTCCGTAAGTCCGGAACAATGGGGTAACTTTCTCTGTACAATTTTTGATGAATGGGTAAAAGA
7 CLGM3_chuR9_KL61 GGACGGTCGTCATCTTGCCTCTCTGGCAGAAGGTAAAGAAGGGGCATTGGCTGATTTTTCCGTAAGTCCGGAACAATGGGGTAACTTTCTCTGTACAATTTTTGATGAATGGGTAAAAGA
. . : . . . . 8 . . . . 840
1 CLGM3_chuR5_KL61 AGATGTGGGCAAATTCTTCATACAGATATTCGATTCTACATTGGCTAACTGGATGGGTGAGCAACCGGGCGTATGTACAATGGCGAAGCATTGCGGACATGCCGGCGTTATGGAATTCAA
2 CLGM3_chuR1_KL61 AGATGTGGGCAAATTCTTCATACAGATATTCGATTCCACATTGGCTAACTGGATGGGCGAGCAACCGGGCGTATGTACAATGGCGAAGCATTGCGGACATGCCGGCGTTATGGAATTCAA
3 CLGM3_chuR3_KL61 AGATGTGGGCAAATTCTTCATACAGATATTCGATTCCACATTGGCTAACTGGATGGGCGAGCAACCGGGCGTATGTACAATGGCGAAGCATTGCGGACATGCCGGCGTTATGGAATTCAA
4 BT3_chuR2_KL61 AGATGTGGGCAAATTCTTCATACAGATATTCGATTCCACATTGGCTAACTGGATGGGCGAGCAACCGGGCGTATGTACAATGGCGAAGCATTGCGGACATGCCGGCGTTATGGAATTCAA
5 CLGM3_chuR8_KL61 AGATGTGGGCAAATTCTTCATACAGATATTCGATTCCACATTGGCTAACTGGATGGGCGAGCAACCGGGCGTATGTACAATGGCGAAGCATTGCGGACATGCCGGCGTTATGGAATTCAA
6 CLGM3_chuR4_KL61 AGATGTGGGCAAATTCTTCATACAGATATTCGATTCCACATTGGCTAACTGGATGGGCGAGCAACCGGGCGTATGTACAATGGCGAAGCATTGCGGACATGCCGGCGTTATGGAATTCAA
7 CLGM3_chuR9_KL61 AGATGTGGGCAAATTCTTCATACAGATATTCGATTCCACATTGGCTAACTGGATGGGCGAGCAACCGGGCGTATGTACAATGGCGAAGCATTGCGGACATGCCGGCGTTATGGAATTCAA
: . . . . 9 . . . . : . 960
1 CLGM3_chuR5_KL61 CGGAGACGTATACTCTTGTGACCACTTCGTATTCCCGGAATATAAATTGGGAAATATCTATAGCCAGACTTTGGTGGAAATGATGCATAGTGAACGACAGCA-AACTTCGGGACAATGAA
2 CLGM3_chuR1_KL61 CGGAGACGTATACTCTTGTGACCACTTCGTATTCCCGGAATAT-AATTGGGAAATATCTATAGCCAAACTTTGGTGGAAATGATGCATAGTGAACGACAGCATAACTTCGGAACAATGAA
3 CLGM3_chuR3_KL61 CGGAGACGTATACTCTTGTGACCACTTCGTATTCCCGGAATATAAATTGGGAAATATCTATAGCCAAACTTTGGTGGAAATGATGCATAGTGAACGACAGCATAACTTC-GAACAATGAA
4 BT3_chuR2_KL61 CGGAGACGTATACTCTTGTGACCACTTCGTATTCCCGGAATATAAATTGGGAAATATCTATAGCCAAACTTTGGTGGAAATGATGCATAGTGAACGACAGCATAACTTCGGAACAATGAA
5 CLGM3_chuR8_KL61 CGGAGACGTATACTCTTGTGACCACTTCGTATTCCCGGAATATAAATTGGGAAATATCTATAGCCAAACTTTGGTGGAAATGATGCATAGTGAACGACAGCATAACTTC-GAACAATGAA
6 CLGM3_chuR4_KL61 CGGAGACGTATACTCTTGTGACCACTTCGTATTCCCGGAATATAAATTGGGAAATATCTATAGCCAAACTTTGGTGGAAATGATGCATAGTGAACGACAGCATAACTTCGGAACAATG-A
7 CLGM3_chuR9_KL61 CGGAGACGTATACTCTTGTGACCACTTCGTATTCCCGGAATATAAATTGGGAAATATCTATAGCCAAACTTTGGTGGAAATGATGCATAGTGAACGACAGCATAACTTC-GAACAATGAA
. . . 0 . . . . : . . . 1080
1 CLGM3_chuR5_KL61 ATACCAATCACTCCCAACACAATGCAAGGAGTGCGACTTTCTATTTGCCTGCAACGGARATGTCCAAAGAACCGCTTCAGTCGGACAGCGGACGGCGAACCCGGTCTG-ACTATTTGTGC
2 CLGM3_chuR1_KL61 ATACCAATCACT-CCAACCCAATGCAAGGAGTGCGACTTTCTATTTG-CTGCAACGGAGATGTC--AAGAA-CGCTTCAGTCGGACAGC-GACG--CGACCCGGTCTG-ACTATCTGTGC
3 CLGM3_chuR3_KL61 ATACCAATCACTCCCAACCC-ATGCAA-GAGTGCGACTTTCTATTTG-CTGCAACGGAGATGTC-AAAGAACCGCTTCAGTCGGACAGC-GACG--CGACCC-GTCTG-ACTATCTGTGC
4 BT3_chuR2_KL61 ATACCAATCACTCCCAACCCAATGCAA-GAGTGCGACTTTCTATTTGCCTGCAACGGAGATGTC--AAGAACCGCTTCAGTCGGACAGC-GACGGCGAACCC-GTCTGAACTATCTGTGC
5 CLGM3_chuR8_KL61 ATACCAATCACTCCCAACCCAATGCAAGGAGTGCGACTTTCTATTTGCCTGCAACGGAGATGTCCAAAGAACCGCTTCAGTCGGACAGCGGACGGCGAACCCGGTCTGAACTATCTGTGC
6 CLGM3_chuR4_KL61 ATACCAATCACTCCCAACCCAATGCAAGGAGTGCGACTTTCTATTTGCCTGCAACGGAGATGTCCAAAGA--CGCTTCAGTCGGACAGCGGACGGCGAACCC-GTCTG-ACTATCTGTGC
7 CLGM3_chuR9_KL61 ATACCAATCACTCCCAACCCAATGCAAGGAGTGCGACTTTCTATTTGCCTGCAACGGAGATGTCCAAAGAACCGCTTCAGTCGGACAGCGGACG-CGAACCC-GTCTG-ACTATCTGTGC
1
Figure 5.22: Sequence anlaysis of chuR ORFs PCR-amplified from positive clones iso-
lated from BT3 and CLGM3 libraries. Alignment of sequences from the chuR ORFs from one
clone from the BT3 library (BT3 chuR2) and six clones from the CLGM3 library (CLGM3 chuR1,
chuR3, chuR4, chuR5, chuR8, and chuR9). Alignment generated using MUSCLE [70] and the
alignment visualized using MView [28] on the EMBL-EBI web server [208], with colouring of
purines/pyrimidines and mismatches.
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Though it was not surprising that nearly all sequenced chuR ORFs from the inte-
grated CLGM3 library clones were exact matches to wild-type B. theta, this outcome
was interesting in a diﬀerent light: it meant that nearly all positive clones isolated
from the human gut metagenomic library in the chuR/anSME screen were of B. theta
origin, albeit of “wild” B. theta from the feces of the volunteers who contributed to
the library. Should we be surprised that nearly all chuR sequences recovered are from
B. theta, rather than from other species? Perhaps no, considering that Bacteroides
is the most common genus in human fecal samples [8] and that B. theta is often a
dominating species in the distal gut [339]. To see if this ORF was present in public
metagenomes, I performed a BLAST analysis, using the B. theta chuR sequence to
query the NCBI database of assembled metagenomic contigs, and found exact or near
identical full-length sequences in over a dozen assembled gut metagenomes (Table D.1
in Appendix D.3), suggesting that this particular chuR sequence may be relatively
widespread, as would be expected for a gene from a common gut microbe. However, I
was also interested in whether non-identical chuR/anSME genes have been annotated
in metagenomes; a BLAST search using blastx against the NCBI env nr database sug-
gests that indeed there may be many proteins of varying sequence similarity that can
potentially complement the ∆chuR mutant (Table D.2 in Appendix D.3)
From the alignment of the chuR sequences, one metagenomic chuR sequence was
not identical to the B. theta wild-type – CLGM3 chuR clone #5 (Figure 5.22). The full
ORF was obtained for this clone by Sanger sequencing (see Section 5.6.13 for primer
and sequence data details). It shared ∼97% nucleotide identity with the wild-type using
blastn, and its best hit in the NCBI nr database was B. theta VPI-5482 using megablast.
Comparing its translated sequence to the B. theta chuR 415-residue protein sequence
revealed three changes at the amino acid level: Asn62Ser, Val232Ile, and His325Gln
(Figure 5.23).
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Figure 5.23: Alignment of the chuR sequence of CLGM3 chuR clone #5 to B. theta
VPI-5482 chuR (BT 0238). Sanger sequencing reads were obtained from CLGM3 chuR clone #5
and the reads were assembled using Geneious version 6.0. The assembly was aligned to the wild-type
sequence using MUSCLE [70] and the alignment visualized using MView [28] on the EMBL-EBI web
server [208]. Alignments were generated for the ORF nucleotide sequence (A) and the translated ORF
sequence (B). Residues diﬀering from B. theta wild-type are indicated in white.
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The three amino acid changes observed for this clone were in not in the three conserved
cysteine clusters thought to be involved in the ability of the chuR enzyme to mature
sulfatase enzymes [18].
The level of sequence similarity of this clone to wild-type B. theta suggests that
this particular chuR gene carried by clone #5 may belong to an as-yet unsequenced
species in the Bacteroides genus or perhaps another strain of B. theta, based on blastx
results from querying the B. theta chuR sequence against the NCBI Refseq protein
database (Table D.3 in Appendix D.3). The identiﬁcation of a chuR gene from a
human gut metagenomic library that is diﬀerent in sequence from the B. theta VPI-
5482 host is a clear indication that functional screening of metagenomic libraries using
B. theta is a viable strategy.
5.4.6 Attempt to use arrayed libraries to track individual donor
fosmids in complementation screens
The unanticipated problem of presumed homologous recombination in B. theta was
an obstacle to screening using the lab’s usual strategy, which requires retrieving the
complementing fosmid from the transconjugant after the functional complementation
screen. Using a recA mutant of B. theta as a host was one possibility that may have re-
duced the probability of recombination; however, a constructed recA mutant of B. theta
was reported to have the unexpected phenotype of sensitivity to oxygen [49]. This in-
creased sensitivity would make B. theta less versatile to work with in a laboratory
setting and therefore the use of a B. theta recA mutant did not seem suitable.
Another solution to tackle the problem of unintended recombination was to modify
the screening strategy so that I could track the fosmid clones being conjugated into the
B. theta recipient. By tracking the clones in individual conjugations, any positive result
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can be traced back to the speciﬁc E. coli clone used as donor, so that there is no need
to retrieve DNA from B. theta at all, and the risk of not being able to retrieve the clone
is obviated. Unfortunately, to track the clones for conjugations into B. theta required
essentially “de-pooling” the fosmid libraries to obtain individual clones for tracking.
To test this strategy with a subset of the libraries, I arrayed ∼600 clones from the BT3
genomic library and ∼1000 clones from the CLGM3 metagenomic library, making an
arrayed collection of individual clone stocks in 96-well format (Figure 5.24).
Figure 5.24: Arraying ∼1000 clones from the CLGM3 fosmid library (A) A
frozen aliquot of the pooled CLGM3 library was diluted and plated for isolated colonies;
(B) colonies were picked, inoculated, and saved in 96-well format. Six blank wells were
included on each of the 12 plates as negative inoculation controls.
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Though the libraries were arrayed to isolate individual clones, it was not feasible
to carry out a separate mating for each clone; considering that the full CLGM3 metage-
nomic library contains ∼115 000 clones, this would not be a viable future strategy –
without prior development of small-scale, high-throughput E. coli -B. theta conjuga-
tions and likely investing in and optimizing a robotic liquid handling system. Rather
than carry out conjugations using single clones as the E. coli donor in matings, I in-
stead used a pooled-clone mating system in which two rounds of conjugation were
required, using a spot-conjugation method devised for moderately increased through-
put (see Section 5.6.8 for description of two E. coli -B. theta conjugation methods used
in this study):
Round 1: Pooled conjugations. In the ﬁrst round, the 12 clones in each
row of every plate of the arrayed collection were pooled (Figure 5.25A) and
the pool was used as the donor in a mating with the B. theta ∆chuR recip-
ient (Figure 5.25B). The conjugation spot was resuspended, washed, and
streaked out on selective media to isolate complemented transconjugants –
that is, those B. theta recipient cells that received a library fosmid carrying
a gene that could provide the missing chuR function (Figure 5.25C).
Round 2: Resolution conjugations. Any positive clone arising from the
ﬁrst round was double checked by streak puriﬁcation on the same selective
media (Figure 5.25D). Then, to resolve which clone in that particular pool
was responsible for the complementation, a second round of conjugation
was carried out using individual clones as donor. Though it is possible that
more than one of the 12 clones led to the positive result, the likely scenario
is that just one of the clones was responsible for the complementation.
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Figure 5.25: Functional complementation of B. theta ∆chuR using pooled E. coli donors
from arrayed CLGM3 library. (A) Clones from each row were pooled for every row of each of
the 12 96-well plates; rows were tracked by plate and row, e.g., the clone pool from Plate 2 Row
A was labeled Pool 2A. (B) Pools from each plate were mated into the B. theta ∆chuR deletion
using the spot conjugation method. (C) Spots were resuspended, washed, and streaked on minimal
media with chondroitin sulfate as sole carbon source; positive pools were identiﬁed, e.g. Pool 2E. (D)
Putative-positive complemented transconjugants were re-streaked on the same media for conﬁrmation
of phenotype.
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This strategy was applied to screen the arrayed CLGM3 metagenomic library for
chuR-complementing clones and in the pooled-conjugation round, a number of rows
from various 96-well plates were identiﬁed as having a positive clone(s). However, the
spot-mating strategy requires optimization because it is diﬃcult to select the comple-
mented transconjugants from the heavy background of E. coli ; put another way, the
mating spot contains high background making it diﬃcult to both obtain and gauge a
positive (Figure 5.25C). Though the natural inclination may be to perform the mat-
ings anaerobically to favour the recipient growth, conjugations using IncP systems have
been documented to require oxygen for high-frequency transfer and may not work well
anaerobically [249].
With putative positives from the pooled conjugations, I then performed resolution-
round conjugations to identify single clones in the pool that were responsible for the
complemented phenotype. Due to the described diﬃculties in this strategy and time
constraints, I was only able to identify two putative positive clones that restored the
ability to use chondroitin sulfate to the B. theta ∆chuR recipient: from the 5B pool
that gave a positive in the ﬁrst round (pooled clones from Plate 5, Row B), clone #5B2
was identiﬁed as the putative clone responsible for the complementation (Well 2). Inter-
estingly, clone #5B9 was also identiﬁed as having an intermediate phenotype, between
that of the wild-type and the deletion mutant; I streak-puriﬁed both of the 5B2 and
5B9 clones to conﬁrm their phenotype on minimal media with chondroitin sulfate as
sole carbon source (Figure 5.26).
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Figure 5.26: Streak purification of B. theta chuR carrying CLGM3 fos-
mid clone 5B2 or 5B9, for confirmation of phenotype. B. theta chuR carrying
CLGM3 fosmid 5B2 (left plate, bottom-left quadrant) exhibits functional complemen-
tation when compared to the positive control wild-type (left plate, top-left quadrant)
and negative control vector-only streak (left plate, top-right quadrant). B. theta chuR
carrying CLGM3 fosmid 5B9 shows an intermediate phenotype between wild-type and
mutant (right plate, bottom-right quadrant).
After identifying the speciﬁc wells of the arrayed collection with the putative clone
carrying a chuR-complementing gene (Plate 5, Row B, Wells 2 and 9), I was then able
to go back to the collection and examine the DNA from E. coli that had never been
passaged through B. theta. Diagnostic digests of these clones showed a high-molecular-
weight insert for both clones, although interestingly, copy number induction of these
clones led to loss of the insert (Figure D.4 in Appendix D.1). BLAST analysis, using
the megablast algorithm, detected no sequence similarity between the ilvGEDA and
rnpB terminators, so it is unclear how the insert could have recombined out.
With only two complementing clones identiﬁed in the resolution mating round,
this two-step strategy to screen the arrayed collection will have to be repeated to
identify more putative individual complementing clones. Further analysis of the two
complementing clones is also required, to determine the origin of insert DNA carried
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by the clones and whether the DNA encodes a chuR ORF that is novel in sequence.
Though this two-step method appears to be a viable strategy for screening human gut
metagenomic libraries in a B. theta host, optimization of the method will be required
to reduce E. coli background, raise the frequency of obtaining transconjugants, and
increase throughput for E. coli -B. theta conjugations as well as selection for phenotypic
complementation.
5.5 Conclusions
B. theta is becoming more widely used in both pure and applied research. Its important
role in degrading polysaccharides in the host gut and its dominance in the microbiota
community make it an ideal candidate for study and manipulation. In this Chapter,
B. theta was chosen to be developed as a host to screen gut-derived metagenomic DNA
because it would likely be able to express a greater fraction of the cloned DNA than
would E. coli . Unexpectedly, the complementation of a B. theta chuR mutant suggested
that B. theta is prone to homologous recombination, which presents diﬃculties for
the screening of pooled metagenomic libraries. Screening of arrayed clone libraries is
possible and is presented here, but the strategy is labour-intensive and likely requires a
semi-automated high-throughput approach; with such an approach, the conditions for
E. coli -B. theta conjugations will also require optimization. Though diﬃculties were
encountered in using a B. theta host to screen a human gut library, the identiﬁcation
of a chuR gene diﬀerent in sequence from the B. theta wild-type demonstrates that
B. theta shows some promise as screening host.
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5.6 Specific materials and methods
5.6.1 Strains and plasmids
The E. coli and B. theta strains and plasmids used were described in Chapter 2, specif-
ically Table 2.1 for strains and Table 2.2 for plasmids.
5.6.2 Growth media and anaerobic culture
Methods for the culture of B. theta were based on those generously shared by Nicole
Koropatkin and Eric C. Martens of the University of Michigan.
Culture in liquid media
B. theta was routinely cultured in liquid broth using brain heart infusion broth (BD
Biosciences B237200), supplemented with 1.2 ➭M histidine, 1.9 ➭M hematin, 1 ➭g/ml
menadione, and 0.5 ➭g/ml cysteine. I called this media BHI+; see Appendix A.4 for
the recipe. Before discovering that B. theta grows very well in BHI+, I also used TYG
for liquid culture; see Appendix A.3 for the recipe.
Cultures of B. theta were started by inoculation either from a single colony or
from frozen stock, using the pyrogallol method [128]: after inoculation, two cotton balls
were inserted into the mouth of the culture tube using sterile forceps, with the second
cotton ball not fully inserted. The cotton was lit using the ﬂame of a Bunsen burner
to purge the culture tube of oxygen; after the ﬂame extinguished, the cotton ball was
pushed about an inch further into the culture tube, and overtop of the cotton ball was
added 200 ➭l of 20% NaCO3 (w/v) and 200 ➭l of 35% pyrogallol (w/v), and the tube
was then immediately plugged with a rubber stopper. Pyrogallol is activated in the
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presence of alkalinity to react with oxygen creating a reducing environment.
Cultures of B. theta were incubated at 37❽ without shaking. Typically, resazurin
was added to the liquid media as an indicator dye (1 ➭g/ml): it is blue in an oxidizing
environment, turns irreversibly pink in a reducing environment, and reversibly colour-
less in the absence of oxygen (Figure 5.5).
Culture on solid media
B. theta was routinely cultured on agar using brain heart infusion broth (BD Bio-
sciences B237200), supplemented with 10% deﬁbrinated horse blood (Bio-media Un-
limited MOHD500); see Appendix A.4 for the recipe. B. theta was also cultured on
solid minimal media; see Appendix A.5 for the recipe.
Agar plates were incubated in air-tight jars with GasPak EZ Anaerobe sachets
(BD Biosciences B260678) to deplete oxygen. Originally, the air-tight container used
was the GasPak 100 System 13 Ö 23 cm polycarbonate jar; however, inexpensive air-
tight containers purchased from local stores demonstrated comparable results, including
Anchor Hocking stainless steel canisters and Lock & Lock glass containers (Figure 5.6).
Lubricating grease was applied to the gaskets of air-tight containers to ensure a good
seal.
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5.6.3 Antibiotics
Antiobiotics used in the culture of B. theta are summarized in Table 5.6. Concentra-
tions for antibiotics are denoted using the abbreviation (see Table 5.6) followed by the
concentration as a subscript; for example erythromycin at 10 ➭g/ml would be Em10.
Note that antibiotic concentrations were halved when used in liquid media.
Table 5.6: Antibiotic concentrations used for B. theta
Antibiotic Abbrev. Solvent Final conc.
erythromycin Em ethanol 10-25 ➭g/ml
gentamicin Gm dH2O 200 ➭g/ml
kanamycin Km dH2O 200 ➭g/ml
nalidixic acid NA dH2O 25 ➭g/ml
tetracycline Tc ethanol 2 ➭g/ml
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5.6.4 Preparation of DNA polylinker/MCS from complemen-
tary oligos
The following protocol was used to phosphorylate and anneal oligos KL10 and KL11 to
form a polylinker. See Table 2.3 for DNA sequences. The protocol for annealing com-
plementary oligos is based on the protocol from OpenWetWare (http://openwetware.
org/wiki/Endy:Annealing_complementary_primers).
Phosphorylation of oligos
Oligos KL10 (30 bases) and KL11 (22 bases) were each diluted to 100 pmol/➭ l and 40 ➭l
of each were used in separate phosphorylation reactions, using T4 polynucleotide kinase
(Thermo-Fisher K0031) according to the recipe in Table 5.7. This volume corresponded
to 36 ➭g and 27 ➭g for KL10 and KL11, respectively. The reactions were incubated at
37❽ for 1.5 hours, followed by heat inactivation at 80-85❽ for 20 minutes and cooling
on ice.
Table 5.7: Recipe for phosphorylating oligos.
oligo DNA (100 pmol/➭ l) 40 ➭l
10Ö T4 DNA Ligase Buﬀer 5 ➭l
T4 PNK (10 units; in excess) 1 ➭l
sterile dH2O 4 ➭l
Total 50 ➭l (80 pmol/➭ l)
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Annealing complementary oligos
Phosphorylated KL10 and KL11 were combined in an annealing reaction mix (Ta-
ble 5.8). The tube was placed in a ﬂoating rack and incubated in a beaker of boiling
water for 5 minutes. The beaker was then removed from the heat and allowed to cool
to room temperature slowly over ∼20 minutes, with later cooling sped up by placing
the beaker on ice. As a check, 0.5 ➭l of the annealed KL10/KL11 reaction was run
on a 2% agarose gel, against 0.5 ➭l and 1 ➭l of the phosphorylated KL10 and KL11 as
controls (Figure D.1 in Appendix D.1). The generated polylinker was stored at -20❽
until ready to be used for ligating to the vector, EcoRI- and KpnI-digested pKL1.
Table 5.8: Recipe for annealing complementary oligos.
phosphorylated KL10 20 ➭l (14.6 ➭g)
phosphorylated KL11 20 ➭l (10.8 ➭g)
0.85% NaCl 10 ➭l (14mM ﬁnal)
Total 50 ➭l (508 ng/➭ l)
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5.6.5 PCR of ermF -repA and oriT
The oriT fragment was ampliﬁed from pJC8 (10 ng) using primers KL12/KL13 (pos-
sessing HindIII adapters) and the ermF -repA fragment was ampliﬁed from pAFD1
(10 ng) using primers KL14/KL15 (possessing EcoRI adapters). KOD Hot Start DNA
Polymerase (Novagen 71086) was used according to the manufacturer’s recommenda-
tions. The touchdown PCR protocol used for both fragments is summarized in Ta-
ble 5.9. To prepare for cloning, the PCR products were gel extracted, digested with
the appropriate restriction enzyme, and column-puriﬁed, using routine protocols pre-
viously described in Chapter 2.
Table 5.9: Touchdown PCR protocol for ermF -repA and oriT .
Temperature Duration
94❽ 2 min
98❽ 10 sec


Ö6 cycles; ❴1❽/cycle65 ✙ 59❽ 30 sec
68❽ 1 min/kb; round up nearest min
98❽ 10 sec


Ö25 cycles58❽ 30 sec
68❽ 1 min/kb; round up to nearest min
68❽ 5 min
20❽ hold
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5.6.6 Primer walking to sequence the ermF -repA fragment
The ermF -repA fragment from pAFD1 was sequenced in order to compile the com-
plete sequence for the constructed vector pKL13. The ∼4-kb fragment was sequenced
by primer walking using oligos KL14, KL16, KL33, KL42, KL43, KL45, and KL46
(Table 2.3). Multiple templates were sequenced from which the consensus was taken,
using diﬀerent combinations of the following for each round of primer walking: pAFD1,
pKL6, pKL7, and pKL8 (Table 2.2). The consensus sequence for the ermF -repA frag-
ment is included in Appendix D.2. See Section 5.6.13 for information on sequence data
availability.
5.6.7 Miniprep of plasmid DNA from B. theta
Plasmid DNA was isolated from liquid B. theta cultures using the QIAprep spin
miniprep kit (Qiagen 27106), according to the manufacturer’s recommendations, in-
cluding optional washes to reduce nuclease contamination. Typically, 5ml of culture
was used for plasmid minipreps.
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5.6.8 Conjugation from E. coli donor to B. theta recipient
Lawn conjugations
The following protocol was based on one shared with me by Nicole Koropatkin and
Eric Martens from the University of Michigan. Matings were carried out using 5 ml of
each of the donor, mobilizer, and recipient strains.
The E. coli donor and mobilizer were cultured in 5-ml LB supplemented with
the appropriate antibiotics and grown to OD600 of ∼0.4; B. theta recipient cultures
were cultured in 5ml BHI+ and grown to OD600 of ∼0.3-0.4 (Spectronic Spec 20D
spectrophotometer). Cultures were placed on ice to halt cell growth. Cultures were
transferred to 15-ml conical tubes and cells were pelleted by centrifuging at 7,000Ög
at room temperature for 5 minutes. The supernatant was removed and the cells were
resuspended in either BHI+ or 1Ö Bt salts (see Appendix A.5). Donor, mobilizer, and
recipient were mixed in a ﬁnal volume of 1ml, and the mixture was swirled evenly over
the surface of a BHIH agar plate. The plate was dried for several minutes in a laminar
ﬂow hood and then incubated aerobically overnight with the agar side down.
Overnight mating lawns were scraped oﬀ the agar plate with a wooden stick and
resuspended in 2ml BHI+ or 1Ö Bt salts. Typically, serial ten-fold dilutions were made
from 10-1 to 10-3, and 100 ➭l of each dilution was plated on the BHIH supplemented
with appropriate antibiotics to select for transconjugants – typically, Km200 and NA25
to select against E. coli and Em10-25 to select for the vector. If the mating lawn was
plated on minimal media, then the initial resuspension of the mating lawn was washed to
remove complex media components; this was accomplished by at least three repititions
of centifugation and resuspension in 1ml 1Ö Bt salts.
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Spot conjugations for increased throughput
I modiﬁed the preceding conjugation protocol shared by Nicole Koropatkin and Eric
Martens to achieve a higher throughput for mating library clones into B. theta. Using
spots rather than lawns, up to 10 or 12 matings can be performed per agar plate
(Figure 5.25B). Matings were carried out using 5ml-equivalents of each of the donor
and mobilizer spotted onto 10-15ml-equivalent of spread-plated recipient.
Cultures of E. coli and B. theta were grown as for the lawn conjugations. 10-15ml
of the B. theta recipient culture was centrifuged; the supernatant was removed and the
cells were resuspended in 100 ➭l 1Ö Bt salts (see Appendix A.5) and spread on a BHIH
plate, and the plate was dried for several minutes in the laminar ﬂow hood. 5ml of each
of the E. coli donor and mobilizer were centrifuged; the supernatant was removed from
both, the mobilizer cell pellet was resuspended in 20 ➭l 1Ö Bt salts, the resuspension
was transferred to the donor cell pellet for resuspension, and then the mixture was
spotted onto the plate overlaying the B. theta cells (Figure 5.25B). The mating spots
were dried for several minutes in the laminar ﬂow hood and then incubated aerobically
overnight with the agar side down.
Overnight spot matings were processed exactly as lawn matings, with the only
diﬀerence being that the volume used for resuspension was smaller: 500 ➭l 1Ö Bt salts
or BHI+ was used instead of 2ml.
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5.6.9 Genomic and metagenomic library construction
The libraries constructed in this chapter using either pKL3 or pKL13 are summarized
in Table 2.12. Libraries were constructed as described previously in Section 3.6.3, with
some exceptions that are detailed below.
pKL3-based libraries
The CLGM2 metagenomic library and BT2 genomic library (see Section 2.6) were both
constructed using pKL3. Library construction was carried out as previously described in
Section 3.6.3, with the minor exception that transductants were selected on ampicillin
instead of tetracycline. This was due to the resistance marker present on the base
vector, pAFD1, which was used to construct pKL3 (Figure 5.8).
pKL13-based libraries
The CLGM3 metagenomic library and BT3 genomic library (see Section 2.6) were
both constructed using pKL13. Library construction was carried out as previously
described in Section 3.6.3, with a few exceptions. First, transductants were selected on
chloramphenicol instead of tetracycline; this was due to the resistance marker present on
the base vector, pCC1FOS, which was used to construct pKL13 (Figure 5.12). Second,
EPI300 was used for the library host instead of HB101, due to its advantageous copy
number control feature when used in conjunction with pCC1FOS.
The third and last exception to library construction is a highly unusual and there-
fore notable one: the pKL13 vector backbone was not puriﬁed away from the stuﬀer
between the Eco72I sites; that is, the vector was simply digested to release the stuﬀer,
and the mixture was used for ligation to high-molecular weight metagenomic or ge-
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nomic DNA. This means that some subset of clones in the CLGM3 and BT3 libraries
may be “contaminated” with the pKL13 stuﬀer. The reason for not removing the
stuﬀer was that I had technical diﬃculties doing so: after purifying the digested and
dephosphorylated backbone by electroelution and achieving a concentrated preparation
of ∼350 ng/➭l, I was no longer able to ligate the vector, which I discovered in carry-
ing out calculations for digestion and dephosphorylation eﬃciency using T4 PNK and
ligase (as described in Section 2.5.6). To ensure that the preparation had not been
contaminated with nucleases, I ran the puriﬁed DNA on an agarose gel and saw that it
was indeed intact (Figure D.2 in Appendix D.1). It is still unclear why the vector was
no longer ligatable, but it is possible that after digestion and dephosporylation, the
vector ends may be sensitive to disruption when subjected to an electric ﬁeld. In any
case, I was forced to make a preparation of the vector without stuﬀer puriﬁcation to use
in library construction. After constructing the CLGM3 and BT3 libraries, I estimated
using the CLGM3 library that the percent of gentamicin-resistant clones is 1-2%, which
provides an estimate of the upper limit for stuﬀer contamination (the stuﬀer carries a
gentamicin resistance gene; see Figure 5.12).
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5.6.10 Construction of thrC and trpD single recombinants
The ∼600-bp thrC (BT 2401) and ∼350-bp trpD (BT 0530) fragments were ampliﬁed
from B. theta genomic DNA (55 ng) using primers thrCIDMF-SalI/thrCIDMR-KpnI
and trpDIDMF-SalI/trpDIDMR-KpnI, respectively (see Table 2.3), with restriction
enzyme adapters as indicated by the primer names. Pfx DNA Polymerase (Invitrogen
11708-013) was used according to the manufacturer’s recommendations. The PCR
protocol used for both fragments is summarized in Table 5.10.
Table 5.10: PCR protocol for thrC and trpD fragments.
Temperature Duration
94❽ 5 min
94❽ 15 sec


Ö30 cycles58❽ 30 sec
68❽ 60 sec
68❽ 5 min
10❽ hold
To prepare for cloning, the PCR products were puriﬁed using a QIAquick PCR
Puriﬁcation Kit (Qiagen 28104) and digested using NEB enzymes according to the
manufacturer’s recommendations in a sequential double digest: puriﬁed PCR products
were digested with SalI in NEB Buﬀer 3 (NEB R0138), the sample was ethanol pre-
cipitated, and the DNA was resuspended in NEB Buﬀer 1 for digest with KpnI (NEB
R0142). The digested fragments were puriﬁed by gel extraction using a QIAquick Gel
Extraction Kit (Qiagen 28704), and ligated to similarly cut and puriﬁed pKNOCK-bla-
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tetQb. Ligations were microdialyzed against water using DNA ﬁlter paper (Millipore
VCWP09025), and then used to electroporate S17-1 λ-pir. Clones were streak-puriﬁed,
then screened and veriﬁed by restriction digest. Clones of pKNOCK-bla-tetQbcarrying
the thrC and trpD fragment were named pKL21 and pKL22, respectively.
pKL21 and pKL22 were conjugated from S17-1 λ-pir into wild-type B. theta in
a biparental mating using the lawn conjugation method (Section 5.6.8). Mating lawns
were resuspended and diluted, and transconjugants carrying the integrated plasmid
were selected on BHIH Gm200 Tc2. Transconjugants were streak-puriﬁed and inoculated
into 5ml TYG Tc2 for generation of frozen stocks; the B. theta BtUW1 and BtUW2
strains were added to the Charles lab strain collection (see Table 2.1). The phenotype
of the strains were also checked on minimal media with and without the appropriate
amino acid supplementation (Figure 5.15B).
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5.6.11 Genomic DNA miniprep of B. theta
This protocol is a scaled-down version of the one described in Section 2.4.6, which
is based on the method described by Charles and Nester [36]. Brieﬂy, B. theta was
cultured in 10ml of liquid media with the appropriate antibiotics, and the cell pellets
were recovered after centrifugation at 7000Ög for 5 minutes at room temperature. Cells
were resuspended in 400 ➭l buﬀer (10mM Tris [pH 8.0], 25mM EDTA). The following
were added: 50 ➭l 5M NaCl, 10 ➭l 10mg/ml RNase A, 5 ➭l 19.2mg/ml proteinase K
(optional), and the tube was inverted several times. 25 ➭l 20% SDS was added and
the sample was incubated at 65❽ for 30-60 minutes. 260 ➭l 7.5M ammonium acetate
was added and the sample was incubated on ice for 20 minutes. The mixture was
centrifuged at 21,000Ög for 15 minutes, the supernatant was decanted carefully, and
the mixture was extracted with chloroform in a 1:1 volume. The DNA was precipitated
with 800 ➭l isopropanol, and pelleted by centrifuging at 21,000Ög for 3 minutes. The
pellet was washed with 100 ➭l 70% ethanol, centrifuged at 21,000Ög for 1 minute, the
supernatant was removed, and the pellet was allowed to dry. Finally, the pellet was
allowed to dissolve in 50 ➭l of TE overnight at 4❽. The DNA was quantiﬁed by gel
electrophoresis, using bacteriophage λ DNA as a standard (see Section 2.5.8).
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5.6.12 Analysis of genomic DNA for fosmid clone recombina-
tion using PCR
Genomic DNA was isolated from the B. theta clones carrying chuR-complementing fos-
mid DNA, and used as template in the PCR. Taq-based 2X PCR Master Mix (Thermo
Scientiﬁc K0171) was used according to the manufacturer’s recommendations, with the
exception that RNAseA was typically added to the reaction in small amounts to remove
RNA contamination from the genomic DNA prep. The general touchdown PCR pro-
tocol used is summarized in Table 5.11. Target PCR products and their corresponding
primer sets were (see Table 2.3 for primer details):
❼ RK2 oriT (∼800 bp): KL12, KL13
❼ chuR ORF (∼1200 bp): KL61, KL62
❼ chuR ORF + 300-bp upstream and downstream (∼1800 bp): KL63, KL65
❼ chuR ORF + 300-bp downstream (∼1500 bp): KL61, KL65
❼ chuR ORF + 300-bp upstream (∼1500 bp): KL63, KL62
Table 5.11: Touchdown PCR protocol for analysis of genomic DNA.
Temperature Duration
95❽ 3 min
95❽ 30 sec


Ö11 cycles; ❴1❽/cycle60 ✙ 50❽ 30 sec
72❽ 1 min/kb
95❽ 30 sec


Ö20 cycles50❽ 30 sec
72❽ 1 min/kb
72❽ 5 min
20❽ hold
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5.6.13 Data availability
The expected sequence for the B. theta-compatible pKL13 fosmid is provided in Ap-
pendix D.2 and has been submitted to NCBI Genbank (NCBI accession KU746975).
The sequence of the ermF -repA fragment from pAFD1 is provided in Appendix D.2.
Sanger sequencing reads for chuR clone #5 are provided in Appendix D.2. Addi-
tionally, raw sequencing data in ABI (.ab1) format can be accessed online: https:
//github.com/itskathylam/phd
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6.2 Abstract
Functional metagenomics is a powerful experimental approach for studying gene func-
tion, starting from the extracted DNA of mixed microbial populations. A functional
approach relies on the construction and screening of metagenomic libraries – physical
libraries that contain DNA cloned from environmental metagenomes. Library construc-
tion is often a technically challenging and laborious endeavour, thus necessitating the
careful design of library cloning vectors to ensure the presence of elements that aid in
the library’s downstream applications.
The commercial fosmid vector pCC1FOS is widely used for the construction of
metagenomic libraries. As I described in Chapter 5, I used pCC1FOS as the base plas-
mid to construct the B. theta-compatible library vector pKL13, introducing various
additional elements, including two transcriptional terminators that ﬂank the cloning
site, which were anticipated to reduce insert-borne transcription into the vector back-
bone should such transcription be problematic for clone stability. The two terminators
are taken from the ilvGEDA and rnpB genes of E. coli MG1655, which were docu-
mented to be strong terminators. Here, I provide the rationale for the design of the
transcriptional terminator (TT) fragment encoding the terminators, describe its syn-
thesis and cloning, and most importantly, present the results of testing the functionality
of the two terminators using the ﬂuorescent reporter GFPuv. With the use of a simple
testing scheme, both terminators appear to be reducing transcription in vivo, justifying
their inclusion in the pKL13 fosmid.
Finally, in the last results section of this chapter, I discuss how the TT fragment
may be taken advantage of in future experiments to test whether the transcriptional
terminators help protect against or alleviate the observed cloning bias of metagenomic
libraries. Several constructs have been built for this purpose and though such ex-
periments are outside the scope of this work, it will be important for the functional
metagenomics approach to understand the factors that aﬀect DNA representation in
clone libraries.
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6.3 Introduction
6.3.1 The challenges of constructing large-insert metagenomic
libraries
The functional metagenomic approach and the steps involved in constructing libraries
using a cos-based vector were previously described (Section 1.6.1 and Figure 1.1). With
the number of steps involved, the construction of a metagenomic library can be a
laborious and time-consuming procedure, requiring a high level of skill at the laboratory
bench. There are several technically challenging steps in the process of metagenomic
library construction. First, the DNA extracted from the environmental sample must be
of suﬃcient length for eﬃcient packaging into lambda phage heads, which have a lower
size limit for packaging [229]. Extraction usually employs gentle lysis to avoid shearing
the DNA [347] but even so it may be diﬃcult to achieve large fragment sizes [141]. I
ﬁnd that starting with crude DNA extracts containing at least ∼75 kb fragments leads
to high-quality cos-based libraries, and it is crucial to check the fragment size range
of crude extracts by pulsed-ﬁeld electrophoresis before proceeding. In my experience,
a particularly useful and aﬀordable molecular ladder to use for pulsed-ﬁeld gels is self-
ligated lambda DNA, which can be easily prepared in-house and results in bands at∼50,
∼100, and ∼150 kb. A freeze-grinding step prior to extraction [175] can substantially
improve cell lysis. Although this additional step might also fragment DNA [26], I ﬁnd
that it does not hinder library construction, consistent with previous work showing that
freeze-grinding results in minimal shearing [347].
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Extracts are often contaminated with compounds that co-purify with DNA, re-
quiring additional puriﬁcation steps that may lead to loss of DNA. Common contami-
nants in soil-derived DNA extracts are humic acids, visible as a brown coloring of the
extract. Such contaminants may interfere with enzymatic reactions [303]. Non-linear
electrophoresis is eﬀective for contaminant removal [232] and generates puriﬁed and
highly concentrated DNA suitable for PCR or metagenomic analysis [75], yet requires
access to specialized equipment. I have found that for library construction, humic
acids can simply be allowed to run oﬀ the gel during pulsed-ﬁeld electrophoresis of
crude extract for size-selection because humic acids travel much faster than large DNA
fragments when subjected to an electric ﬁeld. Alternatively, to avoid contaminating
the circulating buﬀer, electrophoresis can be paused after contaminants have formed a
front, the part of the gel containing humic acids excised, and then this region replaced
with fresh gel [43].
After the DNA has been size-selected and electroeluted from a pulsed-ﬁeld gel, it
must be end-repaired and then ligated to a desphosphorylated and blunt-ended vector.
To ensure a proper size range of DNA (∼25 to 40 kb) before ligation, the DNA can be
checked for co-migration with the largest band of a lambda-HindIII ladder on a typical
agarose gel [26] or, as I prefer, running the sample on a pulsed-ﬁeld gel for a more
accurate size assessment. The end-repair is a particularly challenging step in library
construction because there is no simple way to conﬁrm that ends are indeed blunt
following the end repair step. My current strategy is to use a small amount of the
ligation to transform E. coli prior to the costly packaging step; resulting transformants
indicate the presence of circular DNA molecules arising from ligation of successfully
blunt-ended fragments. Though the ligation conditions may not favour the formation
of circular molecules, this is currently the best proxy for successful end-repair.
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Other challenges include the sensitivity of packaging extracts as well as the prepa-
ration of puriﬁed digested dephosphorylated vector DNA for ligation. Although excel-
lent commercial products are available for both reagents, in-house vector preparation
may still be required when speciﬁc expression hosts are to be used in functional screen-
ing that are outside the host range of available commercial vectors [43,50,308,330]. The
culminating step of library construction is the transduction of E. coli . Although it is
possible to generate many thousands of clones with the ﬁrst attempt, troubleshooting
may be required to increase library size in some cases. When the transduction results
in a disappointingly small number of transductants (zero in the worst case!), it is not
easy to determine the cause.
Indeed, metagenomic library construction is in many ways a craft that takes
time and practice to master. Given that there are substantial challenges and costs
associated with library construction, as well as possible diﬃculties in obtaining rare
environmental samples, a clear corollary is that researchers active in this ﬁeld ought
to ﬁnd ways to maximize these valuable resources for shared beneﬁt. In particular,
collections of metagenomic libraries that can be used in a variety of hosts would be
extremely valuable if able to be accessed by the wider scientiﬁc community. Our lab
and collaborators have previously made metagenomic libraries publicly available [222]
and continue to advocate for increased sharing and strategizing [37]. Though there are
obvious administrative obstacles, services such as Addgene [125] may facilitate these
eﬀorts.
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6.3.2 Properties of pCC1FOS, a popular vector for library
construction
Due to the diﬃculties of library construction, commercial products that aid in genera-
tion of cosmid or fosmid libraries are popular. Indeed, one widely used cloning-ready
commercial vector is pCC1FOS (Genbank accession EU140751; available from Epicen-
tre Biotechnologies), shown in Figure 6.1. In recent years, as functional metagenomics
has gained traction, a number of metagenomic libraries from remarkably diverse envi-
ronments have been constructed using pCC1FOS, some of which are listed in Table 6.1.
Figure 6.1: Commercial fosmid vector, pCC1FOS. pCC1FOS is avilable from
Epicentre Biotechnologies. Notable elements include: chloramphenicol resistance, an
F origin of replication for E. coli , and an RK2 origin of replication for Proteobacteria
compatible with strains carrying trfA.
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Table 6.1: Examples of metagenomic libraries constructed from diverse environmental
samples using cloning vector pCC1FOS or derivatives. Libraries that are based on the com-
mercial pCC1FOS or pCC2FOS vector can be screened in any RK2-compatible host that expresses
the trfA gene product required for the broad-host-range RK2 oriV origin of replication.
Sampled environment Vector; screening host(s) Ref.
Host-associated environments
bovine rumen pCC1FOS; E. coli [321]
elephant feces pCC1FOS; E. coli [237]
human distal ileum pCC1FOS; E. coli [34]
human feces pCC1FOS; E. coli [138]
human feces (pescatarian) pCC1FOS; E. coli [299]
marine sponge pCC1FOS [343]
termite gut pCC1FOS, pCC2FOS; E. coli [191,324]
Extreme environments
Alaskan soil pCC1FOS; E. coli [3]
Alaskan ﬂoodplain soil pCC1FOS; E. coli [335]
Antarctic Pennisula meltwater pCC1FOS; E. coli [87]
glacial ice pCC1FOS; E. coli [270]
hot spring sediment/bioﬁlm pCT3FK; E. coli , T. thermophilus✯ [177]
hydrothermal ﬂuids pCC1FOS; E. coli [24]
Marine or freshwater environments
bog pCC1FOS; E. coli [282]
marine sediment pRS44; P. fluorescens, X. campestris❸ [1]
ocean tidal ﬂat sediment pCC1FOS; E. coli [173,174]
ocean water column pCC1FOS [59]
river sediment pCC1FOS; E. coli [237]
Continued on next page
✯Thermus thermophilus
❸Pseudomonas fluorescens, Xanthomonas campestris
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Table 6.1 – Continued from previous page
Sampled environment Vector; screening host(s) Ref.
Polluted environments
crude oil-contaminated shore pMPO579; E. coli❹ [305]
polluted river pCC1FOS; E. coli [316]
Agricultural, engineered, or other environments
activated sludge pCC1FOS, pCC2FOS; E. coli [294,345]
compost: leaf branch pCC1FOS; E. coli [295]
compost: lumber waste pCT3FK; E. coli , T. thermophilus✯ [177]
compost: wood, manure, plant
debris
pCC1FOS; E. coli [226]
decomposing leaf litter pCC1FOS; E. coli [225]
orchard soil pCC1FOS; E. coli [65]
sugarcane bagasse pCC1FOS [213]
The pCC1FOS cloning vector has several advantages over other commercial op-
tions. It carries a chloramphenicol resistance (cat) marker that is superior to the
common ampicillin resistance (bla) marker; because beta-lactamases that break down
ampicillin are secreted into the media, satellite colony formation sometimes arises on
ampicillin selection plates, and this background growth can be particularly problem-
atic for the dense platings that are often required for library construction. In addition
to an F plasmid origin of replication for single-copy maintenance, the pCC1FOS vec-
tor also carries an oriV origin of replication from the RK2 plasmid. The oriV is a
broad-host-range origin, conferring the ability to replicate in diverse members of the
Proteobacteria [10], but requires the trfA gene product for replication and results in an
❹derivatives of E. coli EPI300 to increase transcription
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estimated 15 copies per cell [68]. Though trfA is not carried by the fosmid, it can be
provided in trans; notably, the commercial E. coli strain EPI300 (also available from
Epicentre Biotechnologies) carries trfA under the control of an inducible promoter that
is advertised to increase copy number from 1 copy per cell to 10-200 copies. The strain
likely possesses a trfA copy-up mutant allele under control of araC -PBAD, which is
induced by L-arabinose [333]. In the past, our lab has preferred HB101 as a library
host due to its receptiveness to transduction, but I have found that EPI300 appears
to transduce at least as well as, if not better than, HB101 (Table 5.4). It also has
the advantages of being an endA1 mutant and supporting copy-number inducibility,
allowing for less-degraded and higher-yield plasmid DNA preparations, respectively.
pCC1FOS lacks an origin of transfer
Despite its popularity, pCC1FOS has some disadvantages that make resulting libraries
less versatile than they could be. First, pCC1FOS does not possess an origin of transfer
(oriT ) that would allow the fosmid to be eﬃciently transferred by conjugation, medi-
ated by a helper plasmid, to other species that may be more suitable for heterologous
expression or even to diﬀerent strains of E. coli . Others have achieved conjugation
capabilities by adding the RK2 oriT to pCC1FOS [1, 29, 305]. To enable conjugation
after library construction has already taken place, still others have retroﬁtted individ-
ual pCC1FOS-based clones with an oriT [29, 179]. This retroﬁtting strategy has also
been used for the cosmid vector SuperCos-1 [115], which is an alternative cos-based
cloning vector (Stratagene, Agilent Technologies). These modiﬁcations illustrate the
need for fosmid and cosmid vector design to include the oriT so that duplication of
work can be avoided. It is possible that transformation can be used to transfer libraries
to other hosts, but only for recipients that are amenable to those techniques and that
will not reject DNA that has been synthesized in E. coli due to the presence of host
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restriction-modiﬁcation systems. There is little leeway here though if desired hosts are
isolates that have not yet been adapted for routine laboratory techniques.
pCC1FOS is not inherently broad-host-range
Given that the broad-host-range oriV is used to achieve a higher copy number in con-
junction with EPI300 expressing the trfA gene, another disadvantage of pCC1FOS is
that trfA is not included on the vector. The consequence is that species that would
otherwise be able to use the oriV cannot replicate pCC1FOS. Perhaps it is not surpris-
ing then that for the vast majority of studies highlighted here (Table 6.1), E. coli was
used as the screening host. This is an enormous disadvantage for functional metage-
nomics because diﬀerent clones can be isolated from the same metagenomic library
when diﬀerent screening hosts are used [50, 204]. Our lab has found that using the
legume-symbiont Sinorhizobium meliloti as a host results in a much greater diversity
of clones than E. coli when screening a corn ﬁeld soil metagenomic library for beta-
galactosidase activity, though this greater diversity does not appear to be related to
phylogenetic distance of the origin of the cloned DNA to the surrogate host [Cheng
et al., in preparation]. The importance of devising systems that allow for functional
screening in diverse expression hosts has been reviewed by others [71, 187, 302, 312],
but what of the large number of libraries that have already been constructed? Can we
make use of them for screening in non-E. coli hosts? The libraries listed in Table 6.1,
as well as potentially many other metagenomic libraries constructed using pCC1FOS
or derivatives, would be accessible to any RK2-compatible host if a copy of the trfA
gene were also made available. This solution has already been applied by others: one
group inserted a wild-type trfA gene into the chromosome of the Gammaproteobac-
teria species Pseudomonas fluorescens and Xanthomonas campestris for screening of
libraries constructed using a pCC1FOS derivative [1]. Another group inserted araC -
225
CHAPTER 6. INCLUSION OF TRANSCRIPTIONAL TERMINATORS IN CLONING VECTORS
PBAD-trfA into the chromosome of E. coli to give copy number inducibility to the
lambda Red recombineering strain EL350 [327]. The introduction of trfA into RK2-
compatible species is a straightforward way to expand the range of expression hosts for
existing pCC1FOS-based libraries.
An alternative to inserting the trfA gene into desired expression hosts for main-
taining metagenomic clones is to modify the vector for integration into the host genome,
which bypasses the requirement for trfA. This strategy has already been employed to
integrate clones into a locus in the genome of the thermophile Thermus thermophilus
for functional screening: pCC1FOS was ﬁrst modiﬁed to include a T. thermophilus
selectable marker as well as regions for homologous recombination at the target lo-
cus [7]. In our lab, pCC1FOS has also been modiﬁed by John Heil to carry ΦC31 att
sites [122] for integrase-mediated site-speciﬁc recombination of cloned insert DNA into
the genomes of landing pad strains, including Sinorhizobium meliloti, Ochrobactrum
anthropi, and Agrobacterium tumefaciens [123]. As a general strategy, however, chro-
mosomal insertion is potentially less useful than recombinant clone maintenance due to
the diﬃculty in retrieving the integrated insert DNA for manipulation, including DNA
sequence analysis, when non-arrayed (i.e., pooled) libraries have been screened.
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6.3.3 Inclusion of transcriptional terminators in cloning
vectors
In addition to an oriT and broad-host range oriV , pCC1FOS may also be improved
by the addition of transcriptional terminators that ﬂank the fosmid’s Eco72I cloning
site (Figure 6.1). The beneﬁts of using terminators for cloning have previously been
discussed (Section 4.4.4); brieﬂy, transcriptional terminators may help alleviate cloning
bias in some cases where DNA, particularly AT-rich DNA, may contain sequences that
resemble the σ70 promoter consensus sequence. Spurious transcription initiating from
eﬃcient promoters near the vector-insert junction can interfere with the plasmid’s origin
of replication or can lead to overproduction of proteins involved in control of plasmid
copy number, aﬀecting plasmid maintenance [291]. For cloning metagenomic DNA,
it may be a good precaution to include terminators that prevent transcription into
the vector backbone and indeed, commercial vectors are available that make use of
transcriptional terminators to combat this problem.
Figure 6.2: Lucigen pEZ BAC cloning vector includes transcriptional ter-
minators. Transcriptional terminators indicated by red stop signs. Two terminators
ﬂank the cloning site to reduce isert-driven transcription and one terminator follows the
parC gene to reduce vector-driven transcription into the insert. Adapted from Lucigen
BAC Cloning Kits product manual.
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For example, the pEZ BAC cloning vector from Lucigen Corporation (Figure 6.2)
has two terminators that ﬂank the cloning site to reduce insert-driven transcription.
Interestingly, it also has another terminator to reduce vector-driven transcription into
the insert. In one particular line of vectors available from Lucigen, the linear pJAZZ
vectors, the two terminators ﬂanking the cloning site were disclosed as the phage T7
terminator and the E. coli rrnB terminator [106], both of which have been documented
as relatively strong terminators in standardized tests of terminator eﬃciency [31].
6.3.4 Testing the efficiency of transcriptional terminators
The characterization of transcriptional terminator strength has been of recent inter-
est as more parts are needed to build complex systems in synthetic biology endeav-
ours. This has led to the standardized testing of hundreds of natural and synthetic
transcriptional terminators to both understand their sequence determinants to aid in
prediction and modelling of terminators, as well as to ﬁnd strong terminators for use
in designed biological systems that require a tight control of transcription by RNA
polymerase [31, 42].
Eﬀorts to characterize terminators so far have focussed on only intrinsic termi-
nation, also called Rho-independent termination, which is one of two ways that tran-
scription can be terminated in E. coli and accounts for ∼80% of terminators in its
genome [252]. Intrinsic terminators consist of a GC-rich hairpin-forming sequence fol-
lowed by a run of Ts in the DNA, which is called the oligoT tract in the DNA [157]
or the U-tract [42] or poly-U tail [31] in the corresponding RNA. The folding of the
nascent RNA into a hairpin disrupts the RNA:DNA hybrid that stabilizes the tran-
scription elongation complex, leading to its dissociation; the stretch of Ts downstream
from the hairpin sequence is important in this process because it contributes to pausing
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of the elongation complex, allowing time for hairpin formation [114,157].
In contrast to intrinsic termination, Rho-dependent termination is more complex:
Rho binds to sites on the RNA in a sequence-speciﬁc manner, and can traverse the
transcript to catch up with the elongation complex to cause RNA release; however, the
binding sites can be separated from the site of transcriptional termination by hundreds
of nucleotides, and the factors leading transcriptional termination by Rho are currently
not well understood [252]. This complexity makes Rho-dependent termination diﬃcult
to predict on the basis of sequence and thus eﬀorts to characterize terminators have
concentrated on the more straightforward intrinsic terminators.
The strength (or eﬃciency) of intrinsic terminators has been measured using
devices designed for standardized testing with ﬂuorescent reporter proteins: brieﬂy,
ﬂow cytometry is used to compare the level of expression of a reporter downstream
of the transcriptional terminator to the level of expression of an upstream reporter,
normalizing to measurements obtained from a control construct lacking a terminator
(Figure 6.3).
RFP GFP
GC Stem (5-9 nts)
Poly-U tail (7-9 nts)
Loop (3-5 nts)
Figure 6.3: Device for standardized testing of transcriptional terminators.
Flourescent protein reporter genes are used to measure the eﬃciency of transcriptional
terminators. Adapted from [31].
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To be able to compare measurements of terminator strength requires careful design
of the testing device, including the choice of upstream and downstream reporters, as
well as understanding possible eﬀects of neighbouring sequence context, which can
inﬂuence terminator strength [31]. In any case, the use of ﬂuorescent reporters is a
convenient way to gauge whether transcriptional terminators are functioning in vivo.
6.3.5 Aims of this work
In Chapter 5, I used the commercial vector pCC1FOS to construct the B. theta-
compatible fosmid vector pKL13. I included the oriT for conjugation ability and two
unidirectional, Rho-independent transcriptional terminators that ﬂank the cloning site
to reduce potential transcription into the vector. The latter were introduced by the
cloning of a synthesized fragment. This chapter elaborates on how the transcriptional
terminator (TT) fragment was designed, providing rationale for each element, par-
ticularly those required for terminator testing. The main objective was to test the
functionality of the terminators, that is, to determine whether each of the two termina-
tors was indeed able to reduce transcription in the fosmid context. Such conﬁrmation
would justify their inclusion in the pKL13 library cloning vector. Given this objective,
the testing was intended to be a crude check and involved just one reporter protein,
GFPuv. This reporter was measured in the presence versus absence of each of the two
transcriptional terminators, demonstrating that each terminator behaved as expected
in reducing transcription.
230
CHAPTER 6. INCLUSION OF TRANSCRIPTIONAL TERMINATORS IN CLONING VECTORS
6.4 Results and discussion
6.4.1 Design of a transcriptional terminator fragment
After deciding to introduce terminators to reduce potential transcription into the
pCC1FOS vector backbone, I considered two options for the synthesis of the frag-
ment encoding transcriptional terminators, using Integrated DNA Technologies (IDT)
as the manufacturer: custom gene synthesis or gBlocks gene fragments. The diﬀerence
between the two is that custom gene synthesis delivers the desired fragment cloned into
a plasmid, whereas gBlock fragments arrive as uncloned double-stranded fragments.
Because a gBlock fragment is not cloned, the product will contain a small proportion
of incorrect sequences, such as insertions or deletions, although the product is accompa-
nied by an estimated purity and a recommendation from IDT regarding the probability
of obtaining the correct clone. For example, for a ∼1,500-bp fragment with approxi-
mately 85% purity, the IDT technical support team suggests that users screen about 6
colonies for >95% chance of the correct clone.
The price for gene synthesis was estimated to be nearly three times that for gBlock
synthesis. The transcriptional terminator (TT) fragment was synthesized as a gBlock,
and because the lab was oﬀered a free trial, I also designed the TT fragment to include
the ∼1-kb gentamicin resistance stuﬀer as well as all the elements required for testing
both the transcriptional terminators, short of a reporter gene. The ﬁnal design came
to 1,500 bp (Figure 6.4; DNA sequences provided in Table 6.2).
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Figure 6.4: Transcriptional terminator (TT) fragment design. The length of
each element is indicated by the number above the element. Note that this diagram is
stylized and is therefore not to scale.
More speciﬁcally, the following elements were included in the TT fragment:
❼ A stuﬀer fragment, ﬂanked by Eco72I sites (a.k.a PmlI; CAC^GTG). As described
in Section 5.4.2, the presence of a stuﬀer aids in complete digestion of the vector;
the vector is typically puriﬁed to remove the stuﬀer prior to ligation.
❼ A gentamicin resistance gene within the stuﬀer, identical to the sequence from
pJC8. The resistance gene is ﬂanked by BstBI sites (a.k.a. Bsp119I; TT^CGAA) for
optional removal or swap of the resistance gene. The resistance gene was included
because (1) there was no cost to synthesis, (2) it would reduce required cloning
downstream, and (3) the resistance gene confers antibiotic resistance that would
make cloning the synthesized fragment more straightforward.
❼ An inducible Ptac promoter, also within the stuﬀer. Ptac is a strong promoter,
possessing the consensus sequence for rpoD/σ70 (Figure 4.9). The promoter is
ﬂanked by Eco81I sites (a.k.a. Bsu36I; CC^TNAGG). This restriction enzyme was
speciﬁcally chosen for being a 7-cutter and lacking speciﬁcity at the centre base;
though Eco81I will cut on either side of the Ptac, the two sites are actually dif-
ferent in sequence: CC^TAAGG on the NheI side versus CC^TCAGG on the NsiI side.
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This design allows for the future swapping-in of diﬀerent promoters, if desired:
complementary oligos can be synthesized, annealed to form the double-stranded
promoter sequence, and then cloned in directionally.
❼ Two transcriptional terminators positioned to reduce transcription outward –
that is, into the vector backbone. Both the ilvGEDA and rnpB T1 transcrip-
tional terminators are from E. coli MG1655; sequences were taken from the com-
prehensive study on terminator eﬃciency by Cambray et al. [31]. These were
not the strongest terminators reported in that study because the strong stem-
loop structures associated with very strong terminators were incompatible with
gBlock synthesis; however, both of the chosen terminators were reported by Cam-
bray et al. to reduce expression 64- to 128-fold, which still make them very good
transcriptional terminators.
❼ A 3-frame translational stop upstream of each of the two transcriptional termina-
tors. These two translational stops diﬀer in sequence to avoid potential problems
with homologous recombination (Table 6.2). They were designed upstream of the
transcriptional stops to ensure that the latter are eﬀective: if perchance ribosomes
were actively translating the nascent mRNA, transcriptional termination may be
abolished due to interference with the formation of the stem-loop structure in
Rho-independent termination [337].
❼ Two primer-binding sites for Sanger end-sequencing of cloned inserts, KL-JC102
and KL-JC103. Other than the addition of an extra base, these sequences are
identical to the sequencing primer sites for pJC8 (the extra base was included
to ensure the 3’ end of the primer ends with two bases that are either C or
G). These sites are internal to the transcriptional terminators because the stem-
loop structures may hinder Sanger sequencing. Furthermore, each primer-binding
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site was positioned between the translational stop and the transcriptional stop
because there is evidence to suggest that transcriptional termination is eﬀective
when the spacing is ∼20-60 bases [337].
❼ A pair of unique restriction sites downstream of each of the two transcriptional
terminators, for directional cloning of a downstream reporter gene to test termi-
nator functionality. The two pairs were: SgsI (a.k.a. AscI; GG^CGCGCC) and PacI
(TTAAT^TAA) on the ilvGEDA side, and CpoI (a.k.a. RsrII; CG^GWCCG) and SfaAI
(a.k.a. SgfI, AsiSI; GCGAT^CGC) on the rnpB side.
❼ Single restriction sites upstream of each translational stop: NheI (G^CTAGC) on
the ilvGEDA side and NsiI (a.k.a. Mph1103I; ATGCA^T) on the rnpB side. These
were included for two reasons, with only the ﬁrst being relevant to this chapter:
(1) in the case that an additional upstream reporter gene had to be cloned for
testing transcriptional termination (as in Figure 6.3) – ideally two sites would
have been included on each side for directional cloning but unique restriction
sites were limited for a vector of this size (Figure 5.12); (2) so that the cloned
insert DNA can be released from the vector for restriction digest analysis of clones
from metagenomic libraries.
❼ A SwaI site (ATTT^AAAT) on both ends of the fragment so that the entire TT
fragment can be subcloned from one vector to another.
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Table 6.2: DNA sequences for elements of the TT fragment.
Element Length Sequence (5’ to 3’)
excess bases 5 GCATA
SwaI 8 ATTTAAAT
SfaAI 8 GCGATCGC
spacer 8 GACCTGCT
CpoI 7 CGGACCG
rnpB T1 TT 82 GACAGTCATTCATCTTTCTGCCCCTCCAAAAGCAAAAACCCGCCGAAGCGGGTTTTTACGTAAATCAGGTGA
AACTGACCGA
➜
KL-JC102 F 31 TAACAATTTCACACAGGAAACAGCTATGACG
3F stop 1 11 TCACCTAGTTA➜
NsiI 6 ATGCAT
Eco72I 6 CACGTG
BstBI 6 TTCGAA
Gm resistance 1056 CGTGTTGCCCCAGCAATCAGCGCGACCTTGCCCCTCCAACGTCATCTCGTTCTCCGCTCATGAGCTCAGCCA
ATCGACTGGCGAGCGGCATCGCATTCTTCGCATCCCGCCCTCTGGCGGATGCAGGAAGATCAACGGATCTCG
GCCCAGTTGACCCAGGGCTGTCGCCACAATGTCGCGGGAGCGGATCAACCGAGCAAAGGCATGACCGACTGG
ACCTTCCTTCTGAAGGCTCTTCTCCTTGAGCCACCTGTCCGCCAAGGCAAAGCGCTCACAGCAGTGGTCATT
CTCGAGATAATCGACGCGTACCAACTTGCCATCCTGAAGAATGGTGCAGTGTCTCGGCACCCCATAGGGAAC
CTTTGCCATCAACTCGGCAAGATGCAGCGTCGTGTTGGCATCGTGTCCCACGCCGAGGAGAAGTACCTGCCC
ATCGAGTTCATGGACACGGGCGACCGGGCTTGCAGGCGAGTGAGGTGGCAGGGGCAATGGATCAGAGATGAT
CTGCTCTGCCTGTGGCCCCGCTGCCGCAAAGGCAAATGGATGGGCGCTGCGCTTTACATTTGGCAGGCGCCA
GAATGTGTCAGAGACAACTCCAAGGTCCGGTGTAACGGGCGACGTGGCAGGATCGAACGGCTCGTCGTCCAG
ACCTGACCACGAGGGCATGACGAGCGTCCCTCCCGGACCCAGCGCAGCACGCAGGGCCTCGATCAGTCCAAG
TGGCCCATCTTCGAGGGGCCGGACGCTACGGAAGGAGCTGTGGACCAGCAGCACACCGCCGGGGGTAACCCC
AAGGTTGAGAAGCTGACCGATGAGCTCGGCTTTTCGCCATTCGTATTGCACGACATTGCACTCCACCGCTGA
TGACATCAGTCGATCATAGCACGATCAACGGCACTGTTGCAAATAGTCGGTGGTGATAAACTTATCATCCCC
TTTTGCTGATGGAGCTGCACATGAACCCATTCAAAGGCCGGCATTTTCAGCGTGACATCATTCTGTGGGCCG
TACGCTGGTACTGCAAATACGGCATCAGTTACCGTGAGCCGGAGGATC
➯
BstBI 6 TTCGAA
Eco81I 7 CCTCAGG
Continued on next page
➜sequence shown has been reverse-complemented for continuity; see Figure 6.4
➯synthesized gBlock fragment diﬀers from this sequence by a point mutation; see Appendix E.2
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Table 6.2 – Continued from previous page
Element Length Sequence (5’ to 3’)
Ptac 67 GAGCTGTTGACAATTAATCATCGGCTCGTATAATGTGTGGAATTGTGAGCGGATAACAATTTCACAC
Eco81I 7 CCTAAGG
Eco72I 6 CACGTG
NheI 6 GCTAGC
3F stop 2 11 TGACTAAGTGA
KL-JC103 R 31 CGAAAACCCTGGCGTTACCCAACTTAATCGC❺
ilvGEDA TT 89 TAGAGATCAAGCCTTAACGAACTAAGACCCCCGCACCGAAAGGTCCGGGGGTTTTTTTTGACCTTAAAAACA
TAACCGAGGAGCAGACA
PacI 8 TTAATTAA
spacer 8 ATCCAGCC
SgsI 8 GGCGCGCC
SwaI 8 ATTTAAAT
excess bases 5 TTGAC
6.4.2 Synthesis and cloning of terminator fragment
The TT fragment was synthesized by IDT as a gBlock gene fragment in the form of
200 fmol (200 ng) of the product – blunt DNA fragments with phosphorylated 5’ ends.
I attempted to clone the TT fragment into two diﬀerent vectors concurrently: ﬁrst,
directly into pKL7 (Figure 5.12) to generate the desired B. theta-compatible fosmid
vector; second, in case the ﬁrst attempt did not work, the TT fragment was also cloned
into the intermediate vector pJET1.2 for eventual transfer to pKL7. Both cloning
attempts were successful and a couple of clones from each were chosen for screening by
sequencing to ﬁnd the correct clone; the pJET1.2-based clones were called pKL9 and
the fosmid-based clones were called pKL10 (Table 2.2).
❺sequence shown has been reverse-complemented for continuity; see Figure 6.4
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Both clones in the fosmid backbone contained a deletion of a critical base in
the ilvGEDA terminator (Figure 6.5A and B) and in fact, all four clones contained a
deletion in the gentamicin resistance gene fragment (Figure 6.5A and C), although this
did not aﬀect the gentamicin resistance phenotype. Not surprisingly, the error in the
terminator was in a run of As (corresponding to the U-tract) near the core stem-loop
structure. From this experience, it is probably advisable to use gBlocks gene fragments
for sequences without known strong secondary structure and for fragments of relatively
small size to minimize the cost of screening by sequencing.
Figure 6.5: Screening by Sanger sequencing for correct TT fragment se-
quence. Six Sanger reads were obtained for pKL10 and aligned to the expected se-
quence (A) revealing two errors: one in the ilvGEDA terminator (B) and the other
in the gentamicin resistance gene fragment (C). Adapted from images generated by
Geneious version 6.0 created by BioMatters.
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Because pKL9 carried only the inconsequential error in the gentamicin resistance
gene fragment, the TT fragment was usable (see Appendix E.2 for sequence). Accord-
ingly, the TT fragment was subcloned from pKL9 as a blunt-ended SwaI-fragment into
the blunt Eco72I site of pKL7, generating pKL13 (Figure 5.12), which was the ﬁnal
library vector that I used for constructing B. theta-compatible libraries in Chapter 5.
After constructing pKL13, the TT fragment was double-checked by restriction digest,
using all of the enzymes whose sites were designed into the fragment (Figure 6.6).
Figure 6.6: Restriction digest check of TT fragment cloned in pKL13.
Restriction enzyme sites and sizes of the elements in the TT fragment (A) were checked
by restriction digest alongside uncut pKL13 as control (B); pullout shows agarose gel
section under adjusted brightness and contrast to increase DNA fragment visibility.
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6.4.3 Testing functionality of transcriptional terminators
Though the two chosen transcriptional terminators, the ilvGEDA and rnpB T1 termi-
nators, had been previously characterized [31], I wanted to conﬁrm that the terminators
were indeed functional in their new context to justify their inclusion in the B. theta-
compatible library vector, pKL13 (Figure 5.12). This conﬁrmation was not meant to
be a precise quantiﬁcation of terminator eﬃciency; rather, it was intended to be a
crude check of function. To do a simple check of transcriptional terminator function-
ality, a reporter gene can be cloned downstream of the terminator, and the level of
expression of that reporter gene can be compared in the presence versus absence of
the terminator. For a reporter, I chose green ﬂuorescent protein (GFP), speciﬁcally
the GFPuv variant isolated by molecular evolution and determined to be 16-18 times
brighter than wild-type GFP [51]. Though the ﬂuoresecence of another variant called
enhanced GFP (EGFP) has been reported to be even higher – about 35 times brighter
than wild-type GFP [344], EGFP may be more appropriate for eukaryotic rather than
bacterial systems [144].
Having chosen the reporter gene, the vector was then prepared for the introduction
of the GFPuv reporter: to test each terminator, the Ptac promoter must be upstream
of that terminator and the GFPuv reporter must be downstream. pKL13 had the
Ptac promoter oriented toward the ilvGEDA terminator, and thus I cloned GFPuv
downstream of the terminator to generate pKL15, and then deleted the terminator
to generate pKL16 (Figure 6.7, left). To generate constructs for testing the rnpB
terminator, I ﬁrst reversed the orientation of the Eco72I stuﬀer (see Section 6.6.2) to
generate in pKL17, which placed the Ptac upstream of the rnpB terminator; analogous
to the ﬁrst set of constructs, I cloned GFPuv downstream of the terminator to generate
pKL18, and then deleted the terminator to generate pKL19 (Figure 6.7, right).
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Figure 6.7: Overview of constructed plasmids for testing of transcriptional terminators using GFPuv reporter gene. To
test functionality of the ilvGEDA and rnpB transcriptional terminator sequences, respectively: the Ptac promoter orientation was manipulated
(pKL13 and pKL17), the GFPuv reporter gene was cloned (pKL15 and pKL18), and the terminators were deleted (pKL16 and pKL19).
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In each of the two plasmids that now lacked either the ilvGEDA or rnpB terminator–
pKL16 or pKL19, respectively – DNA was deleted starting from the translational stop
to the transcriptional stop, inclusive (Figure 6.7). I decided to delete the entire segment
instead of simply deleting the stem-loop-containing sequences because the segment was
designed to work as a unit for the termination of transcription. To see if the deleted
sequences were conferring transcriptional termination in the fosmid context, the ﬂuores-
cence from expressed GFPuv was compared in EPI300 cells carrying constructs with
versus without the terminator unit – that is, pKL15 was compared to pKL16 while
pKL18 was compared to pKL19 – under two diﬀerent conditions (Figure 6.8).
1 mM IPTG, 0.2% arabinose1 mM IPTG
neg. controls
0
200000
400000
600000
800000
1000000
1200000
1400000
1600000
1800000
2000000
pKL15 pKL16 pKL18 pKL19 pKL15 pKL16 pKL18 pKL19 pKL13 EPI300
TT upstream 
of GFPuv: (+) (−) (+) (−) (+) (−) (+) (−)
Ptac induced Ptac induced, copy number induced
na na
Figure 6.8: Fluorescence from EPI300 cells expressing GFPuv with or
without transcriptional terminators. Strains were grown under two diﬀerent con-
ditions to assay GFPuv ﬂuorescence from constructs with and without the ilvGEDA or
rnpB terminating sequences; red line indicates background ﬂuorescence of empty cells.
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The two diﬀerent conditions used to test the presence versus absence of the termi-
nator units were: (1) Ptac promoter induction alone using IPTG, or (2) Ptac promoter
induction in combination with copy number induction using arabinose. In the latter
condition, the presence of the terminators resulted in cells displaying a level of ﬂuores-
cence that was comparable to negative-control cells that lacked GFPuv; conversely, the
absence of either the ilvGEDA terminator unit (pKL16) or the rnpB terminator unit
(pKL19) led to an increase in ﬂuorescence as a result of higher GFPuv transcription
(Figure 6.8, centre and right panels). This result conﬁrmed that the two unidirectional
terminators are functional in the pKL13 context. Interestingly, this diﬀerence was only
observed when plasmid copy number was induced (Figure 6.8, left versus centre panel),
indicating that there is a limit of detection with the current experimental set-up (see
Section 6.6.5). It would be interesting to know what the exact copy number is for these
plasmid constructs that were compared, as Epicentre provides a rather large range for
copy number (from 10 to 200 copies per cell) without explanation of the inﬂuencing
factors [77].
In considering copy number for these constructs, it is conceivable that the copy
number of plasmids with the terminator may be diﬀerent from the copy number of
the those lacking the terminator, as copy number can be aﬀected by various factors,
such as growth media composition and nutrient limitation [95] or, in this case, the
presence/size of cloned DNA [280,333]. In the case of these GFPuv testing constructs,
however, the diﬀerence of ∼150 bases between constructs being compared is unlikely
to lead to very large diﬀerences in copy number, although if there were a diﬀerence,
it is more likely that increased transcription would lead to decreased copy number,
meaning that the diﬀerence observed in GFPuv expression would be even greater if
plasmid copy number were controlled for. It would be interesting to see how strong
transcription aﬀects plasmid copy number for this particular vector. To control for
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diﬀerences in copy number, plasmid copy number can be estimated for each plasmid in
the particular strain under the speciﬁc growth condition [172]; alternatively, diﬀerences
in plasmid copy number can be accounted for by simply using testing constructs that
make use of an upstream reporter gene in addition to a downstream reporter gene so
that transcription can be normalized to variability in reporter gene expression owing to
factors other than transcription termination (Figure 6.3). That being said, the precise
quantiﬁcation of terminator eﬃciency is beyond the scope of this thesis, although I did
design the TT fragment to allow for upstream reporter gene cloning (Figure 6.4).
6.4.4 Constructs for testing the effect of transcription on
cloning bias
The TT fragment was designed with two intentions: (1) to include terminators in the
B. theta-comptaible vector where they may help alleviate cloning bias (as discussed
in Section 4.5), and (2) to use in further experiments to test the extent to which
transcriptional terminators protect against cloning bias. For the latter, one future
goal is to compare the cloning bias between two metagenomic libraries that have been
constructed in a vector with transcriptional terminators versus one without. To prepare
vectors for this purpose, I deleted the Ptac-gentamicin stuﬀer in pKL13 (Figure 5.12)
and replaced it with only the gentamicin stuﬀer gene from pJC8, generating pKL20,
although the orientation of the gentamicin stuﬀer gene in pKL20 is currently uncertain
(Figure 6.9A, B, and C). The next step would be to delete the two transcriptional
terminator units to obtain a vector identical to pKL20 but for the missing terminators
(Figure 6.9C and D).
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Figure 6.9: Vectors for future work to test the effect of transcription terminators on
cloning bias. (A) pKL13, containing the TT fragment; (B) pKL14, in which the Ptac-gentamicin
stuﬀer was removed as a Eco72I frament; (C) pKL20, which contains just the gentamicin resistance
gene stuﬀer from pJC8; (D) and (E) show suggested next steps for removal of the two transcriptional
terminators to generate a vector that can be used for direct comparison to pKL20.
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Cloning bias could then be compared between the two vectors, pKL20 and that
of Figure 6.9E, after using them to construct metagenomic libraries from the same
DNA sample. For cloning bias experiments, it may be desirable to ﬁrst delete the
ermF -repA fragment from pKL20, which would reduce cloning vector size by ∼4 kb
(see Figure 5.12C and D).
A advantage of using the pCC1FOS backbone is that plasmid copy number can be
induced, allowing comparison of cloning bias not only between presence versus absence
of terminators, but also between single-copy versus multi-copy maintenance of metage-
nomic libraries. With carefully designed experiments, it may be possible to tease apart
the factors that aﬀect library representativeness – distinguishing transcriptional eﬀects
from copy-number eﬀects, though it may be easier to do so with cloned fragments
smaller in size than typical fosmid inserts.
Although the pCC1FOS backbone allows for copy number induction, cloning bias
could be observed under even greater copy number, as would be the case for pUC-
based vectors [340], which have been reported in the literature at up to 500-700 copies
per cell [210]. It may be interesting to determine whether transcriptional terminators
alleviate cloning bias under these conditions; in fact, the pUC19-based, high-copy pKL3
cosmid that I constructed is one vector that could be used for this purpose (Figure 5.8).
To transfer the TT fragment – and any derivatives constructed from it – to a diﬀerent
vector, the fragment can simply be subcloned as an blunted SgsI-SfaAI fragment into
the destination plasmid (Figure 6.9).
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6.5 Conclusions
In the previous Chapter 5, pCC1FOS was modiﬁed to include an oriT to allow the
vector to be conjugated between strains, as well as a TT fragment carrying transcrip-
tional terminators that ﬂank the cloning site to block transcription into the vector
backbone. This chapter described the design, synthesis, and characterization of the
TT fragment. Using GFPuv, the ilvGEDA and rnpB transcriptional terminator units
were determined to be functional in the pKL13 fosmid context. This chapter also de-
scribed the construction of plasmids and fragments that may be used to test the eﬀect
of transcription on the observed cloning bias of metagenomic libraries, although the
various factors that lead to cloning bias and their relative contributions remain to be
elucidated.
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6.6 Specific materials and methods
6.6.1 Preparation of pCC1FOS-based vectors using arabinose
induction
Plasmid minipreps of pCC1FOS-based vectors were prepared from cultures that had
been induced with either 1Ö commerical autoinduction solution (Epicentre AIS107F)
or 0.2% arabinose. EpiCentre sells the solution without details about composition,
but based on the literature, it is clear that the inducer of plasmid copy number is
arabinose. I induced using a ﬁnal concentration of 0.2% arabinose (see Appendix E.1)
although it might be useful to drop concentration to 0.02% [147]. I did not test varying
concentrations of arabinose for optimal yields of plasmid DNA.
6.6.2 Reversing orientation of stuffer fragment
The construction of pKL17 from pKL13 required reversing the orientation of the stuﬀer
fragment, so that the Ptac would be oriented in the opposite direction (see Figure 6.7 for
construct diagrams). To release the stuﬀer, 1 ➭g of pKL13 was digested with Eco72I
(Thermo-Fisher FD0364) in 20 ➭l and heat-inactivated at 80❽. For ligation, 1 ➭l of
the digest was used in a 10 ➭l ligation using T4 DNA ligase (Thermo-Fisher EL0014).
Ligations were used to transform EPI300 and clones were streak-puriﬁed and screened
by restriction enzyme digest (see Appendix E.1 for agarose gel image).
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6.6.3 Cloning of GPFuv
The GFPuv ORF and RBS were ampliﬁed from pGFPuv (1 ng; Genbank accession
U62636) using primers KL47/KL48 (with PacI and SgsI adapters) or KL49/KL50 (with
CpoI and SfaAI adapters) for cloning into pKL13 or pKL17, respectively (see Figure 6.7
for construct diagrams).
High-ﬁdelity Phusion DNA polymerase (Thermo-Fisher F-530L) was used ac-
cording to the manufacturer’s recommendations. The two-step PCR protocol used is
summarized in Table 5.9. To prepare for cloning, the PCR products were gel extracted,
digested with the appropriate restriction enzymes, and column-puriﬁed, using routine
protocols previously described in Chapter 2.
Table 6.3: PCR protocol for GFPuv.
Temperature Duration
98❽ 30 sec
98❽ 10 sec


Ö30 cycles
72❽ 30 sec
72❽ 5 min
22❽ hold
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6.6.4 Deletion of transcriptional terminators
Plasmid DNA was prepared for pKL15 and pKL18; 3 ➭g was used for PacI-NheI and
NsiI-CpoI double digestion, respectively, to release the transcriptional terminators (see
Figure 6.7 for construct diagrams). Digestions were incubated at 37❽ for 2.5 hours,
and the vector backbone was gel extracted and puriﬁed. 200 ng of each sample was used
in end-repair reaction using the End-It DNA End-Repair Kit (Epicentre ER81050) in
a volume of 20 ➭l, according to the manufacturer’s instructions. The reaction volume
was then doubled by the addition of water to achieve 0.5mM ATP concentration, and
Fast-Link buﬀer and ligase were added (Epicentre LK0750H), according to the manu-
facturer’s instructions. The ligation was incubated overnight at room temperature.
After the end-repair and ligation, the two desired constructs – with the tran-
scriptional terminator deleted – no longer had the restriction sites that ﬂanked the
deleted terminator sequence. To eﬀectively remove those DNA molecules that still had
these sites due to possible incomplete digestion, the ligations were subjected to another
double digest with the corresponding enzymes; this step digests undesired molecules,
enriching for the correct ones. The digest was then used to transform EPI300 and clones
were streak-puriﬁed and screened by restriction enzyme digest (see Appendix E.1 for
agarose gel images).
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6.6.5 Fluorescence assay for GFPuv expression
Strains were streaked from frozen stock onto solid media with the appropriate antibi-
otics. For each strain, an isolated colony was inoculated in triplicate into 5ml of liquid
media, using experimental and control conditions (Table 6.4). After overnight culture,
500 ➭l was transferred to 4.5ml of saline and used to take an OD600 reading (Spectronic
20 spectrophotometer). The remaining 4.5ml of culture was centrifuged at 8,000Ög for
1 minute and resuspended in 1ml saline.
The sample were eﬀectively standardized by OD in the following manner: using
the OD values, a standardization factor for each sample was calculated by dividing
the OD of the sample with the lowest OD, by the OD of that sample; a fraction
of each 1ml sample was taken corresponding to the calculated dilution factor. Cells
were pelleted by centrifugation at 8,000Ög for 1 minute and resuspended in 300 ➭l
saline. Samples were transferred to a black opaque microtiter plate for ﬂuoresence
assay on the FilterMax F5 Multi-Mode Microplate Reader (Molecular Devices) using
the Softmax Pro software (version 6.2.2); the ﬁlters used were 360/35 nm for excitation
and 535/25 nm for emission.
Table 6.4: Strains used in ﬂuorescence assay to test transcriptional terminators.
Media Strains
LB Cm5, 1mM IPTG, 0.2% arabinose pKL15, pKL16, pKL17, and pKL18; all in EPI300
LB Cm5, 1mM IPTG pKL15, pKL16, pKL17, and pKL18; all in EPI300
LB Cm5 pKL13 in EPI300
LB Sm100 EPI300
250
Chapter 7
Summary, future directions, and
concluding remarks
251
CHAPTER 7. SUMMARY, FUTURE DIRECTIONS, AND CONCLUDING REMARKS
7.1 Acknowledgements and declarations
Part of the discussion of this chapter was published as part of a Perspective article in
the journal Frontiers in Microbiology. I was the primary author of this article. The
citation for the article is:
Lam KN, Cheng J, Engel K, Neufeld JD, Charles TC (2015) Current and fu-
ture resources for functional metagenomics. Frontiers in Microbiology 6:1196.
doi:10.3389/fmicb.2015.01196
I also acknowledge the following contributions:
❼ The text of the Frontiers in Microbiology manuscript was proofread and edited
by Katja Engel, Josh Neufeld, Trevor Charles, and Jiujun Cheng.
❼ This remainder of this chapter was proofread by my supervisor Trevor Charles.
252
CHAPTER 7. SUMMARY, FUTURE DIRECTIONS, AND CONCLUDING REMARKS
7.2 Abstract
Method development will be crucial to the continuing success of functional metage-
nomics for elucidating and understanding microbial gene function. This thesis has
focused on development and analysis of methods for functional metagenomics, includ-
ing devising strategies for large-insert clone sequencing (Chapter 3), understanding se-
quence bias in metagenomic libraries (Chapter 4), expanding screening host range for
gut-derived libraries (Chapter 5), and exploring the importance of transcriptional ter-
minators in cloning vectors (Chapter 6). The results presented in this thesis contribute
towards method advancement, but also suggest new avenues for further investigation.
The near future may bring changes to the functional metagenomics ﬁeld. For
example, improvements in long-read sequencing technology, making it possible to obtain
on the order of thousands of bases of accurate DNA sequence, will undoubtedly change
clone sequencing strategies. On the other hand, expression host development will likely
advance at a slower pace, with steady and likely labour-intensive work to generate or
modify organisms to make them suitable for heterologous screening. Another issue
to be addressed is that of sequence bias in clone libraries, particularly for libraries
constructed using gut-derived DNA; factors contributing to library bias need to be
better understood to inform strategies to address such bias. These methodological
improvements will complement sequence-based metagenomics methods, providing basic
knowledge about gene function as well as supporting applied work aimed at mining
novel enzymes and engineering or modifying microbiomes.
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7.3 Summary and claims of contributions to
knowledge
This section brieﬂy summarizes the broad goals of each of the four data chapters in
this thesis, as well as lists my claims of contributions to scientiﬁc knowledge based on
the results of each chapter.
Chapter 3: Evaluation of pooled sequencing for metagenomic clones
In Chapter 3, I presented the results of using a pooled method for sequencing
large-insert cosmid clones isolated from functional screens of metagenomic libraries.
Illumina sequence data from the pooled approach were evaluated against reference data
obtained from barcoded sequencing of the same clones. The objective was to determine
the extent to which the more cost-eﬀective pooled sequencing strategy was capable of
generating accurate and near-complete assemblies for the metagenomic inserts. My
speciﬁc claims of contributions to knowledge are:
1. By comparison to the barcoded reference data, I showed that DNA sequence
for large-insert metagenomic clones can be eﬀectively recovered from a pooled
short-read (75-base) sequencing approach.
2. I showed that two major factors aﬀecting clone sequence recovery are sequencing
depth and clone sequence similarity. In the ﬁrst case, coverage of the clones can
be improved by increasing the depth of sequencing to close any potential gaps;
however, in the latter case, coverage may not improve for those clones in the pool
that have high sequence similarity (but not identical) due to problems assembling
the short reads.
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Chapter 4: Analysis of cloning bias in metagenomic libraries
In Chapter 4, I presented the results of analyzing sequence bias in metagenomic
libraries and exploring the possible causes of this bias during library construction. I
did this by analyzing data obtained from sequencing the DNA at various points in the
construction of a human fecal metagenomic library. The objective was to determine if
DNA fragmentation was a major cause of cloning bias or alternatively, if events occur-
ring in vivo in E. coli were a more important factor. My speciﬁc claims of contributions
to knowledge are:
3. I showed that the low-copy cosmid-based human gut metagenomic library did
suﬀer from cloning bias but that DNA fragmentation/size selection was not a
major cause of this bias; rather, the bias appears to occur after introduction of
the cloned DNA into E. coli .
4. By analyzing the sequence data for promoter consensus sequences, I provided
support for the hypothesis that spurious transcription in E. coli may be a major
cause of bias. I emphasized how this ﬁnding is in agreement with older published
results which I found by careful examination of the scientiﬁc literature.
Chapter 5: Development of B. theta as a screening host
In Chapter 5, I presented the results of eﬀorts to develop Bacteroides thetaio-
taomicron as a host for screening human gut metagenomic libraries. Arguably the most
important chapter of this thesis, it was also the most challenging. The objective was to
construct a cloning vector able to replicate in B. theta, generate B. theta-compatible
clone libraries using such a vector, and ﬁnally to demonstrate that constructed libraries
can be successfully screened in a B. theta host. Positive clones isolated from a proof-
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of-principle functional screen would support the notion of using B. theta as a host for
screening gut-derived DNA. My speciﬁc claims of contributions to knowledge are:
5. I constructed a mobilizable B. theta-compatible fosmid vector, pKL13, and used
this vector to construct a B. theta genomic library as well as a human gut metage-
nomic library. Both the vector and the libraries are resources that may be useful
in future functional metagenomics work.
6. By introducing both libraries into a B. theta deletion mutant unable to grow on
chondroitin sulfate as sole carbon source, I achieved complementation thereby
demonstrating that it was possible to carry out functional screening in B. theta,
particularly of a metagenomic library.
7. Although I found that fosmid clone DNA appeared to be integrated into the
genome of B. theta, I was able to obtain and analyze partial DNA sequence
data from the metagenomic clones that were able to complement the B. theta
chuR mutant. Through this, I identiﬁed a chuR ORF that showed high sequence
similarity to the VPI-5482 strain but was not found in the NCBI nr database,
indicating that this is a novel chuR ORF.
Chapter 6: Inclusion of transcriptional terminators in cloning vectors
In Chapter 6, I presented the results of designing, cloning, and testing tran-
scriptional terminators for a fosmid vector. The objective was to introduce elements
to reduce insert-driven transcription into the vector backbone, as well as to make a
terminator-containing construct general enough for introduction into other cloning vec-
tors. My speciﬁc claims of contributions to knowledge are:
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8. I incorporated two transcriptional terminators into the B. theta-compatible fos-
mid pKL13 that ﬂank the site of large-insert cloning, and demonstrated their
functionality in that context.
9. I generated constructs that will be useful for future experiments to examine
whether the presence of transcriptional terminators will alleviate the cloning bias
observed for metagenomic libraries.
7.4 Future directions and perspective
Function-based approaches are likely to be increasingly important as the ﬁelds of micro-
bial ecology and metagenomics advance. The development and reﬁnement of methods
for functional metagenomics will be instrumental in this advancement [74]. The work
described in this thesis was carried out towards this goal, although further work needs
to be done to expand on the ﬁndings presented. Accordingly, there are several broad
considerations discussed below that are relevant to method development for functional
metagenomics.
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Sequencing clones from metagenomic libraries
Although Chapter 3 was focused on a pooled-clone Illumina sequencing strategy
and discussed the limitation of pooling clones for short-read sequencing, it is possible
that short-read technologies will soon be obsolete. Within the last decade, there has
been marked increase even in the length of reads obtained by Illumina (Solexa) instru-
ments, from less than 50 bases on the Illumina GA II ten years ago to 2Ö 300 bases
on the Illumina MiSeq today. Although Illumina oﬀers the lowest error rate among
sequencing technologies currently in popular use, at ≤1% [245, 255], other sequencing
technologies that are able to oﬀer much longer read lengths may soon gain the advan-
tage as they improve their error rates. For example, Paciﬁc Biosciences sequencing can
generate reads several-kb long on average, although the throughput and ∼15% error
rate need to be improved for it to gain more widespread usage [76].
A particularly exciting long-read sequencing technology that is being developed
comes from Oxford Nanopore Technologies, with a median length in the thousands of
bases and upper-limit length of tens of thousands of bases [9]; the length obtained,
however, depends on the quality of the input DNA, which oﬀers the prospect of ob-
taining the entire DNA sequence of a typical fosmid insert in just a single read! Like
PacBio sequencing, this technology is also limited by a high error rate, which is close to
∼30% [9] although a rate of 4% has been reported by the company [121]. The reﬁne-
ment and availability of aﬀordable long-read sequencing technologies may soon obviate
the need for the more diﬃcult methods involved in short-read sequencing and assembly,
particularly for clone pools.
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Representativeness of metagenomic libraries
Though not so much a concern for functional screens, it is interesting to consider
the factors that inﬂuence library representativeness; elucidating these factors may lead
to the development of better strategies for accessing the full potential of environmental
metagenomes. If spurious transcription does indeed contribute substantially to cloning
bias, it would be worth investigating strategies to alleviate such transcription. For
example, the use of transcriptional terminators has already been discussed in detail in
Chapter 4 and Chapter 6; in the latter, I generated constructs containing terminators
that ﬂank the site of cloning, which can be introduced into diﬀerent vectors for library
construction and examination of bias (Section 6.4.4). It is important to note that for
fosmid vectors, inserts may be very large and events occurring at the vector-insert
junction may contribute to only a small fraction of the observed bias; on the other
hand, these events may cause the whole insert to be lost.
For tackling potential transcription more globally, that is, across the entire cloned
fragment, another possibility is based on the observation that E. coli H-NS (histone-
like nucleoid structuring) protein binds AT-rich DNA, including sequences that may
be recognized by the E. coli housekeeping sigma factor σ70 [168], silencing spurious
transcription by RNA polymerase [273]. It is possible that increasing the cellular con-
centration of H-NS will suppress transcription from σ70 promoter-like sequences in
cloned metagenomic DNA, thereby reducing transcriptional eﬀects that may poten-
tially lead to insert exclusion. The caveat of using H-NS, however, is that suppression
of transcription may be undesirable if the host used for library construction is to be
used directly for functional screening.
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Appropriate hosts for functional screening
Depending on the target activity, functional screens can exhibit a low hit rate [312]
the reasons for which might include barriers at the level of both transcription and
translation. Improving E. coli as a screening host to address these problems will likely
improve future hit rates. Examples include introducing heterologous sigma factors to
guide RNA polymerase to otherwise untranscribed regions [98], employing T7 RNA
polymerase to help drive transcription [305], as well as forming hybrid ribosomes [151]
that may inﬂuence expression.
Nevertheless, it will be important to move beyond E. coli into diﬀerent screen-
ing hosts, particularly for the complementation of mutant phenotypes not possible in
E. coli , such as those of B. theta and other members of the Bacteroidetes described
in Chapter 5. The future of functional metagenomics will likely see the development
of a greater variety of alternative hosts for functional screening, which will not only
likely lead to an increase in the hit rates of functional screens but also make available
a broader range of phenotypes for functional complementation.
Functional metagenomics using a mouse model
An exciting avenue of research involves performing functional screens in vivo, that
is, in a germ-free (gnotobiotic) mouse model, to explore how particular genes contribute
to ﬁtness in terms of host colonization or other eﬀects on the host organism. This has
already been demonstrated in principle using E. coli to screen a B. theta genomic library
(in an expression vector) for ﬁtness determinants in a mouse model [341]. Moving to
a metagenomic library is the obvious next step [81]. A further exciting step would be
to carry out functional screening in B. theta or another closely related host, should the
development of such organisms for functional metagenomics be successful.
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7.5 Concluding remarks
Method development is and will continue to be important in the functional metage-
nomics ﬁeld, particularly as (1) interest in the human microbiome drives research into
characterizing microbial gene function and understanding the mechanisms that lead to
eﬀects on the host organism, and (2) knowledge of gene function is required to comple-
ment sequence-based metagenomics research. The identiﬁcation of obstacles to cloning
and screening will aid in the development of new tools and technologies for functional
metagenomics, providing us with greater reach in terms of what we are able to gather
from functional screens. Reﬁning function-based methods will be crucial for the bio-
prospecting of novel enzymes and compounds, for the determination of gene function
to guide the development of reliable models of microbial ecosystem functioning, and to
support eﬀorts in microbiome engineering and development of therapeutics.
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A.1 LB: lysogeny broth (or Luria-Bertani media)
This recipe is for the Lennox variety of LB [178].
Prepare:
❼ 10 g tryptone
❼ 5 g yeast extract
❼ 5 g sodium chloride
❼ top to 1000ml with distilled water
Aliquot 200ml per bottle. If preparing solid media, add:
❼ 3-4 g agar per bottle
Autoclave. Store at room temperature and steam agar media prior to use.
A.2 TB: terrific broth media
This protocol was adapted from Cold Spring Harbor Protocols: http://cshprotocols.
cshlp.org/content/2006/1/pdb.rec8620
Prepare:
❼ 12 g tryptone
❼ 24 g yeast extract
❼ 8ml 50% glycerol
❼ top to 900ml with distilled water
Aliquot 90ml per bottle and autoclave. Prior to use, add per bottle:
❼ 10ml 0.17M KH2PO4, 0.72M K2HPO4
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A.3 TYG: tryptone yeast glucose media
This recipe was adapted from one shared with me by Nicole Koropatkin and Eric Martens
from the University of Michigan.
Prepare and autoclave:
❼ 10 g tryptone
❼ 5 g yeast extract
❼ 2 g glucose
❼ top to 860ml with distilled water
Add per 172ml of media:
❼ 20ml potassium phosphate buﬀer, pH 7.2
❼ 8ml TYG salts (per litre: 0.5 g MgSO4 –7H2O, 10 g NaHCO3, 2 g NaCl)
❼ 50 ➭l 0.8% CaCl2
❼ 50 ➭l 0.4 mg/ml FeSO4·7H2O
Store at room temperature. Prior to use, add per 5ml of broth:
❼ 5 ➭l 1.2mM histidine-1.9mM hematin solution (hematin dissolved in 1M NaOH, neu-
tralized with equivalent volume 1M HCl, and histidine solution added)
❼ 5 ➭l 1mg/ml menadione (Vitamin K; dissolved in ethanol)
❼ 20 ➭l 0.25mg/ml resazurin indicator
❼ 50 ➭l 50mg/ml cysteine, thawed from -20❽
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A.4 BHI: brain heart infusion media
BHI blood agar (BHIH)
This recipe was shared with me by Nicole Koropatkin and Eric Martens from the University
of Michigan.
Prepare:
❼ 37 g brain heart infusion power (BD cat. no. B211059)
❼ top to 900ml with distilled water
Aliquot 450ml per bottle and add:
❼ 10 g agar per bottle; include a stir bar
Autoclave. Store at room temperature. Steam prior to use, cool agar on stir plate, and add:
❼ 50ml deﬁbrinated horse blood, equilibrated to room temperature
BHI broth with supplementation (BHI+)
This recipe was adapted from the TYG recipe shared with me by Nicole Koropatkin and Eric
Martens from the University of Michigan.
Prepare:
❼ 37 g brain heart infusion powder (BD cat. no. B211059)
❼ top to 1L with distilled water
Aliquot 200ml per bottle and autoclave. Before use, add per 5 ml of broth:
❼ 5 ➭l 1.2mM histidine-1.9mM hematin solution (hematin dissolved in 1M NaOH, neu-
tralized with equivalent volume 1M HCl, and histidine solution added)
❼ 5 ➭l 1mg/ml menadione (Vitamin K; dissolved in ethanol)
❼ 20 ➭l 0.25mg/ml resazurin indicator
❼ 50 ➭l 50mg/ml cysteine, thawed from -20❽
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A.5 Bt MM: B.theta minimal media
This recipe was adapted from one shared with me by Nicole Koropatkin and Eric Martens
from the University of Michigan, speciﬁcally by addition of trace elements.
Prepare and autoclave to store at room temperature or use directly:
❼ 2.5 g carbon source (e.g. glucose or chondroitin sulfate)
❼ 10 g agar, for solid media; include a stir bar
❼ top to 440ml with distilled water
Use stir plate to mix while adding:
❼ 50ml 10Ö Bt salts (per litre: 136 g KH2PO4, 8.75 g NaCl, 11.25 g (NH4)2SO4)
❼ 5ml 50mg/ml cysteine, thawed from -20❽
❼ 500 ➭l 1.2mM histidine-1.9mM hematin solution (hematin dissolved in 1M NaOH,
neutralized with equivalent volume 1M HCl, and histidine solution added)
❼ 500 ➭l trace elements (per litre: 0.247 g H3BO3, 0.1 g CuSO4·5H2O, 0.338 g MnSO4·H2O,
0.282 g ZnSO4·7H2O, 0.056 g CoSO4·7H2O, 0.048 g Na2MoO4·2H2O)
❼ 500 ➭l 0.8% CaCl2
❼ 500 ➭l 0.4mg/ml FeSO4·7H2O
❼ 500 ➭l 1mg/ml menadione (vitamin K; dissolved in ethanol)
❼ 500 ➭l 0.1M MgCl2
❼ 500 ➭l 0.01mg/ml vitamin B12 (dissolved in ethanol)
Note that B. theta minimal media plates should not be stored at all; they should be prepared
fresh on the day they are required.
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A.6 TAE: tris acetic acid EDTA electrophoresis buffer
This protocol was adapted from OpenWetWare: http://openwetware.org/wiki/1X_TAE
For 50Ö TAE stock, prepare in a starting volume of ∼600-700 ml:
❼ 242 g Tris free base
❼ 18.6 g disodium EDTA (add before glacial acetic acid)
❼ 57.1ml glacial acetic acid
❼ pH to 8.0 (optional; should be about 8)
❼ top to 1000ml
Dilute 1 in 50 with distilled water. The 1Ö dilution can be stored at room temperature for
weeks in a large carboy.
A.7 Plasmid miniprep solutions
Recipes for the following solutions were obtained from OpenWetWare and were based on
buﬀers from the Qiagen QIAprep Spin Miniprep Kit. The recipes are reproduced here but
can be found at: http://openwetware.org/wiki/Qiagen_Buffers
P1: resuspension solution
Prepare and autoclave:
❼ 50mM Tris-HCl pH 8.0
❼ 10mM EDTA
Add:
❼ RNaseA to 100 ➭g/ml
Store at 4❽ .
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P2: lysis solution
Prepare non-sterile:
❼ 200mM NaOH, from 2M stock
❼ 1% SDS, from 20% stock (may require heating if precipitated; do not steam)
N3: neutralization solution
Prepare non-sterile:
❼ 4.2M guanidine hydrchloride (or guanidine isothiocyanate)
❼ 0.9M potassium acetate
❼ pH to 4.8
PB: optional wash solution
Prepare non-sterile:
❼ 5M guanidine hydrchloride (or guanidine isothiocyanate)
❼ 30% isopropanol
PE: ethanol wash solution
Prepare:
❼ 10mM Tris-HCl pH 7.5, sterile
❼ 80% ethanol
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A.8 Gel extraction solutions
The recipe for the binding buﬀer was found in the literature [149]. The recipe for the ethanol
wash was obtained from OpenWetWare and is based on buﬀers from the Qiagen QIAquick
Gel Extraction Kit; see http://openwetware.org/wiki/Qiagen_Buffers
Binding buffer
Prepare non-sterile:
❼ 140mM MES-NaOH (pH 7.0)
❼ 20 mM EDTA
❼ 5.5 M guanidine isothiocyanate
PE: ethanol wash solution
Same as for plasmid miniprep.
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A.9 Plasmid maxiprep solutions
The recipes for these alkaline lysis solutions were provided by my supervisor, Trevor Charles.
TEG: resuspension
Dilute from concentrated stocks using dH2O to make:
❼ 50mM Tris-Cl pH 8.0 (1/20 of 1M stock)
❼ 20mM Na-EDTA pH 8.0 (1/10 of 0.2 stock)
❼ 1% glucose
ALS: alkaline lysis
Dilute from concentrated stocks using sterile dH2O to make:
❼ 0.2M NaOH (1/10 of 2M stock)
❼ 1% SDS (1/20 of 20% stock)
Store in plastic bottle; do not store in glass.
HSS: neutralization
Dissolve in 60ml:
❼ 147 g of K-Ac
Then add:
❼ 282ml glacial acetic acid
❼ top up to 500ml with dH2O
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APPENDIX B. SUPPLEMENTARY INFORMATION FOR CHAPTER 3
B.1 Clone sequencing read depth
Graphs of clone sequencing read depth for each of the 73 clones are presented on the following
pages. For each clone, the barcoded contig was used as a reference, to which raw reads from
pooled sequencing or barcoded sequencing were aligned.
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B.2 Python scripts
Parse all-by-all BLAST results
1 #!/usr/bin/python
2
3 from Bio.Blast import NCBIXML
4 ’’’
5 #From command line, execute all-by-all blastn to generate results.xml:
6 #blastn -query contigs-5.fa -subject contigs-5.fa -evalue .001 -out results.xml
-outfmt 5→֒
7 ’’’
8
9 from interval import Interval, IntervalSet
10
11 file = open("results.xml")
12 blast_records = NCBIXML.parse(file)
13
14 ##accumulate distance between contig pairs in dictionary (where 1 = identical)
15 distance = {}
16
17 ##for each queried sequence
18 for blast_record in blast_records:
19 #print "\n" + blast_record.query
20 #print str(blast_record.query_letters)
21
22 ##for each subject sequence
23 for alignment in blast_record.alignments:
24
25 ##accumulate hsp intervals for each subject sequence, by iterating
through each hsp→֒
26 hsp_interval_list = []
27 for hsp in alignment.hsps:
28
29 ##if alignment was on subject complement, subtract alignment length
from start to get interval→֒
30 if hsp.frame == (1,-1):
31 hsp_interval = IntervalSet([Interval(hsp.sbjct_start,
hsp.sbjct_start - hsp.align_length)])→֒
32 hsp_interval_list.append(hsp_interval)
33
34 ##otherwise, alignment was on subject given strand, add alignment
length to start to get interval→֒
35 else:
36 hsp_interval = IntervalSet([Interval(hsp.sbjct_start,
hsp.sbjct_start + hsp.align_length)])→֒
37 hsp_interval_list.append(hsp_interval)
38
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39
40 ##use interval addition to remove overlapping regions over hsps
41 new_intervalset = IntervalSet()
42 for interval in hsp_interval_list:
43 new_intervalset = new_intervalset + interval
44
45 ##calculate length of the subject sequence that was involved in the
alignment = [aligned length]→֒
46 range_list =[]
47 for interval in new_intervalset:
48 start = interval.lower_bound
49 end = interval.upper_bound
50 for i in range(start, end):
51 range_list.append(i)
52
53 ##check which of query/subject is shorter; then divide the [aligned
length] by length of the shorter one→֒
54 ##note: blast_record.query_letters = query length; alignment.length =
subject length→֒
55 ##keep track of the fraction and query/subject names for putting in dict
56 fraction = 0
57 if blast_record.query_letters <= alignment.length:
58 fraction = float(len(range_list))/blast_record.query_letters
59 else:
60 fraction = float(len(range_list))/alignment.length
61
62 ##save the fraction (distance), which represents the homology between
the query and subject→֒
63 ##put the names into a list to sort; this overwrites duplicate key-value
pairs in the dictionary→֒
64 name_pair = [str(blast_record.query), str(alignment.hit_def)]
65 name_pair = sorted(name_pair)
66 new_name_pair = ":".join(name_pair)
67 distance[str(new_name_pair)] = fraction
68
69 ##write distances to file
70 out = open("out.txt", "w")
71 for item in distance:
72 #print item + "\t\t\t" + str(distance[item])
73 names = item.split(":")
74 row = names[0] + "," + names[1] + "," + str(distance[item]) + "\n"
75 out.write(row)
76
77
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C.1 MetaPhlAn output of taxa abundance
The output of MetaPhlAn is presented on the following pages (Table C.1); results for both
the forward and reverse reads are included for all three samples: the crude extract, the
size-selected, and the cosmid library.
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Table C.1: Summary of Metaphlan output.
ID cosmid_library_F cosmid_library_R size_selected_F size_selected_R crude_extract_F crude_extract_R
k__Archaea 0 0 0.00435 0.00178 0 0
k__Archaea|p__Euryarchaeota 0 0 0.00435 0.00178 0 0
k__Archaea|p__Euryarchaeota|c__Methanobacteria 0 0 0.00435 0.00178 0 0
k__Archaea|p__Euryarchaeota|c__Methanobacteria|o__Methanobacteriales 0 0 0.00435 0.00178 0 0
k__Archaea|p__Euryarchaeota|c__Methanobacteria|o__Methanobacteriales|f__Methanobacteriaceae 0 0 0.00435 0.00178 0 0
k__Archaea|p__Euryarchaeota|c__Methanobacteria|o__Methanobacteriales|f__Methanobacteriaceae|g__Methanosphaera 0 0 0.00435 0.00178 0 0
k__Archaea|p__Euryarchaeota|c__Methanobacteria|o__Methanobacteriales|f__Methanobacteriaceae|g__Methanosphaera|s__Methanosphaera_stadtmanae 0 0 0.00435 0.00178 0 0
k__Bacteria 100 100 99.99565 99.99822 100 100
k__Bacteria|p__Actinobacteria 77.97123 77.44348 13.0776 12.73214 11.14398 10.89272
k__Bacteria|p__Actinobacteria|c__Actinobacteria 77.97123 77.44348 13.0776 12.73214 11.14398 10.89272
k__Bacteria|p__Actinobacteria|c__Actinobacteria|o__Actinomycetales 0.05618 0.05321 0 0 0.00107 0
k__Bacteria|p__Actinobacteria|c__Actinobacteria|o__Actinomycetales|f__Actinomycetaceae 0.01117 0.01193 0 0 0.00107 0
k__Bacteria|p__Actinobacteria|c__Actinobacteria|o__Actinomycetales|f__Actinomycetaceae|g__Actinomyces 0.01117 0.01193 0 0 0.00107 0
k__Bacteria|p__Actinobacteria|c__Actinobacteria|o__Actinomycetales|f__Actinomycetaceae|g__Actinomyces|s__Actinomyces_odontolyticus 0.01117 0.01193 0 0 0.00107 0
k__Bacteria|p__Actinobacteria|c__Actinobacteria|o__Actinomycetales|f__Micrococcaceae 0.045 0.04128 0 0 0 0
k__Bacteria|p__Actinobacteria|c__Actinobacteria|o__Actinomycetales|f__Micrococcaceae|g__Rothia 0.045 0.04128 0 0 0 0
k__Bacteria|p__Actinobacteria|c__Actinobacteria|o__Actinomycetales|f__Micrococcaceae|g__Rothia|s__Rothia_mucilaginosa 0.045 0.04128 0 0 0 0
k__Bacteria|p__Actinobacteria|c__Actinobacteria|o__Bifidobacteriales 54.98204 54.69089 9.20296 8.88183 7.87557 7.72522
k__Bacteria|p__Actinobacteria|c__Actinobacteria|o__Bifidobacteriales|f__Bifidobacteriaceae 54.98204 54.69089 9.20296 8.88183 7.87557 7.72522
k__Bacteria|p__Actinobacteria|c__Actinobacteria|o__Bifidobacteriales|f__Bifidobacteriaceae|g__Bifidobacterium 54.98204 54.69089 9.20296 8.88183 7.87557 7.72522
k__Bacteria|p__Actinobacteria|c__Actinobacteria|o__Bifidobacteriales|f__Bifidobacteriaceae|g__Bifidobacterium|s__Bifidobacterium_adolescentis 18.44349 18.6723 2.55627 2.60934 2.23682 2.20449
k__Bacteria|p__Actinobacteria|c__Actinobacteria|o__Bifidobacteriales|f__Bifidobacteriaceae|g__Bifidobacterium|s__Bifidobacterium_breve 0.24638 0.22541 0.00578 0.00119 0 0
k__Bacteria|p__Actinobacteria|c__Actinobacteria|o__Bifidobacteriales|f__Bifidobacteriaceae|g__Bifidobacterium|s__Bifidobacterium_catenulatum 0.41224 0.39189 0.02275 0.03965 0.03462 0.04135
k__Bacteria|p__Actinobacteria|c__Actinobacteria|o__Bifidobacteriales|f__Bifidobacteriaceae|g__Bifidobacterium|s__Bifidobacterium_longum 16.0106 16.00286 3.40731 2.95913 2.92716 2.95269
k__Bacteria|p__Actinobacteria|c__Actinobacteria|o__Bifidobacteriales|f__Bifidobacteriaceae|g__Bifidobacterium|s__Bifidobacterium_pseudocatenulatum 19.86934 19.39843 3.21084 3.27252 2.67697 2.52669
k__Bacteria|p__Actinobacteria|c__Actinobacteria|o__Coriobacteriales 22.93302 22.69937 3.87464 3.85031 3.26734 3.1675
k__Bacteria|p__Actinobacteria|c__Actinobacteria|o__Coriobacteriales|f__Coriobacteriaceae 22.93302 22.69937 3.87464 3.85031 3.26734 3.1675
k__Bacteria|p__Actinobacteria|c__Actinobacteria|o__Coriobacteriales|f__Coriobacteriaceae|g__Collinsella 21.21125 20.97976 3.40455 3.37866 2.95099 2.88259
k__Bacteria|p__Actinobacteria|c__Actinobacteria|o__Coriobacteriales|f__Coriobacteriaceae|g__Collinsella|s__Collinsella_aerofaciens 21.21125 20.97976 3.40455 3.37866 2.95099 2.88259
k__Bacteria|p__Actinobacteria|c__Actinobacteria|o__Coriobacteriales|f__Coriobacteriaceae|g__Eggerthella 1.32363 1.30562 0.33117 0.33524 0.23774 0.22797
k__Bacteria|p__Actinobacteria|c__Actinobacteria|o__Coriobacteriales|f__Coriobacteriaceae|g__Eggerthella|s__Eggerthella_lenta 1.32363 1.30562 0.33117 0.33524 0.23774 0.22797
k__Bacteria|p__Actinobacteria|c__Actinobacteria|o__Coriobacteriales|f__Coriobacteriaceae|g__Gordonibacter 0.39814 0.414 0.13892 0.13641 0.07862 0.05694
k__Bacteria|p__Actinobacteria|c__Actinobacteria|o__Coriobacteriales|f__Coriobacteriaceae|g__Gordonibacter|s__Gordonibacter_pamelaeae 0.39814 0.414 0.13892 0.13641 0.07862 0.05694
k__Bacteria|p__Bacteroidetes 12.02304 12.32339 21.24834 21.47013 29.50008 29.97218
k__Bacteria|p__Bacteroidetes|c__Bacteroidia 12.02304 12.32339 21.24834 21.47013 29.50008 29.97218
k__Bacteria|p__Bacteroidetes|c__Bacteroidia|o__Bacteroidales 12.02304 12.32339 21.24834 21.47013 29.50008 29.97218
k__Bacteria|p__Bacteroidetes|c__Bacteroidia|o__Bacteroidales|f__Bacteroidaceae 4.38677 4.55248 16.24903 16.56666 19.28831 19.85961
k__Bacteria|p__Bacteroidetes|c__Bacteroidia|o__Bacteroidales|f__Bacteroidaceae|g__Bacteroides 4.38677 4.55248 16.24903 16.56666 19.28831 19.85961
k__Bacteria|p__Bacteroidetes|c__Bacteroidia|o__Bacteroidales|f__Bacteroidaceae|g__Bacteroides|s__Bacteroides_caccae 0.02079 0.02183 0.09667 0.09511 0.11722 0.11225
k__Bacteria|p__Bacteroidetes|c__Bacteroidia|o__Bacteroidales|f__Bacteroidaceae|g__Bacteroides|s__Bacteroides_cellulosilyticus 0.14931 0.13825 0.4679 0.46279 0.58924 0.56722
k__Bacteria|p__Bacteroidetes|c__Bacteroidia|o__Bacteroidales|f__Bacteroidaceae|g__Bacteroides|s__Bacteroides_coprocola 0 0 0.00149 0 0.02463 0.02992
k__Bacteria|p__Bacteroidetes|c__Bacteroidia|o__Bacteroidales|f__Bacteroidaceae|g__Bacteroides|s__Bacteroides_dorei 0.04273 0.04379 0.13965 0.17031 0.16946 0.18184
k__Bacteria|p__Bacteroidetes|c__Bacteroidia|o__Bacteroidales|f__Bacteroidaceae|g__Bacteroides|s__Bacteroides_eggerthii 0 0 0.01255 0.00905 0.02386 0.01879
k__Bacteria|p__Bacteroidetes|c__Bacteroidia|o__Bacteroidales|f__Bacteroidaceae|g__Bacteroides|s__Bacteroides_finegoldii 0.01691 0.01896 0.09499 0.12025 0.16818 0.16985
k__Bacteria|p__Bacteroidetes|c__Bacteroidia|o__Bacteroidales|f__Bacteroidaceae|g__Bacteroides|s__Bacteroides_fragilis 0.00975 0.00487 0.16213 0.16516 0.15296 0.10438
k__Bacteria|p__Bacteroidetes|c__Bacteroidia|o__Bacteroidales|f__Bacteroidaceae|g__Bacteroides|s__Bacteroides_intestinalis 0 0 0.01787 0.01626 0.02399 0.02366
k__Bacteria|p__Bacteroidetes|c__Bacteroidia|o__Bacteroidales|f__Bacteroidaceae|g__Bacteroides|s__Bacteroides_ovatus 0.2891 0.2753 1.00239 0.96548 1.35037 1.24824
k__Bacteria|p__Bacteroidetes|c__Bacteroidia|o__Bacteroidales|f__Bacteroidaceae|g__Bacteroides|s__Bacteroides_stercoris 0 0 0.00534 0 0.04992 0.0393
k__Bacteria|p__Bacteroidetes|c__Bacteroidia|o__Bacteroidales|f__Bacteroidaceae|g__Bacteroides|s__Bacteroides_thetaiotaomicron 0.37345 0.34607 1.03798 1.0592 1.00328 1.09393
k__Bacteria|p__Bacteroidetes|c__Bacteroidia|o__Bacteroidales|f__Bacteroidaceae|g__Bacteroides|s__Bacteroides_unclassified 1.94406 2.20922 7.37793 7.50927 9.23866 9.92434
k__Bacteria|p__Bacteroidetes|c__Bacteroidia|o__Bacteroidales|f__Bacteroidaceae|g__Bacteroides|s__Bacteroides_uniformis 0.20634 0.22197 0.66519 0.67599 0.76074 0.72604
k__Bacteria|p__Bacteroidetes|c__Bacteroidia|o__Bacteroidales|f__Bacteroidaceae|g__Bacteroides|s__Bacteroides_vulgatus 1.24732 1.23935 4.96679 5.15465 5.39491 5.41351
k__Bacteria|p__Bacteroidetes|c__Bacteroidia|o__Bacteroidales|f__Bacteroidaceae|g__Bacteroides|s__Bacteroides_xylanisolvens 0.087 0.03287 0.20016 0.16315 0.22089 0.20633
k__Bacteria|p__Bacteroidetes|c__Bacteroidia|o__Bacteroidales|f__Porphyromonadaceae 0.45788 0.57906 0.53245 0.51046 0.64013 0.66208
k__Bacteria|p__Bacteroidetes|c__Bacteroidia|o__Bacteroidales|f__Porphyromonadaceae|g__Odoribacter 0 0 0.00323 0.00411 0.02077 0.01833
k__Bacteria|p__Bacteroidetes|c__Bacteroidia|o__Bacteroidales|f__Porphyromonadaceae|g__Odoribacter|s__Odoribacter_splanchnicus 0 0 0.00323 0.00411 0.02077 0.01833
k__Bacteria|p__Bacteroidetes|c__Bacteroidia|o__Bacteroidales|f__Porphyromonadaceae|g__Parabacteroides 0.45788 0.57906 0.52921 0.50635 0.61936 0.64376
k__Bacteria|p__Bacteroidetes|c__Bacteroidia|o__Bacteroidales|f__Porphyromonadaceae|g__Parabacteroides|s__Parabacteroides_distasonis 0 0 0.01105 0.00648 0.01848 0.02003
k__Bacteria|p__Bacteroidetes|c__Bacteroidia|o__Bacteroidales|f__Porphyromonadaceae|g__Parabacteroides|s__Parabacteroides_johnsonii 0.00907 0.00771 0.03531 0.03845 0.06263 0.0511
k__Bacteria|p__Bacteroidetes|c__Bacteroidia|o__Bacteroidales|f__Porphyromonadaceae|g__Parabacteroides|s__Parabacteroides_merdae 0.14744 0.15162 0.4486 0.44856 0.46743 0.48847
k__Bacteria|p__Bacteroidetes|c__Bacteroidia|o__Bacteroidales|f__Porphyromonadaceae|g__Parabacteroides|s__Parabacteroides_unclassified 0.30136 0.41973 0.03425 0.01287 0.07082 0.08416
k__Bacteria|p__Bacteroidetes|c__Bacteroidia|o__Bacteroidales|f__Prevotellaceae 0.24934 0.24731 1.55259 1.55722 5.90395 5.86084
k__Bacteria|p__Bacteroidetes|c__Bacteroidia|o__Bacteroidales|f__Prevotellaceae|g__Prevotella 0.24934 0.24731 1.55259 1.55722 5.90395 5.86084
k__Bacteria|p__Bacteroidetes|c__Bacteroidia|o__Bacteroidales|f__Prevotellaceae|g__Prevotella|s__Prevotella_copri 0.24934 0.24731 1.55259 1.55722 5.90395 5.86084
k__Bacteria|p__Bacteroidetes|c__Bacteroidia|o__Bacteroidales|f__Rikenellaceae 6.92906 6.94454 2.91427 2.83578 3.66768 3.58964
k__Bacteria|p__Bacteroidetes|c__Bacteroidia|o__Bacteroidales|f__Rikenellaceae|g__Alistipes 6.92906 6.94454 2.91427 2.83578 3.66768 3.58964
k__Bacteria|p__Bacteroidetes|c__Bacteroidia|o__Bacteroidales|f__Rikenellaceae|g__Alistipes|s__Alistipes_putredinis 4.07745 4.16533 1.93769 1.90829 2.52303 2.4627
k__Bacteria|p__Bacteroidetes|c__Bacteroidia|o__Bacteroidales|f__Rikenellaceae|g__Alistipes|s__Alistipes_shahii 2.85161 2.77921 0.97658 0.92749 1.14465 1.12694
k__Bacteria|p__Firmicutes 0.12246 0.1209 64.05676 64.28564 57.83246 57.5862
k__Bacteria|p__Firmicutes|c__Bacilli 0 0 1.1275 1.12086 0.77354 0.81422
k__Bacteria|p__Firmicutes|c__Bacilli|o__Lactobacillales 0 0 1.1275 1.12086 0.77354 0.81422
k__Bacteria|p__Firmicutes|c__Bacilli|o__Lactobacillales|f__Lactobacillaceae 0 0 0.2723 0.27887 0.18615 0.18228
k__Bacteria|p__Firmicutes|c__Bacilli|o__Lactobacillales|f__Lactobacillaceae|g__Lactobacillus 0 0 0.2723 0.27887 0.18615 0.18228
k__Bacteria|p__Firmicutes|c__Bacilli|o__Lactobacillales|f__Lactobacillaceae|g__Lactobacillus|s__Lactobacillus_ruminis 0 0 0.2723 0.27887 0.18615 0.18228
k__Bacteria|p__Firmicutes|c__Bacilli|o__Lactobacillales|f__Streptococcaceae 0 0 0.8552 0.84199 0.58739 0.63194
k__Bacteria|p__Firmicutes|c__Bacilli|o__Lactobacillales|f__Streptococcaceae|g__Streptococcus 0 0 0.8552 0.84199 0.58739 0.63194
k__Bacteria|p__Firmicutes|c__Bacilli|o__Lactobacillales|f__Streptococcaceae|g__Streptococcus|s__Streptococcus_australis 0 0 0 0 0.00098 0
k__Bacteria|p__Firmicutes|c__Bacilli|o__Lactobacillales|f__Streptococcaceae|g__Streptococcus|s__Streptococcus_parasanguinis 0 0 0.65839 0.62618 0.40991 0.44214
k__Bacteria|p__Firmicutes|c__Bacilli|o__Lactobacillales|f__Streptococcaceae|g__Streptococcus|s__Streptococcus_salivarius 0 0 0.19291 0.20442 0.15672 0.16197
k__Bacteria|p__Firmicutes|c__Bacilli|o__Lactobacillales|f__Streptococcaceae|g__Streptococcus|s__Streptococcus_thermophilus 0 0 0.0039 0.01139 0.01977 0.02783
k__Bacteria|p__Firmicutes|c__Clostridia 0.11169 0.112 59.90936 60.12072 53.74329 53.51115
k__Bacteria|p__Firmicutes|c__Clostridia|o__Clostridiales 0.11169 0.112 59.90936 60.12072 53.74329 53.51115
k__Bacteria|p__Firmicutes|c__Clostridia|o__Clostridiales|f__Clostridiaceae 0 0 2.14418 2.13152 2.01952 2.05992
k__Bacteria|p__Firmicutes|c__Clostridia|o__Clostridiales|f__Clostridiaceae|g__Clostridium 0 0 2.14418 2.13152 2.01952 2.05992
k__Bacteria|p__Firmicutes|c__Clostridia|o__Clostridiales|f__Clostridiaceae|g__Clostridium|s__Clostridium_asparagiforme 0 0 0 0 0.092 0.09041
k__Bacteria|p__Firmicutes|c__Clostridia|o__Clostridiales|f__Clostridiaceae|g__Clostridium|s__Clostridium_bartlettii 0 0 0.09874 0.09638 0.13193 0.13979
k__Bacteria|p__Firmicutes|c__Clostridia|o__Clostridiales|f__Clostridiaceae|g__Clostridium|s__Clostridium_bolteae 0 0 0.24807 0.23127 0.37966 0.3917
k__Bacteria|p__Firmicutes|c__Clostridia|o__Clostridiales|f__Clostridiaceae|g__Clostridium|s__Clostridium_cf 0 0 0.0322 0.03402 0.02676 0.03709
k__Bacteria|p__Firmicutes|c__Clostridia|o__Clostridiales|f__Clostridiaceae|g__Clostridium|s__Clostridium_hathewayi 0 0 0.04425 0.04094 0.03153 0.02295
k__Bacteria|p__Firmicutes|c__Clostridia|o__Clostridiales|f__Clostridiaceae|g__Clostridium|s__Clostridium_leptum 0 0 0.53848 0.53178 0.36475 0.39324
k__Bacteria|p__Firmicutes|c__Clostridia|o__Clostridiales|f__Clostridiaceae|g__Clostridium|s__Clostridium_nexile 0 0 1.00147 1.01887 0.834 0.83276
k__Bacteria|p__Firmicutes|c__Clostridia|o__Clostridiales|f__Clostridiaceae|g__Clostridium|s__Clostridium_scindens 0 0 0.10052 0.1023 0.05908 0.0583
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k__Bacteria|p__Firmicutes|c__Clostridia|o__Clostridiales|f__Clostridiaceae|g__Clostridium|s__Clostridium_symbiosum 0 0 0.08044 0.07595 0.09982 0.09368
k__Bacteria|p__Firmicutes|c__Clostridia|o__Clostridiales|f__Clostridiales_Family_XI_Incertae_Sedis 0 0 0 0.01519 0 0
k__Bacteria|p__Firmicutes|c__Clostridia|o__Clostridiales|f__Clostridiales_Family_XI_Incertae_Sedis|g__Clostridiales_Family_XI_Incertae_Sedis_unclassified 0 0 0 0.01519 0 0
k__Bacteria|p__Firmicutes|c__Clostridia|o__Clostridiales|f__Clostridiales_uncl 0 0 0.17969 0.14638 0.17607 0.12738
k__Bacteria|p__Firmicutes|c__Clostridia|o__Clostridiales|f__Clostridiales_uncl|g__Blautia 0 0 0.17969 0.14638 0.17607 0.12738
k__Bacteria|p__Firmicutes|c__Clostridia|o__Clostridiales|f__Clostridiales_uncl|g__Blautia|s__Blautia_hydrogenotrophica 0 0 0.01461 0.01872 0.01027 0.00784
k__Bacteria|p__Firmicutes|c__Clostridia|o__Clostridiales|f__Clostridiales_uncl|g__Blautia|s__Blautia_unclassified 0 0 0.16508 0.12766 0.16581 0.11954
k__Bacteria|p__Firmicutes|c__Clostridia|o__Clostridiales|f__Eubacteriaceae 0.03335 0.04003 24.42598 24.53932 19.17275 19.06187
k__Bacteria|p__Firmicutes|c__Clostridia|o__Clostridiales|f__Eubacteriaceae|g__Eubacterium 0.03335 0.04003 24.42598 24.53932 19.17275 19.06187
k__Bacteria|p__Firmicutes|c__Clostridia|o__Clostridiales|f__Eubacteriaceae|g__Eubacterium|s__Eubacterium_eligens 0 0 1.01733 1.00474 2.74208 2.69392
k__Bacteria|p__Firmicutes|c__Clostridia|o__Clostridiales|f__Eubacteriaceae|g__Eubacterium|s__Eubacterium_hallii 0 0 2.03682 1.99023 1.17307 1.17818
k__Bacteria|p__Firmicutes|c__Clostridia|o__Clostridiales|f__Eubacteriaceae|g__Eubacterium|s__Eubacterium_limosum 0 0 0.00953 0.00807 0 0.0017
k__Bacteria|p__Firmicutes|c__Clostridia|o__Clostridiales|f__Eubacteriaceae|g__Eubacterium|s__Eubacterium_rectale 0.03335 0.04003 21.04378 21.22138 14.77741 14.73719
k__Bacteria|p__Firmicutes|c__Clostridia|o__Clostridiales|f__Eubacteriaceae|g__Eubacterium|s__Eubacterium_siraeum 0 0 0.02265 0.02074 0.05463 0.05181
k__Bacteria|p__Firmicutes|c__Clostridia|o__Clostridiales|f__Eubacteriaceae|g__Eubacterium|s__Eubacterium_ventriosum 0 0 0.29587 0.29417 0.42556 0.39907
k__Bacteria|p__Firmicutes|c__Clostridia|o__Clostridiales|f__Lachnospiraceae 0 0 5.0478 5.04547 4.05289 4.08144
k__Bacteria|p__Firmicutes|c__Clostridia|o__Clostridiales|f__Lachnospiraceae|g__Coprococcus 0 0 1.31986 1.35062 0.96688 0.94963
k__Bacteria|p__Firmicutes|c__Clostridia|o__Clostridiales|f__Lachnospiraceae|g__Coprococcus|s__Coprococcus_catus 0 0 0.28149 0.27011 0.24307 0.2411
k__Bacteria|p__Firmicutes|c__Clostridia|o__Clostridiales|f__Lachnospiraceae|g__Coprococcus|s__Coprococcus_comes 0 0 1.03837 1.08051 0.72381 0.70853
k__Bacteria|p__Firmicutes|c__Clostridia|o__Clostridiales|f__Lachnospiraceae|g__Dorea 0 0 3.42776 3.43285 2.36608 2.37726
k__Bacteria|p__Firmicutes|c__Clostridia|o__Clostridiales|f__Lachnospiraceae|g__Dorea|s__Dorea_formicigenerans 0 0 1.12478 1.10088 0.73896 0.73629
k__Bacteria|p__Firmicutes|c__Clostridia|o__Clostridiales|f__Lachnospiraceae|g__Dorea|s__Dorea_longicatena 0 0 2.30298 2.33198 1.62712 1.64097
k__Bacteria|p__Firmicutes|c__Clostridia|o__Clostridiales|f__Lachnospiraceae|g__Roseburia 0 0 0.30018 0.262 0.71993 0.75456
k__Bacteria|p__Firmicutes|c__Clostridia|o__Clostridiales|f__Lachnospiraceae|g__Roseburia|s__Roseburia_intestinalis 0 0 0.08844 0.06943 0.1149 0.12747
k__Bacteria|p__Firmicutes|c__Clostridia|o__Clostridiales|f__Lachnospiraceae|g__Roseburia|s__Roseburia_inulinivorans 0 0 0.21175 0.19257 0.60503 0.62708
k__Bacteria|p__Firmicutes|c__Clostridia|o__Clostridiales|f__Ruminococcaceae 0.07834 0.07197 28.11171 28.24284 28.32206 28.18054
k__Bacteria|p__Firmicutes|c__Clostridia|o__Clostridiales|f__Ruminococcaceae|g__Anaerotruncus 0 0 0.07834 0.08228 0.0747 0.07836
k__Bacteria|p__Firmicutes|c__Clostridia|o__Clostridiales|f__Ruminococcaceae|g__Anaerotruncus|s__Anaerotruncus_colihominis 0 0 0.07834 0.08228 0.0747 0.07836
k__Bacteria|p__Firmicutes|c__Clostridia|o__Clostridiales|f__Ruminococcaceae|g__Faecalibacterium 0.06524 0.06307 11.96027 11.82916 17.6229 17.44306
k__Bacteria|p__Firmicutes|c__Clostridia|o__Clostridiales|f__Ruminococcaceae|g__Faecalibacterium|s__Faecalibacterium_cf 0.01223 0.01123 4.52787 4.39973 6.195 6.21572
k__Bacteria|p__Firmicutes|c__Clostridia|o__Clostridiales|f__Ruminococcaceae|g__Faecalibacterium|s__Faecalibacterium_prausnitzii 0.05301 0.05183 6.87077 6.68096 9.82464 10.16358
k__Bacteria|p__Firmicutes|c__Clostridia|o__Clostridiales|f__Ruminococcaceae|g__Faecalibacterium|s__Faecalibacterium_unclassified 0 0 0.56163 0.74848 1.60325 1.06376
k__Bacteria|p__Firmicutes|c__Clostridia|o__Clostridiales|f__Ruminococcaceae|g__Ruminococcus 0.0131 0.00891 16.05678 16.32131 10.61971 10.64383
k__Bacteria|p__Firmicutes|c__Clostridia|o__Clostridiales|f__Ruminococcaceae|g__Ruminococcus|s__Ruminococcus_bromii 0.0131 0.00891 11.80023 11.97115 7.02601 6.99219
k__Bacteria|p__Firmicutes|c__Clostridia|o__Clostridiales|f__Ruminococcaceae|g__Ruminococcus|s__Ruminococcus_gnavus 0 0 0.96046 0.92369 0.60017 0.60577
k__Bacteria|p__Firmicutes|c__Clostridia|o__Clostridiales|f__Ruminococcaceae|g__Ruminococcus|s__Ruminococcus_lactaris 0 0 0.1605 0.15906 0.14736 0.13247
k__Bacteria|p__Firmicutes|c__Clostridia|o__Clostridiales|f__Ruminococcaceae|g__Ruminococcus|s__Ruminococcus_obeum 0 0 1.31916 1.32292 0.88979 0.87322
k__Bacteria|p__Firmicutes|c__Clostridia|o__Clostridiales|f__Ruminococcaceae|g__Ruminococcus|s__Ruminococcus_torques 0 0 1.81643 1.9445 1.95638 2.04018
k__Bacteria|p__Firmicutes|c__Clostridia|o__Clostridiales|f__Ruminococcaceae|g__Subdoligranulum 0 0 0.01632 0.01009 0.00475 0.01528
k__Bacteria|p__Firmicutes|c__Clostridia|o__Clostridiales|f__Ruminococcaceae|g__Subdoligranulum|s__Subdoligranulum_variabile 0 0 0.01632 0.01009 0.00475 0.01528
k__Bacteria|p__Firmicutes|c__Erysipelotrichi 0 0 0.67104 0.67619 0.49115 0.47528
k__Bacteria|p__Firmicutes|c__Erysipelotrichi|o__Erysipelotrichales 0 0 0.67104 0.67619 0.49115 0.47528
k__Bacteria|p__Firmicutes|c__Erysipelotrichi|o__Erysipelotrichales|f__Erysipelotrichaceae 0 0 0.67104 0.67619 0.49115 0.47528
k__Bacteria|p__Firmicutes|c__Erysipelotrichi|o__Erysipelotrichales|f__Erysipelotrichaceae|g__Catenibacterium 0 0 0.21822 0.21838 0.15408 0.14172
k__Bacteria|p__Firmicutes|c__Erysipelotrichi|o__Erysipelotrichales|f__Erysipelotrichaceae|g__Catenibacterium|s__Catenibacterium_mitsuokai 0 0 0.21822 0.21838 0.15408 0.14172
k__Bacteria|p__Firmicutes|c__Erysipelotrichi|o__Erysipelotrichales|f__Erysipelotrichaceae|g__Coprobacillus 0 0 0.17556 0.1848 0.10687 0.10931
k__Bacteria|p__Firmicutes|c__Erysipelotrichi|o__Erysipelotrichales|f__Erysipelotrichaceae|g__Coprobacillus|s__Coprobacillus_bacterium 0 0 0.17556 0.1848 0.10687 0.10931
k__Bacteria|p__Firmicutes|c__Erysipelotrichi|o__Erysipelotrichales|f__Erysipelotrichaceae|g__Holdemania 0 0 0.27726 0.27302 0.23019 0.22424
k__Bacteria|p__Firmicutes|c__Erysipelotrichi|o__Erysipelotrichales|f__Erysipelotrichaceae|g__Holdemania|s__Holdemania_filiformis 0 0 0.27726 0.27302 0.23019 0.22424
k__Bacteria|p__Firmicutes|c__Negativicutes 0.01077 0.0089 2.34886 2.36787 2.82449 2.78555
k__Bacteria|p__Firmicutes|c__Negativicutes|o__Selenomonadales 0.01077 0.0089 2.34886 2.36787 2.82449 2.78555
k__Bacteria|p__Firmicutes|c__Negativicutes|o__Selenomonadales|f__Acidaminococcaceae 0 0 0.14545 0.16028 0.19088 0.15305
k__Bacteria|p__Firmicutes|c__Negativicutes|o__Selenomonadales|f__Acidaminococcaceae|g__Acidaminococcaceae_unclassified 0 0 0.14545 0.16028 0.19088 0.15305
k__Bacteria|p__Firmicutes|c__Negativicutes|o__Selenomonadales|f__Veillonellaceae 0.01077 0.0089 2.20341 2.20758 2.63361 2.6325
k__Bacteria|p__Firmicutes|c__Negativicutes|o__Selenomonadales|f__Veillonellaceae|g__Dialister 0.01077 0.0089 1.6548 1.67255 1.16702 1.19352
k__Bacteria|p__Firmicutes|c__Negativicutes|o__Selenomonadales|f__Veillonellaceae|g__Dialister|s__Dialister_invisus 0.01077 0.0089 1.6548 1.67255 1.16702 1.19352
k__Bacteria|p__Firmicutes|c__Negativicutes|o__Selenomonadales|f__Veillonellaceae|g__Megamonas 0 0 0.54684 0.53234 1.46205 1.42808
k__Bacteria|p__Firmicutes|c__Negativicutes|o__Selenomonadales|f__Veillonellaceae|g__Megamonas|s__Megamonas_hypermegale 0 0 0.54684 0.53234 1.46205 1.42808
k__Bacteria|p__Firmicutes|c__Negativicutes|o__Selenomonadales|f__Veillonellaceae|g__Veillonella 0 0 0.00176 0.00269 0.00454 0.01091
k__Bacteria|p__Firmicutes|c__Negativicutes|o__Selenomonadales|f__Veillonellaceae|g__Veillonella|s__Veillonella_unclassified 0 0 0.00176 0.00269 0.00454 0.01091
k__Bacteria|p__Proteobacteria 9.65819 9.90084 1.57642 1.47372 1.49978 1.52766
k__Bacteria|p__Proteobacteria|c__Deltaproteobacteria 0.68372 0.77154 0.30892 0.28465 0.44194 0.51069
k__Bacteria|p__Proteobacteria|c__Deltaproteobacteria|o__Desulfovibrionales 0.68372 0.77154 0.30892 0.28465 0.44194 0.51069
k__Bacteria|p__Proteobacteria|c__Deltaproteobacteria|o__Desulfovibrionales|f__Desulfovibrionaceae 0.68372 0.77154 0.30892 0.28465 0.44194 0.51069
k__Bacteria|p__Proteobacteria|c__Deltaproteobacteria|o__Desulfovibrionales|f__Desulfovibrionaceae|g__Bilophila 0.4798 0.44882 0.12539 0.1176 0.16021 0.15952
k__Bacteria|p__Proteobacteria|c__Deltaproteobacteria|o__Desulfovibrionales|f__Desulfovibrionaceae|g__Bilophila|s__Bilophila_wadsworthia 0.4798 0.44882 0.12539 0.1176 0.16021 0.15952
k__Bacteria|p__Proteobacteria|c__Deltaproteobacteria|o__Desulfovibrionales|f__Desulfovibrionaceae|g__Desulfovibrio 0.20392 0.32272 0.18353 0.16705 0.28173 0.35117
k__Bacteria|p__Proteobacteria|c__Deltaproteobacteria|o__Desulfovibrionales|f__Desulfovibrionaceae|g__Desulfovibrio|s__Desulfovibrio_desulfuricans 0.06007 0.16577 0.07934 0.04913 0.08314 0.1506
k__Bacteria|p__Proteobacteria|c__Deltaproteobacteria|o__Desulfovibrionales|f__Desulfovibrionaceae|g__Desulfovibrio|s__Desulfovibrio_piger 0.14385 0.15694 0.10419 0.11792 0.19858 0.20057
k__Bacteria|p__Proteobacteria|c__Gammaproteobacteria 8.97448 9.1293 1.2675 1.18907 1.05785 1.01697
k__Bacteria|p__Proteobacteria|c__Gammaproteobacteria|o__Alteromonadales 0.01216 0 0 0 0.03468 0.0038
k__Bacteria|p__Proteobacteria|c__Gammaproteobacteria|o__Alteromonadales|f__Shewanellaceae 0.01216 0 0 0 0.03468 0.0038
k__Bacteria|p__Proteobacteria|c__Gammaproteobacteria|o__Alteromonadales|f__Shewanellaceae|g__Shewanella 0.01216 0 0 0 0.03468 0.0038
k__Bacteria|p__Proteobacteria|c__Gammaproteobacteria|o__Alteromonadales|f__Shewanellaceae|g__Shewanella|s__Shewanella_oneidensis 0.01216 0 0 0 0.03468 0.0038
k__Bacteria|p__Proteobacteria|c__Gammaproteobacteria|o__Enterobacteriales 8.95048 9.12138 1.09247 1.00767 0.94133 0.91524
k__Bacteria|p__Proteobacteria|c__Gammaproteobacteria|o__Enterobacteriales|f__Enterobacteriaceae 8.95048 9.12138 1.09247 1.00767 0.94133 0.91524
k__Bacteria|p__Proteobacteria|c__Gammaproteobacteria|o__Enterobacteriales|f__Enterobacteriaceae|g__Enterobacter 0.08686 0.07763 0 0 0 0
k__Bacteria|p__Proteobacteria|c__Gammaproteobacteria|o__Enterobacteriales|f__Enterobacteriaceae|g__Enterobacter|s__Enterobacter_cloacae 0.08686 0.07763 0 0 0 0
k__Bacteria|p__Proteobacteria|c__Gammaproteobacteria|o__Enterobacteriales|f__Enterobacteriaceae|g__Escherichia 5.16069 5.22912 0.65059 0.56245 0.43353 0.45782
k__Bacteria|p__Proteobacteria|c__Gammaproteobacteria|o__Enterobacteriales|f__Enterobacteriaceae|g__Escherichia|s__Escherichia_coli 5.16069 5.22912 0.65059 0.56245 0.43353 0.45782
k__Bacteria|p__Proteobacteria|c__Gammaproteobacteria|o__Enterobacteriales|f__Enterobacteriaceae|g__Klebsiella 3.70294 3.81462 0.44188 0.44522 0.5078 0.45742
k__Bacteria|p__Proteobacteria|c__Gammaproteobacteria|o__Enterobacteriales|f__Enterobacteriaceae|g__Klebsiella|s__Klebsiella_pneumoniae 3.70294 3.81462 0.42971 0.44389 0.45181 0.40999
k__Bacteria|p__Proteobacteria|c__Gammaproteobacteria|o__Enterobacteriales|f__Enterobacteriaceae|g__Klebsiella|s__Klebsiella_unclassified 0 0 0.01218 0.00133 0.05598 0.04744
k__Bacteria|p__Proteobacteria|c__Gammaproteobacteria|o__Pasteurellales 0.01184 0.00793 0.17502 0.1814 0.08184 0.09792
k__Bacteria|p__Proteobacteria|c__Gammaproteobacteria|o__Pasteurellales|f__Pasteurellaceae 0.01184 0.00793 0.17502 0.1814 0.08184 0.09792
k__Bacteria|p__Proteobacteria|c__Gammaproteobacteria|o__Pasteurellales|f__Pasteurellaceae|g__Haemophilus 0.01184 0.00793 0.17502 0.1814 0.08184 0.09792
k__Bacteria|p__Proteobacteria|c__Gammaproteobacteria|o__Pasteurellales|f__Pasteurellaceae|g__Haemophilus|s__Haemophilus_parainfluenzae 0.01184 0.00793 0.17502 0.1814 0.08184 0.09792
k__Bacteria|p__Verrucomicrobia 0.22507 0.2114 0.03653 0.03659 0.02369 0.02124
k__Bacteria|p__Verrucomicrobia|c__Verrucomicrobiae 0.22507 0.2114 0.03653 0.03659 0.02369 0.02124
k__Bacteria|p__Verrucomicrobia|c__Verrucomicrobiae|o__Verrucomicrobiales 0.22507 0.2114 0.03653 0.03659 0.02369 0.02124
k__Bacteria|p__Verrucomicrobia|c__Verrucomicrobiae|o__Verrucomicrobiales|f__Verrucomicrobiaceae 0.22507 0.2114 0.03653 0.03659 0.02369 0.02124
k__Bacteria|p__Verrucomicrobia|c__Verrucomicrobiae|o__Verrucomicrobiales|f__Verrucomicrobiaceae|g__Akkermansia 0.22507 0.2114 0.03653 0.03659 0.02369 0.02124
k__Bacteria|p__Verrucomicrobia|c__Verrucomicrobiae|o__Verrucomicrobiales|f__Verrucomicrobiaceae|g__Akkermansia|s__Akkermansia_muciniphila 0.22507 0.2114 0.03653 0.03659 0.02369 0.02124
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C.2 Python scripts
Filter E. coli or vector reads using BLAT, in batch
1 #!/usr/bin/python
2
3 from Bio import SeqIO
4 import sys
5 import os
6 import time
7
8 #FUNCTIONS
9
10 #run blat and parse results; return a set of unique read names that are hits to
the subject→֒
11 def run_blat(files_dir, reads_filename, subject_filename):
12
13 #run blat in the shell
14 results_filename = reads_filename + "_BLAT_" + subject_filename + ".psl"
15 os.system("blat " + subject_filename + " " + files_dir + reads_filename + "
" + files_dir + results_filename)→֒
16
17 #open results
18 results_file = open(files_dir + results_filename)
19
20 #clear the header lines
21 for i in range(0,5):
22 results_file.readline()
23
24 #track the names of reads that are 100% identical to E. coli (90 base
identity)→֒
25 match_names = set()
26 for line in results_file:
27
28 #parse the line
29 line = line.split(’\t’)
30 match = line[0]
31 mismatch = line[1]
32 gaps = line[6]
33 query_name = line[9]
34
35 #if the match was 100% identical (90 bases), accumulate the name
36 if match == ’90’ and mismatch == ’0’ and gaps == ’0’:
37 match_names.add(query_name)
38
39 #delete psl files
40 os.system("rm " + files_dir + "*.psl")
41
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42 return match_names
43
44 #INPUT FILES
45
46 filenames_dir = sys.argv[1]
47 vector_filename = sys.argv[2]
48 ec_filename = sys.argv[3]
49
50 #get list of filenames into array to process
51 filenames = os.listdir(filenames_dir)
52 filenames.sort()
53
54 #RUN BLAT AND PARSE RESULTS FOR EACH FILE
55
56 #write summary file of results
57 summary_file = open(filenames_dir + "summary.txt", "w")
58 summary_file.write("filename \ttotal reads \ttotal dirty \tec \tvector \n")
59
60 #process files
61 for filename in filenames:
62
63 #get sets of read names that are hits
64 ec_hits = run_blat(filenames_dir, filename, ec_filename)
65 vector_hits = run_blat(filenames_dir, filename, vector_filename)
66
67 #track for summary file
68 total_count = 0
69 total_dirty_count = 0
70 vector_count = 0
71 ec_count = 0
72
73 #write clean and dirty reads to new files; also summary file
74 clean_file = open(filenames_dir + filename + "_clean_chked.fa", "w")
75 dirty_file = open(filenames_dir + filename + "_dirty_chked.fa", "w")
76
77 #open the reads file; for each FASTA sequence read
78 for seq_record in SeqIO.parse(filenames_dir + filename, "fasta"):
79 total_count = total_count + 1
80
81 if (seq_record.id in ec_hits):
82 SeqIO.write(seq_record, dirty_file, "fasta")
83 ec_hits.remove(seq_record.id) #remove id from set to make following
searches faster→֒
84 ec_count = ec_count + 1
85 total_dirty_count = total_dirty_count + 1
86
87 elif (seq_record.id in vector_hits):
88 SeqIO.write(seq_record, dirty_file, "fasta")
89 vector_hits.remove(seq_record.id) #remove id from set to make
following searches faster→֒
90 vector_count = vector_count + 1
91 total_dirty_count = total_dirty_count + 1
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92
93 #if not in list of read names, it’s a clean read
94 else:
95
96 #write to clean file
97 SeqIO.write(seq_record, clean_file, "fasta")
98
99 #write to summary
100 output = filename + "\t" + str(total_count) + "\t" + str(total_dirty_count)
+ "\t" + str(ec_count) + "\t" + str(vector_count) + "\n"→֒
101 summary_file.write(output)
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Check filtering of E. coli and vector reads, in batch
1 #!/usr/bin/python
2
3 from Bio import SeqIO
4 import sys
5 import os
6 import time
7
8 #input: directory of files to process; fasta Ec file; fasta vector file
9 filenames_dir = sys.argv[1]
10 vector_filename = sys.argv[2]
11 ec_filename = sys.argv[3]
12
13 #get list of filenames into array to process
14 filenames = os.listdir(filenames_dir)
15 filenames.sort()
16
17 #for ec, vector: get the sequence, rev comp of the sequence, in preparation for
checking→֒
18 ec = SeqIO.read(ec_filename, "fasta")
19 ec_rc = ec.reverse_complement()
20 vector = SeqIO.read(vector_filename, "fasta")
21 vector_rc = vector.reverse_complement()
22
23 #prep output file
24 outfile = open(filenames_dir + "results_Ec_or_pJC8.txt", "w")
25 outfile.write("filename \ttotal \tboth \tEc \tvector \tunaccounted \n")
26
27 #process each file
28 for filename in filenames:
29
30 #check whether each read in the file is from pJC8 or Ec or both; should not
be any unaccounted, but track in case→֒
31 both_count = 0
32 ec_count = 0
33 vector_count = 0
34 unaccounted = 0
35 total = 0
36 unaccounted_file = open(filenames_dir + filename + "_unaccounted_reads",
"w")→֒
37
38 for seq_record in SeqIO.parse(filenames_dir + filename, "fasta"):
39 total = total + 1
40
41 #if seq in both
42 if (seq_record.seq in ec.seq or seq_record.seq in ec_rc.seq):
43 ec_count = ec_count + 1
44 if (seq_record.seq in vector.seq or seq_record.seq in
vector_rc.seq):→֒
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45 vector_count = vector_count + 1
46 both_count = both_count + 1
47
48 elif (seq_record.seq in vector.seq or seq_record.seq in vector_rc.seq):
49 vector_count = vector_count + 1
50
51 #this shouldn’t happen
52 else:
53 unaccounted = unaccounted + 1
54 SeqIO.write(seq_record, unaccounted_file, "fasta")
55
56 #write to output file: filename, total num reads, num Ec reads, num pjc8
reads→֒
57 output_line = filename + "\t" + str(total) + "\t" + str(both_count) + "\t" +
str(ec_count) + "\t" + str(vector_count) + "\t" + str(unaccounted) + "\n"→֒
58 outfile.write(output_line)
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Calculate percent GC, in batch
1 #!/usr/bin/python
2 from Bio import SeqIO
3 import sys
4 import os
5
6 #function to calc percent gc from all seqs in a fasta file
7 def get_gc(files_dir, filename):
8
9 #track number of each base
10 bases = {’A’:0, ’C’:0, ’G’:0, ’T’:0}
11
12 #open the reads file; for each FASTA sequence, track bases in seq
13 for seq_record in SeqIO.parse(files_dir + filename, "fasta"):
14 for base in seq_record.seq:
15 if base == ’A’:
16 bases[’A’] = bases[’A’] + 1
17 elif base == ’C’:
18 bases[’C’] = bases[’C’] + 1
19 elif base == ’G’:
20 bases[’G’] = bases[’G’] + 1
21 else:
22 bases[’T’] = bases[’T’] + 1
23
24 #do the stats
25 total_bases = float(sum(bases.values()))
26 gc = (bases[’G’] + bases[’C’]) / total_bases * 100
27 return gc
28
29 #input file in fasta
30 filenames_dir = sys.argv[1]
31 filenames = os.listdir(filenames_dir)
32 filenames.sort()
33
34 #summary file
35 results_file = open(filenames_dir + "summary.txt", "w")
36 results_file.write("filename \t%GC \n")
37
38 #process each file
39 for filename in filenames:
40 gc = get_gc(filenames_dir, filename)
41 output = filename + "\t" + str(gc) + "\n"
42 results_file.write(output)
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Find consensus promoter sequences, in batch
1 #!/usr/bin/python
2
3 from Bio import SeqIO
4 import sys
5 import os
6 import re
7
8 #FUNCTIONS
9
10 #look for consensus sequences 1 promoter; return count
11 def find_one_consensus(sequence, filename):
12
13 #compile regex
14 p = re.compile(sequence)
15 count = 0
16
17 #iterate through each fasta sequence
18 for seq_record in SeqIO.parse(filename, "fasta"):
19
20 #check the sequence
21 for match in p.finditer(str(seq_record.seq)):
22 count = count + 1
23
24 #check the reverse complement
25 for match in p.finditer(str(seq_record.reverse_complement().seq)):
26 count = count + 1
27
28 return count
29
30 #look for consensus sequences for 5 promoters; return a string to be printed to
file→֒
31 def find_all_consensus(files_dir, reads_filename):
32
33 #file location
34 location = files_dir + reads_filename
35
36 #rpoD sigma 70
37 rpod_count = find_one_consensus("TTGACA.{15,19}TATAAT", location)
38
39 #rpoE sigma 24
40 rpoe_count = find_one_consensus("GGAACTT.{15,19}TCAAA", location)
41
42 #rpoH sigma 32
43 rpoh_count = find_one_consensus("TTG[AT][AT][AT].{13,14}CCCCAT[AT]T",
location)→֒
44
45 #rpoN sigma 54
46 rpon_count = find_one_consensus("TGGCA.{7}TGC", location)
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47
48 #Bacteroides sigma AB
49 bacteroides_count = find_one_consensus("TTTG.{19,21}TA.{2}TTTG", location)
50
51 output = filename + "\t" + str(rpod_count) + "\t" + str(rpoe_count) + "\t" +
str(rpoh_count) + "\t" + str(rpon_count)+ "\t" + str(bacteroides_count) +
"\n"
→֒
→֒
52 return output
53
54 #INPUT FILES
55
56 filenames_dir = sys.argv[1]
57 filenames = os.listdir(filenames_dir)
58 filenames.sort()
59
60 #PROCESS ALL FILES
61
62 #write summary file of results
63 summary_file = open(filenames_dir + "summary.txt", "w")
64 summary_file.write("filename \trpoD reads \trpoE \trpoH \trpoN \tBacteroides
\n")→֒
65
66 #process files
67 for filename in filenames:
68
69 #get sets of read names that are hits
70 output = find_all_consensus(filenames_dir, filename)
71
72 #write to summary
73 summary_file.write(output)
323
APPENDIX C. SUPPLEMENTARY INFORMATION FOR CHAPTER 4
Calculate phyla percentages from OTU table
1 import sys
2 import os
3
4 otu_filename = sys.argv[1]
5
6 #prep outfile
7 phyla_filename = os.path.splitext(otu_filename)[0] + "_phyla_percent.txt"
8 phyla_file = open(phyla_filename, "w")
9
10 #get otu table
11 otu_file = open(otu_filename, "r")
12
13 #discard first header line
14 otu_file.readline()
15
16 #start dict to keep phyla counts
17 cosmid = {}
18 bulk = {}
19
20 #process each line, adding to both dicts
21 for line in otu_file:
22 line = line.split(",")
23 bulk_count = int(line[1])
24 cosmid_count = int(line[2])
25 phylum = line[4]
26
27 #check if phylum in either dict and add accordingly
28 if phylum in cosmid:
29 cosmid[phylum] = cosmid[phylum] + cosmid_count
30 bulk[phylum] = bulk[phylum] + bulk_count
31 else:
32 cosmid[phylum] = cosmid_count
33 bulk[phylum] = bulk_count
34
35 #given a dictionary of phyla counts, return dict of phyla fractions
36 def get_phyla_fractions(phyla_dict):
37
38 #get total member count
39 total = 0
40 for phylum in phyla_dict:
41 total = total + phyla_dict[phylum]
42 total = float(total)
43
44 #make new dict of fractions
45 new_dict = {}
46 for phylum in phyla_dict:
47 new_dict[phylum] = phyla_dict[phylum]/total
48
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49 return new_dict
50
51 cosmid_fraction = get_phyla_fractions(cosmid)
52 bulk_fraction = get_phyla_fractions(bulk)
53
54 #write phyla fractions to new file
55 for item in cosmid_fraction:
56 phyla_file.write(item)
57 phyla_file.write("\t")
58 phyla_file.write(str(format(cosmid_fraction[item], ’.9f’)))
59 phyla_file.write("\t")
60 phyla_file.write(str(format(bulk_fraction[item], ’.9f’)))
61 phyla_file.write("\n")
62
63 phyla_file.close()
64
65
66
67
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D.1 Images
Annealing of oligos KL10 and KL11
KL11
phos
KL10
phos
KL10/11
ann
KL11
phos
KL10
phos
KL10/11
ann
250 bp
500 bp
1 μl 0.5 μl 
Figure D.1: Agarose gel of annealed complementary oligos. 1 ➭l and 0.5 ➭l of
phosphorylated and annealed KL10/KL11 were run against unannealed phosphorylated
controls of each individually.
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pKL13 preparation post-stuffer removal
0.5 μl 0.25 μl
23,130 bp
10,000 bp9,416 bp
Figure D.2: Agarose gel of unligatable pKL13 vector prep after removal of
stuffer. Agarose gel showed that the vector preparation was nuclease-free and highly
concentrated, but ligation attempts with this vector were unsuccessful.
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Phenotype of B. theta VPI-5482 wild-type versus ∆tdk on
chondroitin sulfate
Figure D.3: Comparable phenotype of B. theta VPI-5482 wild-type versus
∆tdk on chondroitin sulfate as sole carbon source Note that ∆tdk is isogenic to
the ∆chuR mutant used for functional screening. In the Charles lab collection, they
have been designated B. theta BtUW24 and BtUW25, respectively; see Table 2.1.
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Agarose gel of CLGM3 chuR complementing clones with versus
without arabinose induction
The following gel images show the unexpected negative eﬀect of using copy-number induction
on insert stability. Fosmid DNA of chuR complementing CLGM3 clones was miniprepped
and digested from cultures that were either copy-number induced (Figure D.4A) or cultures
in which fosmid DNA was present in single copy (Figure D.4B). The insert was observed to
be lost in the former case.
Figure D.4: Agarose gel of CLGM3 chuR complementing clones with ver-
sus without copy number induction. (A) CLGM3 clone 5B2 was miniprepped and
digested from cultures grown in the presence of 0.2% arabinose. (B) CLGM3 clones
5B2 and 5B9 were miniprepped and digested from cultures grown in the absence of
arabinose.
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D.2 Sequence data
ermF -repA fragment (pAFD1)
>ermF -repA fragment (pAFD1)
ATAACAGCCGGTGACAGCCGGCTGACAGGGGGTTAAGGGGGCTTGTCCCCTTACACACGCACTCTTTAGGGTGCTAG
TGTGCTATCACCATACTGCATAGGTGCGAAGTTAGTGAATGTTTTGTAAATGCACAAATAAAGGGAAAAACATTTGG
ATTTGCGATAATAAAGTACTACCTTTGTTGCTGACCAAACGGTAGCTGACCGATACGGGAGAGTTACCAAAATACAA
GCCGCTGGAGTTAATTGACGGACATCCGACATCTCCAGCGGCTTTATTTTTGCCTATCTGCTTCGCCTAGGCACACC
AGTACCTCTACTAAAAATGTACTTCAAAGATACTTATTTTCTACCGACTTGATAGTTTTTACCCCATATTCTTGGAC
ATTTTTCCCCCATGAGGTTATCTTTGTAGGGTGAAAGAGAAACCCATAAACGGGGATAGATTGAATGCTGGGAAGCA
TAAACAATCGGGGTAAGGTTAGCGAACCTTGCCTTTCATCCCCCATTATAACTTTACATAGAGGAACTTTATCTATC
CCCCCCCGCCCCCAAAGGGGGAGCGACCAAACGGCAGCTTCACTCAATGGAGTGTTACTGTTCATCAAAGCCAAGTG
ATAATTGTCGTTTCTCTGCTTCTTCTTTCTTTTGGGCAGCTAAAGTCTTTTTCCGAACGTATGTTTTAGCAAATGTC
ACTCGGTCACCATTGAATACTATCAGAGGATTAATAAACCAAAGATTATCGGCTGGTCCTCGGGCTATGATTTCAGC
TTTTACAAGTTCTGCAAGTCCTTTATAAACGGCTTTGTCTGTTTTGTATTTGGTATATTCTAGGCATTTTTTTCTAT
TGAAAATGATTAAATCATTTTTGGGTTTCATGCAGGTCATAAAGTAACCAAAAACCCGAATAGCTGCTTGTGATAGG
TCAAAGAATGCAGCAAAGTTAGAAAGATACAATTTAGTGAATTGTTCTTCATCTACTTCTATTTGACGGATAAACGA
AGTCTTAAACACTTCTCCAGTTTCAGTGTCGGCTAAAGCTACTACAGCTCTCTTATCGCCACCACTATTACTCTTAT
ACTTTTTAACAACATGATTTTCAATACCTTCTATAGCTTGTTTCATAAAAGGATTTTCTTCGTTCTTTTGAAAATCG
GTTAACTTAACTGCTTTTTTATTTTCCATTTTGATATGTTTTTGGGAAATATTATTCTCCACAAAGTAAACTATTAT
TTTCCATAAAAACAATATTAAGGGAAATATTATTTTCCTATTTAGTATCATATTAGGAAATCGGTATTTTCTAGATT
GGAAAATGAGAATTTCCAATATGGAAAATGCCCTATATTGTGTATCAAGTACTTAACTTATTCTATTTCTTTTATTC
TTAATATACCCCCAAAACAGCACAAAATCAGTCACTTAAAAATCATCGGTCGGGGAATGGTGCACTCTCAGTACAAT
CTGCTCTGATGCCGCATAGTTAAGCCAGCCCCGACACCCGCCAACACCCGCTGACGCGCCCTGACGGGCTTGTCTGC
TCCCGGCATCCGCTTACAGACAAGCTGTGACCGTCTCCGGGAGCTGCATGTGTCAGAGGTTTTCACCGTCATCACCG
AAACGCGCGAGACGAAAGGGCCTCGTGATACGCCTATTTTTATAGGTTAATGTCATGATAATAATGGTTTCTTAAAT
TCTGATTAATAATTTGTTTAAATTTTTCGTTTGGCGTGAGGTATCCAAGTCTTTTACGAGGTCGATTATTGAGTTTA
TTTTCAATCCACTTAATCTGTTTGTTGGTTACTTCACTAAAGTCCTTACCCTTTGGGATATACTGCCTGATAAGCCC
GTTGGTGTTTTCATTGGCACCACGTTCCCATGAGTGGTATGGTTTGCAAAAATAGAATTTTATTTCCAATTTTTGCG
CAATTTCCTCGTGCTTTGCAAACTCCTTTCCATTGTCAGCCGTAATTGTGTGTATTAAGTTTTTCACTTTCCGCAGT
GCCCATACTGCAATCTTAGCTACCGGGATGGCTTCTTTTCCCGACAACTTGCGTATCCAGACCCTGCTTGTTGCTCT
GTCGTTAATGGTAAGAATGGCACCTTTGTGGTTCTTACCAATAATTGTATCTATCTCTAAATCACCAAATCTCTCCT
TCAGTTCCACTATCTCGGGACGCTCATCAATATCCACCCTGCCTGGGATAAATCCTCGCCCTGCATTTTTAGAACCA
CGTTTGGCATACCTGCGACCTTGTCTGCGAAGATATTTGTGCAGTTTGCCACCCCGCCGCTTATCCTCCCAAATCCA
GCGATATATCGTTTCGTGAGATACCATCGCAATTCCCTCCAAGCGGCTCCTGCCGACAATCTGCTCCGGGCTGAATC
CTTTCTTCAACAGCTTTATTATCCGTTTTCTCATTGCCGGTGTAAGCACTTCCTTGCGATGTTTTTGCTGCTTGCGC
CTGTCTGCTTTTCGCTGGGCAAGCTCCATGCTATAGCTACCACTTCGGGCGTCGCAATTGCGCTTTATCTCCCTGTA
AACAGTGCTTTTATCTACTCCGATAGCTTCCGCTATTGCTTTTTTGCTCATCGGTATTTGCAACATCATAGAAATTG
CATACCTTTGTTCCTCGGTTATATGTTTGCTCATCTGCAACTTTTTTTTCTTTGGACGGACAATTAAAGCAAAGATA
GCAAACTTTATCCATTCAGAGTGAGAGAAAGGGGGACATTGTCTCTCTTTCCTCTCTGAAAAATAAATGTTTTTATT
GCTTATTATCCGCACCCAAAAAGTTGCATTTATAAGTTGAACTCAAGAAGTATTCACCTGTAAGAAGTTACTAATGA
CAAAAAAGAAATTGCCCGTTCGTTTTACGGGTCAGCACTTTACTATTGATAAAGTGCTAATAAAAGATGCAATAAGA
CAAGCAAATATAAGTAATCAGGATACGGTTTTAGATATTGGGGCAGGCAAGGGGTTTCTTACTGTTCATTTATTAAA
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AATCGCCAACAATGTTGTTGCTATTGAAAACGACACAGCTTTGGTTGAACATTTACGAAAATTATTTTCTGATGCCC
GAAATGTTCAAGTTGTCGGTTGTGATTTTAGGAATTTTGCAGTTCCGAAATTTCCTTTCAAAGTGGTGTCAAATATT
CCTTATGGCATTACTTCCGATATTTTCAAAATCCTGATGTTTGAGAGTCTTGGAAATTTTCTGGGAGGTTCCATTGT
CCTTCAATTAGAACCTACACAAAAGTTATTTTCGAGGAAGCTTTACAATCCATATACCGTTTTCTATCATACTTTTT
TTGATTTGAAACTTGTCTATGAGGTAGGTCCTGAAAGTTTCTTGCCACCGCCAACTGTCAAATCAGCCCTGTTAAAC
ATTAAAAGAAAACACTTATTTTTTGATTTTAAGTTTAAAGCCAAATACTTAGCATTTATTTCCTGTCTGTTAGAGAA
ACCTGATTTATCTGTAAAAACAGCTTTAAAGTCGATTTTCAGGAAAAGTCAGGTCAGGTCAATTTCGGAAAAATTCG
GTTTAAACCTTAATGCTCAAATTGTTTGTTTGTCTCCAAGTCAATGGTTAAACTGTTTTTTGGAAATGCTGGAAGTT
GTCCCTGAAAAATTTCATCCTTCGTAGTTCAAAGTCGGGTGGTTGTCAAGATGATTTTTTTGGTTTGGTGTCGTCTT
TTTTTAAGCTGCCGCATAACGGCTGGCAAATTGGCGATGGAGCCGACTTTTAGCACAAATGTTGAATAGAATTACTA
ATCTTCAACATTGCACAAAAGT
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pKL13
Below is the theoretical sequence for pKL13.
>pKL13 expected
GCGGCCGCAAGGGGTTCGCGTCAGCGGGTGTTGGCGGGTGTCGGGGCTGGCTTAACTATGCGGCATCAGAGCAGATT
GTACTGAGAGTGCACCATATGCGGTGTGAAATACCGCACAGATGCGTAAGGAGAAAATACCGCATCAGGCGCCATTC
GCCATTCAGCTGCGCAACTGTTGGGAAGGGCGATCGGTGCGGGCCTCTTCGCTATTACGCCAGCTGGCGAAAGGGGG
ATGTGCTGCAAGGCGATTAAGTTGGGTAACGCCAGGGTTTTCCCAGTCACGACGTTGTAAAACGACGGCCAGTGAAT
TGTAATACGACTCACTATAGGGCGAATTCATAACAGCCGGTGACAGCCGGCTGACAGGGGGTTAAGGGGGCTTGTCC
CCTTACACACGCACTCTTTAGGGTGCTAGTGTGCTATCACCATACTGCATAGGTGCGAAGTTAGTGAATGTTTTGTA
AATGCACAAATAAAGGGAAAAACATTTGGATTTGCGATAATAAAGTACTACCTTTGTTGCTGACCAAACGGTAGCTG
ACCGATACGGGAGAGTTACCAAAATACAAGCCGCTGGAGTTAATTGACGGACATCCGACATCTCCAGCGGCTTTATT
TTTGCCTATCTGCTTCGCCTAGGCACACCAGTACCTCTACTAAAAATGTACTTCAAAGATACTTATTTTCTACCGAC
TTGATAGTTTTTACCCCATATTCTTGGACATTTTTCCCCCATGAGGTTATCTTTGTAGGGTGAAAGAGAAACCCATA
AACGGGGATAGATTGAATGCTGGGAAGCATAAACAATCGGGGTAAGGTTAGCGAACCTTGCCTTTCATCCCCCATTA
TAACTTTACATAGAGGAACTTTATCTATCCCCCCCCGCCCCCAAAGGGGGAGCGACCAAACGGCAGCTTCACTCAAT
GGAGTGTTACTGTTCATCAAAGCCAAGTGATAATTGTCGTTTCTCTGCTTCTTCTTTCTTTTGGGCAGCTAAAGTCT
TTTTCCGAACGTATGTTTTAGCAAATGTCACTCGGTCACCATTGAATACTATCAGAGGATTAATAAACCAAAGATTA
TCGGCTGGTCCTCGGGCTATGATTTCAGCTTTTACAAGTTCTGCAAGTCCTTTATAAACGGCTTTGTCTGTTTTGTA
TTTGGTATATTCTAGGCATTTTTTTCTATTGAAAATGATTAAATCATTTTTGGGTTTCATGCAGGTCATAAAGTAAC
CAAAAACCCGAATAGCTGCTTGTGATAGGTCAAAGAATGCAGCAAAGTTAGAAAGATACAATTTAGTGAATTGTTCT
TCATCTACTTCTATTTGACGGATAAACGAAGTCTTAAACACTTCTCCAGTTTCAGTGTCGGCTAAAGCTACTACAGC
TCTCTTATCGCCACCACTATTACTCTTATACTTTTTAACAACATGATTTTCAATACCTTCTATAGCTTGTTTCATAA
AAGGATTTTCTTCGTTCTTTTGAAAATCGGTTAACTTAACTGCTTTTTTATTTTCCATTTTGATATGTTTTTGGGAA
ATATTATTCTCCACAAAGTAAACTATTATTTTCCATAAAAACAATATTAAGGGAAATATTATTTTCCTATTTAGTAT
CATATTAGGAAATCGGTATTTTCTAGATTGGAAAATGAGAATTTCCAATATGGAAAATGCCCTATATTGTGTATCAA
GTACTTAACTTATTCTATTTCTTTTATTCTTAATATACCCCCAAAACAGCACAAAATCAGTCACTTAAAAATCATCG
GTCGGGGAATGGTGCACTCTCAGTACAATCTGCTCTGATGCCGCATAGTTAAGCCAGCCCCGACACCCGCCAACACC
CGCTGACGCGCCCTGACGGGCTTGTCTGCTCCCGGCATCCGCTTACAGACAAGCTGTGACCGTCTCCGGGAGCTGCA
TGTGTCAGAGGTTTTCACCGTCATCACCGAAACGCGCGAGACGAAAGGGCCTCGTGATACGCCTATTTTTATAGGTT
AATGTCATGATAATAATGGTTTCTTAAATTCTGATTAATAATTTGTTTAAATTTTTCGTTTGGCGTGAGGTATCCAA
GTCTTTTACGAGGTCGATTATTGAGTTTATTTTCAATCCACTTAATCTGTTTGTTGGTTACTTCACTAAAGTCCTTA
CCCTTTGGGATATACTGCCTGATAAGCCCGTTGGTGTTTTCATTGGCACCACGTTCCCATGAGTGGTATGGTTTGCA
AAAATAGAATTTTATTTCCAATTTTTGCGCAATTTCCTCGTGCTTTGCAAACTCCTTTCCATTGTCAGCCGTAATTG
TGTGTATTAAGTTTTTCACTTTCCGCAGTGCCCATACTGCAATCTTAGCTACCGGGATGGCTTCTTTTCCCGACAAC
TTGCGTATCCAGACCCTGCTTGTTGCTCTGTCGTTAATGGTAAGAATGGCACCTTTGTGGTTCTTACCAATAATTGT
ATCTATCTCTAAATCACCAAATCTCTCCTTCAGTTCCACTATCTCGGGACGCTCATCAATATCCACCCTGCCTGGGA
TAAATCCTCGCCCTGCATTTTTAGAACCACGTTTGGCATACCTGCGACCTTGTCTGCGAAGATATTTGTGCAGTTTG
CCACCCCGCCGCTTATCCTCCCAAATCCAGCGATATATCGTTTCGTGAGATACCATCGCAATTCCCTCCAAGCGGCT
CCTGCCGACAATCTGCTCCGGGCTGAATCCTTTCTTCAACAGCTTTATTATCCGTTTTCTCATTGCCGGTGTAAGCA
CTTCCTTGCGATGTTTTTGCTGCTTGCGCCTGTCTGCTTTTCGCTGGGCAAGCTCCATGCTATAGCTACCACTTCGG
GCGTCGCAATTGCGCTTTATCTCCCTGTAAACAGTGCTTTTATCTACTCCGATAGCTTCCGCTATTGCTTTTTTGCT
CATCGGTATTTGCAACATCATAGAAATTGCATACCTTTGTTCCTCGGTTATATGTTTGCTCATCTGCAACTTTTTTT
TCTTTGGACGGACAATTAAAGCAAAGATAGCAAACTTTATCCATTCAGAGTGAGAGAAAGGGGGACATTGTCTCTCT
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TTCCTCTCTGAAAAATAAATGTTTTTATTGCTTATTATCCGCACCCAAAAAGTTGCATTTATAAGTTGAACTCAAGA
AGTATTCACCTGTAAGAAGTTACTAATGACAAAAAAGAAATTGCCCGTTCGTTTTACGGGTCAGCACTTTACTATTG
ATAAAGTGCTAATAAAAGATGCAATAAGACAAGCAAATATAAGTAATCAGGATACGGTTTTAGATATTGGGGCAGGC
AAGGGGTTTCTTACTGTTCATTTATTAAAAATCGCCAACAATGTTGTTGCTATTGAAAACGACACAGCTTTGGTTGA
ACATTTACGAAAATTATTTTCTGATGCCCGAAATGTTCAAGTTGTCGGTTGTGATTTTAGGAATTTTGCAGTTCCGA
AATTTCCTTTCAAAGTGGTGTCAAATATTCCTTATGGCATTACTTCCGATATTTTCAAAATCCTGATGTTTGAGAGT
CTTGGAAATTTTCTGGGAGGTTCCATTGTCCTTCAATTAGAACCTACACAAAAGTTATTTTCGAGGAAGCTTTACAA
TCCATATACCGTTTTCTATCATACTTTTTTTGATTTGAAACTTGTCTATGAGGTAGGTCCTGAAAGTTTCTTGCCAC
CGCCAACTGTCAAATCAGCCCTGTTAAACATTAAAAGAAAACACTTATTTTTTGATTTTAAGTTTAAAGCCAAATAC
TTAGCATTTATTTCCTGTCTGTTAGAGAAACCTGATTTATCTGTAAAAACAGCTTTAAAGTCGATTTTCAGGAAAAG
TCAGGTCAGGTCAATTTCGGAAAAATTCGGTTTAAACCTTAATGCTCAAATTGTTTGTTTGTCTCCAAGTCAATGGT
TAAACTGTTTTTTGGAAATGCTGGAAGTTGTCCCTGAAAAATTTCATCCTTCGTAGTTCAAAGTCGGGTGGTTGTCA
AGATGATTTTTTTGGTTTGGTGTCGTCTTTTTTTAAGCTGCCGCATAACGGCTGGCAAATTGGCGATGGAGCCGACT
TTTAGCACAAATGTTGAATAGAATTACTAATCTTCAACATTGCACAAAAGTGAATTCGAGCTCGGTACCCGGGGATC
CCACAAATGGCGCGCCGGCTGGATTTAATTAATGTCTGCTCCTCGGTTATGTTTTTAAGGTCAAAAAAAACCCCCGG
ACCTTTCGGTGCGGGGGTCTTAGTTCGTTAAGGCTTGATCTCTAGCGATTAAGTTGGGTAACGCCAGGGTTTTCGTC
ACTTAGTCAGCTAGCCACGTGCCTTAGGGTGTGAAATTGTTATCCGCTCACAATTCCACACATTATACGAGCCGATG
ATTAATTGTCAACAGCTCCCTGAGGTTCGAAGATCCTCCGGCTCACGGTAACTGATGCCGTATTTGCAGTACCAGCG
TACGGCCCACAGAATGATGTCACGCTGAAAATGCCGGCCTTTGAATGGGTTCATGTGCAGCTCCATCAGCAAAAGGG
GATGATAAGTTTATCACCACCGACTATTTGCAACAGTGCCGTTGATCGTGCTATGATCGACTGATGTCATCAGCGGT
GGAGTGCAATGTCGTGCAATACGAATGGCGAAAAGCCGAGCTCATCGGTCAGCTTCTCAACCTTGGGGTTACCCCCG
GCGGTGTGCTGCTGGTCCACAGCTCCTTCCGTAGCGTCCGGCCCCTCGAAGATGGGCCACTTGGACTGATCGAGGCC
CTGCGTGCTGCGCTGGGTCCGGGAGGGACGCTCGTCATGCCCTCGTGGTCAGGTCTGGACGACGAGCCGTTCGATCC
TGCCACGTCGCCCGTTACACCGGACCTTGGAGTTGTCTCTGACACATTCTGGCGCCTGCCAAATGTAAAGCGCAGCG
CCCATCCATTTGCCTTTGCGGCAGCGGGGCCACAGGCAGAGCAGATCATCTCTGATCCATTGCCCCTGCCACCTCAC
TCGCCTGCAAGCCCGGTCGCCCGTGTCCATGAACTCGATGGGCAGGTACTTCTCCTCGGCGTGGGACACGATGCCAA
CACGACGCTGCATCTTGCCGAGTTGATGGCAAAGGTTCCCTATGGGGTGCCGAGACACTGCACCATTCTTCAGGATG
GCAAGTTGGTACGCGTCGATTATCTCGAGAATGACCACTGCTGTGAGCGCTTTGCCTTGGCGGACAGGTGGCTCAAG
GAGAAGAGCCTTCAGAAGGAAGGTCCAGTCGGTCATGCCTTTGCTCGGTTGATCCGCTCCCGCGACATTGTGGCGAC
AGCCCTGGGTCAACTGGGCCGAGATCCGTTGATCTTCCTGCATCCGCCAGAGGCGGGATGCGAAGAATGCGATGCCG
CTCGCCAGTCGATTGGCTGAGCTCATGAGCGGAGAACGAGATGACGTTGGAGGGGCAAGGTCGCGCTGATTGCTGGG
GCAACACGTTCGAACACGTGATGCATTAACTAGGTGACGTCATAGCTGTTTCCTGTGTGAAATTGTTATCGGTCAGT
TTCACCTGATTTACGTAAAAACCCGCTTCGGCGGGTTTTTGCTTTTGGAGGGGCAGAAAGATGAATGACTGTCCGGT
CCGAGCAGGTCGCGATCGCATTTGTGGGATCCTCTAGAGTCGACCTGCAGGCATGCAAGCTTGCGCTTTTCCGCTGC
ATAACCCTGCTTCGGGGTCATTATAGCGATTTTTTCGGTATATCCATCCTTTTTCGCACGATATACAGGATTTTGCC
AAAGGGTTCGTGTAGACTTTCCTTGGTGTATCCAACGGCGTCAGCCGGGCAGGATAGGTGAAGTAGGCCCACCCGCG
AGCGGGTGTTCCTTCTTCACTGTCCCTTATTCGCACCTGGCGGTGCTCAACGGGAATCCTGCTCTGCGAGGCTGGCC
GGCTACCGCCGGCGTAACAGATGAGGGCAAGCGGATGGCTGATGAAACCAAGCCAACCAGGAAGGGCAGCCCACCTA
TCAAGGTGTACTGCCTTCCAGACGAACGAAGAGCGATTGAGGAAAAGGCGGCGGCGGCCGGCATGAGCCTGTCGGCC
TACCTGCTGGCCGTCGGCCAGGGCTACAAAATCACGGGCGTCGTGGACTATGAGCACGTCCGCGAGCTGGCCCGCAT
CAATGGCGACCTGGGCCGCCTGGGCGGCCTGCTGAAACTCTGGCTCACCGACGACCCGCGCACGGCGCGGTTCGGTG
ATGCCACGATCCTCGCCCTGCTGGCGAAGATCGAAGAGAAGCAGGACGAGCTTGGCAAGGTCATGATGGGCGTGGTC
CGCCCGAGGGCAGAGCCATGACTTTTTTAGCCGCTAAAACGGCCGGGGGGTGCGCGTGATTGCCAAGCACGTCCCCA
TGCGCTCCATCAAGAAGAGCGACTTCGCGGAGCTGGTGAAGTACATCACCGACGAGCAAGGCAAGACCGAAAGCTTG
AGTATTCTATAGTCTCACCTAAATAGCTTGGCGTAATCATGGTCATAGCTGTTTCCTGTGTGAAATTGTTATCCGCT
CACAATTCCACACAACATACGAGCCGGAAGCATAAAGTGTAAAGCCTGGGGTGCCTAATGAGTGAGCTAACTCACAT
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TAATTGCGTTGCGCTCACTGCCCGCTTTCCAGTCGGGAAACCTGTCGTGCCAGCTGCATTAATGAATCGGCCAACGC
GAACCCCTTGCGGCCGCCCGGGCCGTCGACCAATTCTCATGTTTGACAGCTTATCATCGAATTTCTGCCATTCATCC
GCTTATTATCACTTATTCAGGCGTAGCAACCAGGCGTTTAAGGGCACCAATAACTGCCTTAAAAAAATTACGCCCCG
CCCTGCCACTCATCGCAGTACTGTTGTAATTCATTAAGCATTCTGCCGACATGGAAGCCATCACAAACGGCATGATG
AACCTGAATCGCCAGCGGCATCAGCACCTTGTCGCCTTGCGTATAATATTTGCCCATGGTGAAAACGGGGGCGAAGA
AGTTGTCCATATTGGCCACGTTTAAATCAAAACTGGTGAAACTCACCCAGGGATTGGCTGAGACGAAAAACATATTC
TCAATAAACCCTTTAGGGAAATAGGCCAGGTTTTCACCGTAACACGCCACATCTTGCGAATATATGTGTAGAAACTG
CCGGAAATCGTCGTGGTATTCACTCCAGAGCGATGAAAACGTTTCAGTTTGCTCATGGAAAACGGTGTAACAAGGGT
GAACACTATCCCATATCACCAGCTCACCGTCTTTCATTGCCATACGAAATTCCGGATGAGCATTCATCAGGCGGGCA
AGAATGTGAATAAAGGCCGGATAAAACTTGTGCTTATTTTTCTTTACGGTCTTTAAAAAGGCCGTAATATCCAGCTG
AACGGTCTGGTTATAGGTACATTGAGCAACTGACTGAAATGCCTCAAAATGTTCTTTACGATGCCATTGGGATATAT
CAACGGTGGTATATCCAGTGATTTTTTTCTCCATTTTAGCTTCCTTAGCTCCTGAAAATCTCGATAACTCAAAAAAT
ACGCCCGGTAGTGATCTTATTTCATTATGGTGAAAGTTGGAACCTCTTACGTGCCGATCAACGTCTCATTTTCGCCA
AAAGTTGGCCCAGGGCTTCCCGGTATCAACAGGGACACCAGGATTTATTTATTCTGCGAAGTGATCTTCCGTCACAG
GTATTTATTCGCGATAAGCTCATGGAGCGGCGTAACCGTCGCACAGGAAGGACAGAGAAAGCGCGGATCTGGGAAGT
GACGGACAGAACGGTCAGGACCTGGATTGGGGAGGCGGTTGCCGCCGCTGCTGCTGACGGTGTGACGTTCTCTGTTC
CGGTCACACCACATACGTTCCGCCATTCCTATGCGATGCACATGCTGTATGCCGGTATACCGCTGAAAGTTCTGCAA
AGCCTGATGGGACATAAGTCCATCAGTTCAACGGAAGTCTACACGAAGGTTTTTGCGCTGGATGTGGCTGCCCGGCA
CCGGGTGCAGTTTGCGATGCCGGAGTCTGATGCGGTTGCGATGCTGAAACAATTATCCTGAGAATAAATGCCTTGGC
CTTTATATGGAAATGTGGAACTGAGTGGATATGCTGTTTTTGTCTGTTAAACAGAGAAGCTGGCTGTTATCCACTGA
GAAGCGAACGAAACAGTCGGGAAAATCTCCCATTATCGTAGAGATCCGCATTATTAATCTCAGGAGCCTGTGTAGCG
TTTATAGGAAGTAGTGTTCTGTCATGATGCCTGCAAGCGGTAACGAAAACGATTTGAATATGCCTTCAGGAACAATA
GAAATCTTCGTGCGGTGTTACGTTGAAGTGGAGCGGATTATGTCAGCAATGGACAGAACAACCTAATGAACACAGAA
CCATGATGTGGTCTGTCCTTTTACAGCCAGTAGTGCTCGCCGCAGTCGAGCGACAGGGCGAAGCCCTCGGCTGGTTG
CCCTCGCCGCTGGGCTGGCGGCCGTCTATGGCCCTGCAAACGCGCCAGAAACGCCGTCGAAGCCGTGTGCGAGACAC
CGCGGCCGGCCGCCGGCGTTGTGGATACCTCGCGGAAAACTTGGCCCTCACTGACAGATGAGGGGCGGACGTTGACA
CTTGAGGGGCCGACTCACCCGGCGCGGCGTTGACAGATGAGGGGCAGGCTCGATTTCGGCCGGCGACGTGGAGCTGG
CCAGCCTCGCAAATCGGCGAAAACGCCTGATTTTACGCGAGTTTCCCACAGATGATGTGGACAAGCCTGGGGATAAG
TGCCCTGCGGTATTGACACTTGAGGGGCGCGACTACTGACAGATGAGGGGCGCGATCCTTGACACTTGAGGGGCAGA
GTGCTGACAGATGAGGGGCGCACCTATTGACATTTGAGGGGCTGTCCACAGGCAGAAAATCCAGCATTTGCAAGGGT
TTCCGCCCGTTTTTCGGCCACCGCTAACCTGTCTTTTAACCTGCTTTTAAACCAATATTTATAAACCTTGTTTTTAA
CCAGGGCTGCGCCCTGTGCGCGTGACCGCGCACGCCGAAGGGGGGTGCCCCCCCTTCTCGAACCCTCCCGGTCGAGT
GAGCGAGGAAGCACCAGGGAACAGCACTTATATATTCTGCTTACACACGATGCCTGAAAAAACTTCCCTTGGGGTTA
TCCACTTATCCACGGGGATATTTTTATAATTATTTTTTTTATAGTTTTTAGATCTTCTTTTTTAGAGCGCCTTGTAG
GCCTTTATCCATGCTGGTTCTAGAGAAGGTGTTGTGACAAATTGCCCTTTCAGTGTGACAAATCACCCTCAAATGAC
AGTCCTGTCTGTGACAAATTGCCCTTAACCCTGTGACAAATTGCCCTCAGAAGAAGCTGTTTTTTCACAAAGTTATC
CCTGCTTATTGACTCTTTTTTATTTAGTGTGACAATCTAAAAACTTGTCACACTTCACATGGATCTGTCATGGCGGA
AACAGCGGTTATCAATCACAAGAAACGTAAAAATAGCCCGCGAATCGTCCAGTCAAACGACCTCACTGAGGCGGCAT
ATAGTCTCTCCCGGGATCAAAAACGTATGCTGTATCTGTTCGTTGACCAGATCAGAAAATCTGATGGCACCCTACAG
GAACATGACGGTATCTGCGAGATCCATGTTGCTAAATATGCTGAAATATTCGGATTGACCTCTGCGGAAGCCAGTAA
GGATATACGGCAGGCATTGAAGAGTTTCGCGGGGAAGGAAGTGGTTTTTTATCGCCCTGAAGAGGATGCCGGCGATG
AAAAAGGCTATGAATCTTTTCCTTGGTTTATCAAACGTGCGCACAGTCCATCCAGAGGGCTTTACAGTGTACATATC
AACCCATATCTCATTCCCTTCTTTATCGGGTTACAGAACCGGTTTACGCAGTTTCGGCTTAGTGAAACAAAAGAAAT
CACCAATCCGTATGCCATGCGTTTATACGAATCCCTGTGTCAGTATCGTAAGCCGGATGGCTCAGGCATCGTCTCTC
TGAAAATCGACTGGATCATAGAGCGTTACCAGCTGCCTCAAAGTTACCAGCGTATGCCTGACTTCCGCCGCCGCTTC
CTGCAGGTCTGTGTTAATGAGATCAACAGCAGAACTCCAATGCGCCTCTCATACATTGAGAAAAAGAAAGGCCGCCA
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GACGACTCATATCGTATTTTCCTTCCGCGATATCACTTCCATGACGACAGGATAGTCTGAGGGTTATCTGTCACAGA
TTTGAGGGTGGTTCGTCACATTTGTTCTGACCTACTGAGGGTAATTTGTCACAGTTTTGCTGTTTCCTTCAGCCTGC
ATGGATTTTCTCATACTTTTTGAACTGTAATTTTTAAGGAAGCCAAATTTGAGGGCAGTTTGTCACAGTTGATTTCC
TTCTCTTTCCCTTCGTCATGTGACCTGATATCGGGGGTTAGTTCGTCATCATTGATGAGGGTTGATTATCACAGTTT
ATTACTCTGAATTGGCTATCCGCGTGTGTACCTCTACCTGGAGTTTTTCCCACGGTGGATATTTCTTCTTGCGCTGA
GCGTAAGAGCTATCTGACAGAACAGTTCTTCTTTGCTTCCTCGCCAGTTCGCTCGCTATGCTCGGTTACACGGCTGC
GGCGAGCGCTAGTGATAATAAGTGACTGAGGTATGTGCTCTTCTTATCTCCTTTTGTAGTGTTGCTCTTATTTTAAA
CAACTTTGCGGTTTTTTGATGACTTTGCGATTTTGTTGTTGCTTTGCAGTAAATTGCAAGATTTAATAAAAAAACGC
AAAGCAATGATTAAAGGATGTTCAGAATGAAACTCATGGAAACACTTAACCAGTGCATAAACGCTGGTCATGAAATG
ACGAAGGCTATCGCCATTGCACAGTTTAATGATGACAGCCCGGAAGCGAGGAAAATAACCCGGCGCTGGAGAATAGG
TGAAGCAGCGGATTTAGTTGGGGTTTCTTCTCAGGCTATCAGAGATGCCGAGAAAGCAGGGCGACTACCGCACCCGG
ATATGGAAATTCGAGGACGGGTTGAGCAACGTGTTGGTTATACAATTGAACAAATTAATCATATGCGTGATGTGTTT
GGTACGCGATTGCGACGTGCTGAAGACGTATTTCCACCGGTGATCGGGGTTGCTGCCCATAAAGGTGGCGTTTACAA
AACCTCAGTTTCTGTTCATCTTGCTCAGGATCTGGCTCTGAAGGGGCTACGTGTTTTGCTCGTGGAAGGTAACGACC
CCCAGGGAACAGCCTCAATGTATCACGGATGGGTACCAGATCTTCATATTCATGCAGAAGACACTCTCCTGCCTTTC
TATCTTGGGGAAAAGGACGATGTCACTTATGCAATAAAGCCCACTTGCTGGCCGGGGCTTGACATTATTCCTTCCTG
TCTGGCTCTGCACCGTATTGAAACTGAGTTAATGGGCAAATTTGATGAAGGTAAACTGCCCACCGATCCACACCTGA
TGCTCCGACTGGCCATTGAAACTGTTGCTCATGACTATGATGTCATAGTTATTGACAGCGCGCCTAACCTGGGTATC
GGCACGATTAATGTCGTATGTGCTGCTGATGTGCTGATTGTTCCCACGCCTGCTGAGTTGTTTGACTACACCTCCGC
ACTGCAGTTTTTCGATATGCTTCGTGATCTGCTCAAGAACGTTGATCTTAAAGGGTTCGAGCCTGATGTACGTATTT
TGCTTACCAAATACAGCAATAGTAATGGCTCTCAGTCCCCGTGGATGGAGGAGCAAATTCGGGATGCCTGGGGAAGC
ATGGTTCTAAAAAATGTTGTACGTGAAACGGATGAAGTTGGTAAAGGTCAGATCCGGATGAGAACTGTTTTTGAACA
GGCCATTGATCAACGCTCTTCAACTGGTGCCTGGAGAAATGCTCTTTCTATTTGGGAACCTGTCTGCAATGAAATTT
TCGATCGTCTGATTAAACCACGCTGGGAGATTAGATAATGAAGCGTGCGCCTGTTATTCCAAAACATACGCTCAATA
CTCAACCGGTTGAAGATACTTCGTTATCGACACCAGCTGCCCCGATGGTGGATTCGTTAATTGCGCGCGTAGGAGTA
ATGGCTCGCGGTAATGCCATTACTTTGCCTGTATGTGGTCGGGATGTGAAGTTTACTCTTGAAGTGCTCCGGGGTGA
TAGTGTTGAGAAGACCTCTCGGGTATGGTCAGGTAATGAACGTGACCAGGAGCTGCTTACTGAGGACGCACTGGATG
ATCTCATCCCTTCTTTTCTACTGACTGGTCAACAGACACCGGCGTTCGGTCGAAGAGTATCTGGTGTCATAGAAATT
GCCGATGGGAGTCGCCGTCGTAAAGCTGCTGCACTTACCGAAAGTGATTATCGTGTTCTGGTTGGCGAGCTGGATGA
TGAGCAGATGGCTGCATTATCCAGATTGGGTAACGATTATCGCCCAACAAGTGCTTATGAACGTGGTCAGCGTTATG
CAAGCCGATTGCAGAATGAATTTGCTGGAAATATTTCTGCGCTGGCTGATGCGGAAAATATTTCACGTAAGATTATT
ACCCGCTGTATCAACACCGCCAAATTGCCTAAATCAGTTGTTGCTCTTTTTTCTCACCCCGGTGAACTATCTGCCCG
GTCAGGTGATGCACTTCAAAAAGCCTTTACAGATAAAGAGGAATTACTTAAGCAGCAGGCATCTAACCTTCATGAGC
AGAAAAAAGCTGGGGTGATATTTGAAGCTGAAGAAGTTATCACTCTTTTAACTTCTGTGCTTAAAACGTCATCTGCA
TCAAGAACTAGTTTAAGCTCACGACATCAGTTTGCTCCTGGAGCGACAGTATTGTATAAGGGCGATAAAATGGTGCT
TAACCTGGACAGGTCTCGTGTTCCAACTGAGTGTATAGAGAAAATTGAGGCCATTCTTAAGGAACTTGAAAAGCCAG
CACCCTGATGCGACCACGTTTTAGTCTACGTTTATCTGTCTTTACTTAATGTCCTTTGTTACAGGCCAGAAAGCATA
ACTGGCCTGAATATTCTCTCTGGGCCCACTGTTCCACTTGTATCGTCGGTCTGATAATCAGACTGGGACCACGGTCC
CACTCGTATCGTCGGTCTGATTATTAGTCTGGGACCACGGTCCCACTCGTATCGTCGGTCTGATTATTAGTCTGGGA
CCACGGTCCCACTCGTATCGTCGGTCTGATAATCAGACTGGGACCACGGTCCCACTCGTATCGTCGGTCTGATTATT
AGTCTGGGACCATGGTCCCACTCGTATCGTCGGTCTGATTATTAGTCTGGGACCACGGTCCCACTCGTATCGTCGGT
CTGATTATTAGTCTGGAACCACGGTCCCACTCGTATCGTCGGTCTGATTATTAGTCTGGGACCACGGTCCCACTCGT
ATCGTCGGTCTGATTATTAGTCTGGGACCACGATCCCACTCGTGTTGTCGGTCTGATTATCGGTCTGGGACCACGGT
CCCACTTGTATTGTCGATCAGACTATCAGCGTGAGACTACGATTCCATCAATGCCTGTCAAGGGCAAGTATTGACAT
GTCGTCGTAACCTGTAGAACGGAGTAACCTCGGTGTGCGGTTGTATGCCTGCTGTGGATTGCTGCTGTGTCCTGCTT
ATCCACAACATTTTGCGCACGGTTATGTGGACAAAATACCTGGTTACCCAGGCCGTGCCGGCACGTTAACCGGGCTG
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CATCCGATGCAAGTGTGTCGCTGTCGACGAGCTCGCGAGCTCGGACATGAGGTTGCCCCGTATTCAGTGTCGCTGAT
TTGTATTGTCTGAAGTTGTTTTTACGTTAAGTTGATGCAGATCAATTAATACGATACCTGCGTCATAATTGATTATT
TGACGTGGTTTGATGGCCTCCACGCACGTTGTGATATGTAGATGATAATCATTATCACTTTACGGGTCCTTTCCGGT
GATCCGACAGGTTACGGGGCGGCGACCTCGCGGGTTTTCGCTATTTATGAAAATTTTCCGGTTTAAGGCGTTTCCGT
TCTTCTTCGTCATAACTTAATGTTTTTATTTAAAATACCCTCTGAAAAGAAAGGAAACGACAGGTGCTGAAAGCGAG
CTTTTTGGCCTCTGTCGTTTCCTTTCTCTGTTTTTGTCCGTGGAATGAACAATGGAAGTCCGAGCTCATCGCTAATA
ACTTCGTATAGCATACATTATACGAAGTTATATTCGAT
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Sanger sequencing reads of CLGM3 chuR clones #5
Primer KL61
>CLGM3 chuR clone 5 primer KL61
AAGCTGCWTGTYMTGGTAAGCCCGTGGGAGCCGTATGTAATCTCGCATGCGAATACTGCTATTATTTGGAAAAGGCG
AACCTATACAAAGAAAACCCCAAACATGTAATGAGCGATGAACTACTGGAAAAGTTTATCGACGAGTATATCAGTTC
TCAAACCATGCCTCAAGTGCTTTTTACCTGGCACGGTGGAGAAACGCTGATGCGTCCGCTTTCTTTTTATAAAAAGG
CGATGGAACTGCAAAAGAAATACGCCCGCGGACGTACGATTGACAATTGTATCCAGACGAATGGGACCTTACTCACA
GACGAATGGTGCGAGTTCTTCCGTGAAAACAACTGGCTGGTAGGGGTTTCTATTGATGGCCCGCAAGAGTTTCATGA
CGAATACCGCAAGAACAAAATGGGCAAACCTTCTTTCGTCAAAGTGATGCAAGGGATTAATCTCCTGAAAAAACATG
GAGTAGAATGGAACGCTATGGCTGTTGTGAACGATTTCAATGCCGAATATCCATTAGACTTTTATAATTTCTTCAAA
GAAATAGATTGCCATTATATCCAGTTCGCCCCGATTGTTGAACGCATTGTTTCACATCAGGACGGTCGTCATCTTGC
CTCTCTGGCAGAAGGTAAAGAAGGAGCATTGGCTGATTTCTCCATAAGTCCGGAACAATGGGGTAACTTTCTCTGTA
CAATTTTTGATGAATGGGTAAAAGAAGATGTGGGCAAATTCTTCATACAGATATTCGATTCTACATTGGCTAACTGG
ATGGGTGAGCAACCGGGCGTATGTACAATGGCGAAGCATTGCGGACATGCCGGCGTTATGGAATTCAACGGAGACGT
ATACTCTTGTGACCACTTCGTATTCCCGGAATATAAATTGGGAAATATCTATAGCCAGACTTTGGTGGAAATGATGC
ATAGTGAACGACAGCAAACTTCGGGACAATGAAATACCAATCACTCCCAACACAATGCAAGGAGTGCGACTTTCTAT
TTGCCTGCAACGGARATGTCCAAAGAACCGCTTCAGTCGGACAGCGGACGGCGAACCCGGTCTGACTATTTGTGCAA
AGGATATTACCAATACTTTCASMWGTAGCYTCCTATWWTGGATTYMTGAAAAARRATTAATGAATCAMCA
Primer KL62
>CLGM3 chuR clone 5 primer KL62
GTAATGATGTTYGGCAGGAGCCTGTTGATTCATTAATTCTTTTTTCATGAAATCCATATAGGGAGCTACATGCTGAA
AGTATYGGTAATATCCTTTGCACAAATAGTTCAGACCGGGTTCGCCGTCCGCTGTCCGACTGAAGCGGTTCTTTGGA
CATTCTCCGTTGCAGGCAAATAGAAAGTCGCACTCCTTGCATTGTGTTGGGAGTGATTGGTATTTCATTGTCCCGAA
GTTTTGCTGTCGTTCACTATGCATCATTTCCACCAAAGTCTGGCTATAGATATTTCCCAATTTATATTCCGGGAATA
CGAAGTGGTCACAAGAGTATACGTCTCCGTTGAATTCCATAACGCCGGCATGTCCGCAATGCTTCGCCATTGTACAT
ACGCCCGGTTGCTCACCCATCCAGTTAGCCAATGTAGAATCGAATATCTGTATGAAGAATTTGCCCACATCTTCTTT
TACCCATTCATCAAAAATTGTACAGAGAAAGTTACCCCATTGTTCCGGACTTATGGAGAAATCAGCCAATGCTCCTT
CTTTACCTTCTGCCAGAGAGGCAAGATGACGACCGTCCTGATGTGAAACAATGCGTTCAACAATCGGGGCGAACTGG
ATATAATGGCAATCTATTTCTTTGAAGAAATTATAAAAGTCTAATGGATATTCGGCATTGAAATCGTTCACAACAGC
CATAGCGTTCCATTCTACTCCATGTTTTTTCAGGAGATTAATCCCTTGCATCACTTTGACGAAAGAAGGTTTGCCCA
TTTTGTTCTTGCGGTATTCGTCATGAAACTCTTGCGGGCCATCAATAGAAACCCCTACCAGCCAGTTGTTTTCACGG
AAGAACTCGCACCATTCGTCTGTGAGTAAGTCCCATTCGTCTGGATACAATTGTCAATCGTACGTCCGCGGGCGTAT
TTCTTTTGCAGTTCCATCGCGTTTTATAAAAGAAAGCGGACGCATCAGCGTTTCTCACGTGCCAGTAAAAGCACTTG
AGCATGGTTTGAGACTGATATACTCGTCGATAACTTTTCCAGTAGTCATCGCTCATACATGTTTGGGGTTTTCTTTT
GTATAGTCGCTTTCAAWAATAGCAGTATCSCATGCGAGAATACATACGCTCACGGGCTTACATGACTAGCRGTTKGC
TAAGTGAG
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Primer KL66
>CLGM3 chuR clone 5 primer KL66
CCAATCTTYCAGGAGCGGACGCATCAGCGTTTCTCCACCGTGCCAGGTAAAAAGCACTTGAGGCATGGTTTGAGAAC
TGATATACTCGTCGATAAACTTTTCCAGTAGTTCATCGCTCATTACATGTTTGGGGTTTTCTTTGTATAGGTTCGCC
TTTTCCAAATAATAGCAGTATTCGCATGCGAGATTACATACGGCTCCCACGGGCTTTACCATGACATAAAGCGGTTT
GGCAAAAGGTGCATAAGTTGGTGCTTTCATCATACTGATGCGCCTGCGTGAGCGAGGTTTCCGGCGAGAGGGGGGTA
AACAGTTCASCCKGYGCCTGCTCCGGCTTCARCCSCAGAGGAGGSSAGCAGAAGAAGARAGGACGGGRGGAGGAGTC
AGAAKCTTATGTTGTTTATTCGWGGGAAGGCCATGTCGGGKGCGCCGATCATKASTGGGATMAGCWASTTTCCSAAG
CCRCCRATTATRATAGGKATRACTATAAAGAAAATTMTAACGAARGCATGGKCGGTAACRATAACATTGTAAATCTG
GACATCACCCATTASGGSCCYGGGTTGGWTTAGCTCGGMTYRRGMAGKGMSGCTTAWKGCCGYGCCRCCTATYCCRG
CTCRGGCACCWAACACTATATRRGGGTGCCKATATCTTRRRWW
Primer KL67
>CLGM3 chuR clone 5 primer KL67
ATGCGTCCGTAAGCACTTGAGGCATGGTTTGAGAACTGATATACTCGTCGATAAACTTTTCCAGTAGTTCATCGCTC
ATTACATGTTTGGGGTTTTCTTTGTATAGGTTCGCCTTTTCCAAATAATAGCAGTATTCGCATGCGAGATTACATAC
GGCTCCCACGGGCTTTACCATGACATAAAGCGGTTTGGCAAAAGGTGCATAAGTTGTTGCTTTCATSATGGGCCTTC
CCCCCCCGGSKGGGGGGCGCTYCYGGSYCCCCCCCCCTMCCTSTKCCTGTCCGCKRGCSYCCKCGGGGGARGMWSSK
SYAAAAKGMWYYMGCTGRCCTCSGWTCCKCCCTCACACCKGARASRKSGWCAKYAKAGGRSCRTMASWWAACYTAMS
AGTTKCYWCCWCCCCYCTTGGWTGGGGGCSCGYCSYTRSTCGGSSYCRCTARTWKTKWWMGAACAARWTSRAACWCG
AAACKCKWAGCTTGWTACTGTTATCMAAACTWCTAARGAGTSWGAWCCGCCMGRMKAAKAYTKGTTCTCCTTCTTCY
CCCCCYCCCMSCKTTGGCAGRTCTWAGTWCTACSCMRWWAWAGMTCRASGACSRRWTTARGMMGTKCYTSTARTGCG
GAYCASGAGYYAACGMWRTRWRMKGTTAKSTRCTGTTTGGAARTTWGCAAAA
Primer KL68
>CLGM3 chuR clone 5 primer KL68
CCCACGCATGAGTGCGACTTTCTATTTGCCTGCAACGGAGAATGTCCAAAGAACCGCTTCAGTCGGACAGCGGACGG
CGAACCCGGTCTGAACTATTTGTGCAAAGGATATTACCAATACTTTCAGCATGTAGCTCCCTATATGGATTTCATGA
AAAAAGAATTAATGAATCAACAGGCTCCTGCCAACATCATGAAAGCACTAAAAGACGGAAGTTTAAAAATAGAATAT
TAAASGCMGSCCGGMGGGACCAARRCTMCSCCCCCCATSKGTTCTTCTGSTGGCCGSCTRAYGAGGKGKWGAAGCCM
SWKMAGAWRTTGWGMKTACTCCTGATCCACRTCTCGTWAGAAACGGGKMCAMGAAMAGAGARAARCRWARCWAWYSA
TTCCTTCCGTCCSCTTAGGTTYCGTACSCSRGMKGRGTGGGWCACWCMAMMSKKTTKGAAYMATWAKWAAMCTGCSA
ARCCCGGCCATAWKACYATAWCCCAAAMYAWTAWWTATWWGGRCSGMSCSYGYAGRACTSTWCYWCTRCYMCTATCC
KYYCWWCCCYRRAWSCCKKARTTSCCMWMCTACTRYMAGATRGAKATKMRTWAGAMGTKCYGGGCAGYGCGGGYGAM
GCGGYWAACRGKKYCTSMGGSTGMTMTRTMTTGMYWYGKGGRAYMCAGYCMKGKARRKWRTTAWAAKGRCAAYWTYT
TTMSAR
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Primer KL69
>CLGM3 chuR clone 5 primer KL69
TAAGAMCGCTTMGTCGGACGCGGACGGCGAACCCGGTCTGAACTATTTGTGCAAAGGATATTACCAATACTTTCAGC
ATGTAGCTCCCTATATGGATTTCATGAAAAAAGAATTAATGAATCAACAGGCTCCTGCCAACATCATGAAAGCACTA
AAAGACGGAAGTTTAAAAATAGAATATTAACGCKTTGGTGYCTTTTGKKCGGATKGKSTTGCYGSATMAMCTTACGA
GSRCGGKCARGTGKAGGWAAAGAAMCKCCMCCCAACYTTCWKSCSWYGCYWGCGAGGGCGGTWGCSGGRGCSAAAAA
RAAAARAGGTTYGTTKTKYCTGCCTTKYTTCWASGSCAGMKGAGRARAGSAAGASARGAARGGCTGRTGARAGTYKC
CRYAAMMTSTGGACGYGGRCTAMKCRMGAGGKGGSSCCKCSARCCRTKATGGAWAWAGGASRKACTCRGATGCCGAA
CCMTGGTACTATWATCCAWYMRACYAMWTAKMAAMGSRGRKCCMAGGGAMARRAAWTCACTKTCATTSTCGSKAYMA
MSCCCTSGCGSCACKAGATCYCTCCGCTGRKMGAAGATKAASTAGGATAAARGMWGTTCCYRYCCAGTSCGGCTCAY
KMAKGMAASRGRTCAAMKGSTGYGASYAGCSTGCKMTASCTGSSGSYWRCCKGTMWKSRTAWTCTCTCMKKWWKATR
TAGAGAGCA
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D.3 BLAST analyses
BLAST of B. theta chuR against NCBI WGS metagenome con-
tigs
The following page summarizes the results of BLAST analysis using the Megablast algo-
rithm, querying the B. theta VPI-5482 chuR/anSME gene (BT 0238) against the NCBI
WGS database, specifying tax id 408169 for assembled metagenomic contigs.
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Table D.1: BLAST (megablast) results for B. theta chuR against metagenomic contigs.
Description Max score Total score Query cover E value Ident Accession
gut metagenome genome assembly P2E7-k21-2014-09-20, contig contig-179000065, whole genome shotgun sequence 2300 2300 100.00% 0 100.00% CEBV01025663.1
gut metagenome genome assembly P2E0-k21-2014-09-20, contig contig-4470000086, whole genome shotgun sequence 2300 2300 100.00% 0 100.00% CEAB01052623.1
gut metagenome genome assembly P22E0-k21-2014-09-20, contig contig-576000124, whole genome shotgun sequence 2300 2300 100.00% 0 100.00% CDZR01059274.1
gut metagenome genome assembly P22E7-k21-2014-09-20, contig contig-4000110, whole genome shotgun sequence 2300 2300 100.00% 0 100.00% CDZN01021567.1
gut metagenome genome assembly P15E7-k21-2014-09-20, contig contig-58, whole genome shotgun sequence 2300 2300 100.00% 0 100.00% CDYN01010010.1
gut metagenome genome assembly P3E7-k21-2014-09-20, contig contig-32000034, whole genome shotgun sequence 2289 2289 100.00% 0 99.00% CEAK01009572.1
gut metagenome genome assembly P23C90-k21-2014-09-20, contig contig-79000054, whole genome shotgun sequence 2274 2274 98.00% 0 100.00% CDZU01019025.1
gut metagenome genome assembly P20E0-k21-2014-09-20, contig contig-328000126, whole genome shotgun sequence 2139 2139 100.00% 0 98.00% CDZL01023776.1
gut metagenome genome assembly P20E90-k21-2014-09-20, contig contig-1784000118, whole genome shotgun sequence 2139 2139 100.00% 0 98.00% CDZJ01030116.1
gut metagenome genome assembly P11E7-k21-2014-09-20, contig contig-475000077, whole genome shotgun sequence 2139 2139 100.00% 0 98.00% CDYJ01032401.1
gut metagenome genome assembly P11E7-k21-2014-09-20, contig contig-64000044, whole genome shotgun sequence 2139 2139 100.00% 0 98.00% CDYJ01018206.1
gut metagenome genome assembly P13E90-k21-2014-09-20, contig contig-4649000084, whole genome shotgun sequence 2134 2134 100.00% 0 98.00% CDYU01038733.1
gut metagenome genome assembly P13E7-k21-2014-09-20, contig contig-2656000067, whole genome shotgun sequence 2134 2134 100.00% 0 98.00% CDYM01021406.1
gut metagenome genome assembly P22E90-k21-2014-09-20, contig contig-158000023, whole genome shotgun sequence 1796 1796 78.00% 0 100.00% CDZS01010650.1
gut metagenome genome assembly P17E90-k21-2014-09-20, contig contig-625000026, whole genome shotgun sequence 1679 1679 78.00% 0 98.00% CDZK01010597.1
gut metagenome genome assembly P9E7-k21-2014-09-20, contig contig-114000075, whole genome shotgun sequence 1546 1546 100.00% 0 89.00% CDZX01019418.1
gut metagenome genome assembly P14E90-k21-2014-09-20, contig contig-1458000087, whole genome shotgun sequence 1546 1546 100.00% 0 89.00% CDZB01057382.1
gut metagenome genome assembly P14E7-k21-2014-09-20, contig contig-10000044, whole genome shotgun sequence 1546 1546 100.00% 0 89.00% CDZA01027718.1
gut metagenome genome assembly P11E90-k21-2014-09-20, contig contig-3536000126, whole genome shotgun sequence 1546 1546 100.00% 0 89.00% CDYR01053020.1
gut metagenome genome assembly P11E90-k21-2014-09-20, contig contig-76000025, whole genome shotgun sequence 1546 1546 100.00% 0 89.00% CDYR01010643.1
gut metagenome genome assembly P10E90-k21-2014-09-20, contig contig-39000086, whole genome shotgun sequence 1546 1546 100.00% 0 89.00% CDYK01030801.1
gut metagenome genome assembly P10E0-k21-2014-09-20, contig contig-19000019, whole genome shotgun sequence 1546 1546 100.00% 0 89.00% CDYI01008742.1
gut metagenome genome assembly P9E90-k21-2014-09-20, contig contig-51000017, whole genome shotgun sequence 1546 1546 100.00% 0 89.00% CDTY01007659.1
gut metagenome genome assembly P38C7-k21-2014-09-20, contig contig-101000018, whole genome shotgun sequence 1541 1541 100.00% 0 89.00% CEAH01010496.1
gut metagenome genome assembly P38C90-k21-2014-09-20, contig contig-618000043, whole genome shotgun sequence 1541 1541 100.00% 0 89.00% CEAG01020626.1
gut metagenome genome assembly P38C0-k21-2014-09-20, contig contig-657000020, whole genome shotgun sequence 1541 1541 100.00% 0 89.00% CEAF01011572.1
gut metagenome genome assembly P25C90-k21-2014-09-20, contig contig-3488000001, whole genome shotgun sequence 1541 1541 100.00% 0 89.00% CEAA01000885.1
gut metagenome genome assembly P25C7-k21-2014-09-20, contig contig-2000100, whole genome shotgun sequence 1541 1541 100.00% 0 89.00% CDZY01046211.1
gut metagenome genome assembly P25C0-k21-2014-09-20, contig contig-3510000034, whole genome shotgun sequence 1541 1541 100.00% 0 89.00% CDZW01013549.1
gut metagenome genome assembly P11E7-k21-2014-09-20, contig contig-403000088, whole genome shotgun sequence 1541 1541 99.00% 0 89.00% CDYJ01036724.1
gut metagenome genome assembly P15E90-k21-2014-09-20, contig contig-135000065, whole genome shotgun sequence 1360 1360 59.00% 0 100.00% CDYY01027497.1
Human gut metagenome DNA, contig sequence: F2-Y_034152, whole genome shotgun sequence 1229 1229 70.00% 0 92.00% BABA01034152.1
Chicken gut metagenome c108720, whole genome shotgun sequence 1227 1227 56.00% 0 98.00% JFBN01021268.1
gut metagenome genome assembly P20E7-k21-2014-09-20, contig contig-146000123, whole genome shotgun sequence 1175 1175 53.00% 0 98.00% CDZM01024581.1
gut metagenome genome assembly P3E7-k21-2014-09-20, contig contig-211000094, whole genome shotgun sequence 1157 1157 93.00% 0 85.00% CEAK01026614.1
gut metagenome genome assembly P6C0-k21-2014-09-20, contig contig-37000001, whole genome shotgun sequence 1153 1153 100.00% 0 83.00% CEBY01000578.1
gut metagenome genome assembly P6C7-k21-2014-09-20, contig contig-846000044, whole genome shotgun sequence 1153 1153 100.00% 0 83.00% CEAZ01023225.1
gut metagenome genome assembly P6C7-k21-2014-09-20, contig contig-75000008, whole genome shotgun sequence 1153 1153 100.00% 0 83.00% CEAZ01004158.1
gut metagenome genome assembly P6C90-k21-2014-09-20, contig contig-95, whole genome shotgun sequence 1153 1153 100.00% 0 83.00% CEAX01040480.1
gut metagenome genome assembly P13E7-k21-2014-09-20, contig contig-86000092, whole genome shotgun sequence 1153 1153 100.00% 0 83.00% CDYM01029143.1
gut metagenome genome assembly P10E90-k21-2014-09-20, contig contig-3440000062, whole genome shotgun sequence 1153 1153 100.00% 0 83.00% CDYK01022411.1
gut metagenome genome assembly P10E7-k21-2014-09-20, contig contig-820000014, whole genome shotgun sequence 1153 1153 100.00% 0 83.00% CDYF01004576.1
gut metagenome genome assembly P8C0-k21-2014-09-20, contig contig-7000103, whole genome shotgun sequence 1134 1134 97.00% 0 84.00% CECJ01021445.1
gut metagenome genome assembly P8C90-k21-2014-09-20, contig contig-56000001, whole genome shotgun sequence 1134 1134 97.00% 0 84.00% CEAI01000265.1
gut metagenome genome assembly P8C7-k21-2014-09-20, contig contig-1902000025, whole genome shotgun sequence 1134 1134 97.00% 0 84.00% CEAE01006842.1
gut metagenome genome assembly P12E90-k21-2014-09-20, contig contig-124000056, whole genome shotgun sequence 1134 1134 97.00% 0 84.00% CDYL01015147.1
gut metagenome genome assembly P12E7-k21-2014-09-20, contig contig-1108000122, whole genome shotgun sequence 1134 1134 97.00% 0 84.00% CDYE01010333.1
gut metagenome genome assembly P22E90-k21-2014-09-20, contig contig-1259000039, whole genome shotgun sequence 1120 1120 98.00% 0 83.00% CDZS01017641.1
gut metagenome genome assembly P3E7-k21-2014-09-20, contig contig-13000052, whole genome shotgun sequence 1118 1118 97.00% 0 83.00% CEAK01014454.1
gut metagenome genome assembly P11E90-k21-2014-09-20, contig contig-358000043, whole genome shotgun sequence 1118 1118 97.00% 0 83.00% CDYR01018557.1
gut metagenome genome assembly P11E7-k21-2014-09-20, contig contig-484000011, whole genome shotgun sequence 1118 1118 97.00% 0 83.00% CDYJ01004907.1
gut metagenome genome assembly P11E0-k21-2014-09-20, contig contig-427000011, whole genome shotgun sequence 1118 1118 97.00% 0 83.00% CDYG01004237.1
Uncultured Bacteroides sp. TS29_contig120613, whole genome shotgun sequence 1118 1118 97.00% 0 83.00% ADJT01001577.1
gut metagenome genome assembly P15E90-k21-2014-09-20, contig contig-3699000064, whole genome shotgun sequence 1114 1114 98.00% 0 83.00% CDYY01027356.1
gut metagenome genome assembly P22E7-k21-2014-09-20, contig contig-580000085, whole genome shotgun sequence 1112 1112 97.00% 0 83.00% CDZN01016749.1
gut metagenome genome assembly P1E90-k21-2014-09-20, contig contig-3956000077, whole genome shotgun sequence 1112 1112 97.00% 0 83.00% CDZF01029773.1
gut metagenome genome assembly P17E90-k21-2014-09-20, contig contig-1000031, whole genome shotgun sequence 1107 1107 97.00% 0 83.00% CDZK01012354.1
gut metagenome genome assembly P17E0-k21-2014-09-20, contig contig-2522000019, whole genome shotgun sequence 1107 1107 97.00% 0 83.00% CDYT01005576.1
gut metagenome genome assembly P8C0-k21-2014-09-20, contig contig-1526000091, whole genome shotgun sequence 1098 1098 100.00% 0 83.00% CECJ01019076.1
gut metagenome genome assembly P4E90-k21-2014-09-20, contig contig-81, whole genome shotgun sequence 1098 1098 100.00% 0 83.00% CEAN01008867.1
gut metagenome genome assembly P4E0-k21-2014-09-20, contig contig-1344000072, whole genome shotgun sequence 1098 1098 100.00% 0 83.00% CEAM01008655.1
gut metagenome genome assembly P2E90-k21-2014-09-20, contig contig-267000058, whole genome shotgun sequence 1098 1098 100.00% 0 83.00% CEAC01018913.1
gut metagenome genome assembly P22E90-k21-2014-09-20, contig contig-174000057, whole genome shotgun sequence 1098 1098 100.00% 0 83.00% CDZS01025645.1
gut metagenome genome assembly P22E0-k21-2014-09-20, contig contig-151000108, whole genome shotgun sequence 1098 1098 100.00% 0 83.00% CDZR01051462.1
gut metagenome genome assembly P22E7-k21-2014-09-20, contig contig-115000011, whole genome shotgun sequence 1098 1098 100.00% 0 83.00% CDZN01002285.1
gut metagenome genome assembly P20E0-k21-2014-09-20, contig contig-4, whole genome shotgun sequence 1098 1098 100.00% 0 83.00% CDZL01000577.1
gut metagenome genome assembly P20E90-k21-2014-09-20, contig contig-1000054, whole genome shotgun sequence 1098 1098 100.00% 0 83.00% CDZJ01013511.1
gut metagenome genome assembly P11E7-k21-2014-09-20, contig contig-82000075, whole genome shotgun sequence 1098 1098 100.00% 0 83.00% CDYJ01031218.1
gut metagenome genome assembly P4E7-k21-2014-09-20, contig contig-7, whole genome shotgun sequence 1092 1092 100.00% 0 83.00% CECB01000484.1
gut metagenome genome assembly P2E7-k21-2014-09-20, contig contig-13000091, whole genome shotgun sequence 1092 1092 100.00% 0 83.00% CEBV01035922.1
gut metagenome genome assembly P2E0-k21-2014-09-20, contig contig-10000091, whole genome shotgun sequence 1092 1092 100.00% 0 83.00% CEAB01054968.1
gut metagenome genome assembly P21E90-k21-2014-09-20, contig contig-39000037, whole genome shotgun sequence 1092 1092 100.00% 0 83.00% CDZQ01017534.1
gut metagenome genome assembly P21E0-k21-2014-09-20, contig contig-3967000011, whole genome shotgun sequence 1092 1092 100.00% 0 83.00% CDZP01004662.1
gut metagenome genome assembly P21E7-k21-2014-09-20, contig contig-67, whole genome shotgun sequence 1092 1092 100.00% 0 83.00% CDZO01021369.1
gut metagenome genome assembly P17E7-k21-2014-09-20, contig contig-1796000017, whole genome shotgun sequence 1092 1092 100.00% 0 83.00% CDYP01003565.1
gut metagenome genome assembly P9E0-k21-2014-09-20, contig contig-52000056, whole genome shotgun sequence 1086 1086 100.00% 0 82.00% CEAD01017927.1
Human gut metagenome DNA, contig sequence: F2-Y_034151, whole genome shotgun sequence 1086 1086 63.00% 0 91.00% BABA01034151.1
gut metagenome genome assembly P20E7-k21-2014-09-20, contig contig-52000037, whole genome shotgun sequence 1085 1085 97.00% 0 83.00% CDZM01007421.1
gut metagenome genome assembly P5E90-k21-2014-09-20, contig contig-31, whole genome shotgun sequence 1081 1081 100.00% 0 82.00% CEAQ01005343.1
gut metagenome genome assembly P5E7-k21-2014-09-20, contig contig-1000113, whole genome shotgun sequence 1081 1081 100.00% 0 82.00% CEAP01016593.1
gut metagenome genome assembly P5E0-k21-2014-09-20, contig contig-1000008, whole genome shotgun sequence 1081 1081 100.00% 0 82.00% CEAO01001616.1
gut metagenome genome assembly P25C90-k21-2014-09-20, contig contig-13000090, whole genome shotgun sequence 1081 1081 100.00% 0 82.00% CEAA01038482.1
gut metagenome genome assembly P25C7-k21-2014-09-20, contig contig-69000065, whole genome shotgun sequence 1081 1081 100.00% 0 82.00% CDZY01029940.1
gut metagenome genome assembly P25C0-k21-2014-09-20, contig contig-171000038, whole genome shotgun sequence 1081 1081 100.00% 0 82.00% CDZW01014946.1
gut metagenome genome assembly P23C7-k21-2014-09-20, contig contig-4814000032, whole genome shotgun sequence 1081 1081 100.00% 0 82.00% CDZV01016032.1
gut metagenome genome assembly P23C90-k21-2014-09-20, contig contig-5000026, whole genome shotgun sequence 1081 1081 100.00% 0 82.00% CDZU01009275.1
gut metagenome genome assembly P23C0-k21-2014-09-20, contig contig-4924000103, whole genome shotgun sequence 1081 1081 100.00% 0 82.00% CDZT01052918.1
gut metagenome genome assembly P11E90-k21-2014-09-20, contig contig-3000020, whole genome shotgun sequence 1081 1081 100.00% 0 82.00% CDYR01008444.1
gut metagenome genome assembly P12E90-k21-2014-09-20, contig contig-6, whole genome shotgun sequence 1081 1081 100.00% 0 82.00% CDYL01001587.1
gut metagenome genome assembly P12E0-k21-2014-09-20, contig contig-98, whole genome shotgun sequence 1081 1081 100.00% 0 82.00% CDYH01018076.1
gut metagenome genome assembly P12E7-k21-2014-09-20, contig contig-13000083, whole genome shotgun sequence 1081 1081 100.00% 0 82.00% CDYE01007002.1
gut metagenome genome assembly P9E90-k21-2014-09-20, contig contig-543000015, whole genome shotgun sequence 1081 1081 100.00% 0 82.00% CDTY01007069.1
gut metagenome genome assembly P18E7-k21-2014-09-20, contig contig-118000077, whole genome shotgun sequence 1070 1070 100.00% 0 82.00% CDZC01019985.1
gut metagenome genome assembly P17E90-k21-2014-09-20, contig contig-1230000094, whole genome shotgun sequence 1042 1042 96.00% 0 82.00% CDZK01036991.1
gut metagenome genome assembly P5E90-k21-2014-09-20, contig contig-113000023, whole genome shotgun sequence 1033 1033 45.00% 0 99.00% CEAQ01004113.1
gut metagenome genome assembly P10E7-k21-2014-09-20, contig contig-820000010, whole genome shotgun sequence 918 918 79.00% 0 83.00% CDYF01003333.1
gut metagenome genome assembly P9E7-k21-2014-09-20, contig contig-850000067, whole genome shotgun sequence 891 891 77.00% 0 83.00% CDZX01017508.1
gut metagenome genome assembly P3E0-k21-2014-09-20, contig contig-335000076, whole genome shotgun sequence 880 880 80.00% 0 82.00% CEAJ01016762.1
gut metagenome genome assembly P3E90-k21-2014-09-20, contig contig-692000068, whole genome shotgun sequence 859 859 67.00% 0 85.00% CEAL01020555.1
gut metagenome genome assembly P17E0-k21-2014-09-20, contig contig-1507000010, whole genome shotgun sequence 843 843 80.00% 0 82.00% CDYT01003220.1
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BLAST of B. theta chuR against NCBI metagenomic proteins
The following page summarizes the results of BLAST analysis using blastx, querying the trans-
lated B. theta VPI-5482 chuR/anSME gene (BT 0238) against the NCBI env nr database for
matches to metagenomic proteins. Bolded results indicate proteins described as regulators of
sulfatases.
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Table D.2: BLAST (blastx) results for B. theta chuR against metagenomic proteins.
Description Max score Total score Query cover E value Identity Accession
regulator of arylsulfatase activity [gut metagenome] 789 789 99.00% 0 89.00% EJX02180.1
transcriptional regulator [gut metagenome] 746 746 97.00% 0 85.00% EJX05687.1
regulator of arylsulfatase activity [gut metagenome] 696 696 97.00% 0 79.00% EJW97079.1
regulator of arylsulfatase activity [gut metagenome] 653 653 97.00% 0 73.00% EJW94445.1
regulator of arylsulfatase activity [gut metagenome] 589 589 97.00% 0 65.00% EJX08867.1
regulator of arylsulfatase activity [mine drainage metagenome] 420 420 94.00% 9.00E-141 49.00% CBI09006.1
hypothetical protein GOS_1705184 [marine metagenome] 408 408 99.00% 9.00E-135 46.00% EDJ38325.1
Anaerobic sulfatase-maturating enzyme-like protein AslB [human gut metagenome] 384 384 94.00% 1.00E-127 45.00% ETJ17740.1
hypothetical protein GOS_2771047 [marine metagenome] 381 381 93.00% 3.00E-126 46.00% ECW15524.1
hypothetical protein GOS_9576743 [marine metagenome] 359 359 94.00% 3.00E-117 43.00% EBF56645.1
hypothetical protein GOS_1912926 [marine metagenome] 342 342 90.00% 5.00E-111 43.00% EDA92056.1
hypothetical protein GOS_2939750 [marine metagenome] 342 342 90.00% 8.00E-111 43.00% ECV22775.1
hypothetical protein LCGC14_0569180 [marine sediment metagenome] 333 333 96.00% 1.00E-107 40.00% KKN56736.1
unnamed protein product [marine sediment metagenome] 322 322 89.00% 2.00E-104 43.00% GAF78354.1
hypothetical protein GOS_1100717 [marine metagenome] 321 321 92.00% 1.00E-102 41.00% EDE61078.1
hypothetical protein GOS_9380034 [marine metagenome] 291 291 62.00% 1.00E-093 50.00% EBG75305.1
hypothetical protein LCGC14_0093800 [marine sediment metagenome] 275 275 90.00% 2.00E-085 38.00% KKO03456.1
unnamed protein product [marine sediment metagenome] 250 250 80.00% 8.00E-077 40.00% GAF67375.1
hypothetical protein LCGC14_0644950 [marine sediment metagenome] 249 249 94.00% 1.00E-075 35.00% KKN49236.1
unnamed protein product [marine sediment metagenome] 247 247 68.00% 3.00E-076 41.00% GAF90965.1
hypothetical protein LCGC14_0691880 [marine sediment metagenome] 244 244 93.00% 1.00E-073 35.00% KKN44555.1
hypothetical protein GOS_9597097 [marine metagenome] 232 232 88.00% 6.00E-069 34.00% EBF44117.1
unnamed protein product [marine sediment metagenome] 230 230 61.00% 5.00E-070 41.00% GAI42214.1
unnamed protein product [marine sediment metagenome] 216 216 55.00% 6.00E-065 47.00% GAI16149.1
unnamed protein product [marine sediment metagenome] 213 213 50.00% 3.00E-064 49.00% GAJ02304.1
hypothetical protein GOS_4005653 [marine metagenome] 185 185 39.00% 2.00E-053 50.00% ECG00326.1
hypothetical protein LCGC14_3094110 [marine sediment metagenome] 181 181 69.00% 1.00E-050 34.00% KKK53506.1
Radical SAM domain protein [mine drainage metagenome] 179 179 52.00% 3.00E-051 40.00% EQD33795.1
unnamed protein product [marine sediment metagenome] 178 178 68.00% 7.00E-050 36.00% GAI74417.1
unnamed protein product [marine sediment metagenome] 176 176 63.00% 1.00E-049 37.00% GAG65792.1
Arylsulfatase regulator (Fe-S oxidoreductase) [human gut metagenome] 168 168 34.00% 1.00E-047 53.00% EKC66373.1
regulator of arylsulfatase activity [human gut metagenome] 164 164 33.00% 4.00E-046 54.00% EKC57400.1
hypothetical protein LCGC14_0496100 [marine sediment metagenome] 162 162 55.00% 1.00E-044 36.00% KKN63973.1
unnamed protein product [marine sediment metagenome] 146 146 33.00% 1.00E-039 49.00% GAG76514.1
anaerobic sulfatase-maturating enzyme [gut metagenome] 144 144 64.00% 2.00E-037 31.00% EJW98913.1
unnamed protein product [marine sediment metagenome] 141 141 34.00% 1.00E-037 48.00% GAG04863.1
hypothetical protein GOS_2819697 [marine metagenome] 136 136 62.00% 2.00E-033 32.00% ECV87608.1
unnamed protein product [marine sediment metagenome] 135 135 27.00% 5.00E-036 53.00% GAG98419.1
unnamed protein product [marine sediment metagenome] 130 130 39.00% 2.00E-033 40.00% GAJ24261.1
unnamed protein product [marine sediment metagenome] 129 129 40.00% 6.00E-033 41.00% GAJ09634.1
unnamed protein product [marine sediment metagenome] 127 127 38.00% 2.00E-032 41.00% GAG08714.1
hypothetical protein GOS_1405925 [marine metagenome] 127 127 83.00% 2.00E-030 27.00% EDC83749.1
unnamed protein product [marine sediment metagenome] 124 124 28.00% 1.00E-031 49.00% GAI25361.1
unnamed protein product [marine sediment metagenome] 123 123 28.00% 2.00E-031 48.00% GAH39779.1
unnamed protein product [marine sediment metagenome] 120 120 30.00% 4.00E-030 45.00% GAH65020.1
hypothetical protein GOS_1097727 [marine metagenome] 116 116 46.00% 4.00E-027 34.00% EDE62797.1
unnamed protein product [marine sediment metagenome] 115 115 29.00% 2.00E-028 46.00% GAH01613.1
hypothetical protein GOS_2866977 [marine metagenome] 115 115 52.00% 3.00E-027 33.00% ECV60952.1
unnamed protein product [marine sediment metagenome] 115 115 51.00% 2.00E-027 32.00% GAF67662.1
unnamed protein product [marine sediment metagenome] 114 114 26.00% 1.00E-027 47.00% GAI73590.1
hypothetical protein GOS_1921962 [marine metagenome] 113 113 83.00% 1.00E-025 25.00% EDA87173.1
hypothetical protein GOS_9432695 [marine metagenome] 110 110 40.00% 4.00E-025 32.00% EBG44141.1
hypothetical protein GOS_1740763 [marine metagenome] 108 108 24.00% 8.00E-026 49.00% EDJ18224.1
unnamed protein product [marine sediment metagenome] 108 108 38.00% 9.00E-026 33.00% GAH64000.1
unnamed protein product [marine sediment metagenome] 108 108 38.00% 4.00E-025 33.00% GAG22266.1
hypothetical protein GOS_8408113 [marine metagenome] 104 104 40.00% 4.00E-022 33.00% EBM44987.1
hypothetical protein LCGC14_2565200 [marine sediment metagenome] 102 102 75.00% 4.00E-022 26.00% KKL09503.1
hypothetical protein GOS_4562577 [marine metagenome] 100 100 32.00% 6.00E-023 38.00% ECJ37744.1
hypothetical protein GOS_9386950 [marine metagenome] 98.6 98.6 56.00% 2.00E-021 24.00% EBG71229.1
sulfatase regulatory protein [mine drainage metagenome] 95.5 95.5 18.00% 8.00E-022 57.00% EQD66842.1
unnamed protein product [marine sediment metagenome] 95.1 95.1 22.00% 2.00E-021 48.00% GAG44443.1
hypothetical protein GOS_5191566 [marine metagenome] 95.1 95.1 35.00% 1.00E-020 33.00% ECB22898.1
hypothetical protein GOS_5526512 [marine metagenome] 92.8 92.8 64.00% 6.00E-019 25.00% ECT54974.1
unnamed protein product [marine sediment metagenome] 92 92 34.00% 2.00E-019 34.00% GAG90103.1
unnamed protein product [marine sediment metagenome] 89 89 22.00% 3.00E-019 43.00% GAH43108.1
unnamed protein product [marine sediment metagenome] 88.2 88.2 20.00% 5.00E-019 45.00% GAH16442.1
hypothetical protein GOS_7334446 [marine metagenome] 87.8 87.8 78.00% 4.00E-017 25.00% EBT06716.1
radical SAM domain-containing protein [mine drainage metagenome] 87.4 87.4 88.00% 1.00E-016 22.00% EQD33563.1
hypothetical protein GOS_1503414 [marine metagenome] 87 87 89.00% 1.00E-016 24.00% EDC28425.1
hypothetical protein GOS_1957776 [marine metagenome] 86.7 86.7 56.00% 2.00E-017 27.00% EDA67724.1
hypothetical protein GOS_9494848 [marine metagenome] 85.9 85.9 22.00% 3.00E-017 43.00% EBG06992.1
hypothetical protein OBE_11873 [human gut metagenome] 80.1 80.1 11.00% 2.00E-016 72.00% EKC54820.1
hypothetical protein GOS_9515512 [marine metagenome] 79.3 79.3 18.00% 5.00E-015 49.00% EBF94215.1
unnamed protein product [marine sediment metagenome] 77.4 77.4 19.00% 1.00E-014 47.00% GAG97456.1
unnamed protein product [marine sediment metagenome] 74.7 74.7 30.00% 6.00E-014 32.00% GAI92648.1
radical SAM domain-containing protein [human gut metagenome] 74.7 74.7 43.00% 2.00E-012 30.00% EKC58775.1
hypothetical protein GOS_7012149 [marine metagenome] 74.7 74.7 36.00% 2.00E-013 28.00% EBU74838.1
hypothetical protein GOS_9617987 [marine metagenome] 73.9 73.9 41.00% 1.00E-012 30.00% EBF31477.1
unnamed protein product [marine sediment metagenome] 73.6 73.6 20.00% 1.00E-013 37.00% GAJ17489.1
hypothetical protein LCGC14_1197950 [marine sediment metagenome] 73.6 73.6 79.00% 5.00E-012 23.00% KKM94474.1
unnamed protein product [marine sediment metagenome] 73.2 73.2 26.00% 3.00E-013 34.00% GAH46004.1
arylsulfatase regulator [human gut metagenome] 73.2 73.2 37.00% 6.00E-013 26.00% EKC74149.1
unnamed protein product [marine sediment metagenome] 71.2 71.2 16.00% 6.00E-013 48.00% GAJ20278.1
hypothetical protein LCGC14_1882520 [marine sediment metagenome] 70.9 70.9 13.00% 4.00E-011 55.00% KKL92659.1
hypothetical protein LCGC14_1566370 [marine sediment metagenome] 70.1 70.1 49.00% 4.00E-011 29.00% KKM29052.1
hypothetical protein LCGC14_1351350 [marine sediment metagenome] 68.6 68.6 18.00% 1.00E-011 43.00% KKM79300.1
hypothetical protein GOS_2993326 [marine metagenome] 68.6 68.6 38.00% 2.00E-010 32.00% ECU92664.1
Radical SAM domain protein [mine drainage metagenome] 68.6 68.6 38.00% 5.00E-011 25.00% EQD79036.1
unnamed protein product [marine sediment metagenome] 68.2 68.2 32.00% 9.00E-011 29.00% GAH57071.1
hypothetical protein Q604_UNBC13573G0001 [human gut metagenome] 66.2 66.2 15.00% 3.00E-011 45.00% ETJ31946.1
unnamed protein product [marine sediment metagenome] 65.5 65.5 43.00% 7.00E-010 26.00% GAF75495.1
hypothetical protein GOS_9625176 [marine metagenome] 63.9 63.9 81.00% 5.00E-009 24.00% EBF27058.1
unnamed protein product [marine sediment metagenome] 63.2 63.2 29.00% 1.00E-009 35.00% GAI24881.1
hypothetical protein GOS_9446156 [marine metagenome] 62.8 62.8 68.00% 1.00E-008 25.00% EBG35936.1
hypothetical protein LCGC14_0223720 [marine sediment metagenome] 62.4 62.4 41.00% 2.00E-008 26.00% KKN90789.1
hypothetical protein LCGC14_0491760 [marine sediment metagenome] 62 62 82.00% 2.00E-008 22.00% KKN64433.1
unnamed protein product [marine sediment metagenome] 61.2 61.2 18.00% 2.00E-009 38.00% GAG90102.1
hypothetical protein GOS_5487000 [marine metagenome] 60.8 60.8 57.00% 3.00E-008 22.00% ECE73955.1
unnamed protein product [marine sediment metagenome] 60.5 60.5 25.00% 1.00E-008 35.00% GAI37089.1
unnamed protein product [marine sediment metagenome] 60.5 60.5 37.00% 1.00E-008 31.00% GAG31974.1
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BLAST of B. theta chuR against NCBI Refseq proteins
The following page summarizes the results of BLAST analysis using blastx, querying the
translated B. theta VPI-5482 chuR/anSME gene (BT 0238) against the NCBI Refseq protein
database for matches to known proteins.
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Table D.3: BLAST (blastx) results for B. theta chuR against Refseq proteins.
Description Max score Score Query cover E value Identity Accession
MULTISPECIES: anaerobic sulfatase maturase [Bacteroides] 874 874 99.00% 0 100.00% WP_008766211.1
anaerobic sulfatase maturase [Bacteroides thetaiotaomicron] 872 872 99.00% 0 99.00% WP_016267954.1
anaerobic sulfatase maturase [Bacteroides thetaiotaomicron] 871 871 99.00% 0 99.00% WP_022471893.1
anaerobic sulfatase-maturase [Bacteroides thetaiotaomicron] 870 870 99.00% 0 99.00% WP_048697144.1
anaerobic sulfatase maturase [Bacteroides thetaiotaomicron] 869 869 99.00% 0 99.00% WP_054959252.1
anaerobic sulfatase maturase [Bacteroides faecis] 851 851 99.00% 0 98.00% WP_010537511.1
anaerobic sulfatase maturase [Bacteroides thetaiotaomicron] 850 850 99.00% 0 97.00% WP_022301748.1
anaerobic sulfatase maturase [Bacteroides caccae] 814 814 99.00% 0 91.00% WP_005680548.1
MULTISPECIES: anaerobic sulfatase maturase [Bacteroides] 811 811 99.00% 0 91.00% WP_004297342.1
anaerobic sulfatase maturase [Bacteroides faecichinchillae] 810 810 99.00% 0 91.00% WP_025074644.1
anaerobic sulfatase maturase [Bacteroides finegoldii] 808 808 99.00% 0 91.00% WP_007759188.1
MULTISPECIES: anaerobic sulfatase maturase [Bacteroides] 813 813 99.00% 0 90.00% WP_008643298.1
MULTISPECIES: anaerobic sulfatase maturase [Bacteroides] 811 811 99.00% 0 90.00% WP_008021790.1
MULTISPECIES: anaerobic sulfatase maturase [Bacteroides] 810 810 99.00% 0 90.00% WP_004315949.1
anaerobic sulfatase maturase [Bacteroides ovatus] 809 809 99.00% 0 90.00% WP_004306013.1
anaerobic sulfatase maturase [Bacteroides finegoldii] 808 808 99.00% 0 90.00% WP_022276071.1
anaerobic sulfatase maturase [Bacteroides finegoldii] 807 807 99.00% 0 90.00% WP_032839687.1
anaerobic sulfatase maturase [Bacteroides ovatus] 807 807 99.00% 0 90.00% WP_004319514.1
anaerobic sulfatase maturase [Bacteroides acidifaciens] 802 802 99.00% 0 90.00% WP_044656247.1
anaerobic sulfatase maturase [Bacteroides pyogenes] 796 796 99.00% 0 90.00% WP_027326227.1
anaerobic sulfatase maturase [Bacteroides pyogenes] 793 793 99.00% 0 89.00% WP_021646122.1
MULTISPECIES: anaerobic sulfatase maturase [Bacteroides] 772 772 98.00% 0 87.00% WP_002561758.1
anaerobic sulfatase maturase [Bacteroides salyersiae] 768 768 98.00% 0 86.00% WP_005923804.1
anaerobic sulfatase maturase [Bacteroides fragilis] 766 766 98.00% 0 86.00% WP_042985698.1
MULTISPECIES: anaerobic sulfatase maturase [Bacteroides] 766 766 98.00% 0 86.00% WP_005789094.1
anaerobic sulfatase maturase [Bacteroides fragilis] 765 765 98.00% 0 86.00% WP_032570972.1
anaerobic sulfatase maturase [Bacteroides fragilis] 764 764 98.00% 0 86.00% WP_014299157.1
anaerobic sulfatase maturase [Bacteroides fragilis] 763 763 98.00% 0 86.00% WP_010993230.1
anaerobic sulfatase maturase [Bacteroides fragilis] 762 762 98.00% 0 86.00% WP_032580200.1
anaerobic sulfatase maturase [Bacteroides fragilis] 762 762 98.00% 0 86.00% WP_032528627.1
anaerobic sulfatase maturase [Bacteroidaceae bacterium MS4] 756 756 97.00% 0 86.00% WP_042368025.1
anaerobic sulfatase maturase [Bacteroides fragilis] 768 768 99.00% 0 85.00% WP_005807432.1
MULTISPECIES: anaerobic sulfatase maturase [Bacteroides] 766 766 99.00% 0 85.00% WP_032530728.1
anaerobic sulfatase maturase [Bacteroides fragilis] 765 765 99.00% 0 85.00% WP_005821013.1
anaerobic sulfatase maturase [Bacteroides fragilis] 764 764 99.00% 0 85.00% WP_005780285.1
anaerobic sulfatase maturase [Bacteroides oleiciplenus] 751 751 97.00% 0 85.00% WP_009131239.1
anaerobic sulfatase maturase [Bacteroides intestinalis] 749 749 97.00% 0 85.00% WP_007664013.1
anaerobic sulfatase maturase [Candidatus Bacteroides timonensis] 747 747 97.00% 0 85.00% WP_044264327.1
anaerobic sulfatase maturase [Bacteroides cellulosilyticus] 746 746 97.00% 0 85.00% WP_029428463.1
MULTISPECIES: anaerobic sulfatase maturase [Bacteroides] 746 746 97.00% 0 85.00% WP_007214474.1
anaerobic sulfatase maturase [Bacteroides cellulosilyticus] 745 745 97.00% 0 85.00% WP_007217653.1
anaerobic sulfatase maturase [Bacteroides reticulotermitis] 753 753 99.00% 0 84.00% WP_044161034.1
anaerobic sulfatase maturase [Bacteroides eggerthii] 747 747 98.00% 0 84.00% WP_004292631.1
anaerobic sulfatase maturase [Bacteroides eggerthii] 745 745 98.00% 0 84.00% WP_004290378.1
anaerobic sulfatase maturase [Bacteroides gallinarum] 745 745 98.00% 0 84.00% WP_018668146.1
anaerobic sulfatase maturase [Bacteroides helcogenes] 744 744 97.00% 0 84.00% WP_013548456.1
anaerobic sulfatase maturase [Bacteroides stercoris] 744 744 98.00% 0 84.00% WP_005654844.1
anaerobic sulfatase maturase [Bacteroides stercoris] 744 744 98.00% 0 84.00% WP_016661344.1
anaerobic sulfatase maturase [Bacteroides plebeius] 734 734 97.00% 0 84.00% WP_007559240.1
MULTISPECIES: anaerobic sulfatase maturase [Bacteria] 745 745 98.00% 0 83.00% WP_005835998.1
anaerobic sulfatase maturase [Bacteroides uniformis] 743 743 98.00% 0 83.00% WP_057088086.1
anaerobic sulfatase maturase [Bacteroides fluxus] 742 742 98.00% 0 83.00% WP_009124014.1
anaerobic sulfatase maturase [Bacteroides clarus] 742 742 98.00% 0 83.00% WP_009120536.1
MULTISPECIES: anaerobic sulfatase maturase [Bacteroides] 741 741 98.00% 0 83.00% WP_005826708.1
anaerobic sulfatase maturase [Bacteroides uniformis] 740 740 98.00% 0 83.00% WP_044467894.1
anaerobic sulfatase maturase [Bacteroides uniformis] 736 736 98.00% 0 83.00% WP_016273382.1
anaerobic sulfatase maturase [Bacteroides uniformis] 734 734 98.00% 0 82.00% WP_035448004.1
anaerobic sulfatase maturase [Bacteroides coprosuis] 720 720 98.00% 0 81.00% WP_006745530.1
anaerobic sulfatase maturase [Bacteroides plebeius] 692 692 96.00% 0 81.00% WP_007558660.1
anaerobic sulfatase maturase [Bacteroides coprophilus] 711 711 97.00% 0 80.00% WP_008140154.1
anaerobic sulfatase maturase [Bacteroides massiliensis] 704 704 98.00% 0 80.00% WP_005941469.1
anaerobic sulfatase maturase [Bacteroides propionicifaciens] 723 723 98.00% 0 79.00% WP_018108809.1
anaerobic sulfatase maturase [Bacteroides coprocola] 702 702 97.00% 0 78.00% WP_007570292.1
anaerobic sulfatase maturase [Bacteroides barnesiae] 698 698 98.00% 0 77.00% WP_018709694.1
MULTISPECIES: anaerobic sulfatase maturase [Bacteroides] 689 689 98.00% 0 77.00% WP_007833026.1
anaerobic sulfatase maturase [Bacteroides vulgatus] 687 687 98.00% 0 77.00% WP_005850852.1
anaerobic sulfatase maturase [Bacteroides vulgatus] 687 687 98.00% 0 77.00% WP_005840257.1
anaerobic sulfatase maturase [Bacteroides vulgatus] 686 686 98.00% 0 77.00% WP_032953086.1
anaerobic sulfatase maturase [Bacteroides vulgatus] 686 686 98.00% 0 77.00% WP_016271815.1
MULTISPECIES: anaerobic sulfatase maturase [Bacteroides] 684 684 98.00% 0 77.00% WP_008667464.1
MULTISPECIES: anaerobic sulfatase maturase [Bacteroides] 682 682 98.00% 0 77.00% WP_016275423.1
anaerobic sulfatase maturase [Bacteroides uniformis] 678 678 97.00% 0 76.00% WP_057253591.1
MULTISPECIES: anaerobic sulfatase maturase [Bacteroides] 670 670 98.00% 0 75.00% WP_005829655.1
anaerobic sulfatase maturase [Prevotella pleuritidis] 675 675 97.00% 0 74.00% WP_021584912.1
anaerobic sulfatase maturase [Prevotella pleuritidis] 672 672 97.00% 0 74.00% WP_024991366.1
anaerobic sulfatase-maturase [Parabacteroides goldsteinii] 657 657 98.00% 0 74.00% WP_048315582.1
MULTISPECIES: anaerobic sulfatase maturase [Parabacteroides] 656 656 98.00% 0 74.00% WP_028729461.1
MULTISPECIES: anaerobic sulfatase maturase [Parabacteroides] 655 655 98.00% 0 74.00% WP_010803049.1
anaerobic sulfatase maturase [Parabacteroides goldsteinii] 655 655 98.00% 0 74.00% WP_007656924.1
anaerobic sulfatase maturase [Parabacteroides goldsteinii] 655 655 98.00% 0 74.00% WP_046147140.1
anaerobic sulfatase maturase [Dysgonomonas capnocytophagoides] 656 656 96.00% 0 73.00% WP_026626529.1
anaerobic sulfatase maturase [Parabacteroides johnsonii] 656 656 98.00% 0 73.00% WP_008149604.1
anaerobic sulfatase maturase [Parabacteroides merdae] 649 649 97.00% 0 73.00% WP_005649385.1
anaerobic sulfatase maturase [Parabacteroides merdae] 648 648 97.00% 0 73.00% WP_005643440.1
MULTISPECIES: anaerobic sulfatase maturase [Bacteroidales] 645 645 96.00% 0 73.00% WP_005862697.1
anaerobic sulfatase maturase [Prevotella enoeca] 657 657 97.00% 0 72.00% WP_036888348.1
anaerobic sulfatase maturase [Prevotella bergensis] 657 657 98.00% 0 72.00% WP_044123378.1
anaerobic sulfatase maturase [Barnesiella viscericola] 656 656 98.00% 0 72.00% WP_025277267.1
anaerobic sulfatase maturase [Parabacteroides johnsonii] 654 654 99.00% 0 72.00% WP_008157651.1
anaerobic sulfatase maturase [Bacteroides salanitronis] 651 651 97.00% 0 72.00% WP_013617485.1
anaerobic sulfatase maturase [Barnesiella intestinihominis] 647 647 97.00% 0 72.00% WP_008862184.1
anaerobic sulfatase maturase [Bacteroides sp. 3_1_19] 645 645 96.00% 0 72.00% WP_008779794.1
anaerobic sulfatase maturase [Parabacteroides distasonis] 644 644 96.00% 0 72.00% WP_057327522.1
MULTISPECIES: anaerobic sulfatase maturase [Parabacteroides] 644 644 96.00% 0 72.00% WP_005857302.1
anaerobic sulfatase maturase [Parabacteroides distasonis] 642 642 96.00% 0 72.00% WP_036611496.1
anaerobic sulfatase maturase [Parabacteroides distasonis] 642 642 96.00% 0 72.00% WP_011966246.1
anaerobic sulfatase maturase [Bacteroides paurosaccharolyticus] 650 650 98.00% 0 71.00% WP_024993888.1
anaerobic sulfatase maturase [Prevotella buccalis] 644 644 97.00% 0 70.00% WP_036873332.1
anaerobic sulfatase maturase [Prevotella buccalis] 642 642 97.00% 0 70.00% WP_004350830.1
MULTISPECIES: anaerobic sulfatase maturase [Prevotella] 639 639 97.00% 0 70.00% WP_023056581.1
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E.1 Images
Arabinose induction
λ-HindIII uninduced commerical
solution
arabinose
Figure E.1: Agarose gel of miniprepped DNA following induction using
arabinose versus commerical solution. Plasmid minipreps of pKL13 were com-
pared from three cultures: an uninduced negative control, induction using 1Ö autoin-
duction solution (Epicentre), or induction using 0.2% arabinose.
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Confirmation of pKL17
Six putative pKL17 clones were screened using two restriction digests; see Figure 6.7 for
construct diagrams.
1. SfaAI-SgsI double digest, to check fragment still present (Figure E.2A)
❼ Expected for pKL17: 1470 bp
2. MssI-XhoI double digest, for orientation of stuﬀer (Figure E.2B)
❼ Expected for pKL13: 1300 bp (control)
❼ Expected for pKL17: 745 bp
B
1000 bp
1500 bp
750 bp
A
1500 bp
123456 123456pKL13
Figure E.2: Agarose gel of putative pKL17 clones. Putative clones of pKL17
were digested with: (A) SfaAI and SgsI, and (B) MssI and XhoI for orientation; white
arrow indicates clone with desired restriction pattern.
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Confirmation of pKL16
Six putative pKL16 clones were screened using two restriction digests; see Figure 6.7 for
construct diagrams.
1. NheI and PacI single digests, along with uncut control (Figure E.3A)
❼ Expected for pKL18: both PacI and NheI cut once (positive control)
❼ Expected for pKL16: neither PacI nor NheI will cut
2. Eco72I-SgsI double digest (Figure E.3B)
❼ Expected for pKL15: 1155 bp, 1021 bp (control)
❼ Expected for pKL16: 1155 bp, 886 bp
A
B
1
N P UC
2
N P UC
3
N P UC
4
N P UC
5
N P UC
6
N P UC
pKL18
N P
1000 bp
1 2 3 4 5 6 pKL15
1500 bp
750 bp
Figure E.3: Agarose gel of putative pKL16 clones. Putative clones of pKL16
were digested with: (A) NheI (N) and PacI (P) individually to check for loss of sites,
using uncut DNA as a control (UC); (B) and Eco72I and SgsI doubly to conﬁrm
deletion of the terminator; white arrow indicates clone with desired restriction pattern.
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Confirmation of pKL19
Six putative pKl19 clones were screened using two restriction digests; see Figure 6.7 for
construct diagrams.
1. NsiI and CpoI single digests, along with uncut control (Figure E.4A)
❼ Expected for pKL18: both NsiI and CpoI cut once (positive control)
❼ Expected for pKL19: neither NsiI nor CpoI will cut
2. Eco72I-SfaAI double digest (Figure E.4B)
❼ Expected for pKL18: 1155 bp, 1012 bp (control)
❼ Expected for pKL19: 1155 bp, 885 bp
A
B
1
N C UC
2
N C UC
3
N C UC
4
N C UC
5
N C UC
6
N C UC
pKL18
N C
1000 bp
1 2 3 4 5 6 pKL18
1500 bp
Figure E.4: Agarose gel of putative pKL19 clones. Putative clones of pKL19
were digested with: (A) NsiI (N) and CpoI (C) individually to check for loss of sites,
using uncut DNA as a control (UC); (B) and Eco72I and SfaAI doubly to conﬁrm
deletion of the terminator; white arrow indicates clones with desired restriction pattern.
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E.2 Sequence data
TT fragment cloned in pKL13
Note that the sequence of the actual TT fragment in pKL13 diﬀers from the designed sequence
by one base, due to a point mutation in the synthesis of the fragment.
>TT fragment cloned in pKL13
AAATGGCGCGCCGGCTGGATTTAATTAATGTCTGCTCCTCGGTTATGTTTTTAAGGTCAAAAAAAACCCCCGGACCT
TTCGGTGCGGGGGTCTTAGTTCGTTAAGGCTTGATCTCTAGCGATTAAGTTGGGTAACGCCAGGGTTTTCGTCACTT
AGTCAGCTAGCCACGTGCCTTAGGGTGTGAAATTGTTATCCGCTCACAATTCCACACATTATACGAGCCGATGATTA
ATTGTCAACAGCTCCCTGAGGTTCGAAGATCCTCCGGCTCACGGTAACTGATGCCGTATTTGCAGTACCAGCGTACG
GCCCACAGAATGATGTCACGCTGAAAATGCCGGCCTTTGAATGGGTTCATGTGCAGCTCCATCAGCAAAAGGGGATG
ATAAGTTTATCACCACCGACTATTTGCAACAGTGCCGTTGATCGTGCTATGATCGACTGATGTCATCAGCGGTGGAG
TGCAATGTCGTGCAATACGAATGGCGAAAAGCCGAGCTCATCGGTCAGCTTCTCAACCTTGGGGTTACCCCCGGCGG
TGTGCTGCTGGTCCACAGCTCCTTCCGTAGCGTCCGGCCCCTCGAAGATGGGCCACTTGGACTGATCGAGGCCCTGC
GTGCTGCGCTGGGTCCGGGAGGGACGCTCGTCATGCCCTCGTGGTCAGGTCTGGACGACGAGCCGTTCGATCCTGCC
ACGTCGCCCGTTACACCGGACCTTGGAGTTGTCTCTGACACATTCTGGCGCCTGCCAAATGTAAAGCGCAGCGCCCA
TCCATTTGCCTTTGCGGCAGCGGGGCCACAGGCAGAGCAGATCATCTCTGATCCATTGCCCCTGCCACCTCACTCGC
CTGCAAGCCCGGTCGCCCGTGTCCATGAACTCGATGGGCAGGTACTTCTCCTCGGCGTGGGACACGATGCCAACACG
ACGCTGCATCTTGCCGAGTTGATGGCAAAGGTTCCCTATGGGGTGCCGAGACACTGCACCATTCTTCAGGATGGCAA
GTTGGTACGCGTCGATTATCTCGAGAATGACCACTGCTGTGAGCGCTTTGCCTTGGCGGACAGGTGGCTCAAGGAGA
AGAGCCTTCAGAAGGAAGGTCCAGTCGGTCATGCCTTTGCTCGGTTGATCCGCTCCCGCGACATTGTGGCGACAGCC
CTGGGTCAACTGGGCCGAGATCCGTTGATCTTCCTGCATCCGCCAGAGGCGGGATGCGAAGAATGCGATGCCGCTCG
CCAGTCGATTGGCTGAGCTCATGAGCGGAGAACGAGATGACGTTGGAGGGGCAAGGTCGCGCTGATTGCTGGGGCAA
CACGTTCGAACACGTGATGCATTAACTAGGTGACGTCATAGCTGTTTCCTGTGTGAAATTGTTATCGGTCAGTTTCA
CCTGATTTACGTAAAAACCCGCTTCGGCGGGTTTTTGCTTTTGGAGGGGCAGAAAGATGAATGACTGTCCGGTCCGA
GCAGGTCGCGATCGCATTT
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